id,label
MONDO:0002865,anus sarcoma
HGNC:17337,LCN6
HP:0001159,Syndactyly
HGNC:29168,RPGRIP1L
CHEBI:20265,lanostane
HGNC:25818,BRD9
HGNC:12488,UBE2L3
HGNC:17359,NUP54
HP:0031258,Delirium
HP:0006977,Deficit in grammar
chembl:CHEMBL12856,INAMRINONE
HGNC:4651,GTF2E2
HGNC:2928,DMD
HGNC:14295,SHANK2
chembl:CHEMBL2103869,DASOLAMPANEL
chembl:CHEMBL1405447,VITAMIN K3H2
HGNC:4191,GCG
Reactome:R-SCE-71288,Creatine metabolism
HGNC:14661,EGLN3
MGI:1277962,Hus1
HGNC:10706,SEC24D
MONDO:0011968,autosomal recessive limb-girdle muscular dystrophy type 2D
chembl:CHEMBL1024,IFOSFAMIDE
chembl:CHEMBL8488,CHEMBL8488
chembl:CHEMBL113150,CETRIMIDE
MONDO:0010830,neuronal ceroid lipofuscinosis 8
chembl:CHEMBL521,IBUPROFEN
chembl:CHEMBL600554,CHEMBL600554
HGNC:7082,CD99
chembl:CHEMBL1185568,DITHIAZANINE
MONDO:0018939,muscle-eye-brain disease
HP:0030190,Oral motor hypotonia
HP:0010442,Polydactyly
chembl:CHEMBL429095,CHEMBL429095
NCBIGene:475258,CYCS
HGNC:11272,SPTA1
chembl:CHEMBL601757,CHEMBL601757
HGNC:16063,MLLT10
MONDO:0019261,infantile neuronal ceroid lipofuscinosis
HGNC:12649,VAPB
HGNC:700,ARNT
HGNC:25118,OTULIN
RGD:1308416,Jph3
HP:0006852,Episodic generalized hypotonia
HGNC:7671,NCOA4
HGNC:9236,PPARG
HP:0034863,Reduced leukocyte arylsulfatase A activity
chembl:CHEMBL1201593,ALTEPLASE
chembl:CHEMBL84,TOPOTECAN
chembl:CHEMBL529,AZITHROMYCIN
MONDO:0020179,palpebral nevus
HP:0000218,High palate
chembl:CHEMBL61872,TALAMPANEL
HGNC:23287,ETHE1
MONDO:0018346,ferro-cerebro-cutaneous syndrome
MONDO:0019262,juvenile neuronal ceroid lipofuscinosis
chembl:CHEMBL8565,CHEMBL8565
HGNC:4333,NOP53
HP:0000529,Progressive visual loss
MONDO:0011694,spinocerebellar ataxia type 15/16
HGNC:10983,SLC25A13
RGD:71027,Grik3
HGNC:234,ADCY3
MONDO:0002501,brain glioblastoma
MONDO:0000761,syndrome caused by partial chromosomal deletion
chembl:CHEMBL998,LORATADINE
HGNC:8891,PGD
chembl:CHEMBL284121,ILX23-7553
chembl:CHEMBL1229517,VEMURAFENIB
HGNC:16657,BCL2L14
HGNC:6925,MBP
GO:0001091,RNA polymerase II general transcription initiation factor binding
MGI:1928369,Slc2a5
MONDO:0003612,uterine ligament cancer
HGNC:3586,FANCE
HGNC:27301,CRTC2
UBERON:0001303,left uterine tube
HGNC:11076,NHERF2
HGNC:12468,UBC
HGNC:7704,NDUFB9
HGNC:9955,RELA
chembl:CHEMBL3661115,TAS-116
NCBIGene:770757,DRD3
HP:0007089,Facial-lingual fasciculations
MONDO:0020753,Orthocoronavirinae infectious disease
chembl:CHEMBL407874,6-O-BENZYLGUANINE
HP:0020035,Lower limb dysmetria
HGNC:9117,PMP2
HGNC:4593,GRM1
HP:0003777,Pili torti
chembl:CHEMBL579957,CHEMBL579957
UBERON:0018303,adrenal tissue
HP:0033725,Thin corpus callosum
MONDO:0001072,mild pre-eclampsia
chembl:CHEMBL1200733,DESFLURANE
HP:0001987,Hyperammonemia
HGNC:4124,GALNT2
chembl:CHEMBL2105866,PROTOPORPHYRIN DISODIUM
chembl:CHEMBL1416084,PROPARGITE
chembl:CHEMBL1093490,CHEMBL1093490
chembl:CHEMBL289228,TIPIFARNIB
chembl:CHEMBL1200983,GALLIUM NITRATE
HGNC:29333,ANKRD36B
WB:WBGene00000064,act-2
UPHENO:0026492,absent vestibular nerve in the vestibulocochlear nerve
HP:0002451,Limb dystonia
chembl:CHEMBL360861,NIFEKALANT
chembl:CHEMBL480626,CHEMBL480626
HGNC:6199,JRK
MONDO:0003409,colonic disorder
HGNC:23508,STOX1
HP:0003380,Decreased number of peripheral myelinated nerve fibers
HP:0002425,Anarthria
HGNC:2746,DDX5
HGNC:23064,GSTO2
HP:0002506,Diffuse cerebral atrophy
HP:0011960,Substantia nigra gliosis
MONDO:0014889,"striatonigral degeneration, childhood-onset"
HP:0009588,Vestibular schwannoma
CHEBI:33019,diphosphate(3-)
HGNC:28912,WDR45
HP:0009053,Distal lower limb muscle weakness
chembl:CHEMBL320295,"O,O'-DIMETHYLCAFFEIC ACID"
NCBIGene:488824,DRD5
CHEBI:76359,butylated hydroxyanisole
chembl:CHEMBL118478,ILEPCIMIDE
MONDO:0008735,adrenocortical unresponsiveness to ACTH with postreceptor defect
chembl:CHEMBL294018,PATULIN
HP:0007867,Restrictive partial external ophthalmoplegia
chembl:CHEMBL581225,CHEMBL581225
HP:0000953,Hyperpigmentation of the skin
HGNC:11283,SRC
HGNC:10705,SEC24C
MONDO:0017809,parkinsonism due to ATP13A2 deficiency
MONDO:0002483,breast myoepithelial tumor
chembl:CHEMBL1333653,OBTUSAQUINONE
chembl:CHEMBL3039502,DUVELISIB
MONDO:0002169,rectum adenocarcinoma
chembl:CHEMBL3601398,CGM-097
HP:0000580,Pigmentary retinopathy
MONDO:0008695,chorea-acanthocytosis
HGNC:7415,MT-ATP8
HGNC:9784,RAB5B
HP:0007018,Attention deficit hyperactivity disorder
CHEBI:17495,cholesteryl beta-D-glucoside
MONDO:0005278,serous adenocarcinoma
HGNC:25613,CWF19L1
UBERON:0004533,left testis
chembl:CHEMBL1879463,DACTOLISIB
chembl:CHEMBL1236682,REFAMETINIB
Reactome:R-HSA-437239,Recycling pathway of L1
HGNC:26483,GLT1D1
HP:0002007,Frontal bossing
WB:WBGene00012067,sqst-3
HGNC:4831,HBG1
HGNC:4908,HIBCH
HGNC:7421,MT-CO2
HP:0000544,External ophthalmoplegia
ZFIN:ZDB-GENE-040801-169,ndufa7
chembl:CHEMBL467084,LANICEMINE
chembl:CHEMBL3544935,XL-418
GO:0001046,core promoter sequence-specific DNA binding
HGNC:7716,NDUFV1
chembl:CHEMBL269732,TACROLIMUS
HGNC:553,AOX1
HGNC:12590,UQCRH
chembl:CHEMBL69863,PICEATANNOL
HGNC:10519,SACS
HP:0002121,Generalized non-motor (absence) seizure
MONDO:0021178,injury
chembl:CHEMBL1200686,PIMECROLIMUS
chembl:CHEMBL4298043,ROLUPERIDONE HYDROCHLORIDE
FB:FBgn0286222,Fum1
NCBIGene:508586,SCO1
HGNC:11003,SLC29A1
MONDO:0031040,"cholestasis, progressive familial intrahepatic, 12"
chembl:CHEMBL41092,CHRYSOPHANOL
WB:WBGene00000417,ced-3
chembl:CHEMBL1110,ALOSETRON
HP:0006794,Loss of ability to walk in first decade
HP:0034585,Cochlear nerve hypoplasia
chembl:CHEMBL1314044,HYDRASTININE
chembl:CHEMBL582278,CHEMBL582278
MGI:1919599,Dusp3
GO:0004111,creatine kinase activity
HGNC:592,XIAP
chembl:CHEMBL1773683,EZUTROMID
GO:0050782,galactose uniporter activity
chembl:CHEMBL198759,CHEMBL198759
HP:0001394,Cirrhosis
HGNC:6138,ITGA2B
CHEBI:85278,17beta-hydroxyandrostan-3-one
MONDO:0007492,early-onset generalized limb-onset dystonia
GO:0090298,negative regulation of mitochondrial DNA replication
RGD:631440,Aadac
HP:0001300,Parkinsonism
HGNC:12472,UBE2A
CHEBI:26355,heme b
chembl:CHEMBL3120215,OSI-027
chembl:CHEMBL142703,VILDAGLIPTIN
HGNC:438,ALPL
MGI:107825,Adam8
MONDO:0007829,"cholestasis, intrahepatic, of pregnancy, 1"
FB:FBgn0029118,ScsβG
WB:WBGene00017981,figl-1
HP:0100706,Abnormal oligodendroglia morphology
MONDO:0011913,Alzheimer disease 3
HP:0002465,Poor speech
MONDO:0020380,autosomal dominant cerebellar ataxia
HP:0002463,Language impairment
HP:0001513,Obesity
MONDO:0014682,"thyroid cancer, nonmedullary, 5"
HGNC:11892,TNF
ZFIN:ZDB-GENE-050417-60,cox16
MONDO:0018492,hereditary clear cell renal cell carcinoma
MONDO:0004994,cardiomyopathy
FB:FBgn0004888,Scsα1
ZFIN:ZDB-GENE-030910-2,drd2b
MONDO:0015069,neuroendocrine tumor of the anal canal
chembl:CHEMBL668,PROTRIPTYLINE
HP:0011350,Mild receptive language delay
GO:2000377,regulation of reactive oxygen species metabolic process
chembl:CHEMBL3545397,ACALISIB
chembl:CHEMBL515,CHLORAMBUCIL
HGNC:29969,MGARP
HGNC:4647,GTF2A2
CHEBI:15738,staurosporine
RGD:1306952,Cmbl
GO:0015370,solute:sodium symporter activity
HGNC:32069,LDLRAD1
HGNC:11408,STK4
HP:0001969,Abnormal tubulointerstitial morphology
GO:0046449,creatinine metabolic process
HGNC:11577,TAFAZZIN
MONDO:0002852,mediastinum sarcoma
NCBIGene:513552,TMEM186
CHEBI:51454,cyclopropanes
MONDO:0000704,lymphocytic colitis
chembl:CHEMBL1016,CANDESARTAN
HGNC:9634,PTP4A1
chembl:CHEMBL46403,STEARIC ACID
chembl:CHEMBL931,HALOTHANE
HGNC:8156,OPRM1
chembl:CHEMBL1643880,PUMOSETRAG
chembl:CHEMBL576208,CHEMBL576208
HGNC:2961,DYNC1H1
chembl:CHEMBL180022,NERATINIB
MONDO:0016703,anaplastic oligoastrocytoma
HGNC:24519,TCTN3
MONDO:0010774,"striatonigral degeneration, infantile, mitochondrial"
HGNC:10047,RNASE4
MONDO:0002278,benign colon neoplasm
HP:0002185,Neurofibrillary tangles
HP:0000121,Nephrocalcinosis
MONDO:0013817,preeclampsia/eclampsia 5
HGNC:7456,MT-ND2
MONDO:0015548,Huntington disease-like syndrome
HGNC:469,AMPD2
HP:0030665,Rubral tremor
chembl:CHEMBL1657,TAZAROTENE
chembl:CHEMBL1272,REPAGLINIDE
chembl:CHEMBL47,VITAMIN E
HGNC:11057,SLC7A1
HGNC:20766,TUBA1A
HGNC:6742,LZTR1
HP:0002180,Neurodegeneration
chembl:CHEMBL602969,CHEMBL602969
chembl:CHEMBL3707227,ATEZOLIZUMAB
HGNC:12363,TSC2
MONDO:0030027,"tremor, hereditary essential, 6"
HGNC:8049,NUDT2
HP:0000089,Renal hypoplasia
UBERON:0001052,rectum
chembl:CHEMBL482767,SNS-314
HGNC:3638,FDX1
HGNC:7800,NFKBIL1
GO:0031088,platelet dense granule membrane
HGNC:7452,MTMR4
RGD:69264,Shank3
chembl:CHEMBL182310,CHEMBL182310
CHEBI:8028,perphenazine
HP:0005988,Congenital muscular torticollis
HP:0001238,Slender finger
HP:0000574,Thick eyebrow
chembl:CHEMBL602807,CHEMBL602807
chembl:CHEMBL296021,CHEMBL296021
CHEBI:28262,dimethyl sulfoxide
HGNC:6149,ITGAM
MONDO:0006235,granular cell tumor
HGNC:11305,SRPK1
HP:0000480,Retinal coloboma
HGNC:4658,GTF2H4
HP:0030216,Inertia
HGNC:20407,CALR3
GO:0005528,FK506 binding
MONDO:0002050,depressive disorder
chembl:CHEMBL7976,CHALCONE
chembl:CHEMBL552212,LEXIBULIN
chembl:CHEMBL1017,TELMISARTAN
chembl:CHEMBL532849,CHEMBL532849
HP:0008181,Abetalipoproteinemia
chembl:CHEMBL577419,CHEMBL577419
HP:0009879,Simplified gyral pattern
CHEBI:48626,pyranoindolizinoquinoline
chembl:CHEMBL180920,MAGNOLOL
HP:0007792,Microsaccadic pursuit
chembl:CHEMBL45816,MIBEFRADIL
GO:0035623,renal glucose absorption
HGNC:7458,MT-ND3
chembl:CHEMBL163,RITONAVIR
HP:0002090,Pneumonia
HP:0010472,Abnormal circulating porphyrin concentration
MONDO:0012994,dopa-responsive dystonia due to sepiapterin reductase deficiency
HGNC:668,RHOB
ZFIN:ZDB-GENE-040426-2592,nnt
MONDO:0018023,hemoglobin M disease
HGNC:2652,CYP7B1
chembl:CHEMBL320361,CHEMBL320361
HGNC:2579,CYC1
HP:0012080,Cerebellar granular layer atrophy
MONDO:0006745,endometrioid stromal sarcoma
chembl:CHEMBL1558,PRAZOSIN HYDROCHLORIDE
chembl:CHEMBL1892987,DINOSEB
UPHENO:0079838,abnormal impulsive behavior
chembl:CHEMBL1730,CEFOTAXIME
MONDO:0014095,dilated cardiomyopathy 1JJ
chembl:CHEMBL10,SB-203580
HGNC:4761,H2BC11
chembl:CHEMBL578276,CHEMBL578276
HP:0011947,Respiratory tract infection
chembl:CHEMBL124660,TANDUTINIB
HGNC:672,RHOG
chembl:CHEMBL1881783,PYROXAMINE MALEATE
chembl:CHEMBL119443,ERGONOVINE
chembl:CHEMBL593,DELAVIRDINE
HGNC:11098,SMARCA2
FB:FBgn0032129,jp
HGNC:1663,CD36
chembl:CHEMBL2010872,CEP-11981
MONDO:0005405,childhood onset asthma
HGNC:13082,LTN1
UBERON:0001876,amygdala
HP:0040200,Motor impersistence
HP:0002197,Generalized-onset seizure
HGNC:3690,FGFR3
HGNC:11588,TBP
HP:0003259,Elevated circulating creatinine concentration
CHEBI:1722,3beta-hydroxy-Delta(5)-steroid
CHEBI:34996,teicoplanin A2-3
Reactome:R-HSA-2132295,MHC class II antigen presentation
CHEBI:16240,hydrogen peroxide
HGNC:8729,PCNA
ZFIN:ZDB-GENE-070508-3,drd4b
HGNC:1144,BTRC
HP:0007429,Few cafe-au-lait spots
HP:0031847,Difficulty walking backward
HP:0002136,Broad-based gait
GO:0071312,cellular response to alkaloid
CHEBI:4027,cyclophosphamide
chembl:CHEMBL3545263,LGX-806
CHEBI:138029,14alpha-methyl steroid
chembl:CHEMBL146506,MOFAROTENE
chembl:CHEMBL367149,DOCONEXENT
chembl:CHEMBL1389,LEVONORGESTREL
HGNC:11697,DYNLT1
chembl:CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE
chembl:CHEMBL1976040,ADAVOSERTIB
MONDO:0002056,breast fibroadenoma
chembl:CHEMBL533082,CHEMBL533082
chembl:CHEMBL530609,CHEMBL530609
HGNC:29796,LAMTOR2
chembl:CHEMBL2110725,VINFLUNINE
chembl:CHEMBL2348411,CHEMBL2348411
HP:0030047,Abnormal lateral ventricle morphology
CHEBI:36683,organochlorine compound
HGNC:21474,INPP5E
CHEBI:51569,N-acyl-amino acid
chembl:CHEMBL180917,CHEMBL180917
UBERON:0004811,endometrium epithelium
chembl:CHEMBL472940,CHEMBL472940
chembl:CHEMBL1160008,IODOPHTHALEIN
chembl:CHEMBL581929,CHEMBL581929
chembl:CHEMBL456807,PHENYLHYDRAZINE
NCBIGene:417157,SURF1
MONDO:0003626,uterine ligament serous adenocarcinoma
HGNC:3629,FDFT1
HGNC:9077,PLK1
CHEBI:26195,polyphenol
HGNC:9232,PPARA
HGNC:13709,DEGS1
HP:0100295,Muscle fiber atrophy
MONDO:0030268,developmental and epileptic encephalopathy 6B
HGNC:3574,FADS1
MONDO:0014144,autosomal recessive limb-girdle muscular dystrophy type R18
HP:0000421,Epistaxis
HGNC:18578,TXLNG
HP:0006863,Severe expressive language delay
HGNC:18996,VRK3
HGNC:20066,USP34
chembl:CHEMBL491550,CHEMBL491550
HGNC:11205,SP1
CHEBI:15394,(-)-borneol
HP:0011665,Takotsubo cardiomyopathy
chembl:CHEMBL152632,NIRIDAZOLE
MONDO:0017706,disorder of carbohydrate transmembrane transport and absorption
HGNC:3518,EXTL3
chembl:CHEMBL481,IRINOTECAN
HGNC:11551,BRF1
chembl:CHEMBL374632,CHEMBL374632
HP:0003557,Increased variability in muscle fiber diameter
MONDO:0002748,rectum mucinous adenocarcinoma
HGNC:4948,HLA-DRB1
GO:0007416,synapse assembly
HGNC:4923,HK2
HGNC:2690,DBI
GO:0015517,galactose:proton symporter activity
chembl:CHEMBL590686,CHEMBL590686
chembl:CHEMBL578512,CHEMBL578512
MGI:88543,Csnk2a1
chembl:CHEMBL1289926,AXITINIB
HGNC:28091,ATP6AP1L
HGNC:4378,GMPS
MONDO:0007533,elliptocytosis 2
GO:0098797,plasma membrane protein complex
wikidata:Q4767903,ANNAMYCIN
HGNC:26070,TRMT61B
HP:0031874,Late chronotype
HGNC:2024,CLCN6
chembl:CHEMBL3545094,ELOCALCITOL
chembl:CHEMBL267475,FPL-55712
MONDO:0019209,Japanese encephalitis
NCBIGene:512500,CYC1
HP:0000518,Cataract
CHEBI:28915,fosfomycin
ZFIN:ZDB-GENE-050417-263,coq10b
MONDO:0005004,clear cell adenocarcinoma
CHEBI:28260,galactose
chembl:CHEMBL242171,CHEMBL242171
HGNC:15517,XYLT2
HP:0011805,Abnormal skeletal muscle morphology
CHEBI:35618,aromatic ether
MONDO:0012784,autosomal recessive ataxia due to ubiquinone deficiency
chembl:CHEMBL15928,GR-127935
chembl:CHEMBL1201585,TRASTUZUMAB
CHEBI:15971,L-histidine
HGNC:853,ATP6V1B1
CHEBI:75885,2-pyranones
HP:0001156,Brachydactyly
HP:0000458,Anosmia
MONDO:0008728,classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
chembl:CHEMBL578420,CHEMBL578420
HGNC:2422,CS
HGNC:9016,PKHD1
HP:0020219,Motor seizure
HP:0007332,Focal hemifacial clonic seizure
HGNC:20064,USP44
chembl:CHEMBL157101,KETOCONAZOLE
HP:0008959,Distal upper limb muscle weakness
HP:0000153,Abnormality of the mouth
HP:0002510,Spastic tetraplegia
HGNC:4235,GFAP
chembl:CHEMBL212579,BENZAMIL
NCBIGene:478981,NDUFS2
HGNC:25751,TRAPPC11
chembl:CHEMBL498,CHLORPROPAMIDE
GO:0016020,membrane
chembl:CHEMBL31965,CANERTINIB
HP:0007209,Facial paralysis
chembl:CHEMBL2107832,PIMASERTIB
HGNC:10991,SLC25A5
HGNC:5004,HMGB3
HGNC:801,ATP1A3
HP:0001548,Overgrowth
MONDO:0000771,allergic respiratory disease
HP:0001291,Abnormal cranial nerve morphology
chembl:CHEMBL398363,CHEMBL398363
HP:0001257,Spasticity
HGNC:18884,TDP1
HP:0007034,Generalized hyperreflexia
HGNC:24065,ARMCX3
HP:0001258,Spastic paraplegia
HGNC:7708,NDUFS2
chembl:CHEMBL338314,CHEMBL338314
chembl:CHEMBL1002,LEVOSALBUTAMOL
HP:0007470,Periarticular subcutaneous nodules
MONDO:0002204,transient arthritis
HGNC:21735,LHX6
HP:0001744,Splenomegaly
HP:0002315,Headache
HGNC:4250,GGT1
CHEBI:131619,C27-steroid
HP:0002014,Diarrhea
MONDO:0013625,Parkinson disease 17
MONDO:0009133,"cerebellar ataxia, intellectual disability, and dysequilibrium"
MONDO:0000709,Crohn ileitis
HGNC:4944,HLA-DQB1
HGNC:6877,MAPK3
chembl:CHEMBL1219,RABEPRAZOLE
chembl:CHEMBL220998,"FUCHSIN, BASIC"
HGNC:2973,DNM1L
MONDO:0013185,"leprosy, susceptibility to, 5"
HP:0000126,Hydronephrosis
chembl:CHEMBL496,HEXACHLOROPHENE
MONDO:0013737,hereditary spastic paraplegia 46
HGNC:25491,FRMD4A
HGNC:13533,ATP8A2
CHEBI:15377,water
HP:0012048,Oromandibular dystonia
HGNC:2709,DCT
HGNC:4075,GABRA1
UBERON:0000006,islet of Langerhans
HGNC:9091,PLS3
GO:0005124,scavenger receptor binding
HGNC:9762,RAB13
chembl:CHEMBL1076347,TRICLOCARBAN
HGNC:5182,HRH1
HGNC:3026,DRD5
Reactome:R-GGA-390651,Dopamine receptors
chembl:CHEMBL546865,CHEMBL546865
HGNC:3358,ENPP3
FB:FBgn0053517,Dop2R
CHEBI:48336,"(2R,4S)-ketoconazole"
HGNC:2073,TPP1
MONDO:0040500,glycosylphosphatidylinositol biosynthesis defect 16
HGNC:5289,HTR1D
MONDO:0100467,preeclampsia/eclampsia 1
HGNC:2292,COX7C
HGNC:18451,MCFD2
HGNC:4570,GRHPR
HGNC:34383,PCARE
CHEBI:58432,histaminium
MONDO:0030805,spinocerebellar ataxia 49
HGNC:16807,SMURF1
chembl:CHEMBL1433,DOXYCYCLINE
HGNC:9802,RAC2
HGNC:28196,TMEM79
chembl:CHEMBL144472,NILE RED
MONDO:0010252,"intellectual disability, X-linked, with panhypopituitarism"
Reactome:R-HSA-2500257,Resolution of Sister Chromatid Cohesion
chembl:CHEMBL1603949,BITHIONOLOXIDE
HGNC:17399,ARHGAP32
UBERON:0036214,rectosigmoid junction
CHEBI:28201,rotenone
NCBIGene:510509,COX11
MONDO:0004152,chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation
MONDO:0021166,inflammatory disease
MGI:1336172,Tbl1x
MONDO:0007920,lymphatic malformation 5
HP:0002493,Upper motor neuron dysfunction
HGNC:29450,GLIS2
MONDO:0009745,neuronal ceroid lipofuscinosis 5
HP:0025312,Esophoria
HP:0000666,Horizontal nystagmus
CHEBI:39270,naphthofuran
HGNC:6923,MBNL1
MONDO:0859147,Marbach-Rustad progeroid syndrome
HGNC:6857,MAP3K5
MONDO:0003544,spinal cord cancer
MONDO:0014233,early-onset Parkinson disease 20
chembl:CHEMBL3989914,GLESATINIB
HGNC:7879,CNOT3
MONDO:0005264,transient ischemic attack
MONDO:0012116,spinocerebellar ataxia type 8
HP:0002483,Bulbar signs
HGNC:7197,MOG
chembl:CHEMBL1256958,EPINEPHRINE BITARTRATE
HGNC:542,ANXA4
chembl:CHEMBL445,NORTRIPTYLINE
chembl:CHEMBL230011,TG100-115
HP:0003743,Genetic anticipation
MONDO:0859214,Marbach-Schaaf neurodevelopmental syndrome
chembl:CHEMBL580,LORAZEPAM
HGNC:7579,MYH9
Reactome:R-BTA-211945,Phase I - Functionalization of compounds
MGI:1916154,Abhd13
chembl:CHEMBL446452,ARUNDINE
CHEBI:176497,geroprotector
HP:0033203,Brachioradialis hyperreflexia
HP:0001284,Areflexia
chembl:CHEMBL221753,BENZETHONIUM CHLORIDE
GO:0048741,skeletal muscle fiber development
GO:0031100,animal organ regeneration
chembl:CHEMBL365739,DIPHENYLENEIODONIUM
HP:0011449,Knee clonus
MONDO:0007089,Alzheimer disease 2
MONDO:0017357,transient hyperammonemia of the newborn
HP:0002151,Increased serum lactate
MONDO:0000001,disease
FB:FBgn0001223,Hsp22
chembl:CHEMBL123040,ALLITRIDIN
MONDO:0005373,meningococcal infection
HP:0002553,Highly arched eyebrow
HP:0025134,Increased serum estradiol
GO:0070821,tertiary granule membrane
chembl:CHEMBL1490332,CHEMBL1490332
MONDO:0009672,"spinal muscular atrophy, type III"
chembl:CHEMBL3544952,RG3487
MONDO:0011184,childhood apraxia of speech
HGNC:30064,PBRM1
HGNC:745,ASIP
HP:0007047,Atrophy of the dentate nucleus
chembl:CHEMBL531269,CHEMBL531269
HGNC:28844,FBXO38
MONDO:0003414,skin pilomatrix carcinoma
MONDO:0100056,exercise-induced anaphylaxis
HGNC:28100,MMGT1
MONDO:0018784,pediatric multiple sclerosis
MONDO:0008731,familial adrenal hypoplasia with absent pituitary luteinizing hormone
MONDO:0018632,11q22.2q22.3 microdeletion syndrome
HGNC:7943,NPR1
chembl:CHEMBL900,ORPHENADRINE
HP:0007311,Short stepped shuffling gait
HGNC:13222,BCL11B
MONDO:0005559,neurodegenerative disease
chembl:CHEMBL786,TAMOXIFEN CITRATE
chembl:CHEMBL1528955,N-METHYLANTHRANILIC ACID
GO:0015371,galactose:sodium symporter activity
CHEBI:30879,alcohol
HP:0032012,Heterotropia
HP:0000753,Autism with high cognitive abilities
HGNC:7102,MINPP1
CHEBI:164200,triclosan
HGNC:5301,HTR6
HP:0000034,Hydrocele testis
MONDO:0005499,brain glioma
HP:0006886,Impaired distal vibration sensation
CHEBI:28748,doxorubicin
UBERON:0001234,left adrenal gland
HGNC:27035,UBXN2B
GO:0070527,platelet aggregation
HGNC:4177,GBA1
MONDO:0030702,autoimmune atherosclerosis
HGNC:7007,RAB8A
CHEBI:15379,dioxygen
HP:0008872,Feeding difficulties in infancy
MONDO:0014606,intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome
chembl:CHEMBL2146121,CALCIUM
CHEBI:204928,cefotaxime
HP:0003205,Curvilinear intracellular accumulation of autofluorescent lipopigment storage material
chembl:CHEMBL509523,IOXYNIL
chembl:CHEMBL507361,PD-0325901
chembl:CHEMBL599943,CHEMBL599943
chembl:CHEMBL72,DESIPRAMINE
HGNC:16744,CIZ1
NCBITaxon:694009,Severe acute respiratory syndrome-related coronavirus
GO:0006287,"base-excision repair, gap-filling"
HGNC:1304,MRAP
chembl:CHEMBL3039597,GENTAMICIN
HGNC:7179,ALDH6A1
HP:0000175,Cleft palate
HGNC:694,ARL3
MGI:1277186,Atg5
CHEBI:59780,cyclic hemiketal
HGNC:8038,NTS
HGNC:4646,GTF2A1
HGNC:21869,AGK
HGNC:11728,TERF1
NCBIGene:397639,EPHX1
HGNC:9438,PRKRA
chembl:CHEMBL1265,ADAPALENE
HP:0001308,Tongue fasciculations
HP:3000013,Abnormal platysma muscle morphology
chembl:CHEMBL475908,CHEMBL475908
HGNC:13487,VPS35
HP:0002721,Immunodeficiency
chembl:CHEMBL1200781,CITALOPRAM HYDROBROMIDE
CHEBI:3962,curcumin
chembl:CHEMBL2104986,TEDATIOXETINE
MONDO:0014835,"striatal degeneration, autosomal dominant 2"
HGNC:4117,B4GALNT1
MONDO:0010940,inherited susceptibility to asthma
chembl:CHEMBL3989514,IRINOTECAN HYDROCHLORIDE
GO:0033300,dehydroascorbic acid transmembrane transporter activity
MONDO:0003513,gastric teratoma
chembl:CHEMBL313737,CHEMBL313737
chembl:CHEMBL100473,U-0126
chembl:CHEMBL24983,CHEMBL24983
HGNC:18676,DDX42
GO:0071897,DNA biosynthetic process
chembl:CHEMBL1142,4-AMINOPHENOL
HGNC:9163,PNOC
HGNC:4399,RACK1
HP:0010535,Sleep apnea
MGI:1929270,Dstn
chembl:CHEMBL22148,CHEMBL22148
HGNC:8647,PCBP1
MONDO:0008947,bilateral striopallidodentate calcinosis
HGNC:7863,NNT
PATO:0002097,"neoplastic, malignant"
GO:0007049,cell cycle
HGNC:20772,TUBB3
chembl:CHEMBL3545285,XL-999
HP:0000073,Ureteral duplication
NCBIGene:100858928,HRH1
MONDO:0005561,aortic disorder
MONDO:0005144,familial amyotrophic lateral sclerosis
WB:WBGene00010698,K08H10.6
HGNC:7419,MT-CO1
HGNC:28125,NAA11
NCBIGene:616109,UQCR10
chembl:CHEMBL1308,FOMEPIZOLE
HP:0002453,Abnormal globus pallidus morphology
ZFIN:ZDB-GENE-070524-2,drd1b
GO:0048471,perinuclear region of cytoplasm
HP:0009004,Hypoplasia of the musculature
chembl:CHEMBL3545323,PWT-33579
HGNC:24539,NECAP1
chembl:CHEMBL1399702,NEBULARINE
HP:0010677,Enuresis nocturna
HP:0002141,Gait imbalance
HGNC:7788,NFIX
MONDO:0044807,inherited dystonia
HGNC:11544,TAF11
GO:0042088,T-helper 1 type immune response
HGNC:20194,POLR1C
MONDO:0032930,intellectual developmental disorder with poor growth and with or without seizures or ataxia
MONDO:0020836,"autism, susceptiblity to"
chembl:CHEMBL1626,CLEMASTINE
chembl:CHEMBL54909,FRAXETIN
chembl:CHEMBL578504,CHEMBL578504
chembl:CHEMBL449520,ATRACTYLENOLIDE I
MONDO:0009830,parkinsonian-pyramidal syndrome
chembl:CHEMBL1255840,NEBOGLAMINE
HGNC:1171,ELP4
chembl:CHEMBL186141,ANDROGRAPHOLIDE
UBERON:0000947,aorta
MONDO:0012004,parathyroid gland carcinoma
MONDO:0018198,acute encephalopathy with biphasic seizures and late reduced diffusion
HGNC:7608,MYO9A
chembl:CHEMBL597874,CHEMBL597874
chembl:CHEMBL553025,VINORELBINE
CHEBI:30920,3-hydroxy-3-methylglutarate(1-)
chembl:CHEMBL541388,FASUDIL HYDROCHLORIDE
chembl:CHEMBL579318,CHEMBL579318
HP:0031765,Partially accomodative esotropia
chembl:CHEMBL530664,CHEMBL530664
HP:0001345,Psychotic mentation
GO:0005488,binding
HGNC:15469,DNAJC6
HP:5200017,Abnormal movements of face and head
HGNC:707,ARPC4
chembl:CHEMBL1200903,SECOBARBITAL SODIUM
CHEBI:132142,"1,4-naphthoquinones"
chembl:CHEMBL1496,ROSUVASTATIN
HP:0007153,Progressive extrapyramidal movement disorder
MONDO:0017999,fatty acid hydroxylase-associated neurodegeneration
chembl:CHEMBL1589,ACETOHEXAMIDE
GO:0015267,channel activity
HGNC:7014,MEOX2
NCBIGene:526221,DRD5
HP:0100035,Phonic tics
CHEBI:35343,17beta-hydroxy steroid
HP:0031434,Abnormal prosody
HGNC:10916,SLC13A1
HGNC:11140,SNCB
HP:0001928,Abnormality of coagulation
HGNC:8547,P4HA2
HP:0002616,Aortic root aneurysm
HP:0020217,Focal aware motor seizure
chembl:CHEMBL1201001,MECHLORETHAMINE HYDROCHLORIDE
chembl:CHEMBL1201201,METHAMPHETAMINE
HGNC:1476,CAPN1
HGNC:16636,KIF1B
chembl:CHEMBL3545135,NV-128
MONDO:0000603,autoimmune disorder of cardiovascular system
HGNC:1034,BECN1
chembl:CHEMBL1590,PSEUDOEPHEDRINE
HGNC:328,AGR2
HGNC:7719,NDUFV3
chembl:CHEMBL512649,CHEMBL512649
HGNC:15455,MBTPS2
NCBIGene:403741,HTR1B
HP:0033200,Triceps hyporeflexia
chembl:CHEMBL222102,KU-55933
MONDO:0012497,congenital stationary night blindness autosomal dominant 3
HP:0006849,Hypodysplasia of the corpus callosum
HGNC:5129,HOXC8
FB:FBgn0037873,SdhC
MONDO:0018055,pediatric hepatocellular carcinoma
MONDO:0042965,Machado-Joseph disease type 5
HP:0004691,2-3 toe syndactyly
chembl:CHEMBL4297689,ALT-801
HGNC:8873,PFKFB2
GO:0006367,transcription initiation at RNA polymerase II promoter
HGNC:29345,KIAA1671
MONDO:0012134,"myoclonic epilepsy, juvenile, susceptibility to, 3"
chembl:CHEMBL502109,BENZALKONIUM CHLORIDE
chembl:CHEMBL267548,PROTOPORPHYRIN
chembl:CHEMBL515505,CHEMBL515505
chembl:CHEMBL574431,SULFOBROMOPHTHALEIN
HP:0002010,Narrow maxilla
HGNC:1388,CACNA1A
HGNC:7460,MT-ND4L
MONDO:0000328,hyperphosphatemia
HGNC:16882,HCN4
MONDO:0007661,Tourette syndrome
HGNC:16978,EDDM3A
HGNC:7714,NDUFS7
HGNC:4021,KDSR
HGNC:7113,MKRN2
chembl:CHEMBL1337502,BENZO[B]FLUORANTHENE
HGNC:19263,LMAN2L
chembl:CHEMBL452954,CHEMBL452954
CL:0000788,naive B cell
chembl:CHEMBL4297538,MK-0812
HGNC:61,ABCD1
HGNC:4425,GOLGA2
CHEBI:23778,dihydroxybenzoic acid
HGNC:857,ATP6V1E1
chembl:CHEMBL191334,NUTLIN-3
HGNC:12474,UBE2D1
GO:0008516,hexose uniporter activity
chembl:CHEMBL122701,CHEMBL122701
MONDO:0000510,synucleinopathy
MONDO:0006029,cecum carcinoma
chembl:CHEMBL174588,CHEMBL174588
chembl:CHEMBL1741,CLARITHROMYCIN
GO:0030426,growth cone
MONDO:0011017,Naxos disease
chembl:CHEMBL3969876,IMARIKIREN HYDROCHLORIDE
HGNC:16031,RNF31
MONDO:0000701,ischemic colitis
chembl:CHEMBL546597,CHEMBL546597
CHEBI:16467,L-arginine
HP:0001283,Bulbar palsy
MONDO:0044704,oropharynx squamous cell carcinoma
MONDO:0000694,seasonal affective disorder
HGNC:4179,NIPSNAP2
CHEBI:26523,reactive oxygen species
HP:0010852,EEG with photoparoxysmal response
HP:0007359,Focal-onset seizure
chembl:CHEMBL2107826,VIBEGRON
chembl:CHEMBL453066,BETA-CCM
UPHENO:0077991,decreased reflex in calcaneal tendon
HP:0000488,Retinopathy
chembl:CHEMBL3348923,MLN-2480
UBERON:0009835,anterior cingulate cortex
HGNC:21224,ZUP1
HP:0011110,Recurrent tonsillitis
HGNC:6836,MAP1B
chembl:CHEMBL1200766,SILVER SULFADIAZINE
MONDO:0012684,arrhythmogenic right ventricular dysplasia 12
HGNC:10026,RLN1
RGD:71047,Epm2a
MONDO:8000015,"46,XY sex reversal 11"
HP:0002074,Increased neuronal autofluorescent lipopigment
chembl:CHEMBL260311,CHEMBL260311
chembl:CHEMBL9249,(+)-EPITAXIFOLIN
HGNC:13291,GABARAPL2
HGNC:9672,PTPRH
chembl:CHEMBL1091644,LINSITINIB
MONDO:0002413,glycogen storage disease I
chembl:CHEMBL548615,CHEMBL548615
HGNC:10477,RXRA
HGNC:9319,PPP4C
HP:0003758,Reduced subcutaneous adipose tissue
CHEBI:606564,prostaglandin E2(1-)
PR:000007496,fibroblast growth factor 5
chembl:CHEMBL46917,CARBARIL
CHEBI:600520,micafungin
MONDO:0800064,osteogenesis imperfecta and a reduction of bone mineral density.
chembl:CHEMBL1346468,CHEMBL1346468
HGNC:21528,DIABLO
chembl:CHEMBL471005,CHEMBL471005
MONDO:0014620,myoclonic dystonia 26
HGNC:18194,ZNF365
MONDO:0014017,intellectual developmental disorder with autism and macrocephaly
chembl:CHEMBL2177390,IPATASERTIB
HGNC:544,ANXA6
HP:0000496,Abnormality of eye movement
HGNC:6257,KCNJ11
NCBIGene:616871,UQCRB
chembl:CHEMBL201325,CHEMBL201325
GO:0097232,lamellar body membrane
HGNC:7685,NDUFA2
HGNC:8893,PGF
MONDO:0009696,juvenile myoclonic epilepsy
HGNC:315,AFG3L2
MONDO:0800486,metabolic bone disorder
HGNC:3527,EZH2
GO:0006914,autophagy
chembl:CHEMBL75880,PERHEXILINE
chembl:CHEMBL462861,CHEMBL462861
NCBIGene:403568,RAD51
HGNC:18318,ASXL1
HGNC:26099,ARHGAP10
HP:0001399,Hepatic failure
HGNC:24634,EPS15L1
MONDO:0003651,macrotrabecular hepatoblastoma
chembl:CHEMBL1277001,MIBAMPATOR
MONDO:0005192,exocrine pancreatic carcinoma
HGNC:2743,DDX20
MONDO:0011408,hereditary spastic paraplegia 10
CHEBI:83813,proteinogenic amino acid
ZFIN:ZDB-GENE-040808-73,ndufv1
MONDO:0007187,nevoid basal cell carcinoma syndrome
HGNC:28139,SPX
HGNC:1958,CHRNA4
CHEBI:25830,p-quinones
CHEBI:29623,manumycin A
MONDO:0005062,lymphoma
HP:0001596,Alopecia
chembl:CHEMBL456295,OXOPURPUREINE
MONDO:0020183,neurogenic palpebral tumor
chembl:CHEMBL1207366,GW468816
CHEBI:5613,haloperidol
HP:0034340,Pseudoautosomal dominant inheritance
HGNC:10442,RPS9
HP:0000767,Pectus excavatum
HGNC:6239,KCND3
chembl:CHEMBL379975,CHEMBL379975
HGNC:11340,SS18
chembl:CHEMBL6318,IDOXIFENE
chembl:CHEMBL939,GEFITINIB
CHEBI:33859,aromatic carboxylic acid
HGNC:14681,SPATA2
ZFIN:ZDB-GENE-050522-437,ndufs5
HGNC:543,ANXA5
MGI:97828,Pygb
HGNC:7720,NEB
chembl:CHEMBL1558498,BUTYL 2-AMINOBENZOATE
HP:0000010,Recurrent urinary tract infections
HGNC:1084,BNIP3
HGNC:29672,MICALL2
HGNC:5951,CADM1
HP:0003028,Abnormality of the ankle
CHEBI:100241,ciprofloxacin
HGNC:986,BCKDHA
GO:0070335,aspartate binding
HP:0007015,Poor gross motor coordination
HP:0100962,Shyness
MONDO:0011892,"epilepsy, idiopathic generalized, susceptibility to, 9"
HGNC:32487,ALKBH2
MONDO:0006210,fibrolamellar hepatocellular carcinoma
HP:0006597,Diaphragmatic paralysis
CHEBI:26518,quinuclidines
chembl:CHEMBL2326966,SF-1126
HGNC:6953,CD46
HGNC:24876,GOLGA7
HP:0002378,Hand tremor
GO:0005178,integrin binding
GO:0016028,rhabdomere
MGI:97602,Prkcz
GO:0006805,xenobiotic metabolic process
HP:0000520,Proptosis
HGNC:16915,HAX1
MONDO:0002412,disorder of glycogen metabolism
CHEBI:26509,quinoline alkaloid
HGNC:6291,KCNN2
chembl:CHEMBL270299,BAY-11-7085
MONDO:0024479,epithelial tumor of colon
HGNC:3555,FABP1
GO:0048839,inner ear development
chembl:CHEMBL269538,HARMINE
HGNC:746,ASL
HGNC:21498,ATG16L1
CHEBI:7782,oripavine
chembl:CHEMBL261118,CHEMBL261118
chembl:CHEMBL411085,CHEMBL411085
MONDO:0012996,AGAT deficiency
MONDO:0002424,rectosigmoid carcinoma
chembl:CHEMBL1927670,CHEMBL1927670
HP:0000819,Diabetes mellitus
HP:0003394,Muscle spasm
chembl:CHEMBL1520282,CHEMBL1520282
HGNC:23244,RBM25
chembl:CHEMBL8,CIPROFLOXACIN
chembl:CHEMBL2109412,L19SIP 131I
chembl:CHEMBL2104955,BECOCALCIDIOL
CHEBI:44185,methotrexate
chembl:CHEMBL480356,CHEMBL480356
HGNC:463,AMFR
HP:0003550,Predominantly lower limb lymphedema
HGNC:1964,CHRNB4
chembl:CHEMBL585443,CHEMBL585443
chembl:CHEMBL412010,DERRUBONE
HGNC:6637,LMNB1
chembl:CHEMBL259615,CHEMBL259615
HGNC:17293,PRKD2
HGNC:6266,KCNJ5
GO:0072748,cellular response to tacrolimus
NCBIGene:478700,BPHL
HGNC:9645,PTPN12
MONDO:0000114,cerebelloparenchymal disorder
HP:0000006,Autosomal dominant inheritance
MONDO:0024537,Brown-Vialetto-van Laere syndrome 1
HGNC:9646,PTPN13
HGNC:12718,VRK1
GO:0030425,dendrite
HGNC:3582,FANCA
chembl:CHEMBL482968,ENMD-2076
HP:0000217,Xerostomia
HP:0012076,Borderline personality disorder
HP:0000478,Abnormality of the eye
chembl:CHEMBL103552,LAVENDUSTIN A
MONDO:0012629,paroxysmal nonkinesigenic dyskinesia 2
CHEBI:35441,antiinfective agent
RGD:3713,Slc5a1
UBERON:0003053,ventricular zone
HP:0011006,Abnormal morphology of the musculature of the neck
chembl:CHEMBL116438,CURCUMIN
HP:0001336,Myoclonus
HP:0001520,Large for gestational age
HGNC:8823,PECAM1
HGNC:4329,GLRB
HGNC:12642,VAMP1
MONDO:0005298,osteoporosis
CHEBI:58349,NADP(3-)
HP:0100835,Benign neoplasm of the central nervous system
chembl:CHEMBL600313,CHEMBL600313
CHEBI:27899,cisplatin
chembl:CHEMBL3301572,NUSINERSEN
HGNC:26190,MTMR14
HGNC:26407,LSM12
chembl:CHEMBL515763,CHEMBL515763
chembl:CHEMBL2364609,ESKETAMINE HYDROCHLORIDE
chembl:CHEMBL2105643,FOSBRETABULIN TROMETHAMINE
CHEBI:15365,acetylsalicylic acid
HGNC:12851,YWHAE
GO:0006865,amino acid transport
HGNC:8124,OGDH
HGNC:4400,GNB3
HGNC:13890,ITCH
HGNC:14579,VPS45
MONDO:0002475,lacrimal gland adenocarcinoma
HGNC:28906,G6PC2
HGNC:21906,CHCHD3
HGNC:25850,RMND5A
MONDO:0041751,multibacillary leprosy
HGNC:2265,COX4I1
HGNC:1814,CEACAM1
NCBIGene:100683938,HTR1F
MONDO:0020488,atypical progressive supranuclear palsy syndrome
HGNC:3725,FKBP9
HGNC:17697,SARS2
HGNC:10681,SDHB
HP:0032398,Dysgyria
CHEBI:26788,streptomycins
HGNC:8728,PCMT1
HGNC:6080,INPPL1
CHEBI:59779,cyclic ketal
GO:0005774,vacuolar membrane
HP:0031825,Freezing of gait
HGNC:13733,CDH23
HGNC:19139,POMGNT1
chembl:CHEMBL488,AMINOGLUTETHIMIDE
MONDO:0006134,cervical adenosquamous carcinoma
chembl:CHEMBL1230020,PLX-4720
HGNC:12836,XRN2
chembl:CHEMBL621,TRAZODONE
MONDO:0100053,anaphylaxis
MONDO:0011151,exudative vitreoretinopathy 4
chembl:CHEMBL2107856,IMETELSTAT
HGNC:4385,GNAI2
HGNC:11027,SLC4A1
MGI:108554,Dab1
HGNC:7984,NR5A2
NCBIGene:424978,NDUFB5
WB:WBGene00012330,zip-3
chembl:CHEMBL633,AMIODARONE
CHEBI:25409,monoterpenoid
chembl:CHEMBL269521,MK-212
HGNC:13176,IKZF1
chembl:CHEMBL15137,MICHLER'S KETONE
chembl:CHEMBL222519,NBQX
MONDO:0013456,constitutional megaloblastic anemia with severe neurologic disease
chembl:CHEMBL267160,CHEMBL267160
HGNC:3607,FBP2
HP:0003774,Stage 5 chronic kidney disease
chembl:CHEMBL3990032,TELISOTUZUMAB VEDOTIN
MONDO:0008725,congenital lipoid adrenal hyperplasia due to STAR deficency
MONDO:0000079,"nephrolithiasis/osteoporosis, hypophosphatemic"
MONDO:0000703,collagenous colitis
chembl:CHEMBL18785,RU-24969
HGNC:20947,TOMM20
HGNC:24537,CHMP2B
UBERON:0001621,coronary artery
chembl:CHEMBL1436980,"4,4'-DIMETHOXYDALBERGIONE"
HGNC:11387,STIP1
HGNC:9285,PPP1R11
HP:0008768,Inappropriate sexual behavior
GO:0120082,smooth endoplasmic reticulum cisterna
HGNC:14415,ELOVL4
HGNC:4373,GMFB
HGNC:18261,NPLOC4
chembl:CHEMBL337173,CHEMBL337173
chembl:CHEMBL15193,LAPACHOL
HGNC:5960,IKBKB
chembl:CHEMBL427216,GLICLAZIDE
chembl:CHEMBL846,CALCITRIOL
HP:0006808,Cerebral hypomyelination
CHEBI:24318,glutamine family amino acid
chembl:CHEMBL600315,CHEMBL600315
chembl:CHEMBL530115,GUTHION
CHEBI:2955,azithromycin
MONDO:0043267,rheumatoid vasculitis
HP:0001274,Agenesis of corpus callosum
HP:0006357,Premature loss of permanent teeth
chembl:CHEMBL602466,CHEMBL602466
MONDO:0005549,renal cell adenocarcinoma
HP:0003218,Oroticaciduria
chembl:CHEMBL4297310,ONC-201
HGNC:1985,CIT
RGD:3548,Rcn2
MONDO:0005752,epidural abscess
UPHENO:0077907,decreased reflex in pectoral complex
HGNC:2060,CLGN
GO:0055054,fructose:proton symporter activity
chembl:CHEMBL1256665,TERAZOSIN HYDROCHLORIDE
HGNC:12828,XRCC1
MONDO:0018686,acquired Creutzfeldt-Jakob disease
chembl:CHEMBL494081,CHEMBL494081
chembl:CHEMBL111,RIMONABANT
MONDO:0001815,extrapyramidal and movement disease
HP:0008765,Auditory hallucinations
chembl:CHEMBL72365,CHEMBL72365
NCBIGene:516036,CBR3
HP:0100952,Enlarged sylvian cistern
chembl:CHEMBL587564,CHEMBL587564
HGNC:6757,MAB21L1
MONDO:0022687,cerebellar degeneration
HGNC:29559,VMP1
HGNC:3221,EFNA1
chembl:CHEMBL434200,TERTATOLOL
HP:0002863,Myelodysplasia
HP:0025132,Abnormal circulating estrogen level
HGNC:37276,CRPPA
chembl:CHEMBL323356,CHEMBL323356
HGNC:4315,GLE1
NCBITaxon:520,Bordetella pertussis
chembl:CHEMBL440084,SB-431542
HGNC:17082,MLC1
chembl:CHEMBL2103826,DAVUNETIDE
HGNC:9229,PLPP3
UPHENO:0084118,abnormally dilated third ventricle
MONDO:0012435,3-methylglutaconic aciduria type 5
MONDO:0001751,cholestasis
HP:0000040,Long penis
chembl:CHEMBL12318,CLODRONIC ACID
chembl:CHEMBL782,TOLBUTAMIDE
MONDO:0000473,arterial disorder
HGNC:16804,WWP2
MONDO:0003876,eyelid carcinoma
chembl:CHEMBL3545005,PLX-8394
HP:0031007,Orofacial action-specific dystonia induced by speech
MGI:1095438,Slc2a2
HP:0002876,Episodic tachypnea
HGNC:21305,KCTD3
Reactome:R-GGA-390650,Histamine receptors
HGNC:2457,CSNK2A1
CHEBI:28364,"all-cis-5,8,11,14,17-icosapentaenoic acid"
MONDO:0006038,indeterminate colitis
MONDO:0006552,folliculitis
chembl:CHEMBL589670,CHEMBL589670
CHEBI:25481,naphthoquinone
chembl:CHEMBL1237044,TRAMADOL
HGNC:1773,CDK4
HP:0003712,Skeletal muscle hypertrophy
HGNC:13875,FOXP2
CHEBI:32807,o-orsellinic acid
MONDO:0003122,striatonigral degeneration
GO:0015304,glucose uniporter activity
HGNC:7688,NDUFA5
HGNC:35410,TSTD1
HGNC:692,ARL1
HGNC:28999,FAM168A
HGNC:23456,ASAH2B
HGNC:14906,NIN
ZFIN:ZDB-GENE-010724-6,fh
chembl:CHEMBL1449575,HARMOL HYDROCHLORIDE
HGNC:18449,LAP3
UBERON:0001966,substantia nigra pars reticulata
MONDO:0006971,sigmoid neoplasm
HGNC:10910,SLC12A1
HGNC:7715,NDUFS8
chembl:CHEMBL1256746,CHEMBL1256746
MONDO:0025691,dystonia 30
chembl:CHEMBL2012520,LY377604
chembl:CHEMBL1464,WARFARIN
HGNC:18071,EMSY
GO:0009679,hexose:proton symporter activity
HP:0001538,Protuberant abdomen
MONDO:0011426,aceruloplasminemia
MONDO:0017763,disorder of iron metabolism and transport
HGNC:4799,HADH
HGNC:17075,TAB2
GO:0016029,subrhabdomeral cisterna
HGNC:2349,ATF6B
HGNC:9437,EIF2AK2
chembl:CHEMBL1200337,METOPROLOL SUCCINATE
chembl:CHEMBL286020,SULMAZOLE
HGNC:2342,CRAT
MONDO:0003939,muscle tissue disorder
chembl:CHEMBL329673,CHEMBL329673
CHEBI:3749,clofazimine
chembl:CHEMBL3681419,BASMISANIL
HGNC:18212,HPCAL4
chembl:CHEMBL1308346,CHEMBL1308346
MONDO:0015653,monogenic epilepsy
MONDO:0001343,impaired renal function disease
HGNC:2180,COCH
HP:0001618,Dysphonia
MONDO:0010321,"autism, susceptibility to, X-linked 1"
HGNC:8923,PHGDH
HGNC:19280,METTL17
chembl:CHEMBL60550,TERLAKIREN
chembl:CHEMBL1650619,PYRITHIONE
chembl:CHEMBL276139,CHEMBL276139
chembl:CHEMBL464,ETRETINATE
chembl:CHEMBL3989990,ISTIRATUMAB
HGNC:11357,STAM
GO:0004087,carbamoyl-phosphate synthase (ammonia) activity
MONDO:0016158,narcolepsy-cataplexy syndrome
CHEBI:87632,statin (naturally occurring)
HP:0500153,Hyperargininemia
chembl:CHEMBL1998001,CHEMBL1998001
chembl:CHEMBL2002487,CHEMBL2002487
chembl:CHEMBL448,PENTOBARBITAL
HGNC:8548,P4HB
HP:0010576,Intracranial cystic lesion
GO:0031092,platelet alpha granule membrane
CL:0000738,leukocyte
Reactome:R-XTR-211945,Phase I - Functionalization of compounds
HP:0011342,Mild global developmental delay
HGNC:16889,PSMD14
chembl:CHEMBL1200970,ETHOPROPAZINE HYDROCHLORIDE
GO:0098827,endoplasmic reticulum subcompartment
FB:FBgn0029663,CG10804
HP:0025143,Chills
chembl:CHEMBL2108702,IMETELSTAT SODIUM
HGNC:4140,GAP43
MONDO:0000707,diversion colitis
HGNC:12629,USP6
WB:WBGene00012967,kvs-4
HGNC:33,ABCA3
HGNC:17089,SYNE1
CHEBI:26893,tetracyclic triterpenoid
GO:0043195,terminal bouton
GO:0030659,cytoplasmic vesicle membrane
chembl:CHEMBL276915,7-HYDROXYFLAVONE
HGNC:591,BIRC3
NCBIGene:514749,RAD51
HGNC:48,ABCB7
HP:0000727,Frontal lobe dementia
MONDO:0014114,cardiofaciocutaneous syndrome 4
chembl:CHEMBL2109384,DEMCIZUMAB
chembl:CHEMBL58,MITOXANTRONE
chembl:CHEMBL258844,CHEMBL258844
CHEBI:36836,3beta-hydroxy steroid
HGNC:14685,F11R
HP:0000648,Optic atrophy
HP:0010943,Echogenic fetal bowel
HP:0002120,Cerebral cortical atrophy
HP:0002188,Delayed CNS myelination
chembl:CHEMBL2104991,VABICASERIN HYDROCHLORIDE
RGD:3979,Ywhaq
HGNC:16098,PHF20
HP:0031139,Frog-leg posture
MONDO:0014559,progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome
MONDO:0016892,partial deletion of the short arm of chromosome 10
HGNC:1565,ACKR2
chembl:CHEMBL1614710,OSI-930
MGI:2444304,Vps13a
HP:0032792,Tonic seizure
chembl:CHEMBL1201049,ECONAZOLE NITRATE
NCBIGene:507536,TACO1
HGNC:7981,NR4A2
HGNC:6638,LMNB2
HGNC:20665,SCN3B
HP:0001954,Recurrent fever
PomBase:SPBC56F2.03,arp10
MONDO:0020143,cerebral lipidosis with dementia
HP:0002566,Intestinal malrotation
HGNC:20415,SUMF2
chembl:CHEMBL221300,CHEMBL221300
chembl:CHEMBL1201065,THIAMYLAL SODIUM
chembl:CHEMBL606460,CHEMBL606460
wikidata:Q798309,BCG VACCINE
HGNC:16815,PHOSPHO1
HGNC:25662,AAGAB
MONDO:0012704,dilated cardiomyopathy 1X
UPHENO:0082557,decreased muscle organ tone
chembl:CHEMBL284733,DICLAZURIL
chembl:CHEMBL600103,CHEMBL600103
chembl:CHEMBL1201731,NEBIVOLOL HYDROCHLORIDE
MONDO:0019260,adult neuronal ceroid lipofuscinosis
MONDO:0014698,microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome
HGNC:10388,RPS15
HGNC:14499,MRPS7
MONDO:0007763,nonpapillary renal cell carcinoma
HGNC:6143,ITGA7
HGNC:12758,WDR6
CHEBI:57538,orotidine 5'-phosphate(3-)
HP:0002445,Tetraplegia
HP:0009590,Unilateral vestibular schwannoma
HGNC:18281,PECR
HGNC:33280,SEPTIN14
chembl:CHEMBL3544936,XL-844
HP:0002716,Lymphadenopathy
HGNC:124,ACP5
MGI:1929699,Arl3
UPHENO:0081739,increased reflex in pectoral complex
HGNC:8784,PDE5A
HGNC:19703,ULK3
CHEBI:38777,azetidines
MONDO:0012805,childhood onset GLUT1 deficiency syndrome 2
HGNC:6834,MAOB
MONDO:0011849,psoriatic arthritis
HP:0000718,Aggressive behavior
chembl:CHEMBL137498,CHEMBL137498
HP:0025160,Abnormal temper tantrums
HP:0000746,Delusions
chembl:CHEMBL292702,MAYTANSINE
chembl:CHEMBL354349,ACRIFLAVINE
CHEBI:30527,flavin
wikidata:Q47521310,CAMPTOSAR
HP:0031960,Arm dystonia
HGNC:2211,COL6A1
HGNC:1774,CDK5
chembl:CHEMBL1516007,"8,2'-DIMETHOXYFLAVONE"
HGNC:4387,GNAI3
HGNC:10484,RYR2
HGNC:14889,DNAJB11
HP:0002073,Progressive cerebellar ataxia
chembl:CHEMBL42336,METHIONINE
HGNC:1382,CA8
chembl:CHEMBL3039516,GEMCITABINE ELAIDATE
HP:0002630,Fat malabsorption
chembl:CHEMBL211502,PHENAMIL
HP:0001691,Muscular subvalvular aortic stenosis
CHEBI:50694,minocycline
chembl:CHEMBL582355,ETHACRIDINE LACTATE
HP:0007440,Generalized hyperpigmentation
HGNC:11018,SLC32A1
chembl:CHEMBL9843,CHEMBL9843
chembl:CHEMBL564201,6-AZAURIDINE
MONDO:0019046,leukodystrophy
chembl:CHEMBL606111,ANTIBIOTIC
HGNC:4093,GAD2
ZFIN:ZDB-GENE-040625-180,cox5ba
chembl:CHEMBL474260,CARUBICIN
HGNC:3353,ENO2
HP:0012179,Craniofacial dystonia
HGNC:10472,RUNX2
HP:0001254,Lethargy
HGNC:4076,GABRA2
HGNC:12030,TRADD
CHEBI:16385,organic sulfide
chembl:CHEMBL1040,CALCIFEDIOL
MGI:2444552,Actbl2
HP:0002705,"High, narrow palate"
HGNC:17598,UBE2J1
chembl:CHEMBL1200947,METIPRANOLOL HYDROCHLORIDE
HGNC:16384,TRIM28
HP:0001413,Micronodular cirrhosis
chembl:CHEMBL592445,GEDATOLISIB
chembl:CHEMBL414883,RADICICOL
chembl:CHEMBL1201584,ABCIXIMAB
HGNC:24990,COA3
HGNC:8646,PCBD1
CHEBI:17549,5-aminolevulinic acid
HGNC:1076,BMPR1A
HGNC:9964,DPF2
HP:0000641,Dysmetric saccades
MONDO:0021921,Arnold stickler bourne syndrome
chembl:CHEMBL522892,DOVITINIB
MONDO:0003008,hereditary renal cell carcinoma
HP:0002691,Platybasia
HP:0002444,Hypothalamic hamartoma
HGNC:2852,DGKE
HP:0008151,Prolonged prothrombin time
MONDO:0014756,"tremor, hereditary essential, 5"
HGNC:6950,MCM7
CHEBI:16349,L-citrulline
MONDO:0030004,"autism, susceptibility to, 20"
CHEBI:38101,organonitrogen heterocyclic compound
CHEBI:35627,beta-lactam
chembl:CHEMBL39541,DOLASTATIN-10
HGNC:12691,EZR
RGD:62058,Aoc3
HGNC:28492,FAM76B
chembl:CHEMBL571700,BIS(DIMETHYLAMINETHIOCARBONYL)MONOSULFIDE
HGNC:4466,GPR12
chembl:CHEMBL1201251,ARBUTAMINE
MONDO:0017175,Machado-Joseph disease type 2
chembl:CHEMBL691,ETHINYL ESTRADIOL
chembl:CHEMBL527584,CHEMBL527584
chembl:CHEMBL418068,RHEIN
HGNC:8774,PDE1A
MONDO:0044325,"Fanconi anemia, complementation group W"
chembl:CHEMBL456340,ARACHIDONOYL GABA
HGNC:82,ACAA1
chembl:CHEMBL235891,CHEMBL235891
HP:0002653,Bone pain
chembl:CHEMBL46516,FLUSPIRILENE
MONDO:0002966,splenic manifestation of prolymphocytic leukemia
HGNC:4910,HIF1A
FB:FBgn0261955,Cs1
HGNC:7516,MUC5B
chembl:CHEMBL44072,ENDRIN
CHEBI:35469,antidepressant
chembl:CHEMBL10878,AGOMELATINE
HGNC:14135,PIGQ
CHEBI:7035,muscimol
MONDO:0003518,mediastinum teratoma
Reactome:R-MMU-549127,Organic cation transport
MONDO:0000507,inclusion body myopathy with Paget disease of bone and frontotemporal dementia
HGNC:6607,LILRB3
MONDO:0006647,anterior cerebral artery infarction
HGNC:7710,NDUFS3
GO:0005308,creatine transmembrane transporter activity
MONDO:0018770,Jeune syndrome
chembl:CHEMBL712,ANISINDIONE
HGNC:613,APOE
MONDO:0100038,complex neurodevelopmental disorder
HP:0002092,Pulmonary arterial hypertension
HGNC:21304,ADPRS
GO:0005354,galactose transmembrane transporter activity
MONDO:0100339,Friedreich ataxia
chembl:CHEMBL252151,CHEMBL252151
HP:0011149,Absence seizure with eyelid myoclonia
GO:1901563,response to camptothecin
chembl:CHEMBL491820,AMORFRUTIN A
NCBIGene:100141309,RAD51
chembl:CHEMBL65,CAMPTOTHECIN
RGD:621551,Cyb5b
CHEBI:29108,calcium(2+)
chembl:CHEMBL331743,DIXANTHOGEN
MONDO:0014875,"hyperaldosteronism, familial, type IV"
MONDO:0100148,X-linked complex neurodevelopmental disorder
HGNC:990,BCL2
HP:0011710,Bundle branch block
MONDO:0045016,cholesterol catabolic process disease
chembl:CHEMBL568,OXAZEPAM
Reactome:R-CFA-390651,Dopamine receptors
chembl:CHEMBL1201827,PANITUMUMAB
HP:0007000,Morning myoclonic jerks
MONDO:0018053,trichothiodystrophy
chembl:CHEMBL1276678,VTP-27999
HGNC:7218,MPO
HGNC:1541,CBL
chembl:CHEMBL1518572,CHEMBL1518572
UPHENO:0071136,absent reflex in pectoral complex
MONDO:0008566,"thyroid cancer, nonmedullary, 2"
HGNC:630,SHROOM2
HP:0000738,Hallucinations
chembl:CHEMBL1200745,OXPRENOLOL HYDROCHLORIDE
MONDO:0017998,PLA2G6-associated neurodegeneration
UBERON:0008971,left colon
GO:0006468,protein phosphorylation
HGNC:9689,PTS
chembl:CHEMBL3989862,PEFCALCITOL
HP:0006101,Finger syndactyly
HGNC:4326,GLRA1
HGNC:33237,DUSP28
HP:0010965,Abnormal circulating phytanic acid concentration
HGNC:8740,CHMP1A
HGNC:17152,ACOT9
GO:0004089,carbonate dehydratase activity
chembl:CHEMBL86537,SPLITOMICIN
HGNC:11438,STX3
HGNC:655,ARF4
HGNC:4165,GAS1
HP:0003621,Juvenile onset
MGI:1328362,Blm
HGNC:5299,HTR4
HGNC:19744,SRGAP3
chembl:CHEMBL532452,CHEMBL532452
HGNC:1736,CDC42
HGNC:9179,POLG
Reactome:R-GGA-419469,Pyrimidine metabolism: de novo synthesis of UMP
HGNC:13585,FBXO6
chembl:CHEMBL270995,BRIVANIB ALANINATE
chembl:CHEMBL312032,CHEMBL312032
HGNC:9323,PPP6C
HGNC:20473,BRIP1
NCBIGene:540225,COX7A2L
chembl:CHEMBL1355965,DIENOCHLOR
GO:0140877,mevastatin biosynthetic process
HP:0007307,Rapid neurologic deterioration
ZFIN:ZDB-GENE-030131-1390,aco2
chembl:CHEMBL403664,BLEOMYCIN
HGNC:19118,TNIP2
MONDO:0859201,neurodevelopmental disorder with impaired language and ataxia and with or without seizures
chembl:CHEMBL29898,QUINALIZARIN
chembl:CHEMBL169233,CHEMBL169233
chembl:CHEMBL368700,DITHIOLETHIONE
CHEBI:16521,lanosterol
HGNC:12680,VEGFA
HGNC:3263,AGO2
HGNC:6561,LGALS1
MONDO:0010622,recessive X-linked ichthyosis
chembl:CHEMBL1517,OXYTETRACYCLINE
chembl:CHEMBL54,HALOPERIDOL
CHEBI:545959,homovanillic acid
HP:0001324,Muscle weakness
chembl:CHEMBL1201746,PRALATREXATE
GO:0005739,mitochondrion
GO:0120025,plasma membrane bounded cell projection
CHEBI:27369,zwitterion
HGNC:5021,FOXA1
chembl:CHEMBL405914,CHEMBL405914
MONDO:0000415,adolescence-adult electroclinical syndrome
HGNC:23068,TRAPPC2
HGNC:11569,TARBP2
HGNC:12712,VPS33B
CHEBI:18089,N-benzoylglycine
chembl:CHEMBL274654,ORANTINIB
HGNC:3823,FOXP1
HGNC:27924,LINC01139
HP:0001370,Rheumatoid arthritis
HGNC:11442,STX7
HP:0007668,Impaired pursuit initiation and maintenance
chembl:CHEMBL117287,PRUCALOPRIDE
chembl:CHEMBL1398126,AMILORIDE HYDROCHLORIDE
HGNC:6246,KCNF1
chembl:CHEMBL1073,GLIPIZIDE
HGNC:1820,CEACAM8
HP:0025233,Sleep paralysis
HGNC:7905,NPHP1
GO:0061436,establishment of skin barrier
HP:0000737,Irritability
chembl:CHEMBL1201485,SOYBEAN OIL
GO:0008333,endosome to lysosome transport
UPHENO:0063698,absent social behavior
HP:0000020,Urinary incontinence
HGNC:14214,CIC
HGNC:4027,FXYD3
chembl:CHEMBL66114,CHEMBL66114
chembl:CHEMBL1354529,VIOLASTYRENE
HGNC:8021,NT5E
chembl:CHEMBL269733,DEPHOSTATIN
chembl:CHEMBL569,PROCAINE
chembl:CHEMBL225304,PIMAGEDINE
chembl:CHEMBL305187,IFENPRODIL
HGNC:21701,BRAT1
HP:0011728,Elbow clonus
HGNC:12672,VDAC2
chembl:CHEMBL120526,METHANANDAMIDE
Reactome:R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins
UBERON:0003074,mesonephric duct
chembl:CHEMBL1253830,ISOBONDUCELLIN
Xenbase:XB-GENE-493040,hap1
NCBIGene:474479,CYB5R3
HGNC:16627,CHEK2
HGNC:833,ATP5F1C
MONDO:0015547,hereditary dementia
MONDO:0005240,kidney disorder
MONDO:0005086,renal cell carcinoma
HGNC:2202,COL4A1
MONDO:0005299,brain ischemia
HGNC:13518,CLIC4
chembl:CHEMBL1327172,CHEMBL1327172
HP:0008311,Spinal cord posterior columns myelin loss
HP:0033694,Tactile hallucination
CHEBI:16180,N-acylglycine
chembl:CHEMBL1343568,CHEMBL1343568
HGNC:3774,FMOD
HP:0002334,Abnormal cerebellar vermis morphology
HGNC:14412,AGXT2
HP:0000286,Epicanthus
CHEBI:16919,creatine
GO:0006874,intracellular calcium ion homeostasis
HP:0000712,Emotional lability
HGNC:11013,SLC30A2
chembl:CHEMBL1082607,SALMETEROL XINAFOATE
HP:0001442,Typified by somatic mosaicism
HGNC:25576,NAXD
HGNC:5292,HTR1F
HGNC:752,GET3
chembl:CHEMBL2088303,CHEMBL2088303
HGNC:11107,SMARCD2
WB:WBGene00018603,F48E3.2
HGNC:8867,PFDN2
HP:0007333,Hypoplasia of the frontal lobes
HGNC:37,ABCA7
HP:0004453,Overfolding of the superior helices
MONDO:0054748,"Fanconi anemia, complementation group S"
HGNC:15968,GDAP1
chembl:CHEMBL50,QUERCETIN
HP:0012323,Sleep myoclonus
chembl:CHEMBL233194,CHEMBL233194
chembl:CHEMBL87333,CIS-RESVERATROL
chembl:CHEMBL43184,AMINACRINE
HGNC:7966,NR1H3
chembl:CHEMBL129795,ISOLIQUIRITIGENIN
HGNC:33911,RNASEK
chembl:CHEMBL628,PENTOXIFYLLINE
Reactome:R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC
CHEBI:11814,3-hydroxy-3-methylglutaryl-CoA
UPHENO:0081741,increased biological_process in pectoral complex
chembl:CHEMBL870,ALENDRONIC ACID
HGNC:14897,ITPKC
Reactome:R-HSA-9022535,Loss of phosphorylation of MECP2 at T308
NCBIGene:478619,CMBL
HGNC:9884,RB1
chembl:CHEMBL1200765,SIBUTRAMINE HYDROCHLORIDE
HP:0000823,Delayed puberty
HGNC:5270,DNAJB1
chembl:CHEMBL1320798,CHEMBL1320798
HGNC:7497,MT-TS1
chembl:CHEMBL1481,GLIMEPIRIDE
CHEBI:132155,hydroxynaphthoquinone
chembl:CHEMBL1256391,PIRFENIDONE
HGNC:14006,TRPV6
chembl:CHEMBL3813873,PEXIDARTINIB
HP:0025234,Parasomnia
HP:0003764,Nevus
chembl:CHEMBL783,NATEGLINIDE
CHEBI:21760,N-methyl-amino acid
MONDO:0037872,bordetellosis
HP:0002476,Primitive reflex
UBERON:0002298,brainstem
HGNC:799,ATP1A1
MGI:101757,Cfl1
chembl:CHEMBL1595865,CHINOMETHIONAT
CHEBI:38514,quinoline alkaloid fundamental parent
HP:0006994,Diffuse leukoencephalopathy
MGI:1860103,Slc2a8
MONDO:0012186,Fanconi anemia complementation group I
MONDO:0850286,exercise-induced bronchoconstriction
HGNC:245,ADD3
MONDO:0005265,inflammatory bowel disease
chembl:CHEMBL1404865,CHEMBL1404865
HGNC:5184,HRH3
HGNC:18856,CREB3L1
UBERON:0004262,upper leg skin
chembl:CHEMBL1200964,AMITRIPTYLINE HYDROCHLORIDE
chembl:CHEMBL1509103,CHEMBL1509103
chembl:CHEMBL259084,MLN-8054
GO:0001889,liver development
NCBIGene:520260,FH
HGNC:10294,RPE65
HGNC:6697,LRP5
HP:0007704,Paroxysmal involuntary eye movements
Reactome:R-HSA-9022692,Regulation of MECP2 expression and activity
chembl:CHEMBL549473,DIPYRITHIONE
MONDO:0007603,Felty syndrome
HGNC:10990,SLC25A4
CHEBI:57947,creatine zwitterion
HGNC:9763,RAB2A
GO:0098743,cell aggregation
HGNC:9402,PRKCG
MONDO:0016865,Kleefstra syndrome due to a point mutation
UPHENO:0079834,abnormal irritability behavior
MONDO:0019383,acute disseminated encephalomyelitis
chembl:CHEMBL122270,LOBELINE
HP:0002392,EEG with polyspike wave complexes
MONDO:0044336,colorectal signet ring cell carcinoma
MGI:1916824,Cmbl
UBERON:0000473,testis
chembl:CHEMBL1488393,"5,7-DIHYDROXYISOFLAVONE"
chembl:CHEMBL119,TRIMETREXATE
chembl:CHEMBL1743358,CHEMBL1743358
GO:0019621,creatinine catabolic process to formate
MGI:1923831,Wipi2
MONDO:0009026,Costello syndrome
CHEBI:26580,rifamycins
chembl:CHEMBL586163,CHEMBL586163
HGNC:11530,TACSTD2
chembl:CHEMBL91153,"3',4'-DIMETHOXYFLAVONE"
chembl:CHEMBL471,SOTALOL
chembl:CHEMBL88,CYCLOPHOSPHAMIDE
HGNC:8014,YBX1
MONDO:0021135,rare or common
MONDO:0043510,brain injury
chembl:CHEMBL1289601,LENVATINIB
MGI:2137706,Actn1
GO:0098796,membrane protein complex
HP:0002461,Dense calcifications in the cerebellar dentate nucleus
HGNC:1739,CDC45
chembl:CHEMBL1568698,GANAXOLONE
chembl:CHEMBL1631540,GSK163090
chembl:CHEMBL135,ESTRADIOL
HGNC:25198,SLC25A46
HGNC:186,ADA
HGNC:3067,DUSP12
HGNC:8787,PDE6C
chembl:CHEMBL300389,CHEMBL300389
GO:0022877,protein-N(PI)-phosphohistidine-fructose phosphotransferase system transporter activity
chembl:CHEMBL2364639,VALBENAZINE
chembl:CHEMBL85826,CHEMBL85826
chembl:CHEMBL296035,BUFURALOL
GO:0042875,D-galactonate transmembrane transport
HP:0000044,Hypogonadotropic hypogonadism
HGNC:8090,OASL
HP:0001350,Slurred speech
HGNC:583,APC
UBERON:0002165,endocardium
chembl:CHEMBL2105107,INECALCITOL
chembl:CHEMBL15177,MK-571
Xenbase:XB-GENE-490883,actb
HGNC:30291,G3BP2
Reactome:R-CEL-390666,Serotonin receptors
CHEBI:17859,glutaric acid
CHR:9606-chr11q22.2-q22.3,
chembl:CHEMBL3545248,DS-7423
chembl:CHEMBL486196,ANGUSTIBALIN
HP:0011468,Facial tics
chembl:CHEMBL2109377,PAMREVLUMAB
chembl:CHEMBL484663,CHEMBL484663
MONDO:0004323,muscular atrophy
UBERON:0036262,uterine ligament
WB:WBGene00000403,casy-1
ZFIN:ZDB-GENE-050522-133,cox5aa
HP:0012477,Vocal tremor
chembl:CHEMBL1610638,DIHYDRO-OBLIQUIN
chembl:CHEMBL4084907,BIMIRALISIB
HGNC:837,ATP5F1D
HP:0009088,Speech articulation difficulties
MONDO:0013928,dystonia 23
chembl:CHEMBL491499,ZEARALANONE
HGNC:23246,MYPN
chembl:CHEMBL89445,TERPYRIDINE
MONDO:0014199,"developmental and epileptic encephalopathy, 17"
CHEBI:27732,caffeine
HGNC:9355,PRDX5
MONDO:0005580,esophageal squamous cell carcinoma
chembl:CHEMBL3545335,AG-13958
CHEBI:33295,diagnostic agent
MGI:1915710,Dhrs7c
chembl:CHEMBL214154,MAYTANSINOL
chembl:CHEMBL411,DIETHYLSTILBESTROL
HGNC:7758,NEU1
MONDO:0002960,polyradiculopathy
HGNC:5041,HNRNPH1
MONDO:0007574,spinocerebellar ataxia type 34
PomBase:SPBC16C6.02c,vps1302
chembl:CHEMBL649,NADOLOL
HGNC:11562,TANK
HGNC:2433,CSF1R
NCBIGene:327673,NDUFA1
HGNC:1116,BSG
HGNC:7565,MYF5
chembl:CHEMBL129177,HARMALOL
chembl:CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE
chembl:CHEMBL428768,(S)-FELODIPINE
GO:0005179,hormone activity
chembl:CHEMBL43482,MITONAFIDE
chembl:CHEMBL91,MICONAZOLE
MONDO:0005534,ileocolitis
HP:0002167,Abnormality of speech or vocalization
HGNC:914,B2M
GO:0003723,RNA binding
chembl:CHEMBL3545021,ANLOTINIB
HP:0002064,Spastic gait
chembl:CHEMBL71,CHLORPROMAZINE
HGNC:29812,DCPS
MONDO:0006684,brain edema
HGNC:28875,DNASE2B
HGNC:16496,ACSL6
MONDO:0100151,nephropathic cystinosis
HP:0007663,Reduced visual acuity
chembl:CHEMBL417,EPIRUBICIN
chembl:CHEMBL1813518,CHEMBL1813518
Reactome:R-XTR-71288,Creatine metabolism
CHEBI:32600,tetracene
NCBIGene:479805,NDUFAB1
HGNC:1479,CAPN2
chembl:CHEMBL1201038,ACRISORCIN
chembl:CHEMBL3621988,TUCIDINOSTAT
HGNC:19691,MECR
chembl:CHEMBL441,THIOPENTAL
chembl:CHEMBL1403281,ERGOCRYPTINE
HGNC:14977,SNX14
HGNC:18337,PADI3
MONDO:0014339,autosomal recessive spinocerebellar ataxia 16
UPHENO:0080596,abnormal impulsive behavior
MONDO:0850283,acute asthma
MGI:1347061,Abcg2
HP:0000962,Hyperkeratosis
HGNC:550,AOC3
FB:FBgn0036565,CG5235
NCBIGene:509995,LRPPRC
HP:0034342,Trapezius muscle aplasia
RGD:621373,Tex101
MGI:2159324,Cln6
MONDO:0005010,coronary artery disorder
chembl:CHEMBL1201262,DIPIVEFRIN
chembl:CHEMBL2141712,PALOMID-529
MONDO:0007182,Machado-Joseph disease
HGNC:14584,VPS16
Reactome:R-HSA-9022538,Loss of MECP2 binding ability to 5mC-DNA
chembl:CHEMBL581152,CHEMBL581152
MONDO:0010375,"developmental and epileptic encephalopathy, 8"
chembl:CHEMBL238624,CHEMBL238624
HGNC:22800,GNAT3
HGNC:7711,NDUFS4
HGNC:6556,LETM1
chembl:CHEMBL42115,THYROXINE
MONDO:0001235,appendix cancer
chembl:CHEMBL477197,HEMATOXYLIN
HP:0032438,Platelet anisocytosis
chembl:CHEMBL86304,MOCLOBEMIDE
chembl:CHEMBL449081,AGROCLAVINE
chembl:CHEMBL1333953,PHENYLMERCURIC ACETATE
MGI:97890,Rad51
GO:0007507,heart development
HGNC:12698,VLDLR
HGNC:14934,SIRT6
chembl:CHEMBL1097999,E-6201
chembl:CHEMBL4206119,UPAMOSTAT
HGNC:3724,FKBP8
chembl:CHEMBL423,BETAXOLOL
chembl:CHEMBL1946170,REGORAFENIB
HGNC:555,AP1G1
chembl:CHEMBL462018,TRICIRIBINE PHOSPHATE
HP:0100820,Glomerulopathy
NCBIGene:510767,CYCS
chembl:CHEMBL55285,BENZYL ISOTHIOCYANATE
HP:0002522,Areflexia of lower limbs
chembl:CHEMBL1696,DESIPRAMINE HYDROCHLORIDE
HGNC:11005,SLC2A1
NCBIGene:482814,HTR5A
CHEBI:46842,sarcosinium
chembl:CHEMBL3545286,CCX140
MONDO:0011811,autosomal recessive cerebellar ataxia-saccadic intrusion syndrome
HGNC:21157,GTF2H5
chembl:CHEMBL3186011,APR-246
HGNC:24862,MOGS
chembl:CHEMBL16687,CGS-15943
CHEBI:139592,tertiary alpha-hydroxy ketone
HGNC:28883,PPA2
chembl:CHEMBL50588,EMETINE
Xenbase:XB-GENE-982586,cln6
HGNC:21367,CGAS
HGNC:8967,PIGN
GO:0005509,calcium ion binding
HP:0002268,Paroxysmal dystonia
HGNC:25507,VAC14
HP:0007703,Abnormality of retinal pigmentation
MONDO:0008159,postmenopausal osteoporosis
HP:0010543,Opsoclonus
MONDO:0013705,"intellectual disability, autosomal recessive 19"
chembl:CHEMBL2104449,SARAKALIM
MONDO:1011336,"nervous system disorder, non-human animal"
HGNC:329,AGRN
HGNC:2076,CLN5
chembl:CHEMBL1304363,CHEMBL1304363
chembl:CHEMBL554190,QUINACRINE DIHYDROCHLORIDE
chembl:CHEMBL681,ETOMIDATE
chembl:CHEMBL1113,AMOXAPINE
chembl:CHEMBL1232076,CHEMBL1232076
MONDO:0002541,spinal cord oligodendroglioma
HGNC:1460,CAMK2A
HGNC:2025,CLCN7
chembl:CHEMBL250711,OLEOYL DOPAMINE
chembl:CHEMBL131921,BIOCHANIN
chembl:CHEMBL970,HALAZEPAM
MONDO:0022742,occupational asthma
HGNC:30950,ZNF639
HGNC:21461,RC3H2
chembl:CHEMBL362223,CHEMBL362223
WB:WBGene00000065,act-3
HGNC:4648,GTF2B
GO:0031624,ubiquitin conjugating enzyme binding
GO:0097386,glial cell projection
MONDO:0002883,intestinal neuroendocrine neoplasm
chembl:CHEMBL186784,XANTHONE
chembl:CHEMBL589909,CHEMBL589909
HGNC:3467,ESR1
MONDO:0006685,brain hypoxia - ischemia
MONDO:0032781,"congenital hypotonia, epilepsy, developmental delay, and digital anomalies"
MONDO:0011487,Huntington disease-like 3
HP:0003738,Exercise-induced myalgia
HP:0000365,Hearing impairment
UPHENO:0080275,decreased motor coordination
HGNC:6187,IVL
MGI:1916847,Afg3l2
HGNC:8512,OTC
HGNC:412,ALDH9A1
chembl:CHEMBL57394,CHEMBL57394
FB:FBgn0250910,Octβ3R
HP:0000407,Sensorineural hearing impairment
HGNC:11999,TP53BP1
chembl:CHEMBL1390716,CHEMBL1390716
MONDO:0006322,non-neoplastic bile duct disorder
HGNC:23166,PNPT1
HP:0007811,Horizontal pendular nystagmus
HGNC:12705,VNN1
HP:0000752,Hyperactivity
chembl:CHEMBL8514,BUTACLAMOL
HGNC:18484,DUSP18
CHEBI:28001,vancomycin
HGNC:29290,LRFN1
MONDO:0025556,isocyanate induced asthma
UBERON:0000458,endocervix
chembl:CHEMBL1256686,CALCIMYCIN
MONDO:0030503,"cholestasis, progressive familial intrahepatic, 7, with or without hearing loss"
HGNC:20073,SNX27
chembl:CHEMBL595227,CHEMBL595227
chembl:CHEMBL2107773,RITOBEGRON
HGNC:3436,ERCC4
chembl:CHEMBL3545320,ME-344
chembl:CHEMBL222280,BROXURIDINE
HP:0031722,Near esotropia
Reactome:R-HSA-500753,Pyrimidine biosynthesis
HGNC:1185,TIGAR
chembl:CHEMBL3137336,UPROSERTIB
HGNC:14581,PINK1
GO:0006810,transport
chembl:CHEMBL508338,THIMEROSAL
chembl:CHEMBL259421,CHEMBL259421
MONDO:0002718,central nervous system teratoma
HGNC:6944,MCM2
HGNC:28032,EMC4
chembl:CHEMBL208427,SOLABEGRON
chembl:CHEMBL1743051,ONARTUZUMAB
chembl:CHEMBL1337519,CHEMBL1337519
chembl:CHEMBL150894,CEP-5214
UPHENO:0001005,abnormal phenotype by ontology source
chembl:CHEMBL1908376,SEOCALCITOL
RGD:2625,Fnta
MGI:1913677,Cyb5b
HGNC:12587,UQCRFS1
MONDO:0013588,Perrault syndrome 3
MONDO:0006857,middle cerebral artery infarction
FB:FBgn0011582,Dop1R1
MONDO:0005301,multiple sclerosis
MONDO:0002444,melancholia
HGNC:28300,NT5C3B
HGNC:7994,NRCAM
chembl:CHEMBL1426508,CHEMBL1426508
HGNC:4740,MACROH2A1
chembl:CHEMBL491473,CEDIRANIB
HGNC:292,ADSS2
chembl:CHEMBL1434057,2-BENZOYL-5-METHOXYBENZOQUINONE
MONDO:0014986,Fanconi anemia complementation group R
MONDO:0024613,bipolar depression
MGI:1095409,Tuba1c
chembl:CHEMBL210208,PYROGALLOL RED
HGNC:697,ARL6IP1
MONDO:0004970,adenocarcinoma
HP:0001884,Talipes calcaneovalgus
PATO:0001863,chronic
chembl:CHEMBL30219,METHOHEXITAL SODIUM
HGNC:28984,WASHC5
chembl:CHEMBL2364614,LIAFENSINE
MONDO:0005005,clear cell renal carcinoma
chembl:CHEMBL3545396,BMS-690514
chembl:CHEMBL1520512,DEHYDROVARIABILIN
chembl:CHEMBL2028663,DABRAFENIB
chembl:CHEMBL3545296,ARQ-736
chembl:CHEMBL2007641,PERTUZUMAB
HGNC:4077,GABRA3
chembl:CHEMBL77098,"3-HYDROXY-3',4'-DIMETHOXYFLAVONE"
chembl:CHEMBL111201,CHEMBL111201
HGNC:26010,SPDL1
chembl:CHEMBL164449,CHEMBL164449
MONDO:0002418,ethmoid sinus adenocarcinoma
chembl:CHEMBL1333512,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE"
chembl:CHEMBL589207,CHEMBL589207
HP:0000021,Megacystis
HGNC:816,ATP2B3
chembl:CHEMBL507026,THIOLUTIN
GO:0005794,Golgi apparatus
chembl:CHEMBL2105467,TEZACITABINE
CHEBI:3638,chloroquine
HGNC:14524,SPAG9
chembl:CHEMBL618,4-CHLORO-BENZOIC ACID
HGNC:817,ATP2B4
GO:0043005,neuron projection
CHEBI:456216,ADP(3-)
chembl:CHEMBL1242194,CYCLOSTREPTIN
MGI:1261831,Hap1
CHEBI:142548,ent-tamsulosin
CHEBI:27560,boron atom
chembl:CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE
HP:0007430,Generalized edema
HGNC:15598,HAMP
HGNC:16290,TRIM33
CHEBI:133930,"5alpha-androst-1-ene-3,17-dione"
CHEBI:57287,coenzyme A(4-)
ZFIN:ZDB-GENE-040426-2143,mdh2
chembl:CHEMBL1413199,DIPHENADIONE
chembl:CHEMBL547,ISOTRETINOIN
HGNC:14582,LAMP3
MONDO:0000837,bone resorption disease
chembl:CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE
HGNC:28727,APOO
HGNC:22219,KIAA1549
HP:0001348,Brisk reflexes
MONDO:0004107,splenic manifestation of leukemia
GO:0014075,response to amine
chembl:CHEMBL1598608,AZASETRON
CHEBI:142549,ent-tamsulosin(1+)
HGNC:23181,RASA4
chembl:CHEMBL428690,ALVOCIDIB
HP:0003006,Neuroblastoma
HGNC:13586,FBXO7
CHEBI:24031,ferulic acids
chembl:CHEMBL43185,PIPERINE
MGI:102773,Ces3a
ZFIN:ZDB-GENE-040426-1963,sucla2
WB:WBGene00019979,R09B5.11
CHEBI:138141,17alpha-hydroxy-C21-steroid
chembl:CHEMBL582473,CHEMBL582473
chembl:CHEMBL75228,1-PHENETHYLPIPERIDINE
chembl:CHEMBL485756,CHEMBL485756
GO:0032839,dendrite cytoplasm
HP:0000565,Esotropia
MONDO:0015004,"dystonia 28, childhood-onset"
HGNC:5384,IDH3A
chembl:CHEMBL7492,PIRITREXIM
HGNC:8621,PAX7
chembl:CHEMBL1773,CAPECITABINE
CHEBI:39447,pyrimidines
MONDO:0100002,food protein-induced allergic proctocolitis
MONDO:0018823,X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome
HGNC:8638,KAT2B
HGNC:886,ATRX
HP:0010863,Receptive language delay
chembl:CHEMBL625,THIABENDAZOLE
HGNC:29639,MAGEF1
MONDO:0007624,Flynn-Aird syndrome
HGNC:28685,OCIAD2
HGNC:21919,PARP12
HP:0100896,Rectal polyposis
HGNC:9786,RAB6A
HGNC:10720,SELL
HGNC:473,AMT
HGNC:2605,CYP27A1
UBERON:0001898,hypothalamus
MONDO:0016019,Rasmussen subacute encephalitis
chembl:CHEMBL56337,EPALRESTAT
HP:0000835,Adrenal hypoplasia
chembl:CHEMBL2103827,DROXIDOPA
chembl:CHEMBL588038,CHEMBL588038
NCBIGene:403980,CAV1
HGNC:12716,TRPV1
CHEBI:29007,ceftriaxone
MGI:1915008,Aadac
MONDO:0005053,ischemic disease
HGNC:1516,CAT
chembl:CHEMBL1200952,METHAMPHETAMINE HYDROCHLORIDE
HGNC:1058,BLM
HGNC:6692,LRP1
HGNC:9760,RAB11A
HGNC:6601,LIG4
HGNC:21689,FIS1
HGNC:2888,DISC1
HGNC:26658,POC5
WB:WBGene00018779,F53H8.3
HGNC:12388,TST
HGNC:2768,DEK
wikidata:Q29005654,COMETRIQ
MGI:88107,Atp1a3
chembl:CHEMBL12014,HARMAN
chembl:CHEMBL1395610,PROROXAN
MONDO:0010726,Rett syndrome
HGNC:19700,CNKSR1
chembl:CHEMBL523200,CHEMBL523200
HGNC:1759,CDH2
HP:0100785,Insomnia
HGNC:3364,ENTPD2
Reactome:R-HSA-380320,Recruitment of NuMA to mitotic centrosomes
chembl:CHEMBL2220442,FLUVASTATIN
HP:0002024,Malabsorption
MONDO:0001756,frontal sinus cancer
HGNC:4394,GNAT2
NCBIGene:423763,NDUFB8
HGNC:5031,HNRNPA1
HGNC:1189,AHSA1
HP:0003657,Vascular granular osmiophilic material deposition
chembl:CHEMBL1333798,CHEMBL1333798
chembl:CHEMBL3545110,RIBOCICLIB
MONDO:0013352,intellectual disability-severe speech delay-mild dysmorphism syndrome
chembl:CHEMBL383824,ALVESPIMYCIN
wikidata:Q29004870,AVASTIN
chembl:CHEMBL3039525,GOLVATINIB
chembl:CHEMBL60889,MOSAPRIDE
HP:0000252,Microcephaly
CHEBI:17203,L-proline
chembl:CHEMBL31574,FISETIN
chembl:CHEMBL1200798,TRAZODONE HYDROCHLORIDE
CHEBI:25698,ether
MONDO:0010790,MERRF syndrome
HP:0009748,Large earlobe
HGNC:16369,PARK7
chembl:CHEMBL483633,CHEMBL483633
HP:0032894,Seizure precipitated by febrile infection
chembl:CHEMBL178862,ANETHOLTRITHION
HGNC:8856,PEX14
Reactome:R-GGA-71288,Creatine metabolism
HGNC:7010,MEN1
HP:0001789,Hydrops fetalis
GO:0010035,response to inorganic substance
chembl:CHEMBL1622,FOLIC ACID
chembl:CHEMBL166486,CHEMBL166486
HGNC:6499,LAMP1
HGNC:17274,TRIM29
chembl:CHEMBL59532,CHEMBL59532
CHEBI:17759,"cholesta-5,7-dien-3beta-ol"
chembl:CHEMBL268229,CHEMBL268229
chembl:CHEMBL103,PROGESTERONE
HGNC:14974,SNX10
HGNC:30788,TLE6
chembl:CHEMBL87708,LOFEPRAMINE
HGNC:4296,GLA
HP:0007374,Atrophy/Degeneration involving the caudate nucleus
HGNC:10474,RUVBL1
MONDO:0008769,neuronal ceroid lipofuscinosis 2
HGNC:16262,YAP1
chembl:CHEMBL434394,NEBIVOLOL
WB:WBGene00016328,pde-5
MONDO:0010476,neurodegeneration with brain iron accumulation 5
HP:0100710,Impulsivity
chembl:CHEMBL460574,LEVISOPRENALINE
HGNC:26489,TMEM154
chembl:CHEMBL493863,CHEMBL493863
HGNC:55,ABCC4
HP:0001347,Hyperreflexia
HP:0031952,Neurogenic claudication
HGNC:9937,RCVRN
HGNC:2726,DDIT3
HP:0000358,Posteriorly rotated ears
chembl:CHEMBL295124,BERBERINE
chembl:CHEMBL3707355,AZD8108
HGNC:18448,NEIL1
MONDO:0015306,Lemierre syndrome
chembl:CHEMBL126077,INDIRUBIN-3-MONOXIME
HP:0001476,Delayed closure of the anterior fontanelle
CHEBI:87114,antibiotic fungicide
chembl:CHEMBL578741,CHEMBL578741
CHEBI:16480,nitric oxide
chembl:CHEMBL1200969,DUTASTERIDE
chembl:CHEMBL603,ZAFIRLUKAST
Reactome:R-DRE-71403,Citric acid cycle (TCA cycle)
CHEBI:47909,3-oxo-Delta(4) steroid
MGI:1354695,Fbxw7
chembl:CHEMBL1201124,KETOROLAC TROMETHAMINE
HGNC:848,ATP5MF
chembl:CHEMBL181633,CHEMBL181633
HGNC:17062,HABP4
CHEBI:26979,organic heterotricyclic compound
HP:0001252,Hypotonia
chembl:CHEMBL1887067,NALED
chembl:CHEMBL4297300,LB-100
MONDO:0700005,idiopathic
MONDO:0020175,malignant tumor of palpebral epidermis
HGNC:20225,DPF1
chembl:CHEMBL433680,ANGUIDIN
chembl:CHEMBL453863,TEROXIRONE
HP:0002168,Scanning speech
HP:0001264,Spastic diplegia
WB:WBGene00000491,che-12
CHEBI:474053,cefazolin
HGNC:4983,HMGB1
HGNC:30646,SND1
CHEBI:7528,netilmycin
HGNC:174,ACVR2B
HP:0004626,Lumbar scoliosis
CHEBI:29991,L-aspartate(1-)
HP:0011834,Moyamoya phenomenon
MONDO:0020047,autosomal recessive syndromic cerebellar ataxia
HGNC:19365,PANK3
Reactome:R-HSA-5626467,RHO GTPases activate IQGAPs
chembl:CHEMBL597246,CHEMBL597246
HGNC:11969,TNRC6A
MONDO:0000621,immune system cancer
HGNC:6853,MAP3K14
HP:0002518,Abnormal periventricular white matter morphology
HGNC:11449,SUCLG1
chembl:CHEMBL480,LANSOPRAZOLE
CHEBI:29985,L-glutamate(1-)
chembl:CHEMBL228792,KINETIN
HGNC:225,ADAR
MONDO:0007483,dyschromatosis symmetrica hereditaria
chembl:CHEMBL65794,CEFPIROME
HGNC:32207,LIN28B
chembl:CHEMBL796,METHYLPHENIDATE
HGNC:3024,DRD3
chembl:CHEMBL155622,NIPRADILOL
HP:0011152,Early onset absence seizures
chembl:CHEMBL1201577,CETUXIMAB
CHEBI:68508,diethyl maleate
MONDO:0002734,anal mucinous adenocarcinoma
HP:0025387,Pill-rolling tremor
NCBIGene:504769,CYP2B6
HGNC:2711,DCTN1
chembl:CHEMBL601351,CHEMBL601351
chembl:CHEMBL1574420,CHEMBL1574420
chembl:CHEMBL151,LUTEOLIN
HGNC:7707,NDUFS1
MONDO:0800301,Friedreich ataxia with retained reflexes
HGNC:4281,GJA8
MGI:2147616,Otub1
HGNC:4573,GRIA3
MONDO:0054835,classic dopamine transporter deficiency syndrome
chembl:CHEMBL1201328,CARPHENAZINE
HP:0100806,Sepsis
chembl:CHEMBL1201356,METHYLERGONOVINE
chembl:CHEMBL379300,A-443654
HP:0031936,Delayed ability to walk
CHEBI:45951,trifluoperazine
HP:0031759,Basic constant esotropia
chembl:CHEMBL532412,CHEMBL532412
MONDO:0003827,transient hypogammaglobulinemia
GO:0031045,dense core granule
HP:0025711,Convergence-retraction nystagmus
HGNC:21156,PCGF6
HGNC:10886,SIRT2
HGNC:171,ACVR1
HGNC:93,ACAT1
HGNC:4855,HDC
wikidata:Q47521966,PARNATE
chembl:CHEMBL1967878,CENISERTIB
HGNC:10012,RHO
HGNC:5331,NOD2
HGNC:6037,ILF2
HGNC:10853,SHOX
chembl:CHEMBL1077259,BISLEUCONOTHINE A
chembl:CHEMBL418134,BUNITROLOL
chembl:CHEMBL2137530,SERDEMETAN
HGNC:812,ATP2A2
ZFIN:ZDB-GENE-040912-101,suclg1
HP:0000742,Self-mutilation
ZFIN:ZDB-GENE-030131-3157,dhodh
MONDO:0010820,autosomal recessive juvenile Parkinson disease 2
chembl:CHEMBL3360203,PILARALISIB
HGNC:12825,XPO1
GO:0042589,zymogen granule membrane
chembl:CHEMBL297812,YONDELIS
chembl:CHEMBL2103858,NARONAPRIDE
MONDO:0010422,Alzheimer disease 16
HGNC:7587,MYL6
MONDO:0005402,lymphoid leukemia
HGNC:9792,RAB9A
chembl:CHEMBL266195,ALPRENOLOL
NCBIGene:488165,SLC2A2
HGNC:18224,ZRANB1
NCBIGene:327680,NDUFS4
HGNC:7745,NEK2
CHEBI:77315,spectinomycin(2+)
MONDO:0014381,"cholestasis, progressive familial intrahepatic, 4"
HGNC:6515,LATS2
HGNC:3498,MECOM
HGNC:6183,ITSN1
UBERON:0001637,artery
HP:0006934,Congenital nystagmus
CHEBI:50401,cholestanoid
chembl:CHEMBL365795,TIAPROFENIC ACID
HGNC:22222,TTYH3
CHEBI:133011,oxytetracycline zwitterion
HP:0034335,Inheritance qualifier
MONDO:0015129,chronic primary adrenal insufficiency
chembl:CHEMBL4298094,ARCHEXIN
HGNC:4580,GRIK2
MONDO:0020774,Menke-Hennekam syndrome
chembl:CHEMBL1366933,ESMIRTAZAPINE
HGNC:19836,KLHDC1
PATO:0000389,acute
NCBIGene:281597,ACTR3
HGNC:3287,EIF4E
chembl:CHEMBL454,BUTALBITAL
HP:0031908,Micrographia
HGNC:569,AP3M1
HGNC:8806,PDHA1
MONDO:0006025,autosomal recessive disease
MONDO:0008727,congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency
chembl:CHEMBL84685,CHEMBL84685
Reactome:R-CFA-611105,Respiratory electron transport
HP:0002039,Anorexia
chembl:CHEMBL351585,PAPAVEROLINE
HP:0011446,Abnormality of mental function
CHEBI:34997,teicoplanin A2-4
HGNC:17327,WAC
HP:0012391,Hyporeflexia of upper limbs
HGNC:17810,AMOT
MONDO:0002057,breast leiomyoma
HP:0003298,Spina bifida occulta
chembl:CHEMBL4297264,BENZODIAZEPINE
HGNC:13481,UNC93B1
FB:FBgn0004168,5-HT1A
HGNC:24284,TRAPPC12
chembl:CHEMBL215152,AZD-1152-HQPA
HGNC:15870,RAB5IF
HGNC:8091,OAT
MONDO:0002032,colon carcinoma
HGNC:7112,MKRN1
MONDO:0018996,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2"
HP:0025404,Abnormal visual fixation
UBERON:0001264,pancreas
HP:0007001,Loss of Purkinje cells in the cerebellar vermis
chembl:CHEMBL1518159,3-METHOXYCATECHOL
chembl:CHEMBL412603,CHEMBL412603
chembl:CHEMBL1341,METHOXYFLURANE
HGNC:327,AGPS
MONDO:0019409,idiopathic juvenile osteoporosis
chembl:CHEMBL844,BRIMONIDINE
CHEBI:16831,3-hydroxy-3-methylglutaric acid
chembl:CHEMBL33859,CHEMBL33859
chembl:CHEMBL145,CAFFEIC ACID
chembl:CHEMBL600694,CHEMBL600694
CHEBI:72588,semisynthetic derivative
MONDO:0011194,Alzheimer disease 5
HGNC:6207,JUP
HGNC:652,ARF1
MONDO:0012358,"leprosy, susceptibility to, 1"
HP:0001249,Intellectual disability
HP:0002059,Cerebral atrophy
GO:0005353,fructose transmembrane transporter activity
HGNC:7128,MLH3
MONDO:0100191,inherited kidney disorder
chembl:CHEMBL11359,CISPLATIN
FB:FBgn0010329,Tbh
HGNC:9284,PPP1R10
HP:0001266,Choreoathetosis
HGNC:12023,TPTE
chembl:CHEMBL1434513,NOREPINEPHRINE BITARTRATE
MONDO:0011489,hereditary spastic paraplegia 12
chembl:CHEMBL605525,DP001
chembl:CHEMBL528791,CHEMBL528791
chembl:CHEMBL1171837,PONATINIB
HP:0005110,Atrial fibrillation
HGNC:18068,SLC15A3
HGNC:23595,VPS13D
chembl:CHEMBL111743,STROPHANTHIDIN
HP:0033063,Shortened sleep cycle
HGNC:8905,PGM1
HGNC:649,ARCN1
chembl:CHEMBL129,ZIDOVUDINE
MONDO:0033369,"developmental and epileptic encephalopathy, 60"
chembl:CHEMBL285674,ESTAZOLAM
HP:0007074,Thick corpus callosum
HP:0001760,Abnormal foot morphology
RGD:3706,Slc2a3
HGNC:17819,NT5C1A
HGNC:7603,MYO5B
chembl:CHEMBL63055,ALRESTATIN
GO:0008645,hexose transmembrane transport
HP:0004374,Hemiplegia/hemiparesis
CHEBI:48422,angiogenesis inhibitor
HGNC:4384,GNAI1
chembl:CHEMBL580381,CHEMBL580381
CHEBI:35352,organonitrogen compound
GO:0061486,high-affinity fructose transmembrane transporter activity
MONDO:0018908,non-Hodgkin lymphoma
chembl:CHEMBL2107841,ALBIGLUTIDE
HGNC:9205,PON2
HP:0000113,Polycystic kidney dysplasia
chembl:CHEMBL61511,PERFOSFAMIDE
chembl:CHEMBL29757,D-ASPARTATE
chembl:CHEMBL340807,HARMALINE
CHEBI:133580,N-hexanoylglycinate
MONDO:0014601,autosomal recessive spinocerebellar ataxia 20
MONDO:0005071,nervous system disorder
CHEBI:71392,tetracycline(1-)
NCBIGene:477762,HTR7
MONDO:0013886,cerebellar dysfunction with variable cognitive and behavioral abnormalities
HGNC:24912,LARP7
chembl:CHEMBL531048,PHANQUONE
chembl:CHEMBL1393,SPIRONOLACTONE
chembl:CHEMBL34241,ROTTLERIN
chembl:CHEMBL839,CARTEOLOL
MONDO:0008383,rheumatoid arthritis
chembl:CHEMBL592123,CHEMBL592123
HGNC:3438,ERCC6
HGNC:7499,MT-TT
HP:0004305,Involuntary movements
GO:0047496,vesicle transport along microtubule
HP:0002600,Hyporeflexia of lower limbs
HGNC:20452,INSIG2
HGNC:19383,SOCS1
HGNC:12833,XRCC5
CHEBI:16347,(R)-carnitine
HGNC:5164,HPSE
CHEBI:67194,cannabinoid
chembl:CHEMBL121,ROSIGLITAZONE
MONDO:0012721,progressive myoclonic epilepsy type 3
wikidata:Q47521502,DOXIL
HGNC:2899,DLEC1
HGNC:10021,RIPK3
chembl:CHEMBL13045,CHELERYTHRINE
MONDO:0012050,major depressive disorder 1
HGNC:239,ADCY8
HP:0008026,Horizontal opticokinetic nystagmus
HGNC:16731,FBXO32
HP:0000758,Abnormal nonverbal communicative behavior
chembl:CHEMBL2105160,NAMINIDIL
HGNC:16394,CARD6
HGNC:30677,GPKOW
MONDO:0008723,very long chain acyl-CoA dehydrogenase deficiency
HGNC:9993,RGS11
MONDO:0003819,childhood teratoma of the ovary
chembl:CHEMBL1256661,PROPIONYLPROMAZINE HYDROCHLORIDE
chembl:CHEMBL2386346,RO-5045337
chembl:CHEMBL501617,IONOMYCIN
MONDO:0000980,aortic atherosclerosis
UBERON:0013554,Brodmann (1909) area 23
chembl:CHEMBL1215,PHENYLEPHRINE
HGNC:14550,CDHR1
HGNC:21077,CMTR1
HGNC:23513,USP54
HGNC:6047,IMMT
HGNC:30793,EIF5B
chembl:CHEMBL1613209,CEAROIN
HGNC:869,ATP7A
HGNC:16974,SRCAP
HP:0010951,Abnormal third ventricle morphology
HGNC:10332,RPL3
ZFIN:ZDB-GENE-031118-95,idh2
chembl:CHEMBL1371696,CHEMBL1371696
HGNC:28204,NTPCR
chembl:CHEMBL477989,SB590885
chembl:CHEMBL395091,ESKETAMINE
HP:0007141,Sensorimotor neuropathy
HGNC:3788,FOLH1
HGNC:4396,GNB1
HGNC:10894,PRMT5
MONDO:0013776,spastic ataxia 5
chembl:CHEMBL1256028,FIDUXOSIN HYDROCHLORIDE
chembl:CHEMBL590,MENADIONE
HGNC:34528,TOMM6
CHEBI:46640,diketone
HGNC:11151,SNRPA
GO:0017022,myosin binding
chembl:CHEMBL1200875,FLAVOXATE HYDROCHLORIDE
HGNC:11934,TNFSF4
chembl:CHEMBL530291,CHEMBL530291
chembl:CHEMBL4297489,CXD-101
HP:0000124,Renal tubular dysfunction
HGNC:6079,INPP5D
HGNC:7133,KMT2D
chembl:CHEMBL574737,UCN-01
MONDO:0002419,transient tic disorder
MONDO:0011716,acute hemorrhagic leukoencephalitis
HP:0034345,Mendelian inheritance
MONDO:0008049,"myopathy, distal, infantile-onset"
HP:0002730,Chronic noninfectious lymphadenopathy
chembl:CHEMBL89250,CHEMBL89250
chembl:CHEMBL271227,ABIRATERONE ACETATE
HGNC:9891,RBBP8
HP:0003596,Middle age onset
GO:0004639,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity
MONDO:0024476,epithelial neoplasm of rectum
MONDO:0002764,urethra squamous cell carcinoma
GO:0140735,lovastatin biosynthetic process
HGNC:29434,RC3H1
HP:0033252,Palmar hyperlinearity
HGNC:9950,RECQL5
HGNC:12393,TTC3
UBERON:0001965,substantia nigra pars compacta
chembl:CHEMBL2105763,QUISINOSTAT
HP:0031422,Abnormal cerebellar cortex morphology
HGNC:411,ALDH3B2
chembl:CHEMBL265715,CHEMBL265715
MONDO:0013764,Joubert syndrome 16
HGNC:2240,COPS5
chembl:CHEMBL263664,CHEMBL263664
HP:0003560,Muscular dystrophy
MONDO:0013477,hypertrophic cardiomyopathy 20
chembl:CHEMBL267345,AMPHOTERICIN B
HP:0200147,Neuronal loss in basal ganglia
HGNC:758,ASS1
HP:0002066,Gait ataxia
GO:0098858,actin-based cell projection
HGNC:7064,MGST3
MONDO:0003630,pancreatic serous cystadenocarcinoma
CHEBI:18243,dopamine
HGNC:27110,ANKRD29
MONDO:0020074,progressive myoclonus epilepsy
MONDO:0006658,arteriolosclerosis
MONDO:0005661,babesiosis
HP:0012187,Increased erythrocyte protoporphyrin concentration
MONDO:0018044,idiopathic hypersomnia
HGNC:11804,TIAL1
CHEBI:50427,platelet aggregation inhibitor
HGNC:3811,FOXG1
MONDO:0002562,demyelinating disease
HGNC:16205,MGME1
HGNC:11585,TBL1X
HP:0009830,Peripheral neuropathy
chembl:CHEMBL586031,CHEMBL586031
HGNC:5017,HMX1
chembl:CHEMBL1098427,HIPPURISTANOL
MONDO:0957819,"arthrogryposis, distal, type 12"
CHEBI:5615,halothane
HGNC:9602,PTGIR
chembl:CHEMBL723,CARVEDILOL
HGNC:620,APP
chembl:CHEMBL127579,CHEMBL127579
chembl:CHEMBL2386889,SCH-900776
chembl:CHEMBL422,TRIFLUOPERAZINE
chembl:CHEMBL67,COMBRETASTATIN A4
HGNC:6025,CXCL8
MONDO:0007110,Diamond-Blackfan anemia 1
HGNC:68,ABCD4
HP:0030842,Choking episodes
HGNC:393,AKT3
MONDO:0003735,central nervous system immature teratoma
HGNC:14561,ARHGEF9
chembl:CHEMBL1554531,4-METHOXYDALBERGIONE
CHEBI:16737,creatinine
HGNC:13353,MAP1LC3C
HGNC:7695,NDUFB1
HGNC:7843,NMBR
chembl:CHEMBL1200478,DYCLONINE HYDROCHLORIDE
HGNC:17376,AK3
HGNC:11524,TACC3
MONDO:0005134,experimental autoimmune encephalomyelitis
chembl:CHEMBL288441,BOSUTINIB
dictyBase:DDB_G0286545,vps13D
chembl:CHEMBL2110727,CENICRIVIROC
HGNC:11104,SMARCC1
HGNC:7783,NFE2L3
chembl:CHEMBL4297361,1.ALPHA.-HYDROXYVITAMIN D5
chembl:CHEMBL1328898,MELEVODOPA
MONDO:0019436,psoriasis-related juvenile idiopathic arthritis
MONDO:0002184,drug-induced hepatitis
HGNC:3381,EPB42
HP:0007289,Limb fasciculations
MONDO:0001358,bronchial disorder
chembl:CHEMBL224214,CARBONYL CYANIDE M-CHLOROPHENYLHYDRAZONE
HP:0007221,Progressive truncal ataxia
chembl:CHEMBL1255835,DIAMIDE
chembl:CHEMBL1078442,BERGAMOTTIN
HGNC:25716,COA7
chembl:CHEMBL541887,IRINOTECAN HYDROCHLORIDE
chembl:CHEMBL17423,VESNARINONE
UBERON:0001154,vermiform appendix
chembl:CHEMBL596380,CHEMBL596380
MONDO:0009049,Cushing syndrome due to macronodular adrenal hyperplasia
MONDO:0010185,methylmalonic aciduria and homocystinuria type cblD
HP:0007166,Paroxysmal dyskinesia
chembl:CHEMBL11417,STREPTONIGRIN
HGNC:7808,NGF
chembl:CHEMBL3989926,SITRAVATINIB
chembl:CHEMBL97858,CHEMBL97858
HP:0003325,Limb-girdle muscle weakness
HP:0008000,Decreased corneal reflex
chembl:CHEMBL296586,KENPAULLONE
chembl:CHEMBL2103851,AMUVATINIB
chembl:CHEMBL1201532,THYROTROPIN
HP:0010505,Limitation of movement at ankles
MONDO:0019794,autosomal dominant cerebellar ataxia type IV
HGNC:20663,SLC25A25
HP:0000550,Undetectable electroretinogram
HGNC:115,ACLY
NCBIGene:506370,CYB5B
HP:0007269,Spinal muscular atrophy
HGNC:30688,CAND1
chembl:CHEMBL671,THIOTEPA
chembl:CHEMBL2348314,TYROSOL SINAPATE
MONDO:0018945,McLeod neuroacanthocytosis syndrome
MONDO:0021327,carcinoma of urethra
MONDO:0002286,renal artery disease
HGNC:2649,CYP51A1
chembl:CHEMBL581865,CHEMBL581865
HGNC:3670,FGF13
HGNC:2671,DAO
UBERON:0004991,mucosa of transverse colon
chembl:CHEMBL505670,CHEMBL505670
HGNC:11159,SNRPD2
HGNC:18618,LRRK2
chembl:CHEMBL1230609,FORETINIB
chembl:CHEMBL443683,TELOMESTATIN
MONDO:0002487,breast granular cell tumor
MGI:103262,Yap1
MONDO:0009502,pyruvate dehydrogenase E2 deficiency
NCBIGene:533445,ARNT2
HGNC:14180,PDIA2
chembl:CHEMBL1908360,EVEROLIMUS
chembl:CHEMBL1213492,GIVINOSTAT
MONDO:0024189,"neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset"
NCBIGene:537713,SUCLG2
HGNC:391,AKT1
HGNC:12932,TRIM25
MONDO:0010444,X-linked dyserythropoetic anemia with abnormal platelets and neutropenia
GO:0015407,ABC-type monosaccharide transporter activity
MONDO:0021427,squamous cell carcinoma of lip
chembl:CHEMBL99408,CHEMBL99408
HP:0002353,EEG abnormality
HGNC:26709,SCAI
HGNC:21063,MOXD1
HP:0001167,Abnormal finger morphology
MGI:1913362,Mtarc1
chembl:CHEMBL1241855,RIGOSERTIB
MONDO:0700007,idiopathic disease
chembl:CHEMBL359164,TROXACITABINE
HGNC:1908,VPS13A
CHEBI:16796,melatonin
chembl:CHEMBL565893,CHEMBL565893
HGNC:17587,MTCH2
chembl:CHEMBL41275,CHEMBL41275
HP:0033748,Hypoesthesia
HGNC:1956,CHRNA2
UBERON:0001007,digestive system
chembl:CHEMBL533954,CHEMBL533954
HP:0007159,Fluctuations in consciousness
HGNC:25419,ARL13B
HGNC:21652,OSTM1
CHEBI:15816,D-arginine
chembl:CHEMBL1092743,CHEMBL1092743
chembl:CHEMBL274826,ANDROSTENEDIONE
MONDO:0020173,benign tumor of palpebral epidermis
HP:0002344,Progressive neurologic deterioration
FB:FBgn0263116,5-HT1B
HP:0012001,EEG with generalized polyspikes
chembl:CHEMBL546649,CHEMBL546649
chembl:CHEMBL555017,GAMBOGIC ACID
HP:0007979,Gaze-evoked horizontal nystagmus
HGNC:2631,CYP2E1
ZFIN:ZDB-GENE-050320-87,ndufc2
HGNC:3155,ECT2
HP:0002069,Bilateral tonic-clonic seizure
HP:0003687,Centrally nucleated skeletal muscle fibers
chembl:CHEMBL2110670,VABICASERIN
HP:0410153,Increased level of methylsuccinic acid in urine
chembl:CHEMBL499,TIMOLOL
HP:0031956,Elevated circulating aspartate aminotransferase concentration
CHEBI:50919,antiemetic
HP:0011394,Hypoplasia of the vestibular nerve
HGNC:6883,MAPK8IP2
chembl:CHEMBL578502,CHEMBL578502
HGNC:6893,MAPT
HGNC:735,ASAH1
HGNC:10943,SLC1A5
chembl:CHEMBL519873,PYRACLOSTROBIN
HGNC:12619,USP20
MONDO:0004186,cranial nodular fasciitis
HGNC:24526,ATL3
chembl:CHEMBL114544,CHEMBL114544
CHEBI:37325,alloxazine
HGNC:251,ADH1C
chembl:CHEMBL465980,ONONIN
MONDO:0020683,acute disease
HGNC:16090,PGRMC1
HGNC:6859,MAP3K7
HP:0002179,Opisthotonus
MONDO:0000706,chemical colitis
CHEBI:19168,17-oxo steroid
MONDO:0010796,"Parkinson disease, mitochondrial"
chembl:CHEMBL405355,NIGULDIPINE
MONDO:0016489,delta-beta-thalassemia
chembl:CHEMBL252925,GAMMA-FAGARINE
NCBIGene:444878,COX5A
MONDO:0014737,dehydrated hereditary stomatocytosis 2
GO:0035577,azurophil granule membrane
GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding
HP:5200044,Reduced attention regulation
HGNC:5302,HTR7
MONDO:0007256,hepatocellular carcinoma
chembl:CHEMBL591834,CHEMBL591834
HGNC:26486,CNST
chembl:CHEMBL599088,CHEMBL599088
FB:FBgn0024994,Ugalt
HGNC:2976,DNMT1
chembl:CHEMBL258767,CHEMBL258767
HGNC:34,ABCA4
CHEBI:68489,"alkyl,acyl-sn-glycero-3-phosphocholine"
chembl:CHEMBL1522,ESZOPICLONE
HGNC:7763,NEUROD2
chembl:CHEMBL278041,SB-202190
CHEBI:33572,resorcinols
HGNC:24229,CIDEC
HGNC:3350,ENO1
chembl:CHEMBL530361,CHEMBL530361
HGNC:6525,LCN1
HGNC:2018,CLCA4
MONDO:0009066,juvenile nephropathic cystinosis
MONDO:0021534,rectal neuroendocrine tumor G1
HGNC:6664,LOX
HGNC:428,ALMS1
MONDO:0007200,blepharonasofacial malformation syndrome
UBERON:0000989,penis
HGNC:1361,AOPEP
CHEBI:33853,phenols
MONDO:0010456,"renal cell carcinoma, Xp11-associated"
HGNC:9243,PPEF1
chembl:CHEMBL2354444,PIRARUBICIN
HP:0001629,Ventricular septal defect
chembl:CHEMBL1042,CHOLECALCIFEROL
HGNC:1837,CEBPG
HGNC:6541,LDHB
HP:0002487,Hyperkinetic movements
HP:0011856,Pica
MONDO:0020590,mycobacterial infectious disease
GO:0005929,cilium
CHEBI:192979,nystatin A2
HP:0000750,Delayed speech and language development
chembl:CHEMBL3545424,AZD-8186
MONDO:0004139,normocytic anemia
Reactome:R-BTA-71288,Creatine metabolism
MGI:2449818,Cyp3a44
MONDO:0011743,Alzheimer disease 4
HGNC:8533,P2RX1
HGNC:21146,ZMYND19
MGI:1891917,Ywhab
MGI:1347062,Creb3l1
HGNC:8983,PI4KA
HP:0007042,Focal white matter lesions
HGNC:6484,LAMA4
chembl:CHEMBL1255778,BENSERAZIDE HYDROCHLORIDE
HGNC:3363,ENTPD1
HGNC:4398,GNB2
MONDO:0004538,endocervical type cervical mucinous adenocarcinoma
chembl:CHEMBL17442,CHEMBL17442
chembl:CHEMBL363648,TAK-715
chembl:CHEMBL12948,SEMUSTINE
chembl:CHEMBL388823,CHEMBL388823
chembl:CHEMBL1332032,TRIFLUSAL
CHEBI:22984,calcium atom
chembl:CHEMBL3545007,RG-7602
HGNC:3072,DUSP6
HGNC:7576,MYH6
HGNC:27302,IBA57
ZFIN:ZDB-GENE-050706-62,rcn2
GO:0014012,peripheral nervous system axon regeneration
HGNC:811,ATP2A1
chembl:CHEMBL109480,TANESPIMYCIN
MONDO:0956979,nocturnal asthma
HP:0010866,Abdominal wall defect
chembl:CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE
GO:0019194,sorbose transmembrane transporter activity
HGNC:7501,MT-TW
MONDO:0009268,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
UBERON:0003027,cingulate cortex
HGNC:15472,ALDH1A2
HGNC:26927,FOXRED1
chembl:CHEMBL1201002,CARTEOLOL HYDROCHLORIDE
HP:0031931,Ocular flutter
chembl:CHEMBL581872,CHEMBL581872
MGI:1923322,Rnf183
HGNC:11447,STYX
MONDO:0016810,autosomal recessive progressive external ophthalmoplegia
FB:FBgn0000043,Act42A
CHEBI:600103,daptomycin
WB:WBGene00011559,umps-1
WB:WBGene00001053,dop-2
CHEBI:47724,vancomycin aglycone
chembl:CHEMBL1448,NICLOSAMIDE
HGNC:1349,SAMD9L
WB:WBGene00013132,strd-1
HP:0001369,Arthritis
chembl:CHEMBL1579,PARAMETHASONE
HGNC:20090,DNAJC1
HGNC:6898,MARS1
HGNC:7670,NCOA3
CHEBI:25179,melanins
CHEBI:24995,lactam
MONDO:0010283,syndromic X-linked intellectual disability Lubs type
chembl:CHEMBL2356023,DIHYDROTACHYSTEROL
NCBIGene:421447,EPHX1L
chembl:CHEMBL1200810,DOXERCALCIFEROL
HP:0008935,Generalized neonatal hypotonia
Reactome:R-CEL-500753,Pyrimidine biosynthesis
chembl:CHEMBL1909300,HEPARIN
PR:000007497,fibroblast growth factor 6
HGNC:13815,BCO1
MONDO:0016681,gliosarcoma
CHEBI:28304,heparin
chembl:CHEMBL689,MANNITOL
chembl:CHEMBL577660,CHEMBL577660
HGNC:16712,FBXW7
HGNC:2859,DHCR24
HGNC:5042,HNRNPH2
chembl:CHEMBL705,ALITRETINOIN
chembl:CHEMBL1367746,CLOFENOXYDE
chembl:CHEMBL275665,ICRF-193
HGNC:19104,NPHP4
HGNC:386,AKR1C3
MONDO:0025699,Coffin-Siris syndrome 12
MONDO:0044319,"intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies"
HP:0004906,Hypernatremic dehydration
HGNC:29932,COASY
chembl:CHEMBL480477,GLABRIDIN
chembl:CHEMBL27006,CHEMBL27006
MONDO:0013208,cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome
HGNC:17964,RDH11
HP:0001272,Cerebellar atrophy
CL:0000576,monocyte
chembl:CHEMBL121626,TOLFENAMIC ACID
HP:0007286,Horizontal jerk nystagmus
HP:0002133,Status epilepticus
HP:0000193,Bifid uvula
HP:0010851,EEG with burst suppression
CL:0000182,hepatocyte
HGNC:1391,CACNA1D
HGNC:21062,FARS2
CHEBI:6076,itraconazole
HP:0002448,Progressive encephalopathy
MONDO:0100231,"psoriatic arthritis, susceptibility to, 1"
chembl:CHEMBL3545144,TAS-115
MONDO:0033135,"Charcot-Marie-Tooth disease, demyelinating, type 1G"
chembl:CHEMBL1546223,CHEMBL1546223
HGNC:12612,USP14
UBERON:0002030,nipple
UPHENO:0080594,abnormal social behavior
GO:0030424,axon
chembl:CHEMBL545,ALCOHOL
HP:0011442,Abnormal central motor function
HP:0000708,Atypical behavior
HP:0001285,Spastic tetraparesis
chembl:CHEMBL1458880,CADMIUM DICHLORIDE
chembl:CHEMBL579550,CHEMBL579550
chembl:CHEMBL1200705,HYDROXYAMPHETAMINE HYDROBROMIDE
chembl:CHEMBL190412,TEGLARINAD CHLORIDE
HP:0006929,Hypoglycemic encephalopathy
HGNC:1395,CACNA1H
HP:0002365,Hypoplasia of the brainstem
MONDO:0001641,severe pre-eclampsia
UPHENO:0079831,abnormal visual pursuit
MONDO:0002086,clear cell acanthoma
HP:0030215,Inappropriate crying
HGNC:9717,PEX2
HGNC:12774,WNT1
UPHENO:0003586,abnormal vestibulocochlear nerve
chembl:CHEMBL525191,CHEMBL525191
MONDO:0020352,"multiple system atrophy, parkinsonian type"
MGI:1351646,Abca7
MONDO:0002158,fallopian tube cancer
HGNC:11278,SPTLC2
HGNC:26784,MTRFR
GO:0005185,neurohypophyseal hormone activity
chembl:CHEMBL75967,PENTACHLOROPHENOL
HGNC:6341,KISS1
HGNC:28746,FUNDC1
Reactome:R-HSA-196783,Coenzyme A biosynthesis
chembl:CHEMBL1514715,ETHAMSYLATE
chembl:CHEMBL460433,CALPHOSTIN C
MONDO:0004104,splenic manifestation of hairy cell leukemia
HGNC:939,BAG3
MONDO:0014864,hypermanganesemia with dystonia 2
UPHENO:0071137,absent reflex in pelvic complex
HGNC:30626,YTHDC1
HGNC:19962,ATG14
chembl:CHEMBL1270168,CHEMBL1270168
chembl:CHEMBL276711,SEMAXANIB
chembl:CHEMBL592124,CHEMBL592124
CHEBI:17810,1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine
HGNC:11448,SUCLA2
chembl:CHEMBL252556,IDEBENONE
HP:0001644,Dilated cardiomyopathy
HGNC:12640,UVRAG
chembl:CHEMBL1332616,ERYTHROSINE
GO:0003700,DNA-binding transcription factor activity
chembl:CHEMBL89977,CHEMBL89977
MONDO:0018130,brain dopamine-serotonin vesicular transport disease
chembl:CHEMBL2104926,CINOLAZEPAM
RGD:1561555,Fancb
HP:0003073,Hypoalbuminemia
HP:0012671,Abulia
HP:0002621,Atherosclerosis
HGNC:29186,ANKRD26
chembl:CHEMBL1200363,PENBUTOLOL SULFATE
chembl:CHEMBL317869,CHEMBL317869
GO:0098708,glucose import across plasma membrane
HGNC:11828,TJP2
WB:WBGene00012929,rsks-1
chembl:CHEMBL61350,CYSTAMINE
HP:0007301,Oromotor apraxia
HGNC:30829,TUBB2B
HGNC:11926,TNFSF11
ZFIN:ZDB-GENE-040822-17,sdhdb
chembl:CHEMBL685,MEBENDAZOLE
CHEBI:46920,N-methylpiperazine
chembl:CHEMBL1161520,CHEMBL1161520
HP:0002322,Resting tremor
MONDO:0044332,childhood-onset benign chorea with striatal involvement
GO:0016521,pituitary adenylate cyclase activating polypeptide activity
MONDO:0021063,malignant colon neoplasm
GO:0015757,galactose transmembrane transport
HGNC:26261,LRRC31
HP:0004298,Abnormality of the abdominal wall
UBERON:0000002,uterine cervix
HGNC:21033,HACE1
chembl:CHEMBL457504,CHEMBL457504
GO:0042092,type 2 immune response
chembl:CHEMBL1911631,YUANHUADINE
HGNC:10548,ATXN1
MONDO:0009319,pantothenate kinase-associated neurodegeneration
MONDO:0024495,"tumor grade 1 or 2, general grading system"
CHEBI:57670,N-acylglycinate
Reactome:R-HSA-211945,Phase I - Functionalization of compounds
MONDO:0020482,myotonia permanens
chembl:CHEMBL1691,BETAXOLOL HYDROCHLORIDE
HGNC:2584,CYLD
HGNC:30579,SSH1
UBERON:0002106,spleen
MONDO:0032865,"pulmonary fibrosis and/or bone marrow failure, telomere-related, 5"
chembl:CHEMBL1255944,CHEMBL1255944
chembl:CHEMBL1094,FELBAMATE
chembl:CHEMBL307341,AURAPTENE
chembl:CHEMBL570,TRIFLUPROMAZINE
HP:0003722,Neck flexor weakness
MONDO:0100096,COVID-19
HP:0011150,Myoclonic absence seizure
chembl:CHEMBL2368924,DOLASETRON MESYLATE
HGNC:4776,H3C2
HGNC:6263,KCNJ2
HGNC:3951,FXN
MONDO:0002765,plantar verrucous skin carcinoma
CHEBI:133131,spiro-epoxide
HP:0100951,Enlarged fossa interpeduncularis
UBERON:0000955,brain
MONDO:0958095,"Nodal T-follicular helper cell lymphoma, follicular type"
HGNC:11543,TAF10
HGNC:946,MAGI1
chembl:CHEMBL221733,CHEMBL221733
HGNC:10421,RPS3A
chembl:CHEMBL1200332,PROTRIPTYLINE HYDROCHLORIDE
chembl:CHEMBL1679,LEUCOVORIN
HGNC:89,ACADM
HGNC:2661,DAB1
CHEBI:63611,moxifloxacin
chembl:CHEMBL31741,CHEMBL31741
CHEBI:72564,temozolomide
HGNC:23782,POLDIP3
chembl:CHEMBL799,CILOSTAZOL
chembl:CHEMBL441282,PROPYLPYRAZOLETRIOL
HP:0002936,Distal sensory impairment
chembl:CHEMBL3707401,MK-8777
HP:0009886,Trichorrhexis nodosa
chembl:CHEMBL515914,AZARIBINE
chembl:CHEMBL29741,IRAMPANEL
HGNC:395,ALAD
MONDO:0044299,"myasthenic syndrome, congenital, 22"
HGNC:9099,PLXNA1
HGNC:67,ABCD3
chembl:CHEMBL56731,CHEMBL56731
MONDO:0002060,intraductal papilloma
HGNC:5286,HTR1A
MONDO:0013903,"nystagmus 7, congenital, autosomal dominant"
WB:WBGene00012536,Y37A1A.3
HGNC:11580,TBCC
MONDO:0017283,DeSanto-Shinawi Syndrome due to 10p11.21p12.31 microdeletion
GO:0005359,low-affinity glucose:proton symporter activity
MONDO:0030355,"facioscapulohumeral muscular dystrophy 4, digenic"
chembl:CHEMBL894,BUPROPION
wikidata:Q31686490,ANDROSTANOLONE
chembl:CHEMBL444186,RAZOXANE
HGNC:18276,SEC61A1
UBERON:0007808,adipose tissue of abdominal region
chembl:CHEMBL563919,CHEMBL563919
MONDO:0859224,intellectual disability and myopathy syndrome
MONDO:0016369,Rothmund-Thomson syndrome type 2
HGNC:25358,RNF170
HP:0000646,Amblyopia
chembl:CHEMBL1200843,METHYLERGONOVINE MALEATE
HGNC:12827,XPR1
HGNC:9588,PTEN
GO:0046332,SMAD binding
MONDO:0004765,intrinsic asthma
MGI:103293,Ptpn13
HGNC:3689,FGFR2
MONDO:0014096,microcephaly-intellectual disability-phalangeal and neurological anomalies syndrome
HP:0007123,Subcortical dementia
GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific"
FB:FBgn0037643,ScsβA
HGNC:3573,FADD
MONDO:0004877,transient neonatal thrombocytopenia
HP:0000716,Depression
HP:0031958,Spastic paraparetic gait
MONDO:0012850,hypophosphatemic nephrolithiasis/osteoporosis 1
HGNC:11277,SPTLC1
chembl:CHEMBL3545195,LY-3009120
CHEBI:132130,hydroxyquinone
MONDO:0019771,oromandibular dystonia
HGNC:9081,PLOD1
MONDO:0008943,autosomal recessive spinocerebellar ataxia 2
HGNC:2676,DAPK3
HGNC:10252,ROCK2
chembl:CHEMBL66279,CHEMBL66279
chembl:CHEMBL452231,TENIPOSIDE
HP:0008278,Cerebellar cortical atrophy
HGNC:6901,MASP1
HP:0030147,Truncal titubation
chembl:CHEMBL538965,CHEMBL538965
Reactome:R-CFA-211945,Phase I - Functionalization of compounds
chembl:CHEMBL527620,CHEMBL527620
HGNC:2843,DGAT1
MONDO:0003734,adult central nervous system immature teratoma
HGNC:4204,GCNT2
HGNC:17663,PITRM1
HGNC:2623,CYP2C9
chembl:CHEMBL16312,4'-METHOXYFLAVONE
chembl:CHEMBL1610591,AMCINAFIDE
HGNC:9208,POR
chembl:CHEMBL502835,NINTEDANIB
chembl:CHEMBL1200485,SORAFENIB TOSYLATE
HGNC:13408,PDCD11
chembl:CHEMBL486422,DAIDZIN
UBERON:0001765,mammary duct
WB:WBGene00004860,sma-6
MONDO:0004481,pancreatic intraductal papillary-mucinous neoplasm with an associated invasive carcinoma
HGNC:7691,NDUFA7
HGNC:26075,PIH1D1
HGNC:12877,ZMPSTE24
CL:0000094,granulocyte
chembl:CHEMBL55400,PROFLAVINE
chembl:CHEMBL43064,CINNARIZINE
chembl:CHEMBL1869551,CHLORFENAPYR
chembl:CHEMBL1801219,CHEMBL1801219
MONDO:0012812,"developmental and epileptic encephalopathy, 4"
HGNC:43984,HELLPAR
MONDO:0019791,recessive mitochondrial ataxia syndrome
HP:0002013,Vomiting
HGNC:4778,H3-4
chembl:CHEMBL15192,LAPACHONE
HGNC:7660,NCF1
CHEBI:17154,nicotinamide
HGNC:2285,COX6C
HGNC:11022,SLC35A2
chembl:CHEMBL582073,CHEMBL582073
MONDO:0009419,Woodhouse-Sakati syndrome
chembl:CHEMBL217354,CHEMBL217354
HGNC:12515,UCHL3
HP:0020046,Accommodative esotropia
HGNC:17170,TRUB2
GO:0043279,response to alkaloid
chembl:CHEMBL728,PROCHLORPERAZINE
CHEBI:17002,cholesteryl ester
chembl:CHEMBL1440,TETRACYCLINE
HP:0001999,Abnormal facial shape
CHEBI:48339,"1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine"
MONDO:0040998,Pasteurella multocida infectious disease
HGNC:16077,DUSP22
GO:0045944,positive regulation of transcription by RNA polymerase II
HGNC:9462,PRPS1
HGNC:4274,GJA1
chembl:CHEMBL580727,CHEMBL580727
chembl:CHEMBL41,FLUOXETINE
chembl:CHEMBL1517651,HYDRASTININE HYDROCHLORIDE
chembl:CHEMBL334533,DEXANABINOL
HGNC:9823,RAD51D
HP:0000514,Slow saccadic eye movements
chembl:CHEMBL602987,CHEMBL602987
HP:0007747,Monocular horizontal nystagmus
MONDO:0005498,botulism
MONDO:0004855,tenosynovitis
HGNC:1440,CALCR
chembl:CHEMBL787,MONTELUKAST
HGNC:4415,GNMT
HGNC:5386,IDH3G
chembl:CHEMBL1201533,THYROTROPIN ALFA
Reactome:R-MMU-71288,Creatine metabolism
MONDO:0002269,gastroenteritis
HGNC:17146,ARL2BP
HGNC:28913,HSCB
chembl:CHEMBL1697737,CLOTIAZEPAM
HP:0000176,Submucous cleft hard palate
HGNC:7067,CIITA
GO:0070293,renal absorption
chembl:CHEMBL587856,CHEMBL587856
HGNC:1237,UBQLN4
chembl:CHEMBL3545325,SAR-125844
chembl:CHEMBL1228,OXYPHENBUTAZONE
HP:0020216,Visually-induced seizure
HP:0002060,Abnormal cerebral morphology
chembl:CHEMBL59030,CHEMBL59030
HP:0002317,Unsteady gait
HGNC:24188,SDF4
chembl:CHEMBL930,GLUTAMINE
CHEBI:16189,sulfate
HGNC:34410,NEURL4
MONDO:0000705,Clostridium difficile colitis
CHEBI:36054,benzoate ester
HGNC:4410,GNG7
MONDO:0011240,megalencephaly-capillary malformation-polymicrogyria syndrome
CHEBI:31927,nystatin A3
HP:0031761,Infantile constant esotropia
HP:0000707,Abnormality of the nervous system
MONDO:0006669,bacterial endocarditis
chembl:CHEMBL582439,ZAMPANOLIDE
GO:0006457,protein folding
CHEBI:38070,anti-arrhythmia drug
HP:0002119,Ventriculomegaly
MONDO:0016487,beta-thalassemia intermedia
GO:0005770,late endosome
chembl:CHEMBL77456,TYRPHOSTIN 1
CHEBI:24261,glucocorticoid
HP:0010994,Abnormal corpus striatum morphology
HGNC:1553,CBX3
HGNC:9986,RFX5
CHEBI:22315,alkaloid
chembl:CHEMBL2108361,AMEDIPLASE
HP:0001302,Pachygyria
chembl:CHEMBL1200617,RIMEXOLONE
HP:0002396,Cogwheel rigidity
MONDO:0007088,Alzheimer disease type 1
HGNC:6886,MAPK9
chembl:CHEMBL1235482,GLUTARAL
chembl:CHEMBL24828,VANDETANIB
NCBIGene:476735,NDUFA11
HP:0031008,Lingual dystonia
chembl:CHEMBL73711,CHEMBL73711
HGNC:9652,PTPN22
HGNC:14063,HDAC4
HGNC:29090,SMCHD1
HGNC:2681,DAXX
HP:0001332,Dystonia
HGNC:9476,HTRA1
CHEBI:32955,epoxide
HGNC:4741,H2AZ1
HGNC:4867,HERC1
chembl:CHEMBL1200930,RABEPRAZOLE SODIUM
chembl:CHEMBL435,HYDROCHLOROTHIAZIDE
chembl:CHEMBL820,BUSULFAN
chembl:CHEMBL81,RALOXIFENE
chembl:CHEMBL578,ENALAPRIL
chembl:CHEMBL1014,CANDESARTAN CILEXETIL
HGNC:6392,KIF23
chembl:CHEMBL228281,NORSTICTIC ACID
HGNC:6081,INS
UBERON:0001255,urinary bladder
CHEBI:73693,ketone body
MONDO:0018369,immature ovarian teratoma
chembl:CHEMBL549386,FOTEMUSTINE
CHEBI:45863,paclitaxel
MGI:88031,Anxa7
MONDO:0014627,dystonia 27
HGNC:8949,SERPINB5
HP:0012672,Akinetic mutism
HGNC:7881,NOTCH1
HGNC:84,ACACA
HP:0003484,Upper limb muscle weakness
HGNC:9636,PTP4A3
HGNC:8066,NUP62
HGNC:10604,SCO2
chembl:CHEMBL1200338,PINACIDIL
chembl:CHEMBL2109406,PATRITUMAB
HGNC:12027,TRA
MONDO:0003937,spondylitis
HGNC:8859,PEX6
HGNC:8790,PDE6H
GO:0070530,K63-linked polyubiquitin modification-dependent protein binding
chembl:CHEMBL509032,TAE-684
chembl:CHEMBL259784,CHEMBL259784
chembl:CHEMBL605708,CHEMBL605708
HGNC:4388,GNAL
HGNC:20229,DCAF4
HGNC:8957,PIGA
CHEBI:15940,nicotinic acid
MONDO:0004329,pancreatic intraductal papillary-mucinous neoplasm with high grade dysplasia
chembl:CHEMBL2111110,TEDISAMIL
HP:0012169,Self-biting
HP:0031589,Suicidal ideation
HP:0005157,Concentric hypertrophic cardiomyopathy
HGNC:11498,SYNGR1
chembl:CHEMBL1200622,PARICALCITOL
HGNC:11752,TFE3
chembl:CHEMBL2387080,TASELISIB
HGNC:31677,ANO7
chembl:CHEMBL590706,CHEMBL590706
chembl:CHEMBL377559,RETASPIMYCIN HYDROCHLORIDE
chembl:CHEMBL3545322,PANULISIB
MONDO:0030800,"cholestasis, progressive familial intrahepatic, 9"
HP:0000256,Macrocephaly
HGNC:976,BCAT1
HGNC:3377,EPB41
HGNC:4781,H4C1
chembl:CHEMBL483,TENOFOVIR
chembl:CHEMBL278751,CHEMBL278751
HP:0002527,Falls
HGNC:12367,TSFM
HGNC:6186,IVD
HP:0012893,Neck muscle hypertrophy
MONDO:0007495,dystonia 5
chembl:CHEMBL322862,CHEMBL322862
HGNC:12338,TRPC6
MONDO:0007915,systemic lupus erythematosus
chembl:CHEMBL173530,STICTIC ACID
HP:0006817,Aplasia/Hypoplasia of the cerebellar vermis
wikidata:Q58526200,HUMAN GROWTH HORMONE
HP:0011098,Speech apraxia
HGNC:12816,XPC
CHEBI:30616,ATP(4-)
HP:0007738,Uncontrolled eye movements
HP:0006989,Dysplastic corpus callosum
HGNC:27344,TMEM218
HP:0034251,Abnormal corneal reflex
HP:0012735,Cough
HP:0001129,Large central visual field defect
HGNC:21034,NDUFAF4
MONDO:0002741,uterine ligament adenocarcinoma
chembl:CHEMBL187266,TANSHINONE IIA
HGNC:20390,SQOR
MONDO:0011175,Friedreich ataxia 2
Xenbase:XB-GENE-5917368,rcn2
MGI:1926089,Slc5a10
chembl:CHEMBL1534878,IPRONIAZID SULFATE
HP:0009928,Thick nasal alae
HGNC:2740,DDX17
HGNC:21359,HMGCLL1
HGNC:30098,CPSF7
chembl:CHEMBL225513,CHEMBL225513
chembl:CHEMBL3545053,EMD-1204831
HGNC:15905,L3MBTL1
HGNC:2554,CUL4A
CHEBI:17790,methanol
HP:0030786,Photopsia
MONDO:0032673,"basal ganglia calcification, idiopathic, 7, autosomal recessive"
HGNC:121,ACOX3
chembl:CHEMBL3989759,EXATECAN MESYLATE
HP:0000658,Eyelid apraxia
HGNC:7805,NFYB
MONDO:0000914,"cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1"
HGNC:12524,UGCG
HP:0010695,Sutural cataract
HGNC:24628,MED28
HGNC:31326,ATXN2L
chembl:CHEMBL17594,QUINIZARIN
RGD:621384,Kcne3
chembl:CHEMBL1567571,CHEMBL1567571
CHEBI:26512,quinolinemonocarboxylic acid
UBERON:0002118,right ovary
HGNC:644,AR
HP:0007207,Photosensitive tonic-clonic seizure
HGNC:2600,CYP21A2
MONDO:0002280,anemia
Reactome:R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane
HP:0007064,Progressive language deterioration
MONDO:0009497,Kifafa seizure disorder
GO:0005783,endoplasmic reticulum
HP:0011808,Decreased patellar reflex
HGNC:29021,CEP290
HGNC:7577,MYH7
chembl:CHEMBL445102,CHEMBL445102
chembl:CHEMBL107131,DIMETHYLPINOCEMBRIN
HGNC:4861,HELLS
HGNC:971,BCAR1
CHEBI:26051,phosphoamino acid
chembl:CHEMBL2108583,CINTREDEKIN BESUDOTOX
HGNC:18154,RNF115
HGNC:32925,ATXN8
HGNC:10839,SHBG
HGNC:3999,FTL
HP:0000728,Impaired ability to form peer relationships
HGNC:4271,GIPR
HP:0001055,Erysipelas
HP:0002275,Poor motor coordination
HGNC:9210,POU1F1
MONDO:0021661,coronary atherosclerosis
CHEBI:145790,mupirocin(1-)
chembl:CHEMBL1488010,HAPLAMINE
MONDO:0019079,proximal spinal muscular atrophy
chembl:CHEMBL578928,CHEMBL578928
GO:0043204,perikaryon
HGNC:19360,KLHL12
chembl:CHEMBL4297850,XENTUZUMAB
HGNC:29079,KDM1A
chembl:CHEMBL396848,MACROCARPAL B
CHEBI:25000,lactone
HP:0012046,Areflexia of upper limbs
HGNC:172,ACVR1B
MONDO:0013200,hypertrophic cardiomyopathy 15
CHEBI:37143,organofluorine compound
HP:0003397,Generalized hypotonia due to defect at the neuromuscular junction
chembl:CHEMBL74852,CHEMBL74852
RGD:1566036,Spidr
HP:0002464,Spastic dysarthria
chembl:CHEMBL1336287,"3,4-DIDESMETHYL-5-DESHYDROXY-3'-ETHOXYSCLEROIN"
CHEBI:175901,gemcitabine
HP:0003678,Rapidly progressive
HGNC:8851,PEX10
HGNC:7461,MT-ND5
HP:0001873,Thrombocytopenia
HP:0040096,Neoplasm of the inner ear
CHEBI:28794,coumarin
chembl:CHEMBL203191,KRESOXIM-METHYL
chembl:CHEMBL278819,MINAPRINE
Reactome:R-HSA-9634600,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism"
chembl:CHEMBL971,PENTOBARBITAL SODIUM
HGNC:8976,PIK3CB
HP:0002367,Visual hallucinations
HGNC:53924,NOTCH2NLC
chembl:CHEMBL1476898,CADMIUM ACETATE
CL:0000655,secondary oocyte
UBERON:0004534,right testis
chembl:CHEMBL19224,PAPAVERINE
CHEBI:24613,homodetic cyclic peptide
chembl:CHEMBL3545300,CP-459632
MONDO:0037847,vertebral joint disorder
chembl:CHEMBL1329957,RICININE
chembl:CHEMBL113262,METHOXYARACHIDONOYL FLUOROPHOSPHONATE
MONDO:0014419,ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome
HGNC:8620,PAX6
HGNC:76,ABL1
MGI:2448558,Fancb
MGI:1347343,Usp5
chembl:CHEMBL2172394,(-)-OLEOCANTHAL
HGNC:12003,TP73
chembl:CHEMBL421486,THUNBERGINOL E
HGNC:16948,MYDGF
HP:0003581,Adult onset
GO:0036457,keratohyalin granule
MONDO:0012651,spastic ataxia 2
CL:0000023,oocyte
HGNC:23664,SH3PXD2A
HGNC:5275,KAT5
MONDO:0035646,congenital-onset Steinert myotonic dystrophy
MONDO:0042983,neurocutaneous syndrome
chembl:CHEMBL3187723,BINIMETINIB
CHEBI:17015,riboflavin
HP:0001355,Megalencephaly
HP:0003763,Bruxism
chembl:CHEMBL1200728,GUANIDINE HYDROCHLORIDE
HGNC:16711,TLR6
HGNC:11905,TNFRSF10B
chembl:CHEMBL210868,AURIN
HP:0002186,Apraxia
MONDO:0002831,non-keratinizing sinonasal squamous cell carcinoma
HGNC:15483,CDKL3
HGNC:25519,ANO10
HGNC:24987,NMRAL1
HGNC:26087,HEATR3
HP:0003593,Infantile onset
Reactome:R-RNO-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
HGNC:12496,UBE3A
chembl:CHEMBL487805,SCUTELLARIN
chembl:CHEMBL83294,COUMARIN-3-CARBOXYLIC ACID
HGNC:6641,LMO1
HGNC:9644,PTPN11
chembl:CHEMBL964,DISULFIRAM
HP:0001009,Telangiectasia
chembl:CHEMBL1200348,SULCONAZOLE NITRATE
HGNC:9119,PMPCB
HP:0030185,Isometric tremor
HP:0003155,Elevated circulating alkaline phosphatase concentration
CHEBI:134251,guaiacols
CHEBI:55370,imidazolidinone
HP:0012077,Histrionic personality disorder
chembl:CHEMBL1201567,FILGRASTIM
chembl:CHEMBL481161,CHEMBL481161
chembl:CHEMBL809,SERTRALINE
HP:0007328,Impaired pain sensation
chembl:CHEMBL1256,ISOFLURANE
HGNC:18955,SYNJ2BP
HGNC:4162,GARS1
MONDO:0008457,spinocerebellar ataxia type 6
HGNC:11572,TARS1
HGNC:2468,SMC3
HGNC:2079,CLN8
CHEBI:41879,dexamethasone
MONDO:0016696,anaplastic oligodendroglioma
HGNC:1615,CCT2
UBERON:0003454,small intestine Peyer's patch
chembl:CHEMBL1200472,QUAZEPAM
HP:0002490,Increased CSF lactate
HP:0032273,Increased circulating N-acetylaspartic acid concentration
CHEBI:63607,linezolid
chembl:CHEMBL134561,ICLAPRIM
MONDO:0054763,neurodegeneration with brain iron accumulation 7
MONDO:0016698,ependymoma
HGNC:23619,NIPSNAP3A
CHEBI:9150,simvastatin
WB:WBGene00002179,jph-1
chembl:CHEMBL1788402,CHINIOFON
HP:0005415,Decreased proportion of CD8-positive T cells
HGNC:959,BAX
MONDO:0023696,Marinesco-Sjogren-like syndrome
chembl:CHEMBL1729,CISAPRIDE
HP:0001250,Seizure
HGNC:9477,PRSS12
HP:0001953,Diabetic ketoacidosis
MONDO:0002420,tic disorder
HGNC:936,BAD
chembl:CHEMBL460508,CHEMBL460508
MONDO:0003665,cervical endometrioid adenocarcinoma
chembl:CHEMBL486817,HARMOL
HGNC:12757,WDR5
UBERON:0002736,lateral nuclear group of thalamus
MONDO:0013725,"colorectal cancer, hereditary nonpolyposis, type 7"
HGNC:7223,MPST
CHEBI:65191,second generation antipsychotic
chembl:CHEMBL3334567,SAVOLITINIB
chembl:CHEMBL408563,CHEMBL408563
HGNC:10073,RNGTT
MONDO:0015792,transient congenital hypothyroidism
MONDO:0016242,hemoglobin C disease
chembl:CHEMBL596,FENTANYL
HGNC:129,ACTA1
HGNC:4045,FZD7
HGNC:11289,SREBF1
HP:0025237,Confusional arousal
HGNC:4332,BICRA
HGNC:24834,GPRASP1
HGNC:11169,SNTB2
HGNC:26189,MTARC1
CHEBI:77906,minocycline zwitterion
chembl:CHEMBL64894,GENTIAN VIOLET
HP:0003749,Pelvic girdle muscle weakness
HGNC:26775,TMEM192
HP:0025682,Crouch gait
GO:0005886,plasma membrane
HGNC:33848,COA5
MONDO:0005595,laryngeal squamous cell carcinoma
HP:0012167,Hair-pulling
chembl:CHEMBL49732,HERNIARIN
chembl:CHEMBL642,ACEBUTOLOL
MONDO:0002665,extrahepatic bile duct adenocarcinoma
MONDO:0000646,ovarian benign neoplasm
HGNC:145,ACTG2
chembl:CHEMBL227075,DIHYDROTANSHINONE I
HGNC:18178,VPS28
MONDO:0004976,amyotrophic lateral sclerosis
RGD:621261,Pla1a
chembl:CHEMBL197,DEXVERAPAMIL
HGNC:1623,CCT8
HGNC:3386,EPHA2
CHEBI:2637,amikacin
chembl:CHEMBL911,ZOLPIDEM
chembl:CHEMBL2094833,CHEMBL2094833
HGNC:11936,FASLG
HGNC:19833,FBXO33
HP:0001251,Ataxia
WB:WBGene00012716,Y39E4B.5
HGNC:12585,UQCRC1
HP:0100851,Abnormal emotion/affect behavior
MONDO:0024557,ataxia-telangiectasia-like disorder 1
chembl:CHEMBL2112314,CHEMBL2112314
chembl:CHEMBL1201167,CARVEDILOL PHOSPHATE
WB:WBGene00006459,tag-89
HGNC:167,ACTR1A
MONDO:0020481,myotonia fluctuans
NCBIGene:281126,DRD2
chembl:CHEMBL1702181,CHEMBL1702181
HP:0031472,Risk taking
chembl:CHEMBL576809,CHEMBL576809
chembl:CHEMBL457246,CHEMBL457246
MONDO:0016833,14q12 microdeletion syndrome
HGNC:4886,HFE
chembl:CHEMBL3545137,PF-00477736
chembl:CHEMBL3188267,CAPMATINIB
HGNC:9498,PSAP
GO:0016015,morphogen activity
chembl:CHEMBL1450486,THIPHENAMIL
UPHENO:0081740,increased biological_process in patella
HGNC:19316,P3H1
HGNC:9561,PSMD4
chembl:CHEMBL398673,(R)-FLECAINIDE
MONDO:0016304,classic pantothenate kinase-associated neurodegeneration
chembl:CHEMBL363506,CORALYNE
HGNC:15714,LRPPRC
chembl:CHEMBL1489,AZACITIDINE
MONDO:0005098,stroke disorder
HGNC:4376,GMPR
chembl:CHEMBL451197,OXIDOPAMINE HYDROCHLORIDE
CHEBI:21766,N-methylglycines
CHEBI:529996,cytochalasin D
GO:0017166,vinculin binding
HP:0000577,Exotropia
HGNC:18344,HINT2
chembl:CHEMBL1160028,TETRAIDOFLUORESCEIN
MONDO:0054845,"developmental and epileptic encephalopathy, 66"
chembl:CHEMBL273103,CHEMBL273103
chembl:CHEMBL1201295,BITOLTEROL
HGNC:12403,TTN
HGNC:987,BCKDHB
HGNC:18809,TUBA1B
SGD:S000003826,ARP3
MONDO:0008097,linear nevus sebaceous syndrome
chembl:CHEMBL70501,THUNBERGINOL B
chembl:CHEMBL108,CARBAMAZEPINE
MONDO:0007403,inherited Creutzfeldt-Jakob disease
HP:0012443,Abnormality of brain morphology
chembl:CHEMBL259805,CHEMBL259805
chembl:CHEMBL569864,CHEMBL569864
HGNC:795,ATM
HP:0001427,Mitochondrial inheritance
HGNC:678,ARHGDIA
HP:0025372,Loud snoring
MP:0001524,impaired limb coordination
HGNC:4037,FYN
WB:WBGene00019550,K09C4.5
chembl:CHEMBL1235157,PENTABROMOPHENOL
Reactome:R-SPO-71288,Creatine metabolism
chembl:CHEMBL3544963,DS-3078A
chembl:CHEMBL1224483,CHEMBL1224483
CHEBI:77932,tetracycline zwitterion
chembl:CHEMBL1213252,CLORAZEPIC ACID
HP:0002791,Hypoventilation
HGNC:449,ALX3
HGNC:5235,HSPA2
chembl:CHEMBL606532,CHEMBL606532
HP:0031766,Convergence excess esotropia
HGNC:29945,TENM4
Reactome:R-CEL-549127,Organic cation transport
HGNC:11115,KDM5D
HP:0003208,Fingerprint intracellular accumulation of autofluorescent lipopigment storage material
Reactome:R-HSA-71288,Creatine metabolism
chembl:CHEMBL601719,CRIZOTINIB
HP:0001138,Optic neuropathy
HGNC:11427,STUB1
chembl:CHEMBL275809,FR-122047
HGNC:16877,MFN2
chembl:CHEMBL1096979,BENSERAZIDE
UPHENO:0074374,abnormally decreased rate of limb coordination
HP:0025430,High-pitched cry
GO:0016251,RNA polymerase II general transcription initiation factor activity
CHEBI:7735,olanzapine
HGNC:25705,KCTD17
ZFIN:ZDB-GENE-030131-5400,zgc:162592
chembl:CHEMBL406381,KRN-633
HGNC:3057,DTNA
chembl:CHEMBL1476858,PHENTHOATE
HGNC:25420,RNF208
HGNC:11730,TERT
HGNC:8878,PFKP
HP:0002172,Postural instability
MONDO:0013977,combined oxidative phosphorylation defect type 13
chembl:CHEMBL1420370,CHEMBL1420370
HGNC:27310,FLCN
HGNC:6465,KSR1
UBERON:0001870,frontal cortex
chembl:CHEMBL1742994,BRENTUXIMAB VEDOTIN
HGNC:8031,NTRK1
Reactome:R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
MONDO:0014041,"autism, susceptibility to, 19"
chembl:CHEMBL70971,CARBENDAZIM
UPHENO:0088155,abnormal platysma morphology
Xenbase:XB-GENE-5806009,cmbl
HP:0040064,Abnormality of limbs
MONDO:0012789,dystonia 16
HGNC:6912,MATR3
chembl:CHEMBL1393904,MIRIPIRIUM
MONDO:0024609,vulvar squamous cell carcinoma
HGNC:4687,GUCY1B1
chembl:CHEMBL1200982,BUTABARBITAL SODIUM
MONDO:0021095,parkinsonian disorder
chembl:CHEMBL885,EMTRICITABINE
HP:0007078,Decreased amplitude of sensory action potentials
HGNC:13371,MS4A4A
HGNC:8827,PELI1
MONDO:0017859,colchicine poisoning
HGNC:11849,TLR3
HGNC:22932,GMPPB
HGNC:23112,FAT3
MGI:97175,Map2
HGNC:17818,NT5C1B
chembl:CHEMBL105442,CI-1040
MONDO:0023076,eosinophilic pustular folliculitis
HGNC:11425,STS
CHEBI:7025,mupirocin
GO:0055085,transmembrane transport
UBERON:0001626,left coronary artery
CHEBI:10106,zearalenone
UBERON:0004359,corpus epididymis
chembl:CHEMBL521686,OLAPARIB
chembl:CHEMBL70,MORPHINE
HGNC:5244,HSPA9
chembl:CHEMBL23812,AZIETOMIDATE
MONDO:0020512,precursor T-cell acute lymphoblastic leukemia
HGNC:5295,HTR2C
chembl:CHEMBL581880,CHEMBL581880
HP:0003715,Myofibrillar myopathy
HGNC:2602,CYP24A1
NCBIGene:415752,UQCRFS1
chembl:CHEMBL103667,DORAMAPIMOD
HP:0012651,Abasia
HGNC:9509,PSEN2
MONDO:0019643,transient pseudohypoaldosteronism
HP:0100034,Motor tics
CHEBI:47622,acetate ester
GO:0005576,extracellular region
MONDO:0007959,medulloblastoma
HGNC:6597,LIFR
HGNC:17158,PLD3
HGNC:5218,HSD3B2
HGNC:15927,ERGIC3
MONDO:0011264,torsion dystonia 6
MONDO:0018315,X-linked osteoporosis with fractures
MONDO:0014020,hereditary spastic paraplegia 55
WB:WBGene00004780,ser-7
chembl:CHEMBL1276138,FARAMPATOR
HP:0010542,Vestibular nystagmus
chembl:CHEMBL2105109,ITASETRON
HP:0100539,Periorbital edema
NCBIGene:418118,NDUFB2
MONDO:0017704,familial partial epilepsy
UPHENO:0005625,decreased reflex
MONDO:0010183,methylmalonic aciduria and homocystinuria type cblF
WB:WBGene00044568,ntc-1
chembl:CHEMBL388979,CHEMBL388979
HGNC:9957,RELN
MONDO:0010065,spinocerebellar degeneration with slow eye movements
HGNC:7530,MVK
MONDO:0009723,Leigh syndrome
HP:0002148,Hypophosphatemia
chembl:CHEMBL472437,KAMEBANIN
HGNC:4816,HARS1
HGNC:14085,RTN4
HP:0100315,Lewy bodies
MONDO:0956971,intermittent asthma
HP:0011966,Elevated plasma citrulline
chembl:CHEMBL15023,TRIFLUPERIDOL
chembl:CHEMBL444236,CHEMBL444236
MONDO:0014410,spinocerebellar ataxia type 37
GO:0005777,peroxisome
HP:0001944,Dehydration
chembl:CHEMBL672,FENOFIBRATE
HGNC:11431,STX16
HGNC:28654,ZDHHC23
chembl:CHEMBL84567,TRACAZOLATE
MONDO:0000211,"striatal degeneration, autosomal dominant"
MONDO:0018204,20q11.2 microduplication syndrome
HGNC:1777,CDK6
HGNC:4241,GFPT1
WB:WBGene00016162,crh-2
GO:0140425,galactose import across plasma membrane
chembl:CHEMBL2041933,AZD-7762
MONDO:0010772,Leber optic atrophy and dystonia
chembl:CHEMBL3545096,BGT-226
chembl:CHEMBL281594,VANOXERINE
HGNC:7692,NDUFA8
HP:0000007,Autosomal recessive inheritance
chembl:CHEMBL3545366,VOXTALISIB
MONDO:0013216,Diamond-Blackfan anemia 9
HGNC:7106,ATXN3
chembl:CHEMBL261557,CHEMBL261557
chembl:CHEMBL3187365,ASENAPINE
chembl:CHEMBL51628,UMBELLIFERONE
chembl:CHEMBL1290,PENBUTOLOL
chembl:CHEMBL803,CYTARABINE
chembl:CHEMBL322970,CHEMBL322970
HGNC:24281,OTUD6B
CHEBI:58007,streptomycin(3+)
HGNC:4199,GCN1
HGNC:4379,GNA11
HGNC:20858,SLC39A14
HGNC:8041,NUBP1
MONDO:0054794,"hydrocephalus, congenital, 3, with brain anomalies"
SGD:S000003963,VPS13
chembl:CHEMBL196537,CHLORDANE
MGI:1929866,Rgs20
MONDO:0018370,KLHL9-related early-onset distal myopathy
HGNC:26467,CHCHD4
chembl:CHEMBL138921,ARACHIDONOYL DOPAMINE
HGNC:9171,PODXL
HGNC:26258,C1orf54
MONDO:0022736,occupational lung disease
HP:0011400,Abnormal CNS myelination
chembl:CHEMBL3545133,JNJ-26483327
HGNC:11290,SREBF2
MONDO:0016910,partial deletion of the long arm of chromosome 11
HP:0031126,Impaired clot retraction
chembl:CHEMBL1668,RESCINNAMINE
HGNC:25095,DCAF15
chembl:CHEMBL611,TERAZOSIN
CHEBI:6827,methicillin
HGNC:1689,CD59
chembl:CHEMBL1200748,CARBIDOPA
HP:0000504,Abnormality of vision
HGNC:6735,LYN
NCBIGene:477115,AADAC
HGNC:861,ATP6V0B
chembl:CHEMBL1189150,LINSIDOMINE
MONDO:0033043,"spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy"
chembl:CHEMBL1201182,TEMSIROLIMUS
HGNC:8101,OCA2
HGNC:13945,GPSM3
HP:0001761,Pes cavus
UPHENO:0081315,muscle of neck hypoplasia
MONDO:0000565,infective endocarditis
CHEBI:134547,TOP-53
chembl:CHEMBL15870,INDOPROFEN
chembl:CHEMBL207538,BREXANOLONE
chembl:CHEMBL255044,FLUPIRTINE
HGNC:407,ALDH1B1
chembl:CHEMBL1201082,FLUOXETINE HYDROCHLORIDE
chembl:CHEMBL267633,NEUROPEPTIDE-Y
HGNC:18001,TOMM40
HP:0033643,Increased circulating very long-chain fatty acid concentration
chembl:CHEMBL514,LOMUSTINE
HP:0000709,Psychosis
HGNC:10295,RPGR
chembl:CHEMBL221721,CHEMBL221721
HGNC:11906,TNFRSF10C
chembl:CHEMBL24955,BEXLOSTERIDE
CHEBI:28859,5alpha-androstane
chembl:CHEMBL305660,EBASTINE
HGNC:9023,PKP1
UBERON:0004810,nephron tubule epithelium
HGNC:30384,NENF
MONDO:0019296,subcutaneous tissue disorder
chembl:CHEMBL1456848,CHEMBL1456848
HGNC:19692,NRBF2
HP:0008003,Jerky ocular pursuit movements
HGNC:4617,GSK3B
HGNC:10805,SGCA
MONDO:0014392,"developmental and epileptic encephalopathy, 25"
HGNC:17363,YAF2
CHEBI:57433,sarcosine zwitterion
HP:0001397,Hepatic steatosis
GO:0004594,pantothenate kinase activity
chembl:CHEMBL1201244,ROCURONIUM
HGNC:4135,GALT
MONDO:0010848,spinocerebellar ataxia type 5
chembl:CHEMBL341898,"(R,S)-INDATRALINE"
MONDO:0015770,congenital hypogonadotropic hypogonadism
chembl:CHEMBL383634,GLIQUIDONE
HP:0004326,Cachexia
HGNC:17142,OPTN
chembl:CHEMBL12,DIAZEPAM
chembl:CHEMBL1615374,VILAZODONE HYDROCHLORIDE
chembl:CHEMBL316796,CHEMBL316796
HGNC:6395,KPNA2
MONDO:0020172,palpebral epidermal tumor
HGNC:850,ATP5PO
MONDO:0008948,cerebrotendinous xanthomatosis
HGNC:188,ADAM10
chembl:CHEMBL1555467,ANAZOLENE
HGNC:12032,TRAF2
chembl:CHEMBL406557,CHEMBL406557
MONDO:0008119,spinocerebellar ataxia type 1
chembl:CHEMBL1095777,INDACATEROL
chembl:CHEMBL1089321,CHEMBL1089321
chembl:CHEMBL290106,BITHIONOL
HGNC:2603,CYP26A1
HGNC:24358,TSPYL2
HGNC:4556,GPX4
chembl:CHEMBL4297422,RG-4733
HGNC:10327,RPL26
HGNC:4812,HAP1
HP:0000035,Abnormal testis morphology
chembl:CHEMBL513,CARMUSTINE
chembl:CHEMBL67535,CHEMBL67535
chembl:CHEMBL3188551,GSK-2636771
HP:0025425,Laryngospasm
HGNC:12117,TRAV20
MONDO:0013866,neuronal ceroid lipofuscinosis 11
HGNC:11571,TARDBP
HP:0007020,Progressive spastic paraplegia
MONDO:0018531,carcinoma of liver and intrahepatic biliary tract
WB:WBGene00019547,K09C4.1
chembl:CHEMBL1751,DIGOXIN
CHEBI:16436,CDP-choline
chembl:CHEMBL1822792,MK-2461
MONDO:0010953,Fanconi anemia complementation group E
CHEBI:16452,oxaloacetate(2-)
chembl:CHEMBL275311,CHEMBL275311
HGNC:26202,MRM1
HGNC:16935,ATG7
GO:0008514,organic anion transmembrane transporter activity
chembl:CHEMBL1173655,AFATINIB
HP:0002457,Abnormal head movements
HGNC:3227,EFNB2
HGNC:11503,SYNJ1
chembl:CHEMBL23507,5-FLUOROINDOLE-2-CARBOXYLIC ACID
chembl:CHEMBL12089,BERBERINE CHLORIDE
chembl:CHEMBL1200789,TRICLOFOS SODIUM
chembl:CHEMBL1323699,PADIMATE O
HGNC:11291,SRF
chembl:CHEMBL483302,CHEMBL483302
chembl:CHEMBL321585,CHEMBL321585
MONDO:0018608,pure autonomic failure
NCBIGene:403882,HTR2A
HGNC:12854,YWHAQ
HGNC:11138,SNCA
MONDO:0024457,neurodegeneration with brain iron accumulation 2A
MONDO:0015140,early-onset autosomal dominant Alzheimer disease
chembl:CHEMBL233302,2-(PHENOXYMETHYL)BENZOTHIAZOLE
HP:0001290,Generalized hypotonia
HGNC:659,ARF6
MONDO:0004663,colon carcinoma in situ
HP:0002419,Molar tooth sign on MRI
chembl:CHEMBL596633,CHEMBL596633
MONDO:0002235,eyelid neoplasm
HGNC:9390,PRKAR1B
HP:0002155,Hypertriglyceridemia
HP:0000546,Retinal degeneration
RGD:1310823,Recql5
HP:0002075,Dysdiadochokinesis
MONDO:0016490,hemoglobin C-beta-thalassemia syndrome
MONDO:0015068,"neuroendocrine tumor of rectum, well differentiated, low or intermediate grade"
HP:0000473,Torticollis
HGNC:19960,KIAA0586
HP:0012407,Scissor gait
MONDO:0011823,developmental malformations-deafness-dystonia syndrome
HGNC:13575,BRD4
HGNC:4136,GAMT
chembl:CHEMBL1709259,CHEMBL1709259
HP:0040201,Simultanapraxia
MGI:1930638,Cyp3a25
chembl:CHEMBL1989750,CHEMBL1989750
CHEBI:15372,"5,6,7,8-tetrahydrobiopterin"
HGNC:582,APBB2
HGNC:2747,DDX6
HGNC:4341,GLUL
HGNC:4586,GRIN2B
chembl:CHEMBL1094636,NIRAPARIB
CHEBI:15866,2-deoxy-D-glucose
MONDO:0956977,near-fatal asthma
HGNC:12852,YWHAG
HGNC:17194,NDUFA13
HP:0000506,Telecanthus
HGNC:22948,NLRP2
chembl:CHEMBL277062,BROMAZEPAM
HGNC:2363,CRKL
HP:0000188,Short upper lip
MONDO:0014265,Alzheimer disease 18
HP:0002093,Respiratory insufficiency
chembl:CHEMBL222863,OUABAIN
MONDO:0015059,progressive non-fluent aphasia
chembl:CHEMBL450613,ZERANOL
chembl:CHEMBL961,DITIOCARB
GO:0048870,cell motility
HGNC:18305,ATP6AP2
chembl:CHEMBL508649,5-METHOXYCANTHINONE
MONDO:0005602,ovarian teratoma
chembl:CHEMBL450,METHARBITAL
CHEBI:10119,ziprasidone
HGNC:11329,SST
NCBIGene:480204,NDUFV2
HP:0003390,Sensory axonal neuropathy
chembl:CHEMBL2106767,LINTOPRIDE
chembl:CHEMBL587714,"3',4' DICHLOROBENZAMIL"
CHEBI:57774,2-acetyllactate
MONDO:0017174,Machado-Joseph disease type 1
HP:0000054,Micropenis
chembl:CHEMBL1591080,METHOXYVONE
chembl:CHEMBL299155,TRANSTORINE
chembl:CHEMBL1692,IMIPRAMINE HYDROCHLORIDE
HP:0000037,Male pseudohermaphroditism
GO:0006886,intracellular protein transport
HP:0007361,Abnormal pons morphology
chembl:CHEMBL272980,MOCETINOSTAT
HGNC:7797,NFKBIA
HP:0012157,Subcortical cerebral atrophy
chembl:CHEMBL3545008,SAR-260301
HGNC:9665,PTPRB
chembl:CHEMBL296468,BMS-387032
GO:0006601,creatine biosynthetic process
HGNC:8127,OGT
chembl:CHEMBL292303,D-TRYPTOPHAN
HP:0006785,Limb-girdle muscular dystrophy
GO:0030427,site of polarized growth
HP:0000821,Hypothyroidism
chembl:CHEMBL1374360,MERCURIC CHLORIDE
HP:0033349,Seizure cluster
MONDO:0100232,"psoriatic arthritis, susceptibility to"
chembl:CHEMBL422942,CHEMBL422942
HGNC:20584,SLC35B4
HGNC:14353,DNALI1
chembl:CHEMBL1425,MERCAPTOPURINE
chembl:CHEMBL772,RESERPINE
chembl:CHEMBL969,PRAZEPAM
HGNC:7096,MID2
HGNC:3748,FLG
HGNC:9829,RAF1
chembl:CHEMBL193,NIFEDIPINE
chembl:CHEMBL589390,LATREPIRDINE
MONDO:0016987,neuroacanthocytosis
Reactome:R-DME-549127,Organic cation transport
HGNC:24664,PATE1
GO:0008503,benzodiazepine receptor activity
HGNC:28985,LPGAT1
chembl:CHEMBL1201631,INSULIN
dictyBase:DDB_G0274917,vps13B
HGNC:33882,INPP5K
chembl:CHEMBL34431,CILOSTAMIDE
chembl:CHEMBL36327,EPICATECHIN GALLATE
chembl:CHEMBL1341830,CHEMBL1341830
GO:0016027,inaD signaling complex
MONDO:0018935,hairy cell leukemia
HGNC:1620,CCT6A
CHEBI:15611,sarcosine
HP:0001114,Xanthelasma
chembl:CHEMBL2029988,CEP-32496
HGNC:11460,SUOX
HGNC:17909,DUSP16
HGNC:2591,CYP11B1
HGNC:682,ARHGEF2
chembl:CHEMBL1180,O-DEMETHYLATED ADAPALENE
chembl:CHEMBL56564,TROPISETRON
HGNC:6008,IL2RA
chembl:CHEMBL36,PYRIMETHAMINE
HGNC:17287,SUV39H2
HP:0002240,Hepatomegaly
HP:0007164,Slowed slurred speech
HGNC:7224,MPV17
HGNC:17888,CRCP
chembl:CHEMBL403183,CHEMBL403183
HGNC:6949,MCM6
chembl:CHEMBL7917,TYRPHOSTIN AG-1478
chembl:CHEMBL1935538,CHEMBL1935538
MONDO:0003334,demyelinating polyneuropathy
MONDO:0001651,scrotum squamous cell carcinoma
HP:0012452,Restless legs
HGNC:2389,CRYAB
HGNC:6677,LPL
HGNC:706,ARPC3
MONDO:0003333,benign struma ovarii
chembl:CHEMBL589245,CHEMBL589245
HP:0001271,Polyneuropathy
HGNC:3468,ESR2
GO:0097447,dendritic tree
CHEBI:192484,ciprofloxacin zwitterion
HGNC:3767,FLT4
HGNC:1743,CDC5L
HGNC:2347,CREB3
HP:0002301,Hemiplegia
HP:0003487,Babinski sign
HP:0040082,Happy demeanor
MGI:1351624,Abcg3
MGI:1924834,Spidr
chembl:CHEMBL2107771,RALFINAMIDE
GO:0032127,dense core granule membrane
MGI:96756,Lck
chembl:CHEMBL1795737,CHEMBL1795737
chembl:CHEMBL514800,APREMILAST
HGNC:1919,CHD4
chembl:CHEMBL77,ARTEMISIN
chembl:CHEMBL1201134,LUBIPROSTONE
chembl:CHEMBL1223,PENICILLIN G POTASSIUM
HGNC:6943,MCL1
chembl:CHEMBL302449,GO-6976
chembl:CHEMBL1381098,1-NAPHTHYLISOTHIOCYANATE
HGNC:14210,SUN2
HGNC:9412,PRKCZ
chembl:CHEMBL334255,CETYLPYRIDINIUM BROMIDE
chembl:CHEMBL42624,PHYSCION
CHEBI:17650,cortisol
HGNC:5542,IGHMBP2
HGNC:18994,BRSK1
chembl:CHEMBL1200595,CHLORPHENTERMINE HYDROCHLORIDE
HGNC:9461,PRPH
HGNC:1874,CFL1
GO:0006383,transcription by RNA polymerase III
chembl:CHEMBL1557,DOPAMINE HYDROCHLORIDE
HGNC:6181,ITPR2
chembl:CHEMBL219553,GIGANTOL
HGNC:28948,TMEM41B
chembl:CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE
chembl:CHEMBL393417,DEGUELIN
HGNC:1789,CDKN2C
CHEBI:149836,tigecycline
HGNC:10702,SEC23B
HGNC:8831,PENK
HGNC:11916,TNFRSF1A
HP:0000741,Apathy
chembl:CHEMBL1551453,FURATHIOCARB
MONDO:0002363,papilloma
HGNC:11075,NHERF1
HGNC:3606,FBP1
HGNC:5213,HSD17B4
HGNC:10765,SF3A1
HGNC:11538,TAF4B
HGNC:28273,TENT5B
HGNC:20760,ZFYVE21
HGNC:6874,MAPK12
MONDO:0013874,glucocorticoid deficiency 4
HGNC:17646,NGLY1
chembl:CHEMBL469309,CHEMBL469309
CHEBI:30839,orotate
HGNC:19009,CLUAP1
MONDO:0005165,benign neoplasm
MONDO:0015134,constitutional neutropenia
HP:0000774,Narrow chest
chembl:CHEMBL259422,CHEMBL259422
HGNC:17929,AADAT
HGNC:30826,NT5DC3
HGNC:1594,CCNH
chembl:CHEMBL2107188,PANCOPRIDE
chembl:CHEMBL1395,METHYLTESTOSTERONE
CHEBI:194135,"9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid"
HP:0003232,Mitochondrial malic enzyme reduced
HP:0011352,Severe receptive language delay
HGNC:20297,SLITRK1
MONDO:0004958,oral cavity squamous cell carcinoma
MONDO:0002882,colon neuroendocrine neoplasm
MONDO:0003300,appendix leiomyoma
RGD:1309504,Actbl2
HP:0012705,Abnormal metabolic brain imaging by MRS
HGNC:13055,ZMYM4
chembl:CHEMBL3545080,RG-7256
chembl:CHEMBL260933,GS 6201
chembl:CHEMBL366603,DIALLYLDISULFIDE
HGNC:8782,PDE4C
chembl:CHEMBL514057,GERONTOXANTHONE H
HGNC:9036,PLA2G4B
HP:0012049,Laryngeal dystonia
WB:WBGene00000423,ced-9
HGNC:348,AHR
chembl:CHEMBL602127,CHEMBL602127
chembl:CHEMBL361506,PENTAMIDINE ISETHIONATE
HGNC:3356,ENPP1
chembl:CHEMBL1401,NITAZOXANIDE
HP:0003744,Genetic anticipation with paternal anticipation bias
HGNC:257,ADK
HP:0003474,Somatic sensory dysfunction
MONDO:0003821,ovarian biphasic or triphasic teratoma
HGNC:10382,RPN2
HGNC:11019,SLC34A1
HP:0000099,Glomerulonephritis
MONDO:0018243,intellectual disability-hyperkinetic movement-truncal ataxia syndrome
HGNC:7045,MGAT2
MONDO:0014544,osteogenesis imperfecta type 16
HP:0008404,Nail dystrophy
chembl:CHEMBL12208,HYMECROMONE
HGNC:1965,CHRND
HGNC:854,ATP6V1B2
MONDO:0002810,pancreatic serous cystic neoplasm
HGNC:14652,PARVA
HGNC:10937,SLC19A1
CHEBI:13601,3-oxo-5alpha-steroid
chembl:CHEMBL497,CLIOQUINOL
chembl:CHEMBL76903,OLVANIL
HGNC:17947,THEM4
UBERON:0002119,left ovary
HGNC:25018,TMEM216
HGNC:344,AHCYL1
HGNC:5144,HPCA
HGNC:4318,GLI2
chembl:CHEMBL156897,CANTHIN-6-ONE
HP:0002267,Exaggerated startle response
chembl:CHEMBL135400,ZOPICLONE
HGNC:9295,PPP1R7
MONDO:0014612,"pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4"
chembl:CHEMBL383015,RADANAMYCIN
HP:0002883,Hyperventilation
chembl:CHEMBL337612,DIMIRACETAM
chembl:CHEMBL3545402,XL-820
CHEBI:32158,streptomycin sulfate
chembl:CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE
HP:0006915,Inability to walk by childhood/adolescence
HGNC:496,RIPK4
HGNC:30002,DCAF6
chembl:CHEMBL3402762,TEPOTINIB
chembl:CHEMBL1200323,LABETALOL HYDROCHLORIDE
chembl:CHEMBL59,DOPAMINE
HP:0010821,Focal emotional seizure with laughing
HGNC:8820,PDYN
chembl:CHEMBL434063,CHEMBL434063
MONDO:0006757,extrahepatic cholestasis
chembl:CHEMBL185,FLUOROURACIL
HP:0002607,Bowel incontinence
chembl:CHEMBL475536,"1R,9S-HYDRASTINE"
MONDO:0013541,complex cortical dysplasia with other brain malformations 1
HGNC:2227,COMP
HP:0010819,Atonic seizure
HGNC:13581,FBXO2
HGNC:4627,GSTA2
HGNC:2891,DKK1
dictyBase:DDB_G0269902,act26
HGNC:7573,MYH3
HP:0002350,Cerebellar cyst
HGNC:4798,HABP2
HGNC:21690,GET4
MONDO:0010449,"autism, susceptibility to, X-linked 5"
MONDO:0030634,"leukoencephalopathy, hereditary diffuse, with spheroids 2"
MP:0001516,abnormal motor coordination/balance
chembl:CHEMBL1200790,METHYPRYLON
chembl:CHEMBL271023,CHEMBL271023
chembl:CHEMBL486193,RETINYL ACETATE
HP:0000026,Male hypogonadism
HGNC:9635,PTP4A2
MONDO:0018892,Wyburn-Mason syndrome
Reactome:R-HSA-9022699,MECP2 regulates neuronal receptors and channels
HGNC:4324,GLP1R
MONDO:0014147,neuronal ceroid lipofuscinosis 13
HGNC:4087,GABRG2
CHEBI:133598,chlortetracycline(1-)
chembl:CHEMBL485253,METHYSERGIDE
FB:FBgn0005626,ple
HGNC:18150,MYO18B
HGNC:4408,GNG5
chembl:CHEMBL729,LOPINAVIR
HGNC:20790,ATG4B
MONDO:0004150,breast giant fibroadenoma
chembl:CHEMBL1212972,NANAOMYCIN
chembl:CHEMBL323197,MANGOSTIN
CHEBI:8386,pregnane
HGNC:29827,MYL12B
HGNC:30092,NAMPT
MONDO:0002912,brainstem cancer
MGI:3646373,Cyp3a57
MONDO:0011330,spinocerebellar ataxia type 10
HP:0006962,"Gait instability, worse in the dark"
HGNC:379,AKAP9
chembl:CHEMBL151797,CHEMBL151797
CHEBI:59066,oxolinate
Reactome:R-HSA-5617833,Cilium Assembly
chembl:CHEMBL1200596,CHLOROXINE
chembl:CHEMBL1475252,TENATOPRAZOLE
chembl:CHEMBL677,LEVONORDEFRIN
chembl:CHEMBL76904,TYRPHOSTIN 23
HGNC:126,ACR
MONDO:0034976,iatrogenic Creutzfeldt-Jakob disease
HGNC:29608,MTDH
HP:0004866,Impaired ADP-induced platelet aggregation
HP:5200068,Socially innappropriate questioning
chembl:CHEMBL768,ESMOLOL
HGNC:5385,IDH3B
chembl:CHEMBL104255,FLAVOKAWAIN B
CHEBI:27902,tetracycline
HP:0031947,Tongue tremor
HGNC:2348,CREBBP
chembl:CHEMBL1256971,METAPHIT METHANESULFONATE
chembl:CHEMBL592943,TINORIDINE
chembl:CHEMBL1332922,ETHYL ANTHRANILATE
HGNC:3578,FAF1
MGI:1351342,Grm5
MONDO:0010709,early-onset parkinsonism-intellectual disability syndrome
HP:0000531,Corneal crystals
chembl:CHEMBL128,SUMATRIPTAN
HGNC:9159,PNMA2
MONDO:0004285,pancreatic intraductal papillary-mucinous carcinoma
NCBIGene:789307,SAO
HGNC:30887,TRAPPC2L
HGNC:26114,EDC3
MONDO:0009258,classic galactosemia
chembl:CHEMBL4297971,PEPTIDE YY HUMAN (3-36)
GO:0004336,galactosylceramidase activity
HGNC:11323,SSR1
HP:0007367,Atrophy/Degeneration affecting the central nervous system
HGNC:10941,SLC1A3
HGNC:29012,KDM6B
MONDO:0016563,progressive supranuclear palsy-corticobasal syndrome
MGI:95757,Slc2a3
Reactome:R-MMU-211945,Phase I - Functionalization of compounds
HGNC:24280,PHF20L1
CHEBI:28073,chromium atom
MONDO:0003331,ovarian monodermal teratoma
chembl:CHEMBL165790,IPRIFLAVONE
HGNC:2444,CSK
CHEBI:16444,2-acetyllactic acid
chembl:CHEMBL35482,CHEMBL35482
HGNC:6366,KLK5
MONDO:0016430,Balo concentric sclerosis
UBERON:0003128,cranium
HGNC:794,ATIC
MGI:1923957,Clasp1
chembl:CHEMBL511142,BUPRENORPHINE
HGNC:29944,TENM3
MONDO:0859365,"neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures"
HP:0003510,Severe short stature
HP:0001382,Joint hypermobility
MONDO:0011299,Huntington disease-like 1
MONDO:0018014,transient neonatal multiple acyl-CoA dehydrogenase deficiency
chembl:CHEMBL52885,ENMD-981693
NCBIGene:281125,DRD1
chembl:CHEMBL2103762,AMBAZONE
HGNC:2753,DECR1
chembl:CHEMBL1639,ALISKIREN
HGNC:11275,SPTBN1
chembl:CHEMBL554041,ALEXIDINE DIHYDROCHLORIDE
CHEBI:26338,prostaglandins E
chembl:CHEMBL1201119,LIOTHYRONINE SODIUM
chembl:CHEMBL225164,CLOXYQUIN
HP:0012168,Head-banging
GO:0005775,vacuolar lumen
chembl:CHEMBL260213,CHEMBL260213
CHEBI:6887,methylphenidate
chembl:CHEMBL264931,(R)-INDOPROFEN
CHEBI:27644,chlortetracycline
MONDO:0009728,nephronophthisis 1
HP:0002793,Abnormal pattern of respiration
HP:0002548,Parkinsonism with favorable response to dopaminergic medication
HGNC:9557,PSMD12
CHEBI:27656,camptothecin
GO:0033282,protein C inhibitor-acrosin complex
HGNC:7794,NFKB1
HGNC:48813,HNRNPCL2
HGNC:24723,ACSS3
HGNC:28486,MFSD8
GO:0008092,cytoskeletal protein binding
chembl:CHEMBL279260,RAFABEGRON
MONDO:0013888,"tremor, hereditary essential, 4"
HP:0000743,Frontal release signs
chembl:CHEMBL1481873,PHOSMET
chembl:CHEMBL15594,ARACHIDONIC ACID
HGNC:3374,EPAS1
MONDO:0010997,"supranuclear palsy, progressive, 1"
chembl:CHEMBL20684,ABT-751
MONDO:0010397,severe neonatal-onset encephalopathy with microcephaly
HP:0002266,Focal clonic seizure
MONDO:0011214,progressive familial intrahepatic cholestasis type 3
GO:0046872,metal ion binding
chembl:CHEMBL1414353,LOMATIN
HP:0000467,Neck muscle weakness
wikidata:Q47521323,CASODEX
HGNC:13480,ULK2
HGNC:9508,PSEN1
HGNC:16971,FRS2
HGNC:2535,CTSH
HP:0002094,Dyspnea
chembl:CHEMBL55814,ATHRAQUINONES A
MONDO:0003110,skin hemangioma
HGNC:3236,EGFR
chembl:CHEMBL398765,CHEMBL398765
CHEBI:9215,spectinomycin
HP:0033044,Motor regression
MONDO:0024888,mesonephric neoplasm
chembl:CHEMBL2426136,NAMOLINE
MONDO:0003852,ovarian solid teratoma
MONDO:0009397,neonatal severe primary hyperparathyroidism
chembl:CHEMBL59150,CHEMBL59150
MONDO:0019793,autosomal dominant cerebellar ataxia type III
HP:0008770,Obsessive-compulsive trait
HGNC:12449,TYROBP
GO:0015571,N-acetylgalactosamine transmembrane transporter activity
HGNC:3012,DPYD
chembl:CHEMBL445153,CHEMBL445153
MONDO:0012391,neuronal ceroid lipofuscinosis 8 northern epilepsy variant
chembl:CHEMBL337702,OXIDOPAMINE
chembl:CHEMBL1482931,THYMOL IODIDE
CHEBI:59769,acetal
HGNC:1125,BTF3
chembl:CHEMBL70582,CHEMBL70582
MONDO:0017325,early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
HGNC:11547,TAF15
chembl:CHEMBL119625,ZONAMPANEL
CHEBI:36421,phenanthridine
MGI:1921367,Actr3
MONDO:0850001,congenital neuronal ceroid lipofuscinosis
chembl:CHEMBL389621,HYDROCORTISONE
HP:0012622,Chronic kidney disease
HP:0007076,Extrapyramidal muscular rigidity
MONDO:0006692,central pontine myelinolysis
UPHENO:0079844,abnormal physical aggression behavior
GO:0005198,structural molecule activity
HGNC:470,AMPD3
HGNC:9670,PTPRF
chembl:CHEMBL546,OXPRENOLOL
chembl:CHEMBL708,ZIPRASIDONE
HP:0033230,Biceps areflexia
HGNC:18801,POGZ
HGNC:11509,SYT1
chembl:CHEMBL2219773,CUSTIRSEN SODIUM
HP:0032104,Saccadic oscillation
chembl:CHEMBL165,RESVERATROL
HP:0010982,Polygenic inheritance
MONDO:0012529,Diamond-Blackfan anemia 3
HP:0012378,Fatigue
CHEBI:23765,quinolone
HGNC:12307,TRIP13
chembl:CHEMBL243580,CARBAZOLE
HGNC:3388,EPHA4
HGNC:20675,CNDP1
CHEBI:26177,polyene antibiotic
HP:0033683,Jaw hyperreflexia
HGNC:25582,SLC38A7
HGNC:4601,GRN
chembl:CHEMBL1473252,TANSHINONE IIA SULFONATE
HGNC:9813,RAD23B
UBERON:0003701,calcaneal tendon
MONDO:0054791,"leukodystrophy, hypomyelinating, 16"
HP:0002339,Abnormal caudate nucleus morphology
MONDO:0016305,atypical pantothenate kinase-associated neurodegeneration
MONDO:0016163,autosomal dominant cerebellar ataxia type II
MONDO:0008083,"ceroid lipofuscinosis, neuronal, 4 (Kufs type)"
chembl:CHEMBL1709,SERTRALINE HYDROCHLORIDE
HGNC:587,APEX1
HP:0008997,Proximal muscle weakness in upper limbs
MONDO:0005081,preeclampsia
chembl:CHEMBL462576,KEPONE
MONDO:0011381,dominant beta-thalassemia
chembl:CHEMBL123,ELLIPTECINE
chembl:CHEMBL1256775,PHENAMIL METHANESULFONATE
chembl:CHEMBL34398,4'-METHOXYCHALCONE
GO:0005102,signaling receptor binding
chembl:CHEMBL1770916,NIROGACESTAT
chembl:CHEMBL92281,FLUACIZINE
CHEBI:350546,serotonin(1+)
CHR:9606-chr10p11.21-p12.31,
MONDO:0009896,"polymyoclonus, infantile"
MONDO:0012655,"myoclonic epilepsy, juvenile, susceptibility to, 4"
MONDO:0011724,encephalopathy due to GLUT1 deficiency
RGD:621358,Kcnc3
HP:0002100,Recurrent aspiration pneumonia
HGNC:8528,OXT
HP:0005445,Enlarged posterior fossa
MONDO:0010915,autosomal dominant nonsyndromic hearing loss 4A
chembl:CHEMBL810,TEMOZOLOMIDE
HP:0000511,Vertical supranuclear gaze palsy
chembl:CHEMBL6206,BROMOENOL LACTONE
chembl:CHEMBL254218,DESMETHOXYYANGONIN
HGNC:6512,LARS1
chembl:CHEMBL29097,CHEMBL29097
HGNC:9201,POMC
HP:0031691,Severe viral infection
HGNC:8858,PEX3
HP:0100617,Testicular seminoma
MONDO:0005536,pancolitis
MONDO:0800302,glycogen storage disease Id
MONDO:0009288,glycogen storage disease Ib
HGNC:7667,NCL
HGNC:10917,SLC13A2
MONDO:0015067,"neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor"
chembl:CHEMBL13291,FLUDIAZEPAM
HGNC:6088,INSL5
HGNC:404,ALDH2
HGNC:10703,SEC24A
HP:0031392,Abnormal proportion of CD4-positive T cells
MONDO:0005311,atherosclerosis
HGNC:3229,EGF
chembl:CHEMBL38,TRETINOIN
HGNC:16695,BCAP31
chembl:CHEMBL265502,SURAMIN
chembl:CHEMBL601764,CHEMBL601764
HGNC:29679,PAM16
HP:0002086,Abnormality of the respiratory system
HGNC:9872,RASA2
MONDO:0024491,"tumor grade 1, general grading system"
HGNC:6600,LIG3
HP:0002360,Sleep disturbance
chembl:CHEMBL177820,TETRABROMOBENZOTRIAZOLE
HGNC:6122,IRF7
chembl:CHEMBL3622533,FIMEPINOSTAT
chembl:CHEMBL2103852,CROLIBULIN
HGNC:33939,CLRN2
chembl:CHEMBL2105719,DACOMITINIB
HGNC:1578,CCNA2
HGNC:9280,PPOX
chembl:CHEMBL151649,PHENETHYLISOTHIOCYANATE
HGNC:24927,CHP2
chembl:CHEMBL2105738,GALETERONE
GO:0008017,microtubule binding
chembl:CHEMBL573339,PI-103
HGNC:2264,COX17
MONDO:0011178,infantile convulsions and choreoathetosis
HGNC:457,AMD1
HP:0001974,Leukocytosis
chembl:CHEMBL3545401,X-82
chembl:CHEMBL3545236,BPI-9016
MONDO:0012639,hereditary spastic paraplegia 18
HGNC:5344,ICAM1
HGNC:26404,NADK2
HP:0007082,Dilated third ventricle
chembl:CHEMBL192627,CHLORANIL
HP:0002169,Clonus
MONDO:0010080,familial infantile bilateral striatal necrosis
HP:0100716,Self-injurious behavior
chembl:CHEMBL1201168,ISOCARBOXAZID
HP:0000662,Nyctalopia
HGNC:1100,BRCA1
GO:0005524,ATP binding
MONDO:0010354,Allan-Herndon-Dudley syndrome
HGNC:13209,ARHGEF5
HGNC:3953,NCS1
HGNC:9701,PURA
HGNC:3312,ELAVL1
HGNC:8546,P4HA1
HP:0007377,Abnormality of somatosensory evoked potentials
HP:0012082,Cerebellar Purkinje layer atrophy
MONDO:0002941,anal margin carcinoma
HP:0002362,Shuffling gait
HP:0012075,Personality disorder
HGNC:4056,G6PC1
FB:FBgn0038980,Octβ1R
HP:0031844,Euphoria
HGNC:14289,NLGN3
chembl:CHEMBL27,PROPRANOLOL
HP:0001927,Acanthocytosis
HGNC:11178,SOAT2
HGNC:10274,RP2
chembl:CHEMBL186526,CHEMBL186526
UBERON:0000451,prefrontal cortex
chembl:CHEMBL530149,CHEMBL530149
HGNC:11177,SOAT1
HGNC:11537,TAF4
UBERON:0001760,frontal sinus
HGNC:3750,FLII
HGNC:6293,KCNN4
chembl:CHEMBL261693,CHEMBL261693
HGNC:11370,STAU1
HP:0031767,Consecutive esotropia
MONDO:0002381,sweat gland neoplasm
HGNC:29509,APH1A
RGD:1587185,Slc6a17
HGNC:343,AHCY
HGNC:6284,KCNMA1
HP:0002299,Brittle hair
HP:0000194,Open mouth
chembl:CHEMBL119604,DIETHANOLAMINE
MONDO:0030810,"cholestasis, progressive familial intrahepatic, 10"
chembl:CHEMBL484785,CRISABOROLE
HGNC:1307,CBY1
chembl:CHEMBL1500740,CHEMBL1500740
HGNC:1884,CFTR
CHEBI:28940,calciol
GO:0015149,hexose transmembrane transporter activity
HP:0004302,Functional motor deficit
chembl:CHEMBL463210,CHLORPYRIFOS
MONDO:0100057,food-dependent exercise-induced anaphylaxis
MONDO:0011559,benign recurrent intrahepatic cholestasis type 2
chembl:CHEMBL135561,CHEMBL135561
FB:FBgn0262476,CG43066
HGNC:12463,UBB
HGNC:16926,KRTAP9-2
chembl:CHEMBL3707317,LOREDIPLON
chembl:CHEMBL1200833,DIPIVEFRIN HYDROCHLORIDE
MONDO:0011866,pontocerebellar hypoplasia type 1A
HP:0025382,Hypodipsia
UBERON:0002810,right frontal lobe
chembl:CHEMBL71191,CHEMBL71191
HP:0003473,Fatigable weakness
chembl:CHEMBL1371756,GRAVEOLINE
UBERON:0035827,right adrenal gland cortex
WB:WBGene00011629,vps-13
HP:0100957,Abnormal renal medulla morphology
chembl:CHEMBL202721,CHEMBL202721
Reactome:R-HSA-9022534,Loss of MECP2 binding ability to 5hmC-DNA
HP:0007240,Progressive gait ataxia
CHEBI:17334,penicillin
HGNC:2696,DBNL
MONDO:0018851,familial keratoacanthoma
MONDO:0006133,cervical adenoid cystic carcinoma
MONDO:0010264,X-linked adrenal hypoplasia congenita
HGNC:18412,ZDHHC17
HGNC:4426,GOLGA3
CHEBI:134396,secondary allylic alcohol
chembl:CHEMBL34259,METHOTREXATE
chembl:CHEMBL1699,MEMANTINE HYDROCHLORIDE
HGNC:1867,CETN2
HGNC:17072,ERC1
HP:0025435,Increased circulating lactate dehydrogenase concentration
HGNC:4193,GCH1
chembl:CHEMBL345768,THIOURACIL
chembl:CHEMBL98350,LY-294002
HP:0008767,Self-mutilation of tongue and lips due to involuntary movements
chembl:CHEMBL1201274,LEVOBETAXOLOL
HP:0002495,Impaired vibratory sensation
Reactome:R-HSA-190861,Gap junction assembly
chembl:CHEMBL582286,CHEMBL582286
HGNC:12631,USP8
HP:0009589,Bilateral vestibular schwannoma
chembl:CHEMBL504936,HERNANDEZINE
HGNC:756,ASPA
chembl:CHEMBL53463,DOXORUBICIN
MONDO:0009279,triple-A syndrome
CHEBI:46577,dextrofloxacin
HGNC:7713,NDUFS6
MONDO:0010341,"autism, susceptibility to, X-linked 2"
chembl:CHEMBL585656,CHEMBL585656
HGNC:5183,HRH2
HGNC:10704,SEC24B
CHEBI:17781,lumichrome
HGNC:3756,FLNC
HGNC:9178,POLE2
HGNC:2514,CTNNB1
MONDO:0016692,pilomyxoid astrocytoma
HGNC:29652,WDR77
chembl:CHEMBL1569,AMANTADINE HYDROCHLORIDE
MONDO:0023149,infection due to clostridium perfringens
HGNC:676,ARHGAP6
HP:0031375,Refractory
chembl:CHEMBL249973,LINTITRIPT
NCBIGene:478577,NDUFB4
chembl:CHEMBL98,VORINOSTAT
chembl:CHEMBL421215,CHEMBL421215
CHEBI:30087,guanidinium
UPHENO:0078629,abnormal drinking behavior
CHEBI:38763,chromanone
chembl:CHEMBL4297526,REMIMAZOLAM
HGNC:3508,EWSR1
HGNC:14004,ANO3
chembl:CHEMBL473735,CHEMBL473735
chembl:CHEMBL2103758,PRAMLINTIDE
chembl:CHEMBL591429,PAC-1
HP:0010869,Asynergia
CHEBI:8081,phentolamine
HP:0002080,Intention tremor
chembl:CHEMBL960,LEFLUNOMIDE
MONDO:0003233,essential tremor
HGNC:1455,CALR
HGNC:11237,SPG7
HP:0008046,Abnormal retinal vascular morphology
CHEBI:35623,anticonvulsant
Reactome:R-HSA-375276,Peptide ligand-binding receptors
chembl:CHEMBL1168,RAMIPRIL
HGNC:25221,MMADHC
chembl:CHEMBL469424,ASTERRIC ACID
WB:WBGene00019641,cank-26
HP:0000243,Trigonocephaly
CHEBI:86411,"cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine"
HGNC:10593,SCN5A
chembl:CHEMBL467,HYDROXYUREA
HGNC:17676,RABGEF1
chembl:CHEMBL1089641,TRYPAN BLUE
MGI:2429635,Hrh4
HGNC:10735,SEMA4G
HGNC:21182,NUP43
HGNC:21151,RNF126
HGNC:7572,MYH2
HGNC:6535,LDHA
HGNC:4848,HCRTR1
HP:0012126,Stomach cancer
chembl:CHEMBL447,SECOBARBITAL
CHEBI:52289,wortmannin
chembl:CHEMBL405317,CHEMBL405317
MONDO:0002935,penis basal cell carcinoma
HGNC:7114,MKRN3
chembl:CHEMBL1200694,SEVOFLURANE
HGNC:17097,EXOSC2
HGNC:18714,DCP1A
HGNC:10586,SCN1B
HGNC:17190,OLFM4
HGNC:1974,CHUK
chembl:CHEMBL218394,BOCEPREVIR
chembl:CHEMBL1721885,SU-014813
chembl:CHEMBL328250,ADINAZOLAM
HGNC:8872,PFKFB1
HGNC:10549,ATXN10
HGNC:7225,MPZ
HP:0030186,Kinetic tremor
chembl:CHEMBL71851,SCOPOLETIN
HGNC:25610,FGGY
HGNC:786,ATF4
HP:0031467,Negative affectivity
chembl:CHEMBL584905,CHEMBL584905
HGNC:17008,TOPBP1
HP:0008947,Infantile muscular hypotonia
HP:0004756,Ventricular tachycardia
HGNC:12669,VDAC1
MONDO:0011038,cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
CHEBI:27881,resveratrol
HGNC:8140,OPA1
HGNC:17429,CGN
HGNC:16463,PRPF40A
chembl:CHEMBL1417951,MECARBAM
MONDO:0020127,hereditary peripheral neuropathy
HP:0025169,Left ventricular systolic dysfunction
chembl:CHEMBL85194,CHEMBL85194
chembl:CHEMBL1908391,MASITINIB
HP:0005202,Helicobacter pylori infection
HGNC:5346,ICAM3
HP:0006979,Sleep-wake cycle disturbance
MGI:1920958,Dppa3
HGNC:7804,NFYA
HGNC:2703,ECI1
Reactome:R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
chembl:CHEMBL3545049,BAY-1125976
MONDO:0014104,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4"
chembl:CHEMBL3306803,LUMATEPERONE
HGNC:545,ANXA7
HGNC:15971,TSG101
CHEBI:28593,quinidine
HP:0008619,Bilateral sensorineural hearing impairment
HGNC:3066,DUSP11
HGNC:7061,MGST1
HGNC:842,ATP5MC2
MONDO:0001631,vertebral artery insufficiency
HGNC:10471,RUNX1
HGNC:15983,WNT3A
HP:0000597,Ophthalmoparesis
chembl:CHEMBL2094789,CHEMBL2094789
HGNC:12558,ULK1
HGNC:10435,RPS6KA6
HGNC:17091,NCSTN
HGNC:16235,DNAJC5
chembl:CHEMBL221137,EMBELIN
chembl:CHEMBL2158051,AT-406
HGNC:51504,CYP3A7-CYP3A51P
HGNC:9949,RECQL4
HGNC:11715,TEAD2
HP:0031469,Low self esteem
GO:0007026,negative regulation of microtubule depolymerization
HP:0001482,Subcutaneous nodule
GO:0015284,fructose uniporter activity
HGNC:6845,MAP2K5
HGNC:646,ARAF
chembl:CHEMBL4297188,MIRANSERTIB
HGNC:13583,FBXO4
chembl:CHEMBL491960,CAMBINOL
chembl:CHEMBL8706,CLORGILINE
HGNC:7978,NR3C1
CHEBI:30031,succinate(2-)
chembl:CHEMBL493,BROMOCRIPTINE
chembl:CHEMBL588525,CHEMBL588525
MONDO:0012264,preeclampsia/eclampsia 2
chembl:CHEMBL247378,7-NITROINDAZOLE
chembl:CHEMBL442687,TIOXOLONE
HP:5200024,Abnormal relationship
HGNC:15492,ANKH
chembl:CHEMBL597251,CHEMBL597251
HGNC:4650,GTF2E1
HGNC:12336,TRPC4
MONDO:0005077,pertussis
MONDO:0100118,hereditary skin disorder
HGNC:4883,CFH
chembl:CHEMBL485053,LEUCETTAMINE B
chembl:CHEMBL2,PRAZOSIN
chembl:CHEMBL3545269,SAR425899
HGNC:5309,HUS1
HP:0000790,Hematuria
chembl:CHEMBL285848,MANUMYCIN A
CHEBI:33308,carboxylic ester
HGNC:20823,DPP10
HGNC:3976,FTH1
GO:0006225,UDP biosynthetic process
chembl:CHEMBL1764,LEVOMEPROMAZINE
HGNC:21155,MYLIP
chembl:CHEMBL288114,GALLIC ACID
chembl:CHEMBL1585652,CHEMBL1585652
chembl:CHEMBL1131,ACITRETIN
HGNC:4982,HMBS
chembl:CHEMBL1396626,DICHLOFENTHION
FB:FBgn0050169,Brca2
chembl:CHEMBL415879,PHENANTHROLINE
UPHENO:0078006,decreased reflex in cornea
HP:0030391,Spoken word recognition deficit
HGNC:28240,HVCN1
HGNC:4083,GABRB3
CHEBI:134361,allylic alcohol
MONDO:0009287,glycogen storage disease due to glucose-6-phosphatase deficiency type IA
chembl:CHEMBL244743,ESCULETIN
CHEBI:35348,3beta-sterol
NCBIGene:415826,COX4I1
MONDO:0030679,Noonan syndrome 14
CHEBI:16389,ubiquinones
HGNC:10418,RPS28
chembl:CHEMBL46874,PINAFIDE
chembl:CHEMBL395915,CHEMBL395915
RGD:68327,Hap1
HGNC:6442,KRT5
chembl:CHEMBL590919,CHEMBL590919
HGNC:11917,TNFRSF1B
HGNC:3061,DTYMK
chembl:CHEMBL206452,CATECHIN
HGNC:25009,UBE2T
MONDO:0024536,glucocorticoid deficiency 1
HGNC:30866,UEVLD
chembl:CHEMBL240963,LAWSONE
chembl:CHEMBL1466186,CHEMBL1466186
GO:0070837,dehydroascorbic acid transport
HGNC:23366,ARPC5L
chembl:CHEMBL2180604,TAK-593
chembl:CHEMBL78257,TYRPHOSTIN 51
HP:0011392,Abnormality of the vestibular nerve
HGNC:11208,SP3
CHEBI:35720,enrofloxacin
HGNC:549,AOC2
chembl:CHEMBL376408,ABT 737
chembl:CHEMBL1537417,CHEMBL1537417
CHEBI:29035,manganese(2+)
chembl:CHEMBL92,DOCETAXEL
MONDO:0003337,acute hemorrhagic encephalitis
MONDO:0859305,neurodevelopmental disorder with eye movement abnormalities and ataxia
chembl:CHEMBL2107387,VORTIOXETINE HYDROBROMIDE
chembl:CHEMBL3218576,COPANLISIB
HGNC:2263,COX15
HGNC:19985,SUB1
chembl:CHEMBL1892201,MOFEBUTAZONE
HGNC:25490,NTAQ1
NCBIGene:613338,IDH3B
CHEBI:37323,"7,8-dimethylisoalloxazine"
MONDO:0014143,Noonan syndrome 8
chembl:CHEMBL1096380,PLINABULIN
HGNC:11157,SNRPC
HGNC:10680,SDHA
MONDO:0014377,"developmental and epileptic encephalopathy, 24"
HGNC:6204,JUN
HGNC:7329,MSH6
MONDO:0004993,carcinoma
HGNC:2675,DAPK2
HGNC:4688,GUCY2C
GO:0032869,cellular response to insulin stimulus
chembl:CHEMBL1465049,CHEMBL1465049
MONDO:0008294,acute intermittent porphyria
HGNC:29535,MTF2
HGNC:4313,GLDC
HGNC:17296,RRM2B
MONDO:0020752,"myoclonic epilepsy, juvenile, susceptibility to, 1"
chembl:CHEMBL24,ATENOLOL
MONDO:0011057,cerebrovascular disorder
HGNC:1554,CBX4
chembl:CHEMBL303846,XANTHYLETIN
MONDO:0008567,"thyroid cancer, nonmedullary, 1"
HP:0033204,Triceps hyperreflexia
chembl:CHEMBL15848,ANANDAMIDE
Reactome:R-CFA-71288,Creatine metabolism
CHEBI:9588,ticlopidine
GO:0032868,response to insulin
chembl:CHEMBL1200943,MERSALYL
GO:0070887,cellular response to chemical stimulus
HGNC:14888,DNAJB6
HGNC:11553,TAGLN
HP:0008763,No social interaction
HP:0006801,Hyperactive deep tendon reflexes
HGNC:10802,SFTPC
chembl:CHEMBL11608,TYRAMINE
HGNC:15663,UGGT1
UBERON:0001554,skin of hip
ZFIN:ZDB-GENE-050417-274,ndufs3
MONDO:0031071,Diamond-Blackfan anemia 21
chembl:CHEMBL545437,AMIBEGRON HYDROCHLORIDE
MONDO:0005341,skin basal cell carcinoma
HGNC:7063,MGST2
HGNC:16828,SEC22C
MONDO:0030455,dystonia 31
HP:0004372,Reduced consciousness/confusion
FB:FBgn0027291,Idh3a
chembl:CHEMBL2323775,MK-8033
chembl:CHEMBL1189679,PALONOSETRON
MONDO:0000568,autoimmune disorder of central nervous system
chembl:CHEMBL88147,CHEMBL88147
MONDO:0100062,developmental and epileptic encephalopathy
chembl:CHEMBL1201131,PIPERONYL BUTOXIDE
chembl:CHEMBL1308677,CHEMBL1308677
chembl:CHEMBL258867,EUPALININ A
HGNC:17787,LIN7A
HGNC:8172,OR10H1
CHEBI:17698,chloramphenicol
UBERON:0000945,stomach
HGNC:5253,HSP90AA1
HGNC:29419,EARS2
GO:0004638,phosphoribosylaminoimidazole carboxylase activity
HGNC:658,ARF5
HGNC:10120,RNU1-1
MGI:1333889,Bub1b
HP:0002478,Progressive spastic quadriplegia
MONDO:0013060,autosomal recessive Parkinson disease 14
HGNC:9354,PRDX3
chembl:CHEMBL62,SCH-23390
HP:0007100,Progressive ventriculomegaly
chembl:CHEMBL1200645,ETOPOSIDE PHOSPHATE
HGNC:13780,GFM1
HGNC:1172,VPS51
CHEBI:36709,aminoquinoline
HGNC:3650,FEN1
chembl:CHEMBL460026,ICOSAPENT
HP:0030903,Grasp reflex
chembl:CHEMBL502774,CHEMBL502774
HGNC:30531,C11orf52
NCBIGene:415129,CYP3A12
HGNC:17893,PGAP2
NCBIGene:477798,NDUFB8
chembl:CHEMBL496102,AMG-208
HGNC:405,ALDH3A1
Reactome:R-RNO-549127,Organic cation transport
MONDO:0011835,"sensory ataxic neuropathy, dysarthria, and ophthalmoparesis"
chembl:CHEMBL51085,EBSELEN
chembl:CHEMBL3544967,GSK-2256098
HGNC:2092,CLTC
HGNC:21750,LLCFC1
HGNC:24316,TACO1
HP:0003396,Syringomyelia
chembl:CHEMBL599255,CHEMBL599255
chembl:CHEMBL1703,METFORMIN HYDROCHLORIDE
chembl:CHEMBL43612,JUGLONE
HGNC:4390,GNAQ
chembl:CHEMBL173929,LUTEIN
HP:0001426,Non-Mendelian inheritance
NCBIGene:476659,NDUFA13
Reactome:R-CFA-549127,Organic cation transport
chembl:CHEMBL1173445,LARGAZOLE
chembl:CHEMBL266481,GLUCAGON
HGNC:12036,TRAF6
GO:1901858,regulation of mitochondrial DNA metabolic process
MONDO:0044637,infantile-onset generalized dyskinesia with orofacial involvement
HGNC:20758,ZFYVE19
chembl:CHEMBL2105728,CRENOLANIB
HP:0002027,Abdominal pain
HGNC:12420,TUFM
chembl:CHEMBL1447476,BITHIONOLATE SODIUM
chembl:CHEMBL363160,PHA-680632
MONDO:0006039,infectious colitis
HP:0031826,Abnormal reflex
MONDO:0011833,spinocerebellar ataxia type 21
HGNC:558,AP1M2
HGNC:15578,REPS1
MONDO:0005185,chronic childhood arthritis
HGNC:7,A2M
NCBIGene:475214,NDUFA5
MONDO:0002517,tenosynovitis of foot and ankle
chembl:CHEMBL118218,IROFULVEN
HP:0002514,Cerebral calcification
chembl:CHEMBL548,DINOPROSTONE
HGNC:11199,SOX3
HGNC:3226,EFNB1
HP:0010529,Echolalia
chembl:CHEMBL220845,CHEMBL220845
HGNC:4208,GCSH
chembl:CHEMBL266459,ZOMEPIRAC SODIUM
MONDO:0700089,paroxysmal nonkinesigenic dyskinesia 1
HP:0031355,Maintenance insomnia
MONDO:0006732,drug-induced dyskinesia
HGNC:8587,PAICS
MONDO:0013521,"dyskeratosis congenita, autosomal dominant 2"
GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding
HP:0003144,Increased serum serotonin
chembl:CHEMBL1513985,ANTHRACENE-9-CARBOXYLIC ACID
HGNC:2001,GREM1
chembl:CHEMBL542157,SARAFLOXACIN HYDROCHLORIDE
CHEBI:172923,fluorescein (acid form)
CHEBI:29105,zinc(2+)
HGNC:30697,ITFG1
HP:0002983,Micromelia
chembl:CHEMBL161343,ARACHIDONOYL GLYCINE
chembl:CHEMBL275516,CANTHARIDIC_ACID
chembl:CHEMBL492399,VERUBULIN
HP:0032105,Macrosaccadic oscillations
HP:0002550,Absent facial hair
chembl:CHEMBL1098,BUPIVACAINE
HGNC:29918,NDUFAF3
HGNC:6349,KLF5
HGNC:117,ACO1
HP:0001187,Hyperextensibility of the finger joints
HP:0032677,Generalized-onset motor seizure
chembl:CHEMBL14173,ANTHRANILIC ACID
chembl:CHEMBL1488,URACIL MUSTARD
HGNC:18986,GBA2
chembl:CHEMBL184450,CHEMBL184450
chembl:CHEMBL188,WIN-552122
HGNC:3671,FGF14
HGNC:9177,POLE
GO:0140271,hexose import across plasma membrane
HGNC:30035,PIK3R5
chembl:CHEMBL140220,CHEMBL140220
HP:0001508,Failure to thrive
MONDO:0033480,spinocerebellar ataxia 45
CHEBI:23367,molecular entity
wikidata:Q29006769,ZYTIGA
chembl:CHEMBL291278,N-METHYL-D-ASPARTIC ACID (NMDA)
chembl:CHEMBL30,CIMETIDINE
HP:0002002,Deep philtrum
HGNC:6679,LPP
chembl:CHEMBL3286830,LORLATINIB
MONDO:0010808,fatal familial insomnia
HGNC:10935,SLC18A2
chembl:CHEMBL154580,CHEMBL154580
HP:0001260,Dysarthria
chembl:CHEMBL838,BENAZEPRIL
Reactome:R-DDI-611105,Respiratory electron transport
HP:0002650,Scoliosis
chembl:CHEMBL399530,CHEMBL399530
MONDO:0016695,oligodendroglioma
chembl:CHEMBL7724,AG1295
HGNC:1788,CDKN2B
HP:0001195,Single umbilical artery
CHEBI:5118,fluoxetine
MONDO:0003731,adult central nervous system teratoma
chembl:CHEMBL555196,SILVESTROL
HGNC:26941,UFC1
MONDO:0007488,Lewy body dementia
HP:0011877,Increased mean platelet volume
HGNC:14896,SPTBN4
HGNC:5044,HNRNPK
HGNC:688,RHOJ
HGNC:8048,NUDT1
chembl:CHEMBL3989843,TRANYLCYPROMINE
HP:0003128,Lactic acidosis
CHEBI:17287,N-phosphocreatine
MONDO:0016564,progressive supranuclear palsy-progressive non-fluent aphasia syndrome
HGNC:8975,PIK3CA
MONDO:0957545,"cardiomyopathy, dilated, 2I"
chembl:CHEMBL397420,ACENOCOUMAROL
HGNC:9143,PHOX2B
chembl:CHEMBL413376,SURAMIN HEXASODIUM
chembl:CHEMBL580076,CHEMBL580076
MONDO:0000167,Huntington disease and related disorders
PATO:0002096,"neoplastic, non-malignant"
PR:000007494,fibroblast growth factor 3
ZFIN:ZDB-GENE-040718-467,cox20
HP:0031466,Impairment in personality functioning
chembl:CHEMBL1263,SALMETEROL
HP:0100275,Diffuse cerebellar atrophy
HGNC:8896,PGK1
CHEBI:26191,polyol
HGNC:5466,IGF2
GO:0042581,specific granule
chembl:CHEMBL459,METHYLDOPA
HP:0001635,Congestive heart failure
chembl:CHEMBL3545261,BRONTICTUZUMAB
HP:0030188,Tremor by anatomical site
CHEBI:37324,"7,8-dimethylbenzo[g]pteridine-2,4-dione"
MONDO:0005401,colonic neoplasm
chembl:CHEMBL2107457,ITOPRIDE
HP:0100832,Vitreous floaters
MONDO:0010493,Diamond-Blackfan anemia 14 with mandibulofacial dysostosis
chembl:CHEMBL1201178,LISDEXAMFETAMINE DIMESYLATE
chembl:CHEMBL1980297,ILORASERTIB
HGNC:7690,NDUFA6
HP:0000734,Disinhibition
CHEBI:132124,"1,4-benzoquinones"
MONDO:0018905,diffuse large B-cell lymphoma
chembl:CHEMBL2108628,PACLITAXEL POLIGLUMEX
CHEBI:47779,aminoglycoside
MONDO:0019202,myxofibrosarcoma
chembl:CHEMBL1201111,ONDANSETRON HYDROCHLORIDE
HGNC:9153,PNKD
HGNC:17860,SERBP1
HGNC:9175,POLD1
CHEBI:28918,(R)-adrenaline
CHEBI:17263,estrone
UBERON:0001114,right lobe of liver
MONDO:0012048,endogenous depression
HGNC:16059,PAK4
HGNC:28971,SPIDR
HGNC:16435,HM13
HGNC:5173,HRAS
HGNC:12687,VHL
HGNC:16999,CLP1
HGNC:4879,HEXB
CHEBI:16526,carbon dioxide
HGNC:840,ATP5PB
chembl:CHEMBL481160,CHEMBL481160
chembl:CHEMBL3545042,SELURAMPANEL
HP:0003388,Easy fatigability
HGNC:17761,TREM2
HGNC:31859,TRIM67
HP:0010549,Weakness due to upper motor neuron dysfunction
HGNC:564,AP2M1
chembl:CHEMBL406845,CHEMBL406845
chembl:CHEMBL2165191,AZD-6482
HP:0000135,Hypogonadism
MONDO:0009567,Marinesco-Sjogren syndrome
chembl:CHEMBL1201866,LIRAGLUTIDE
HGNC:2698,DBT
HP:0002814,Abnormality of the lower limb
chembl:CHEMBL1290347,RETUSIN 7-METHYL ETHER
HGNC:21680,SIK2
chembl:CHEMBL44657,ETOPOSIDE
chembl:CHEMBL355014,FLUORANTHENE
chembl:CHEMBL3099551,CMX-2043
HGNC:29,ABCA1
HP:0002492,Morphological abnormality of the corticospinal tract
CHEBI:41983,4'-epidoxorubicinium
MONDO:0012278,"supranuclear palsy, progressive, 2"
HGNC:32017,ACSM2A
MONDO:0007108,anal canal carcinoma
HP:0000494,Downslanted palpebral fissures
CHEBI:4885,ethionamide
FB:FBgn0000447,Dhod
HGNC:6251,KCNH2
CL:0002255,stromal cell of endometrium
MONDO:0016689,gemistocytic astrocytoma
HGNC:7744,NEK1
HP:0020181,Reduced haptoglobin level
chembl:CHEMBL521851,PICTILISIB
MONDO:0008590,"tremor, hereditary essential, 1"
CHEBI:61313,C21-steroid
chembl:CHEMBL3989695,REGADENOSON
CHEBI:16962,cortisone
HGNC:1583,CCND2
MONDO:0019942,distal arthrogryposis
HP:0001321,Cerebellar hypoplasia
HP:0001155,Abnormality of the hand
chembl:CHEMBL581677,CHEMBL581677
HGNC:2197,COL1A1
HGNC:18291,DMAP1
HGNC:13315,HDAC8
CHEBI:16643,L-methionine
CHEBI:50852,glycinyl ester
CHEBI:2038,5-azacytidine
chembl:CHEMBL336467,FUROXAN
chembl:CHEMBL1498652,CHEMBL1498652
HGNC:2383,CRX
chembl:CHEMBL1594935,CYSTAMINE DIHYDROCHLORIDE
HP:0002488,Acute leukemia
HP:0000762,Decreased nerve conduction velocity
HP:0003713,Muscle fiber necrosis
chembl:CHEMBL373742,VASOPRESSIN
chembl:CHEMBL211045,CHEMBL211045
chembl:CHEMBL1630084,CHEMBL1630084
MONDO:0020044,autosomal recessive metabolic cerebellar ataxia
HGNC:20145,GPR143
MONDO:0012764,RIDDLE syndrome
chembl:CHEMBL306946,TRYPTANTHRIN
HGNC:4331,GLS
HGNC:13867,SH3KBP1
MONDO:0021042,glioma
HGNC:20731,GNB4
HGNC:7821,NID1
CHEBI:50854,hydrocortamate hydrochloride
MONDO:0003009,hyperaldosteronism
chembl:CHEMBL200102,PU-H71
chembl:CHEMBL986,RETINOL
HGNC:9293,PPP1R3C
CHEBI:474180,caspofungin
HP:0001374,Congenital hip dislocation
HGNC:3585,FANCD2
MGI:2139279,Hrh3
chembl:CHEMBL2108893,ALFIMEPRASE
MONDO:0012334,hereditary spastic paraplegia 29
chembl:CHEMBL2103839,RIDAFOROLIMUS
CHEBI:36885,20-oxo steroid
HP:0005184,Prolonged QTc interval
HP:0006323,Premature loss of primary teeth
HP:0002194,Delayed gross motor development
chembl:CHEMBL317094,IMIDAPRIL
HGNC:26909,HTRA4
HGNC:29534,ESYT1
RGD:71103,Slc27a2
UBERON:0008338,plantar part of pes
CHEBI:31355,carboplatin
HGNC:20771,TUBB4B
HGNC:12613,USP15
chembl:CHEMBL408850,CHEMBL408850
HGNC:6256,KCNJ10
chembl:CHEMBL1200885,ALOSETRON HYDROCHLORIDE
HGNC:2933,DMPK
HP:0008722,Urethral diverticulum
chembl:CHEMBL602922,CHEMBL602922
HGNC:11128,SNAI1
MGI:1350922,Cadps
chembl:CHEMBL3218578,BGT-226
chembl:CHEMBL608862,CHEMBL608862
HGNC:3621,FCGRT
HGNC:32486,RTP2
MONDO:0054695,"myopathy, centronuclear, 6, with fiber-type disproportion"
HGNC:7479,MT-TE
HGNC:9532,PSMA3
HGNC:17382,SRGAP1
HGNC:843,ATP5MC3
MONDO:0003504,anal canal neuroendocrine neoplasm
MONDO:0012595,"leprosy, susceptibility to, 4"
Reactome:R-HSA-390650,Histamine receptors
HGNC:1537,CBFA2T3
chembl:CHEMBL6,INDOMETHACIN
HGNC:21268,ANKRD13A
MONDO:0024237,inherited neurodegenerative disorder
MONDO:0020046,autosomal recessive degenerative and progressive cerebellar ataxia
MONDO:0009620,Say-Barber-Miller syndrome
chembl:CHEMBL643,PROMETHAZINE
HGNC:20776,TUBB6
HGNC:1734,CDC34
HP:0007200,Episodic hypersomnia
HGNC:7703,NDUFB8
MONDO:0003246,sclerosing hepatic carcinoma
HGNC:4657,GTF2H3
chembl:CHEMBL3039517,RABUSERTIB
HGNC:9386,PRKAG2
HP:0100660,Dyskinesia
HP:0006191,Deep palmar crease
NCBIGene:427897,NDUFA6
UPHENO:0079820,abnormally increased rate of hallucination
HP:0000093,Proteinuria
HGNC:23238,HSD17B14
HP:0000745,Diminished motivation
HP:0040202,Abnormal consumption behavior
MONDO:0850048,classic eosinophilic pustular folliculitis
chembl:CHEMBL13,METOPROLOL
MONDO:0014867,spinocerebellar ataxia 43
chembl:CHEMBL1477036,DOCUSATE
Reactome:R-GGA-611105,Respiratory electron transport
CHEBI:22160,acetamides
chembl:CHEMBL2104619,OCAPERIDONE
wikidata:Q29006033,IRESSA
HP:0002529,Neuronal loss in central nervous system
chembl:CHEMBL187460,CRYPTOTANSHINONE
chembl:CHEMBL6246,ELLAGIC ACID
HGNC:2151,CNGB1
HGNC:5300,HTR5A
HGNC:10526,SALL2
HGNC:12563,UMPS
HP:0006986,Upper limb spasticity
CHEBI:85251,teicoplanin A2-2
chembl:CHEMBL1697838,GLYMIDINE
MONDO:0004695,liver lymphoma
MGI:2388633,Cltc
HGNC:16412,NLRC4
MONDO:0004948,B-cell chronic lymphocytic leukemia
GO:0020018,ciliary pocket membrane
chembl:CHEMBL525826,CHEMBL525826
ZFIN:ZDB-GENE-050320-17,ndufa5
chembl:CHEMBL1200813,ACEBUTOLOL HYDROCHLORIDE
HP:0003546,Exercise intolerance
HGNC:15464,SPINK5
HGNC:9479,LONP1
MONDO:0014290,neurodegeneration with brain iron accumulation 6
chembl:CHEMBL968,FLURAZEPAM
HGNC:240,ADCY9
MONDO:0035713,FOXG1 syndrome due to intragenic alteration
HGNC:7154,MME
chembl:CHEMBL1552997,RHODOMYRTOXIN B
chembl:CHEMBL4297163,MUPARFOSTAT
MGI:1891497,Jph3
HGNC:3052,DSP
MONDO:0002379,cystic teratoma
MONDO:0010482,X-linked parkinsonism-spasticity syndrome
chembl:CHEMBL578890,CHEMBL578890
MONDO:0012214,glucocorticoid deficiency 3
Reactome:R-HSA-1660499,Synthesis of PIPs at the plasma membrane
HGNC:2159,CNR1
MONDO:0800112,non-atopic asthma
GO:0016922,nuclear receptor binding
CHEBI:16933,ergosterol
HGNC:19918,MYORG
HGNC:7765,NF1
chembl:CHEMBL4297787,MONALIZUMAB
chembl:CHEMBL153057,CHEMBL153057
MONDO:0010246,"developmental and epileptic encephalopathy, 9"
UBERON:0002728,entorhinal cortex
HGNC:11153,SNRPB
Reactome:R-HSA-8874211,CREB3 factors activate genes
HGNC:9381,PRKACB
chembl:CHEMBL602923,CHEMBL602923
NCBIGene:514472,TRAP1
HGNC:9675,PTPRM
MONDO:0011658,autosomal recessive early-onset Parkinson disease 7
chembl:CHEMBL1416006,EVOXINE
GO:0097338,response to clozapine
GO:0009410,response to xenobiotic stimulus
HGNC:21219,CILK1
MONDO:0010788,Leber hereditary optic neuropathy
MONDO:0003631,cervical serous adenocarcinoma
MONDO:0006135,cervical clear cell adenocarcinoma
chembl:CHEMBL2105199,OCINAPLON
chembl:CHEMBL1086397,CHEMBL1086397
HP:0002718,Recurrent bacterial infections
HGNC:8543,P2RY6
GO:0030175,filopodium
GO:0006602,creatinine catabolic process
HGNC:1386,CABP4
chembl:CHEMBL1200837,LEVOBETAXOLOL HYDROCHLORIDE
chembl:CHEMBL1369257,PHENYLSTIBONIC ACID
MONDO:0004110,refractory hairy cell leukemia
chembl:CHEMBL74415,CANNABINOL
UPHENO:0081703,paralysed facial muscle
HGNC:2938,DMXL2
UPHENO:0014081,cerebellar vermis atrophy
CHEBI:34848,mevastatin
chembl:CHEMBL2105631,BUDIODARONE
HGNC:11578,TBC1D1
chembl:CHEMBL1490,TRIHEXYPHENIDYL
MONDO:0043544,nosocomial infection
NCBIGene:489110,DRD1
chembl:CHEMBL2095212,MIRABEGRON
HGNC:6220,KCNA2
HGNC:4699,GYG1
chembl:CHEMBL2103868,CABOZANTINIB S-MALATE
HGNC:7614,MYOM2
MONDO:0015674,late infantile neuronal ceroid lipofuscinosis
chembl:CHEMBL1256186,CHEMBL1256186
HP:0030217,Limb apraxia
MONDO:0011551,TH-deficient dopa-responsive dystonia
chembl:CHEMBL3126832,OBP-801
MONDO:0010542,dilated cardiomyopathy 3B
chembl:CHEMBL361362,SYRINGARESINOL
HGNC:603,APOB
HGNC:1962,CHRNB2
chembl:CHEMBL307145,PYROGALLOL
HGNC:160,ACTL6B
CHEBI:65173,iloperidone
HGNC:7414,MT-ATP6
HGNC:15886,AAR2
HP:0006913,Frontal cortical atrophy
HGNC:3151,ECHS1
MONDO:0001390,transient refractive change
HGNC:3296,EIF4G1
GO:0043209,myelin sheath
HP:0011848,Abdominal colic
MONDO:0001391,indeterminate leprosy
HGNC:2498,CTDP1
HGNC:11168,SNTB1
chembl:CHEMBL606166,CHEMBL606166
HGNC:11411,CDKL5
HGNC:3432,ERBB4
CHEBI:168396,mycophenolic acid
HGNC:804,ATP1B1
chembl:CHEMBL193240,ROFLUMILAST
GO:0005765,lysosomal membrane
Reactome:R-HSA-389977,Post-chaperonin tubulin folding pathway
chembl:CHEMBL941,IMATINIB
chembl:CHEMBL8739,LINOLENIC ACID
chembl:CHEMBL2108129,SARUPLASE
HGNC:20,AARS1
HGNC:708,ARPC5
chembl:CHEMBL279229,URAPIDIL
chembl:CHEMBL31088,DEOXIEPINEPHRINE
GO:0030674,protein-macromolecule adaptor activity
MONDO:0006702,chronic inflammatory demyelinating polyradiculoneuropathy
HP:0006956,Lateral ventricle dilatation
chembl:CHEMBL1437,NOREPINEPHRINE
chembl:CHEMBL42355,CHEMBL42355
chembl:CHEMBL1201505,"FIBRINOLYSIN, HUMAN"
chembl:CHEMBL553939,CHEMBL553939
chembl:CHEMBL601400,CHEMBL601400
chembl:CHEMBL119878,CHEMBL119878
HGNC:5962,IL10
HGNC:25679,ATG101
HGNC:3622,FKTN
HGNC:3331,EMD
HGNC:3065,DUSP10
HP:0002277,Horner syndrome
HGNC:8780,PDE4A
GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific"
Reactome:R-HSA-390666,Serotonin receptors
MONDO:0041752,paucibacillary leprosy
HGNC:713,ARSA
chembl:CHEMBL50882,TIRAPAZAMINE
HGNC:10561,ATXN8OS
HGNC:4585,GRIN2A
HGNC:30167,PDIA4
MONDO:0015003,"dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities"
chembl:CHEMBL2103884,OPROZOMIB
chembl:CHEMBL290916,EDARAVONE
RGD:3763,Sstr2
Reactome:R-SSC-71288,Creatine metabolism
HGNC:7493,MT-TN
HGNC:6972,MDK
MGI:104913,Abi1
HGNC:13448,SLC38A2
HGNC:2000,CKS2
HGNC:30661,UBA2
HP:0002414,Spina bifida
HGNC:1701,CD81
chembl:CHEMBL1374101,POTASSIUM DICHROMATE 
HGNC:7450,MTMR2
HGNC:29118,TMEM63A
ZFIN:ZDB-GENE-050522-542,uqcrb
HGNC:2062,CLIC1
chembl:CHEMBL45068,PHLORETIN
chembl:CHEMBL208484,KARANJIN
HGNC:865,ATP6V0A1
MONDO:0010237,X-linked intellectual disability-plagiocephaly syndrome
HGNC:6235,KCNC3
MONDO:0006980,struma ovarii
chembl:CHEMBL445969,CAULIBUGULONE C
HGNC:9325,PPT1
HGNC:6140,ITGA4
chembl:CHEMBL1526240,DIHYDROGAMBOGIC ACID
chembl:CHEMBL591618,CHEMBL591618
chembl:CHEMBL2105729,DABRAFENIB MESYLATE
CHEBI:28757,fructose
HGNC:6177,ITPK1
HP:0012678,Iron accumulation in substantia nigra
HGNC:12392,DNAJC7
chembl:CHEMBL31,GATIFLOXACIN
CHEBI:63598,levofloxacin
chembl:CHEMBL1201237,LEVOBUNOLOL
chembl:CHEMBL3989872,APIMOSTINEL
HGNC:32930,IGFL3
HGNC:6317,KIF1C
HGNC:20305,SLC34A3
chembl:CHEMBL532,ERYTHROMYCIN
chembl:CHEMBL139,DICLOFENAC
chembl:CHEMBL4297451,XL-888
HGNC:5287,HTR1B
chembl:CHEMBL65717,MEPINDOLOL
MONDO:0018767,severe primary trimethylaminuria
HGNC:20716,KLC2
HGNC:10483,RYR1
CHEBI:133744,homovanillate
MONDO:0042972,meningococcemia
HP:0002789,Tachypnea
chembl:CHEMBL501680,BILIRUBIN
HGNC:10978,SLC24A4
HGNC:7464,MTNR1B
HGNC:1502,CASP14
HGNC:9537,PSMB1
HGNC:29529,TBL1XR1
HGNC:18572,HSDL2
CHEBI:142708,tigecycline(1+)
MONDO:0018710,megalencephaly-severe kyphoscoliosis-overgrowth syndrome
HGNC:13221,BCL11A
chembl:CHEMBL481049,CITROPTEN
chembl:CHEMBL2331680,RG-7603
NCBIGene:770937,UQCR10
HGNC:403,ALDH3A2
chembl:CHEMBL898,DIFLUNISAL
HP:0011153,Focal motor seizure
chembl:CHEMBL255863,NILOTINIB
HGNC:18171,CD244
HP:0012523,Oral aversion
HGNC:20247,MEPCE
NCBIGene:538821,COQ10A
MONDO:0016702,oligoastrocytoma
HGNC:17358,TPK1
UBERON:0009834,dorsolateral prefrontal cortex
HGNC:8912,PHB1
HGNC:4510,KISS1R
chembl:CHEMBL96926,THAPSIGARGIN
MONDO:0032613,"mitochondrial complex 1 deficiency, nuclear type 8"
HGNC:33846,ARHGEF35
HGNC:11233,SPAST
MONDO:0008961,Charcot-Marie-Tooth disease type 4A
CHEBI:6801,metformin
HP:0001178,Ulnar claw
HGNC:399,ALB
HP:0003552,Muscle stiffness
chembl:CHEMBL1129,TRIFLURIDINE
chembl:CHEMBL504323,BERBAMINE
HGNC:10896,SKI
HGNC:11998,TP53
chembl:CHEMBL1333049,CHEMBL1333049
HGNC:402,ALDH1A1
chembl:CHEMBL581910,CHEMBL581910
MONDO:0013645,autosomal recessive spinocerebellar ataxia 11
MONDO:0016295,neuronal ceroid lipofuscinosis
HP:0011172,Complex febrile seizure
HP:0001574,Abnormality of the integument
HGNC:6190,JAK1
HGNC:29005,TRIM66
MONDO:0006973,skin appendage carcinoma
HGNC:712,ARRB2
RGD:619776,Pfkfb3
NCBIGene:415876,DHODH
HGNC:15842,ERBIN
MONDO:0005011,Crohn disease
chembl:CHEMBL171699,CHEMBL171699
chembl:CHEMBL3545428,CHIAURANIB
GO:0103116,ABC-type D-galactofuranose transporter
chembl:CHEMBL81977,3-AMINOBENZAMIDE
CHEBI:46847,N-iminopiperazine
GO:0004348,glucosylceramidase activity
MONDO:0003516,adult teratoma
chembl:CHEMBL2105704,LENVATINIB MESYLATE
HGNC:11010,SLC2A5
MONDO:0002066,breast adenomyoepithelioma
HGNC:20739,IPMK
chembl:CHEMBL76370,TEGASEROD
HGNC:29600,MED19
HP:0001161,Hand polydactyly
MONDO:0015905,syndromic dyslipidemia
MONDO:0021465,benign neoplasm of appendix
MONDO:0018513,squamous cell carcinoma of colon
MONDO:0004496,myocarditis
GO:0022881,protein-N(PI)-phosphohistidine-N-acetylgalactosamine phosphotransferase system transporter activity
HP:0001100,Heterochromia iridis
UPHENO:0086129,non-functional eyelid
UPHENO:0081710,paralysed diaphragm
chembl:CHEMBL264938,GALLOCATECHIN GALLATE
chembl:CHEMBL2364628,RICOLINOSTAT
UBERON:0015488,sural nerve
HGNC:7876,NOS3
GO:0042995,cell projection
chembl:CHEMBL53,APOMORPHINE
MGI:102675,Crym
HGNC:4115,GALC
CHEBI:38925,benzopteridine
chembl:CHEMBL265686,CHEMBL265686
HGNC:16962,CGREF1
MONDO:0018326,transient neonatal myasthenia gravis
chembl:CHEMBL1371125,BENZO[E]PYRENE
chembl:CHEMBL581044,CHEMBL581044
Xenbase:XB-GENE-1007450,cyp2a6.9
HGNC:18370,RAB1B
MONDO:0011529,spinocerebellar ataxia type 13
ZFIN:ZDB-GENE-040801-26,sdhc
MONDO:0043543,iatrogenic disease
HGNC:11280,SQSTM1
HP:0040081,Abnormal circulating creatine kinase concentration
HGNC:16951,IVNS1ABP
MONDO:0008585,HELLP syndrome
HP:0007817,Horizontal supranuclear gaze palsy
HP:0025392,Nodular pattern on pulmonary HRCT
HP:0001304,Torsion dystonia
HP:0001423,X-linked dominant inheritance
HP:0003623,Neonatal onset
chembl:CHEMBL650,METHYLPREDNISOLONE
HGNC:18644,KLHL8
HGNC:21111,BICRAL
HGNC:3584,FANCC
HGNC:3382,DMTN
HGNC:17890,HPGDS
HP:0000317,Facial myokymia
HGNC:18732,KLHL9
HGNC:6947,MCM4
MONDO:0024278,proctocolitis
HGNC:7605,MYO6
chembl:CHEMBL236150,CLIOXANIDE
HGNC:16629,RAPGEF3
HGNC:32,ABCA2
MONDO:0012414,neuronal ceroid lipofuscinosis 10
chembl:CHEMBL1096009,ALLOXAN
chembl:CHEMBL1200328,DULOXETINE HYDROCHLORIDE
HGNC:11195,SOX2
HGNC:3025,DRD4
CHEBI:46848,N-arylpiperazine
HP:0009942,Duplication of thumb phalanx
HP:0002084,Encephalocele
CHEBI:49167,anti-asthmatic drug
chembl:CHEMBL1550879,MECETRONIUM
RGD:620119,Fntb
HGNC:7907,NPHP3
HP:0000023,Inguinal hernia
HGNC:2460,CSNK2B
CHEBI:2676,amoxicillin
CHEBI:24026,fatty alcohol
CHEBI:473992,nystatin A1
GO:0019902,phosphatase binding
HP:0005547,Myeloproliferative disorder
HGNC:11133,SNAP29
HGNC:1727,CDC25C
HGNC:3046,PIGP
HGNC:23594,VPS13C
HP:0001298,Encephalopathy
chembl:CHEMBL319244,CAFFEIC ACID PHENETHYL ESTER
UBERON:0002240,spinal cord
HGNC:11026,SLC3A2
HP:0003808,Abnormal muscle tone
HP:0430015,Abnormal morphology of musculature of pharynx
HGNC:5269,HSPE1
chembl:CHEMBL1742992,BLINATUMOMAB
MONDO:0017825,silent pituitary adenoma
chembl:CHEMBL211501,ANTIMYCIN A
HGNC:28270,R3HDM4
chembl:CHEMBL117785,TETRABENAZINE
chembl:CHEMBL1980715,LAUROGUADINE
MONDO:0018804,MYO5B-related progressive familial intrahepatic cholestasis
chembl:CHEMBL1465,PHENPROCOUMON
HGNC:4172,GATA3
HGNC:12476,UBE2D3
MONDO:0013878,"pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1"
MONDO:0014938,aniridia 3
NCBIGene:417112,NDUFA8
MONDO:0010765,"46,XY complete gonadal dysgenesis"
chembl:CHEMBL1489223,SAPPANONE A DIMETHYL ETHER
GO:0004346,glucose-6-phosphatase activity
MONDO:0015152,autosomal recessive limb-girdle muscular dystrophy
chembl:CHEMBL2381408,SAR-405838
chembl:CHEMBL297784,CHEMBL297784
HP:0002300,Mutism
HP:0007448,Hyperkeratosis over edematous areas
HGNC:16178,BPIFB3
HGNC:27407,SMCO1
HGNC:16524,RAB14
chembl:CHEMBL258316,CHEMBL258316
HGNC:6053,IMPDH2
HGNC:25564,ARL8B
HGNC:26600,WDR81
CHEBI:23618,deoxycortisol
chembl:CHEMBL1518,PROPYLTHIOURACIL
chembl:CHEMBL1334465,CHEMBL1334465
MONDO:0003818,childhood mature teratoma of the ovary
HGNC:17997,FKRP
chembl:CHEMBL346631,CEP-7055
chembl:CHEMBL1102,GLUTETHIMIDE
CHEBI:50402,androstanoid
chembl:CHEMBL1599768,PYRANTEL PAMOATE
HGNC:132,ACTB
HGNC:4623,GSR
chembl:CHEMBL12658,CHEMBL12658
chembl:CHEMBL2336325,VISTUSERTIB
MONDO:0005188,iatrogenic Kaposi's sarcoma
HGNC:637,AQP4
HGNC:18169,FKBP10
chembl:CHEMBL471036,LITOXETINE
HP:0001328,Specific learning disability
HGNC:28771,TMEM109
MONDO:0014884,"cholestasis, progressive familial intrahepatic, 5"
HP:0500001,Body odor
UBERON:0001017,central nervous system
GO:0001525,angiogenesis
HGNC:20421,LNX2
chembl:CHEMBL588683,CHEMBL588683
GO:0072757,cellular response to camptothecin
HGNC:19071,ALYREF
CHEBI:28971,ampicillin
chembl:CHEMBL52387,(RS)-ROSCOVITINE
HP:0410067,Increased level of L-fucose in urine
HGNC:9326,PPT2
chembl:CHEMBL584883,CHEMBL584883
chembl:CHEMBL2105648,PALOVAROTENE
chembl:CHEMBL454746,CLADRIN
chembl:CHEMBL1336,SORAFENIB
HGNC:7972,NR2C2
chembl:CHEMBL282433,DITOLYLGUANIDINE
HGNC:757,ASPH
HP:0031959,Leg dystonia
chembl:CHEMBL1326499,CHEMBL1326499
HGNC:1785,CDKN1B
HGNC:32060,H3-7
HGNC:7939,NPPA
HP:0001317,Abnormal cerebellum morphology
HP:0007354,Amyotrophic lateral sclerosis
MONDO:0030505,"cholestasis, progressive familial intrahepatic, 8"
MONDO:0006047,pancreatic adenocarcinoma
HGNC:9713,PEX19
chembl:CHEMBL1201658,ALKAVERVIR
HGNC:18806,CAMTA1
HP:0011463,Childhood onset
GO:0019900,kinase binding
chembl:CHEMBL2108463,GARLIC
chembl:CHEMBL1452696,FEPRAZONE
GO:0008361,regulation of cell size
HP:0100022,Abnormality of movement
HGNC:4624,GSS
HP:0002176,Spinal cord compression
HP:0031982,Abnormal putamen morphology
MONDO:0016705,angiocentric glioma
HGNC:21168,RHOT1
chembl:CHEMBL1255834,CHEMBL1255834
HP:5200123,Abnormal response to social norms
HP:0008339,Diaminoaciduria
CHEBI:4031,cyclosporin A
MONDO:0012756,proximal 16p11.2 microdeletion syndrome
MONDO:0007080,glucocorticoid-remediable aldosteronism
HGNC:4901,HHEX
HGNC:4637,GSTM5
HP:0002519,Hypnagogic hallucinations
HGNC:4285,GJB3
HGNC:28688,CCDC24
MONDO:0011785,hereditary spastic paraplegia 19
chembl:CHEMBL411066,KINETIN RIBOSIDE
MONDO:0018155,lateral sclerosis
HGNC:7455,MT-ND1
CHEBI:140325,secondary carboxamide
CHEBI:23359,colchicine
MONDO:0003243,hepatocellular clear cell carcinoma
HP:0006980,Progressive leukoencephalopathy
HGNC:7578,MYH8
CHEBI:26125,phytosterols
HP:0100963,Hyperesthesia
chembl:CHEMBL4297574,TEPRASIRAN
MONDO:0011719,gastrointestinal stromal tumor
HGNC:9777,RAB3A
UPHENO:0074367,abnormally decreased rate of motor coordination
chembl:CHEMBL3301612,ENCORAFENIB
CHEBI:37948,oxaspiro compound
UPHENO:0082827,increased hallucination
chembl:CHEMBL1479195,CHEMBL1479195
NCBIGene:423179,NDUFS3
HGNC:18751,RIN3
MONDO:0013258,"autism, susceptibility to, 16"
CHEBI:15741,succinic acid
HP:0002371,Loss of speech
chembl:CHEMBL2108675,DUPILUMAB
HGNC:12735,WASL
GO:0032836,glomerular basement membrane development
HP:0010867,Dyssynergia
HGNC:263,ADORA2A
MONDO:0019064,hereditary spastic paraplegia
MGI:106388,Abhd17a
HGNC:1509,CASP8
chembl:CHEMBL590427,CHEMBL590427
MONDO:0044740,salivary gland squamous cell carcinoma
ZFIN:ZDB-GENE-030131-4257,trap1
chembl:CHEMBL122355,CHEMBL122355
HP:0000005,Mode of inheritance
HP:0025116,Fetal distress
HGNC:11773,TGFBR2
MONDO:0011562,autosomal dominant Parkinson disease 4
MONDO:0003281,ovarian cystic teratoma
UBERON:0003728,mediastinum
chembl:CHEMBL6966,VERAPAMIL
HP:0001123,Visual field defect
CHEBI:39442,fluorescent probe
HGNC:8571,PACSIN2
HGNC:20885,AGPAT4
UBERON:0009853,body of uterus
HP:0000570,Abnormal saccadic eye movements
HGNC:11787,THBS3
chembl:CHEMBL217894,DECYLUBIQUINONE
HGNC:16085,SFXN1
MONDO:0003663,uterine ligament endometrioid adenocarcinoma
chembl:CHEMBL333121,CHEMBL333121
HGNC:3721,FKBP5
HGNC:1622,CCT7
MONDO:0016788,obsolete genetic hyperferritinemia without iron overload
chembl:CHEMBL287542,RAFOXANIDE
chembl:CHEMBL584,NELFINAVIR
CHEBI:46691,"2,3-dihydroxy-5-methyl-1,4-benzoquinone"
HGNC:8803,PDGFRA
HGNC:20134,GLRX5
HGNC:6636,LMNA
MONDO:0005172,skeletal system disorder
HGNC:10780,SRSF1
HGNC:6416,KRT14
chembl:CHEMBL579956,CHEMBL579956
HGNC:14090,RAB9B
MONDO:0006715,coronary stenosis
chembl:CHEMBL1492044,FLUORESCEIN DIACETATE
HGNC:28957,EMC1
CHEBI:8116,phorbol
chembl:CHEMBL546475,CHEMBL546475
HGNC:4114,GAL
chembl:CHEMBL53904,ZUCLOPENTHIXOL
chembl:CHEMBL551064,AEW-541
HP:0002020,Gastroesophageal reflux
HP:0001882,Leukopenia
HGNC:4319,GLI3
HGNC:6062,ING1
chembl:CHEMBL417799,SANGUINARIUM
chembl:CHEMBL2108738,NIVOLUMAB
HGNC:11117,SMN1
HGNC:21148,RNF123
HP:0006855,Cerebellar vermis atrophy
chembl:CHEMBL587259,CHEMBL587259
HGNC:4458,GPI
GO:0060170,ciliary membrane
chembl:CHEMBL407501,CHEMBL407501
MONDO:0100320,post-COVID-19 disorder
MONDO:0012235,autosomal recessive spinocerebellar ataxia 7
HP:0007928,Abnormal flash visual evoked potentials
HP:0000505,Visual impairment
NCBIGene:475251,AHR
HP:0012531,Pain
chembl:CHEMBL680,CEFACLOR
HGNC:4006,FUCA1
chembl:CHEMBL3544927,L-21649
chembl:CHEMBL527,PIROXICAM
HGNC:5047,HNRNPR
HGNC:16354,ADHFE1
HGNC:25784,DCAF17
HGNC:6150,ITGAV
HGNC:19391,SOCS3
NCBIGene:526682,CYP3A76
chembl:CHEMBL112750,CHEMBL112750
HGNC:18860,ASAH2
HGNC:7491,MT-TL2
HGNC:5474,IGFBP5
chembl:CHEMBL2108989,ASPARAGINASE
MONDO:0014741,DeSanto-Shinawi syndrome due to WAC point mutation
HGNC:26661,RNF168
HGNC:1394,CACNA1G
chembl:CHEMBL284028,"2,3-DIHYDROXY-6,7-DICHLOROQUINOXALINE"
GO:0005615,extracellular space
chembl:CHEMBL428496,WORTMANNIN
HGNC:2198,COL1A2
UBERON:0002115,jejunum
MONDO:0018666,hepatoblastoma
MONDO:0006637,acute kidney tubular necrosis
HGNC:11167,SNTA1
Reactome:R-HSA-2467813,Separation of Sister Chromatids
Reactome:R-HSA-1614517,Sulfide oxidation to sulfate
chembl:CHEMBL1451116,IODOFORM
CHEBI:15727,carnosine
GO:0043025,neuronal cell body
MONDO:0003196,appendix carcinoma
HGNC:17288,APOA5
HGNC:4574,GRIA4
HGNC:9382,PRKACG
HGNC:9554,PSMD1
NCBIGene:423016,DRD4
HP:0000640,Gaze-evoked nystagmus
MONDO:0007566,multiple self-healing squamous epithelioma
GO:0001221,transcription coregulator binding
HGNC:4667,GTF3C4
HGNC:9502,CYTH2
HGNC:21197,FA2H
HP:0003737,Mitochondrial myopathy
PomBase:SPAC1071.06,arp9
chembl:CHEMBL4298097,ROMILKIMAB
HP:0002921,Abnormal cerebrospinal fluid morphology
chembl:CHEMBL545900,CHEMBL545900
MONDO:0005306,ankylosing spondylitis
chembl:CHEMBL54044,CHEMBL54044
GO:0016913,follicle-stimulating hormone activity
MONDO:0011445,hereditary spastic paraplegia 11
chembl:CHEMBL4297494,GSK-3117391
CHEBI:3745,clindamycin
HP:0001276,Hypertonia
chembl:CHEMBL1441574,BENZO(K)FLUORANTHENE
MONDO:0002542,spinal cord glioma
chembl:CHEMBL1423,PIMOZIDE
HGNC:32952,SNORD118
HGNC:10947,SLC20A2
HGNC:6971,MDH2
MONDO:0005355,coronary restenosis
CHEBI:16632,vanillate
chembl:CHEMBL3301578,EMIBETUZUMAB
HGNC:11809,TIE1
HP:0025153,Transient
chembl:CHEMBL1489812,CHEMBL1489812
HP:0002505,Loss of ambulation
UBERON:0000399,jejunal mucosa
GO:0016608,growth hormone-releasing hormone activity
MONDO:0011970,rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome
chembl:CHEMBL1897070,TEBUFENPYRAD
HGNC:11896,TNFAIP3
HP:0032524,Long thumb
HGNC:45,ABCB4
MONDO:0006659,arteriosclerosis obliterans
UBERON:0001950,neocortex
MONDO:0012895,torsion dystonia 17
HGNC:3299,EIF5
chembl:CHEMBL473721,CHEMBL473721
MONDO:0007171,atrial standstill 1
HP:0007350,Hyperreflexia in upper limbs
chembl:CHEMBL500,PINDOLOL
CHEBI:15705,L-alpha-amino acid
HGNC:12011,TPM2
HP:0000164,Abnormality of the dentition
chembl:CHEMBL1200666,CALCIPOTRIENE
HGNC:2269,COX5B
HP:0002366,Abnormal lower motor neuron morphology
MONDO:0011249,torsion dystonia with onset in infancy
MONDO:0016239,cystinosis
CHEBI:16610,spermidine
HGNC:20612,TDRD3
chembl:CHEMBL1481721,CHEMBL1481721
chembl:CHEMBL1201570,ANAKINRA
HGNC:8977,PIK3CD
chembl:CHEMBL3545212,AMG-337
MGI:87977,Ak1
chembl:CHEMBL280998,CATECHOL
HGNC:18301,SLC2A14
HGNC:4711,GZMK
HP:0000713,Agitation
HGNC:5238,HSPA5
MONDO:0010334,severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome
HP:0002355,Difficulty walking
MONDO:0009764,"ocular motor apraxia, Cogan type"
HGNC:13667,AP1M1
HGNC:9587,PTDSS1
chembl:CHEMBL1351571,4-BENZYLOXYANILINE
HGNC:7646,NAT2
MONDO:0012851,hypophosphatemic nephrolithiasis/osteoporosis 2
MP:0001405,impaired coordination
chembl:CHEMBL23327,PURVALANOLA
HP:0031849,Sleep-wake inversion
chembl:CHEMBL16,PHENYTOIN
chembl:CHEMBL1082407,ENZALUTAMIDE
HGNC:1112,NCAPH
GO:0097305,response to alcohol
HGNC:1421,SLC25A20
chembl:CHEMBL1201260,BETHANIDINE
chembl:CHEMBL609628,CHEMBL609628
HGNC:12502,SUMO1
HGNC:6913,MAX
chembl:CHEMBL1201454,ALSEROXYLON
HGNC:29799,SGMS1
MONDO:0043512,traumatic encephalopathy
chembl:CHEMBL1351,CARBOPLATIN
HGNC:285,ADRB1
HP:0012154,Anhedonia
NCBIGene:613899,UQCRH
CHEBI:132992,radiosensitizing agent
HP:0002376,Developmental regression
chembl:CHEMBL3137318,TALAZOPARIB TOSYLATE
HP:0034434,Abnormal communication
CHEBI:6078,ivermectin
MONDO:0010085,Schilder disease
chembl:CHEMBL413,SIROLIMUS
MONDO:0008892,progressive familial intrahepatic cholestasis type 1
HGNC:16831,TSPOAP1
HGNC:18745,DYNC1LI1
HGNC:12509,UBQLN2
HGNC:17095,LARS2
HP:0002231,Sparse body hair
HP:0002283,Global brain atrophy
HGNC:9188,POLR2B
chembl:CHEMBL83154,2-AMINOANTHRACENE
chembl:CHEMBL542541,HYDRALAZINE HYDROCHLORIDE
HP:0007158,Progressive extrapyramidal muscular rigidity
WB:WBGene00020932,dhod-1
chembl:CHEMBL485832,GUANIDINONALTRINDOLE
HGNC:2979,DNMT3B
Reactome:R-GGA-549127,Organic cation transport
MGI:1858451,Cyp3a41a
HP:0001376,Limitation of joint mobility
UBERON:0014890,right hemisphere of cerebellum
chembl:CHEMBL582081,CHEMBL582081
HGNC:6119,IRF4
CHEBI:35681,secondary alcohol
HGNC:3771,FMO3
chembl:CHEMBL2107762,NERISPIRDINE
HP:0002138,Subarachnoid hemorrhage
HGNC:29006,SEC16A
HGNC:1006,BCL7C
HP:0000341,Narrow forehead
chembl:CHEMBL704,MESALAMINE
HGNC:11763,TFRC
HGNC:6427,KRT17
HP:0011499,Mydriasis
chembl:CHEMBL19476,L-765314
HGNC:11393,AURKA
HGNC:14000,PRDM16
HGNC:21202,KIF6
chembl:CHEMBL1863429,CYAZOFAMID
CHEBI:8871,risperidone
chembl:CHEMBL1422704,CHEMBL1422704
MONDO:0044745,nervous system injury
HGNC:59,ABCC8
chembl:CHEMBL1556914,METHYL 7-DESHYDROXYPYROGALLIN-4-CARBOXYLATE
MONDO:0011647,Alzheimer disease 7
MONDO:0008730,congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency
HGNC:28973,MLEC
chembl:CHEMBL1009,LEVODOPA
CHEBI:3647,chlorpromazine
MONDO:0016759,pontocerebellar hypoplasia type 2
UPHENO:0055092,increased reflex
MONDO:0014742,"Parkinson disease 22, autosomal dominant"
chembl:CHEMBL2040682,CICLESONIDE
MONDO:0016751,malignant perineurioma
RGD:1563603,Rad51
HGNC:1585,CCND3
chembl:CHEMBL275260,CHEMBL275260
GO:0022871,protein-N(PI)-phosphohistidine-sorbose phosphotransferase system transporter activity
HP:0001105,Retinal atrophy
chembl:CHEMBL1452868,SPHONDIN
HGNC:18157,TAB1
chembl:CHEMBL1200708,BISOPROLOL FUMARATE
chembl:CHEMBL1200492,NEFAZODONE HYDROCHLORIDE
HGNC:13557,ACE2
chembl:CHEMBL415,CLOMIPRAMINE
HGNC:3569,ACSL1
HP:0006919,"Abnormal aggressive, impulsive or violent behavior"
MONDO:0009064,ocular cystinosis
chembl:CHEMBL3833346,TOFERSEN
chembl:CHEMBL781,MAZINDOL
MONDO:0014033,dystonia 25
HP:0033206,Hyperactive Achilles reflex
UBERON:0002107,liver
HP:0001320,Cerebellar vermis hypoplasia
HGNC:21698,RNF216
chembl:CHEMBL506871,VELIPARIB
chembl:CHEMBL802,MINOXIDIL
HP:0003236,Elevated circulating creatine kinase concentration
HP:0000773,Short ribs
chembl:CHEMBL584458,CHEMBL584458
RGD:621321,Myo1d
chembl:CHEMBL1236854,XANTHOPTERIN
chembl:CHEMBL1374986,BISSALICYL FUMARATE
chembl:CHEMBL1214124,PERAMPANEL
MONDO:0020655,juvenile ankylosing spondylitis
MONDO:0010787,Kearns-Sayre syndrome
HP:0100021,Cerebral palsy
MONDO:0030815,"cholestasis, progressive familial intrahepatic, 11"
MONDO:0005095,spondyloarthropathy
HGNC:10979,SLC25A1
HGNC:14895,ULBP3
chembl:CHEMBL491981,7-HYDROXY ISOFLAVONE
CHEBI:25681,omega-3 fatty acid
HP:0025423,Abnormal larynx morphology
chembl:CHEMBL1326944,"7,3'-DIMETHOXYFLAVONE"
dictyBase:DDB_G0287055,vps13F
HGNC:24624,SIL1
HP:0008760,Violent behavior
HGNC:24969,NPRL2
HGNC:3009,DPP4
FB:FBgn0262716,Arp3
HGNC:12482,UBE2G1
MONDO:0005026,endometrioid adenocarcinoma
HP:0030214,Hypersexuality
HGNC:4494,GPR37
chembl:CHEMBL1743018,FICLATUZUMAB
HGNC:27265,UBXN2A
CHEBI:2468,secondary alpha-hydroxy ketone
HGNC:16074,OCIAD1
HGNC:16501,PDLIM4
HGNC:6218,KCNA1
chembl:CHEMBL954,ENCLOMIPHENE
HP:0000605,Supranuclear gaze palsy
chembl:CHEMBL296522,RENZAPRIDE
MONDO:0017824,familial isolated pituitary adenoma
HGNC:21602,TBC1D22B
chembl:CHEMBL591126,CHEMBL591126
HGNC:29955,SLC51A
HGNC:11306,SRPK2
HGNC:16002,MPLKIP
HGNC:16832,ATP6V1F
MONDO:0010823,rhizomelic chondrodysplasia punctata type 3
GO:0042827,platelet dense granule
chembl:CHEMBL1750,CLOFARABINE
chembl:CHEMBL3545307,MERESTINIB
UBERON:0001711,eyelid
chembl:CHEMBL22,TRIMETHOPRIM
HP:0000085,Horseshoe kidney
HGNC:18395,SCGB1D1
HGNC:779,ATCAY
HGNC:9605,PTGS2
MONDO:0007493,torsion dystonia 4
chembl:CHEMBL6437,MIANSERIN
GO:0098588,bounding membrane of organelle
MONDO:0033115,"spinocerebellar ataxia, autosomal recessive 25"
chembl:CHEMBL526034,CHEMBL526034
HGNC:7137,AFDN
HGNC:11049,SLC6A3
HP:5200029,Social disinhibition
chembl:CHEMBL1201733,PAZOPANIB HYDROCHLORIDE
CHEBI:16733,D-alpha-amino acid
HGNC:3483,ETFDH
WB:WBGene00043980,F11D5.7
chembl:CHEMBL1712057,OXYCARBOXIN
HP:0031762,Distance esotropia
chembl:CHEMBL278164,NAPHTHYLAMINE
chembl:CHEMBL3545173,IRX4310
MONDO:0009131,Riley-Day syndrome
HGNC:290,GRK3
HGNC:26120,RBFA
HP:0008984,Neck muscle hypoplasia
HP:0011951,Aspiration pneumonia
HGNC:9394,PICK1
HGNC:461,AMELX
HGNC:9056,PLCB3
HGNC:20662,SLC25A24
MONDO:0012177,posterior column ataxia-retinitis pigmentosa syndrome
HGNC:2519,CTPS1
HP:0031247,Whooping cough
chembl:CHEMBL2104993,VORTIOXETINE
HGNC:6513,LASP1
HP:0002099,Asthma
MONDO:0010156,Troyer syndrome
HP:0003445,EMG: neuropathic changes
chembl:CHEMBL1801204,AZD-8055
HP:0007057,Poor hand-eye coordination
CHEBI:71365,rifampicin zwitterion
chembl:CHEMBL1700,SOTALOL HYDROCHLORIDE
HP:0003387,Decreased number of large peripheral myelinated nerve fibers
chembl:CHEMBL1089,PHENELZINE
HGNC:25250,ADPGK
HGNC:17007,DUSP14
NCBIGene:535293,EPHX1
GO:1901327,response to tacrolimus
HGNC:8032,NTRK2
MONDO:0005560,brain disorder
GO:0030027,lamellipodium
HGNC:1551,CBX1
HGNC:634,AQP2
HGNC:3148,TYMP
MONDO:0002889,orbital cancer
CHEBI:171741,cerulenin
CHEBI:55346,anidulafungin
HGNC:9879,RASGRP2
HGNC:12618,USP2
chembl:CHEMBL14762,SELICICLIB
MONDO:0018117,"disorder of phospholipids, sphingolipids and fatty acids biosynthesis"
HGNC:4181,GBF1
chembl:CHEMBL3545050,BMS-817378
GO:0005362,low-affinity glucose:sodium symporter activity
ZFIN:ZDB-GENE-000329-3,actb2
HP:0000733,Abnormal repetitive mannerisms
HGNC:4336,GLUD2
MONDO:0040502,glucocorticoid deficiency 5
chembl:CHEMBL1477383,CHEMBL1477383
HGNC:10067,RNF4
MONDO:0011638,neuroferritinopathy
HP:0012343,Decreased circulating ferritin concentration
HP:0000617,Abnormality of ocular smooth pursuit
CHEBI:25461,myxothiazol
CHEBI:53665,oxazinoquinoline
HGNC:7029,MET
MONDO:0001876,renal artery atheroma
HP:0002105,Hemoptysis
HGNC:12034,TRAF4
HP:0007270,Atypical absence seizure
MONDO:0014475,spinocerebellar ataxia type 40
HGNC:10912,SLC12A3
chembl:CHEMBL1184904,RETASPIMYCIN
HGNC:19094,IL4I1
chembl:CHEMBL1193948,AMIBEGRON
CHEBI:9398,tamsulosin
UBERON:0000992,ovary
CHEBI:16810,2-oxoglutarate(2-)
HP:0031723,Secondary esotropia
HP:0033505,Livedo reticularis
chembl:CHEMBL254760,MGCD-265
chembl:CHEMBL1255743,TRANYLCYPROMINE HYDROCHLORIDE
chembl:CHEMBL1588679,CHEMBL1588679
HP:0007366,Atrophy/Degeneration affecting the brainstem
CHEBI:27641,cycloheximide
HP:0002446,Astrocytosis
chembl:CHEMBL578063,ALAZANINE
HP:0012444,Brain atrophy
HP:0001278,Orthostatic hypotension
HGNC:7871,NONO
chembl:CHEMBL212948,DAMNACANTHAL
CHEBI:17544,hydrogencarbonate
CHEBI:17276,phloretin
NCBIGene:475428,NDUFA12
chembl:CHEMBL388676,CAPTAN
HGNC:23472,SLC25A28
UBERON:0002661,superior frontal gyrus
HP:0045025,Narrow palpebral fissure
HP:0000303,Mandibular prognathia
chembl:CHEMBL144757,CHEMBL144757
chembl:CHEMBL55934,NAPHTHOQUINONE
HP:0010544,Vertical nystagmus
MONDO:0003384,uterine ligament clear cell adenocarcinoma
chembl:CHEMBL1200710,CLOMIPRAMINE HYDROCHLORIDE
chembl:CHEMBL219568,GUANINE
chembl:CHEMBL13662,CI-218872
CHEBI:23697,dichlorobenzene
HGNC:1014,BCR
HGNC:6308,KEL
MONDO:0005395,movement disorder
GO:0015937,coenzyme A biosynthetic process
FB:FBgn0003257,r-l
HGNC:11986,TOP1
HP:0002340,Caudate atrophy
HP:0000400,Macrotia
NCBIGene:615506,MTARC2
chembl:CHEMBL8659,OLEIC ACID
MONDO:0011144,"ceroid lipofuscinosis, neuronal, 6A"
chembl:CHEMBL449,BUTABARBITAL
HGNC:20486,UBAC2
MONDO:0011858,"spastic paraplegia, ataxia, and intellectual disability"
HGNC:2704,DCK
HGNC:17018,SEC23IP
HGNC:13516,BIRC6
HGNC:12814,XPA
chembl:CHEMBL285819,CHEMBL285819
HGNC:9801,RAC1
chembl:CHEMBL299613,2-METHOXYESTRADIOL
HGNC:8800,PDGFB
MONDO:0054764,neurodegeneration with brain iron accumulation 8
GO:0098674,extrinsic component of neuronal dense core vesicle membrane
Xenbase:XB-GENE-5915063,actr3
chembl:CHEMBL1096,AMLEXANOX
CHEBI:16827,corticosterone
HGNC:12491,UBE2M
HP:0100518,Dysuria
chembl:CHEMBL410484,CHEMBL410484
MONDO:0010404,X-linked non progressive cerebellar ataxia
HGNC:9051,PLAT
MONDO:0014748,progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome
CHEBI:33570,benzenediols
GO:0097333,response to olanzapine
chembl:CHEMBL26320,CHEMBL26320
WB:WBGene00019800,mtss-1
HGNC:3688,FGFR1
HGNC:29623,MAN2B2
WB:WBGene00012699,Y39B6A.41
HP:0002335,Agenesis of cerebellar vermis
chembl:CHEMBL27759,ENTINOSTAT
HGNC:24500,VIRMA
HGNC:1748,CDH1
chembl:CHEMBL3544960,AT-13148
chembl:CHEMBL56367,NIMESULIDE
MONDO:0007485,"dyskeratosis congenita, autosomal dominant 1"
chembl:CHEMBL1367478,LEVDOBUTAMINE
MONDO:0010184,methylmalonic aciduria and homocystinuria type cblC
chembl:CHEMBL1394829,PROPACHLOR
chembl:CHEMBL3137309,VENETOCLAX
HP:0005301,Persistent left superior vena cava
CHEBI:50851,hydrocortamate
GO:0042803,protein homodimerization activity
HGNC:4170,GATA1
CHEBI:7731,ofloxacin
HGNC:5045,HNRNPL
MONDO:0043377,juvenile spondyloarthropathy
HP:0007185,Loss of consciousness
NCBIGene:478853,COQ10B
chembl:CHEMBL349803,PIRETANIDE
chembl:CHEMBL2103829,FAXELADOL
chembl:CHEMBL1355821,TEMEFOS
HGNC:15912,NSFL1C
MONDO:0008729,congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency
CHEBI:29347,monocarboxylic acid amide
HGNC:1659,CD33
MONDO:0005890,osteitis fibrosa
HGNC:3023,DRD2
chembl:CHEMBL2109608,L19IL2
MONDO:0010130,dihydropyrimidine dehydrogenase deficiency
HGNC:4401,GNB5
chembl:CHEMBL1456870,GARCINOLIC ACID
HGNC:52297,STRIT1
chembl:CHEMBL1720,PALONOSETRON HYDROCHLORIDE
CHEBI:36785,carbobicyclic compound
MONDO:0100030,adolescent/adult-onset epilepsy syndrome
HGNC:20182,SLC39A9
MONDO:0012187,Fanconi anemia complementation group J
HP:0000842,Hyperinsulinemia
HP:0007441,Hyperpigmented/hypopigmented macules
HP:0006858,Impaired distal proprioception
GO:0042789,mRNA transcription by RNA polymerase II
ZFIN:ZDB-GENE-030131-8005,sdhb
HGNC:2095,CLU
HGNC:32016,ACSM4
HGNC:3265,EIF2S1
HP:0100008,Schwannoma
HGNC:10682,SDHC
chembl:CHEMBL1453,DIGITOXIGENIN
HP:0006955,Olivopontocerebellar hypoplasia
GO:0010961,intracellular magnesium ion homeostasis
chembl:CHEMBL2109159,PITRAKINRA
HP:0002460,Distal muscle weakness
RGD:1309728,Cbr3
CHEBI:27958,cocaine
chembl:CHEMBL1109,SULFAPHENAZOLE
HP:0002751,Kyphoscoliosis
chembl:CHEMBL3545026,FAMITINIB
CHEBI:17579,beta-carotene
UPHENO:0025440,absent vestibular nerve in the independent continuant
chembl:CHEMBL1275,PERGOLIDE MESYLATE
HGNC:10560,ATXN7
GO:0031514,motile cilium
HP:0011362,Abnormal hair quantity
Xenbase:XB-GENE-971750,cyp3a4.2
HGNC:11036,SLC5A1
chembl:CHEMBL289277,EMODIN
MONDO:0006140,"cervical mucinous adenocarcinoma, minimal deviation variant"
HGNC:6881,MAPK8
HGNC:626,APRT
HGNC:23703,ERMP1
MONDO:0006893,Pasteurella hemorrhagic septicemia
HGNC:22140,FAM20C
HGNC:4800,HSD17B10
HP:0001395,Hepatic fibrosis
chembl:CHEMBL453818,CHEMBL453818
HP:0007256,Abnormal pyramidal sign
HGNC:2482,CSTB
HGNC:30077,REEP5
chembl:CHEMBL521083,CHEMBL521083
HGNC:10430,RPS6KA1
HGNC:24648,ETAA1
HGNC:9217,POU3F4
HGNC:26064,MTARC2
HGNC:29038,OTUD3
CHEBI:70979,N-isobutyrylglycine
HGNC:170,ACTR3
HGNC:10018,RING1
chembl:CHEMBL447876,CAULIBUGULONE D
CHEBI:87071,conazole antifungal drug
chembl:CHEMBL12636,HYMECROMONE METHYL ETHER
chembl:CHEMBL1201728,DESVENLAFAXINE SUCCINATE
HGNC:7127,MLH1
HGNC:14082,ANLN
HGNC:10074,RNH1
dictyBase:DDB_G0274993,bzpJ
HP:0012745,Short palpebral fissure
chembl:CHEMBL404954,CHEMBL404954
HGNC:28963,EMC2
HGNC:17042,PUF60
GO:0004707,MAP kinase activity
HGNC:4751,H2BC3
HGNC:728,ARVCF
HP:0010880,Increased nuchal translucency
HGNC:10348,RPL37A
chembl:CHEMBL1873475,IBRUTINIB
chembl:CHEMBL533602,CHEMBL533602
chembl:CHEMBL35,FUROSEMIDE
GO:0036464,cytoplasmic ribonucleoprotein granule
NCBIGene:478880,NDUFS1
HGNC:1464,CAMK4
MONDO:0003410,Wolffian duct adenocarcinoma
chembl:CHEMBL932,DIPYRIDAMOLE
RGD:3704,Slc2a1
HGNC:1573,KRIT1
chembl:CHEMBL414804,OXALIPLATIN
chembl:CHEMBL1321398,METHYLBENZETHONIUM CHLORIDE
MONDO:0021137,not rare
HGNC:14454,GABRQ
HGNC:15894,PANK2
HGNC:3597,FAU
HGNC:9657,PTPN5
chembl:CHEMBL378544,VINBLASTINE SULFATE
MONDO:0858950,traumatic brain injury
UBERON:0001245,anus
HGNC:5273,HSPG2
HGNC:9676,PTPRN
chembl:CHEMBL908,CHLORPROTHIXENE
HP:0030784,Anomic aphasia
HGNC:17939,SLC45A1
Reactome:R-GGA-211945,Phase I - Functionalization of compounds
HGNC:94,ACAT2
MGI:106210,Dmbt1
chembl:CHEMBL841,LOPERAMIDE
chembl:CHEMBL1331521,"3,6-DIMETHOXYFLAVONE"
chembl:CHEMBL172064,E324
chembl:CHEMBL21396,SKIMMIANINE
chembl:CHEMBL1671,PROPRANOLOL HYDROCHLORIDE
HGNC:11443,STX8
HGNC:20151,SLC17A8
HGNC:12729,WARS1
MONDO:0005116,Whipple disease
chembl:CHEMBL58033,(-)-U-50488
HGNC:30766,TRAF3IP3
chembl:CHEMBL603469,LESTAURTINIB
HGNC:12033,TRAF3
MONDO:0018901,left ventricular noncompaction
HGNC:12703,BEST1
chembl:CHEMBL592118,CHEMBL592118
UPHENO:0079840,abnormal sexual inhibition
chembl:CHEMBL92708,CALPEPTIN
HP:0002960,Autoimmunity
HGNC:13312,GSTO1
HGNC:5246,HSPB1
chembl:CHEMBL852,MELPHALAN
HGNC:10980,SLC25A10
chembl:CHEMBL197194,VIDOFLUDIMUS
CHEBI:83403,monochlorobenzenes
UBERON:0001507,biceps brachii
chembl:CHEMBL3545000,MK-2201
Reactome:R-DRE-611105,Respiratory electron transport
HP:0025149,Atrophic muscularis propria
HP:0008873,Disproportionate short-limb short stature
MONDO:0006640,adrenal gland hyperfunction
HGNC:4801,HADHA
GO:0005412,glucose:sodium symporter activity
MONDO:0019171,familial long QT syndrome
HGNC:2020,CLCN2
GO:0030667,secretory granule membrane
MONDO:0005574,tauopathy
HP:3000046,Abnormal geniohyoid muscle morphology
HGNC:14247,ATP5MG
CHEBI:58359,L-glutamine zwitterion
MONDO:0002238,ascending colon cancer
wikidata:Q27088419,PLX8394
chembl:CHEMBL3989870,BERZOSERTIB
MONDO:0018511,epithelial tumor of the appendix
RGD:1309714,Cln6
HGNC:11989,TOP2A
CHEBI:35757,monocarboxylic acid anion
chembl:CHEMBL598477,CHEMBL598477
chembl:CHEMBL1096882,FLUDARABINE PHOSPHATE
HGNC:6231,KCNB1
HGNC:18669,PALS1
MONDO:0018763,tubulinopathy-associated dysgyria
UPHENO:0077942,decreased reflex in patella
NCBIGene:326346,NDUFA11
chembl:CHEMBL1079959,KHRINONE E
chembl:CHEMBL19449,IBUDILAST
chembl:CHEMBL21731,MAPROTILINE
HGNC:10402,RPS19
HGNC:3700,FH
CHEBI:86324,quinolone antibiotic
MONDO:0002740,uterine ligament mucinous adenocarcinoma
Reactome:R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs
GO:0007417,central nervous system development
chembl:CHEMBL50894,ALSTERPAULLONE
chembl:CHEMBL22077,HYCANTHONE
CHEBI:32695,argininate
HP:0002714,Downturned corners of mouth
ECTO:0001591,
chembl:CHEMBL278315,GELDANAMYCIN
MONDO:0012246,spinocerebellar ataxia type 26
chembl:CHEMBL2108027,DULAGLUTIDE
HGNC:662,ARFRP1
chembl:CHEMBL39677,ACRIDINE
MONDO:0024542,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1"
Reactome:R-RNO-71288,Creatine metabolism
MONDO:0010412,X-linked intellectual disability-craniofacioskeletal syndrome
HGNC:1557,CBX7
chembl:CHEMBL539947,TYRPHOSTIN AG 879
MONDO:0030689,"Charcot-Marie-Tooth disease, demyelinating, IIA 1H"
chembl:CHEMBL284328,HOMIDIUM BROMIDE
CHEBI:42820,guanidine
HGNC:1160,TWNK
MONDO:0004967,acute lymphoblastic leukemia
HGNC:21099,ARMC12
GO:0005355,glucose transmembrane transporter activity
NCBITaxon:747,Pasteurella multocida
chembl:CHEMBL2088301,CHEMBL2088301
chembl:CHEMBL599712,CHEMBL599712
HGNC:2595,CYP1A1
CHEBI:63580,ribavirin
HGNC:14479,MRPL21
HGNC:9722,ALDH18A1
HP:0000938,Osteopenia
MGI:97138,Mpv17
chembl:CHEMBL604321,CHEMBL604321
HP:0001387,Joint stiffness
MONDO:0002548,cellular schwannoma
chembl:CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE
chembl:CHEMBL31601,REMIKIREN
MONDO:0002766,larynx verrucous carcinoma
HGNC:11364,STAT3
chembl:CHEMBL568150,CHEMBL568150
MGI:1917816,Abhd17b
HP:0032113,Semidominant inheritance
chembl:CHEMBL1514569,DALBERGIONE
chembl:CHEMBL404422,BUTETHAL
Reactome:R-BTA-549127,Organic cation transport
HGNC:7568,MYH10
HGNC:26278,ISOC2
GO:0022857,transmembrane transporter activity
MONDO:0014389,polyglucosan body myopathy 1 with or without immunodeficiency
MONDO:0005767,gas gangrene
GO:0002080,acrosomal membrane
HGNC:10968,SLC22A4
HP:0000076,Vesicoureteral reflux
HGNC:25766,CCDC14
HGNC:427,ALK
chembl:CHEMBL254328,ABIRATERONE
HGNC:226,ADARB1
GO:0032433,filopodium tip
chembl:CHEMBL2107860,TASPOGLUTIDE
HP:0000729,Autistic behavior
HP:0034341,Pseudoautosomal recessive inheritance
HGNC:3765,FLT3
HGNC:23720,CREB3L2
HGNC:9834,RAI1
HP:0025235,Non-rapid eye movement parasomnia
HGNC:2745,DDX3X
HP:0002072,Chorea
CHEBI:47898,4'-epidoxorubicin
MONDO:0018189,autosomal recessive cerebellar ataxia - pyramidal signs - nystagmus - oculomotor apraxia syndrome
CHEBI:26895,tetracyclines
chembl:CHEMBL464707,WISTIN
HGNC:20069,USP40
HP:0003731,Quadriceps muscle weakness
WB:WBGene00020838,trak-1
HGNC:13532,TLX3
MONDO:0014613,"pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3"
HP:0031206,Striatal T2 hyperintensity
HGNC:10671,SDCCAG8
RGD:620217,Slc5a2
HGNC:18756,RHOBTB2
MONDO:0000942,corneal disorder
CHEBI:40303,lovastatin
chembl:CHEMBL49642,INDIBULIN
HP:0100578,Lipoatrophy
HGNC:23746,NECAB2
HGNC:2531,CTSF
MONDO:0011687,Charcot-Marie-Tooth disease axonal type 2F
MONDO:0021100,breast neoplasm
chembl:CHEMBL317115,CHEMBL317115
MONDO:0003406,sleep-wake disorder
chembl:CHEMBL591598,CHEMBL591598
chembl:CHEMBL408653,CHEMBL408653
HP:0002509,Limb hypertonia
UBERON:0002453,ethmoid sinus
MONDO:0006617,vesiculobullous skin disease
HGNC:4249,GGPS1
GO:0042584,chromaffin granule membrane
HGNC:6929,MC1R
HP:0032860,Generalized non-convulsive status epilepticus without coma
chembl:CHEMBL1234231,CALCIPOTRIOL
chembl:CHEMBL2144069,CHEMBL2144069
chembl:CHEMBL434,ISOPROTERENOL
HGNC:12601,USH2A
NCBIGene:768048,COX14
chembl:CHEMBL61,PODOFILOX
chembl:CHEMBL32147,2'-HYDROXYCHALCONE
chembl:CHEMBL1201217,DYCLONINE
HGNC:4635,GSTM3
chembl:CHEMBL1765740,CHEMBL1765740
HGNC:18594,L3MBTL2
chembl:CHEMBL1326164,CHEMBL1326164
MONDO:0003539,T-cell adult acute lymphocytic leukemia
HP:0002530,Axial dystonia
WB:WBGene00013177,rsy-1
chembl:CHEMBL590665,CHEMBL590665
Reactome:R-BTA-500753,Pyrimidine biosynthesis
chembl:CHEMBL118678,CHEMBL118678
chembl:CHEMBL514499,GW843682X
MONDO:0009469,benign recurrent intrahepatic cholestasis type 1
HGNC:6563,LGALS3
chembl:CHEMBL600334,CHEMBL600334
MONDO:0011510,Bohring-Opitz syndrome
HGNC:18241,PRMT6
Reactome:R-HSA-9837999,Mitochondrial protein degradation
HGNC:28734,DCUN1D3
HGNC:14139,PRR35
WB:WBGene00017382,F11D5.5
HP:0033205,Biceps hyperreflexia
HGNC:3482,ETFB
chembl:CHEMBL1200782,DEXTROAMPHETAMINE ADIPATE
HGNC:19317,P3H2
HP:0000157,Abnormality of the tongue
GO:0016084,myostimulatory hormone activity
MONDO:0002758,vulva verrucous carcinoma
chembl:CHEMBL1569494,CHEMBL1569494
HGNC:9817,RAD51
HGNC:4433,GOT2
HP:0009020,Exercise-induced muscle fatigue
HGNC:4223,MSTN
HGNC:9719,PEX5
HP:0002540,Inability to walk
MONDO:0021125,disease characteristic
HGNC:2674,DAPK1
HGNC:2873,CYB5R3
HP:0006889,"Intellectual disability, borderline"
HGNC:30855,U2SURP
HP:0002633,Vasculitis
HGNC:15719,OBSCN
MONDO:0018083,transient tyrosinemia of the newborn
CHEBI:27666,actinomycin D
UPHENO:0014097,cerebellar cortex atrophy
chembl:CHEMBL3137343,PEMBROLIZUMAB
MGI:108482,Hrh2
HGNC:6930,MC2R
HGNC:23576,HOOK3
chembl:CHEMBL1284,"3,4-DIHYDROXYPHENYLACETIC ACID "
chembl:CHEMBL1553726,TRIAZOPHOS
HGNC:744,ASH2L
chembl:CHEMBL1200940,METOCLOPRAMIDE HYDROCHLORIDE
GO:0019463,glycine catabolic process to creatine
HGNC:8727,PCM1
chembl:CHEMBL451,CHLORDIAZEPOXIDE
HGNC:4691,GUCY2F
HGNC:25941,TET2
CHEBI:53212,isocyanates
MONDO:0011886,torsion dystonia 13
HP:0002370,Poor coordination
MONDO:0002466,eye carcinoma
UBERON:0001231,nephron tubule
MONDO:0043424,digestive system infectious disorder
chembl:CHEMBL10316,IDAZOXAN
chembl:CHEMBL1310701,CHEMBL1310701
chembl:CHEMBL298734,LONAFARNIB
UBERON:0001300,scrotum
chembl:CHEMBL83,TAMOXIFEN
HP:0100513,Decreased circulating vitamin E concentration
HP:0012392,Jaw hyporeflexia
HGNC:703,ARPC1A
MONDO:0000090,progressive external ophthalmoplegia with mitochondrial DNA deletions
HP:0001293,Cranial nerve compression
chembl:CHEMBL249190,CHEMBL249190
HGNC:17586,MTCH1
chembl:CHEMBL241608,CALYCOSIN
HP:0003398,Abnormal synaptic transmission at the neuromuscular junction
chembl:CHEMBL550495,METHYLENE BLUE
HGNC:26827,MPV17L
HP:0002028,Chronic diarrhea
MONDO:0003351,colon leiomyosarcoma
HGNC:8805,PDGFRL
chembl:CHEMBL1224528,DIHYDROXIDINE
GO:0005788,endoplasmic reticulum lumen
SO:1000008,
chembl:CHEMBL546170,CHEMBL546170
chembl:CHEMBL602561,CHEMBL602561
MONDO:0004988,breast adenocarcinoma
HP:0006970,Periventricular leukomalacia
chembl:CHEMBL603130,CHEMBL603130
chembl:CHEMBL584269,CHEMBL584269
FB:FBgn0262872,milt
chembl:CHEMBL389471,COUMERMYCIN A1
chembl:CHEMBL3545221,AZD2423
HGNC:610,APOC3
HP:0003587,Insidious onset
MONDO:0043224,multi-infarct dementia
chembl:CHEMBL217092,SARACATINIB
HGNC:3188,EED
MONDO:0009539,"lymphoblastic leukemia, acute, with lymphomatous features"
MONDO:0002090,eccrine sweat gland neoplasm
chembl:CHEMBL580340,CHEMBL580340
HP:0002342,"Intellectual disability, moderate"
chembl:CHEMBL18442,PLERIXAFOR
HP:0006803,Vivid hallucinations
MONDO:0100426,iatrogenic
HGNC:6839,MAP2
HGNC:11541,TAF7
HGNC:18278,RAD18
HGNC:7673,NCOR2
GO:0005515,protein binding
chembl:CHEMBL1399,ANASTROZOLE
GO:0042592,homeostatic process
NCBIGene:487748,CBR3
HP:0030891,Periventricular white matter hyperintensities
CHEBI:46245,coenzyme Q10
CHEBI:142546,5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamide
HGNC:21658,FBXL13
CHEBI:59905,dopaminium(1+)
HGNC:20774,TUBB4A
chembl:CHEMBL1091971,CHEMBL1091971
HP:0007787,Posterior subcapsular cataract
MONDO:0013972,Perrault syndrome 2
FB:FBgn0261439,SdhA
MONDO:0002909,hyperglycemia
CHEBI:58228,carbamoyl phosphate(2-)
chembl:CHEMBL306226,BENZIMIDAZOLE
HGNC:4206,OPN1MW
HGNC:5284,HTN3
chembl:CHEMBL160145,ORTHO-PHTHALALDEHYDE
CHEBI:58017,5-O-phosphonato-alpha-D-ribofuranosyl diphosphate(5-)
MONDO:0800043,Stüve-Wiedemann syndrome 1
chembl:CHEMBL1922094,APITOLISIB
MONDO:0021313,eyelid cancer
HGNC:24999,ARMC8
HGNC:3401,EPHX1
HGNC:18855,CREB3L3
chembl:CHEMBL1479103,HAEMATOXYLIN
HGNC:9343,PRCC
HGNC:4907,HIBADH
HP:0002380,Fasciculations
chembl:CHEMBL56900,LERISETRON
HGNC:11150,SNRNP70
HP:0032507,Labiomental fasciculations
HGNC:19140,TTBK1
HGNC:11037,SLC5A2
HGNC:16626,RAPGEF4
MONDO:0033549,optic atrophy 12
NCBIGene:475322,NDUFS5
chembl:CHEMBL1453126,CHEMBL1453126
chembl:CHEMBL2103791,ADIPIPLON
HP:0031468,Separation insecurity
MONDO:0000702,microscopic colitis
chembl:CHEMBL600968,CHEMBL600968
chembl:CHEMBL585,TRIAMTERENE
HGNC:11226,SPG11
MONDO:0024650,drug-induced osteoporosis
HGNC:7717,NDUFV2
CHEBI:184376,streptidine(2+)
HGNC:25229,LYRM2
chembl:CHEMBL1591258,"3,4-DIMETHOXYDALBERGIONE"
chembl:CHEMBL29166,CHEMBL29166
MONDO:0001092,colon leiomyoma
chembl:CHEMBL3544989,VOLANESORSEN SODIUM
HGNC:4392,GNAS
HGNC:30004,SULT1A4
GO:0004817,cysteine-tRNA ligase activity
chembl:CHEMBL1416586,BENZPIPERYLON
UPHENO:0080582,abnormal sexual inhibition
CHEBI:47881,3-oxo monocarboxylic acid
CHEBI:15378,hydron
HGNC:1875,CFL2
HP:0003334,Elevated circulating catecholamine level
HGNC:23360,CCAR2
HGNC:3594,FASN
MONDO:0001613,vertebrobasilar insufficiency
HGNC:11038,SLC5A3
HP:0011711,Left anterior fascicular block
chembl:CHEMBL1542,AZATHIOPRINE
chembl:CHEMBL305695,CHEMBL305695
NCBIGene:476794,NDUFC2
HGNC:2452,CSNK1D
HGNC:24124,ACTL6A
CHEBI:64390,N-hexanoylglycine
HP:0002494,Abnormal rapid eye movement sleep
HGNC:11274,SPTB
MONDO:0003847,hereditary disease
HGNC:18237,CD99L2
HGNC:9126,GIGYF1
HP:0006943,Diffuse spongiform leukoencephalopathy
MONDO:0009092,polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly
HGNC:18656,RIOK1
chembl:CHEMBL1437888,CHEMBL1437888
HGNC:8974,PIK3C3
MONDO:0001023,prolymphocytic leukemia
chembl:CHEMBL3039504,NINTEDANIB ESYLATE
MGI:1914344,Abhd2
Reactome:R-MMU-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
HGNC:15518,DCTN4
HGNC:18423,DEPDC5
HGNC:838,ATP5F1E
HP:0002671,Basal cell carcinoma
CHEBI:36416,mancude organic heterotricyclic parent
HGNC:19305,SLC30A6
HGNC:2021,CLCN3
HP:0002071,Abnormality of extrapyramidal motor function
GO:0071407,cellular response to organic cyclic compound
WB:WBGene00015381,C03B1.13
HGNC:3801,FOXC2
chembl:CHEMBL290624,CHLORACYZINE
CHEBI:16027,adenosine 5'-monophosphate
HP:0007086,Social and occupational deterioration
HP:0007295,Chaotic rapid conjugate ocular movements
HGNC:30213,ATP13A2
chembl:CHEMBL338474,HELENALIN
wikidata:Q415571,BLEOMYCIN
MONDO:0044638,hypopharynx squamous cell carcinoma
chembl:CHEMBL407391,DIMETHYLADENINE
HP:0000301,Abnormality of facial musculature
MONDO:0010747,X-linked dystonia-parkinsonism
HGNC:15450,TGOLN2
chembl:CHEMBL1403041,METHYL ROBUSTONE
HGNC:27561,TSEN54
HGNC:13397,CYB5R1
CHEBI:3766,clozapine
HGNC:4716,H1-2
UPHENO:0080280,decreased limb coordination
MONDO:0018002,adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy
HP:0030858,Addictive behavior
MONDO:0013968,PGM1-congenital disorder of glycosylation
chembl:CHEMBL3544909,CALCIFEDIOL
GO:1990539,fructose import across plasma membrane
HGNC:30628,SPSB1
HGNC:11480,SVIL
CHEBI:132157,"hydroxy-1,4-naphthoquinone"
chembl:CHEMBL28,APIGENIN
HGNC:1101,BRCA2
HP:0025336,Delayed ability to sit
HGNC:1069,BMP2
HGNC:11276,SPTBN2
HGNC:15514,PICALM
HGNC:29269,MARCHF4
MONDO:0850282,chronic asthma
CHEBI:17196,L-asparagine
HGNC:23781,POLDIP2
chembl:CHEMBL535,SUNITINIB
HP:0000723,Restrictive behavior
chembl:CHEMBL308688,"5,7-DIMETHOXYISOFLAVONE"
chembl:CHEMBL77030,TYRPHOSTIN 47
chembl:CHEMBL1236107,SGX-523
GO:0005778,peroxisomal membrane
MONDO:0003554,adenosquamous colon carcinoma
GO:0042910,xenobiotic transmembrane transporter activity
ZFIN:ZDB-GENE-040625-38,cycsb
MONDO:0850284,extrinsic asthma
chembl:CHEMBL70418,CLOBAZAM
HGNC:30528,DNAJC19
HGNC:3373,EP300
MONDO:0011834,spinocerebellar ataxia type 18
MONDO:0005124,leprosy
HGNC:20856,THAP1
chembl:CHEMBL1456697,(Z)-PIPLARTINE
CHEBI:15956,biotin
HP:0100546,Carotid artery stenosis
HP:0031879,Abnormal eyelid physiology
UBERON:0002116,ileum
chembl:CHEMBL295316,PLUMBAGIN
chembl:CHEMBL1276308,MIFEPRISTONE
MONDO:0007462,"multiple sclerosis, susceptibility to"
HGNC:1779,CDK8
HP:0011391,Morphological abnormality of the nerves of the inner ear
MONDO:0003664,hemolytic anemia
MONDO:0003997,colon Kaposi sarcoma
HP:0001151,Impaired horizontal smooth pursuit
chembl:CHEMBL203135,BERBERRUBINE
HP:0004209,Clinodactyly of the 5th finger
HP:0007199,Progressive spastic paraparesis
HGNC:18165,STYXL1
GO:0017134,fibroblast growth factor binding
HGNC:17847,STK38
chembl:CHEMBL68534,CHEMBL68534
HGNC:992,BCL2L1
HP:0030220,Socially inappropriate behavior
HP:0002900,Hypokalemia
chembl:CHEMBL460702,BMS-777607
HGNC:14211,BLNK
HGNC:30882,USE1
HGNC:1461,CAMK2B
HGNC:2234,COPE
MONDO:0030318,"spinocerebellar ataxia, autosomal recessive 30"
chembl:CHEMBL3,NICOTINE
HP:0010747,Medial flaring of the eyebrow
HP:0000009,Functional abnormality of the bladder
HP:0000072,Hydroureter
HGNC:179,ACYP1
GO:0019899,enzyme binding
HGNC:9583,PTBP1
HGNC:38606,BECN2
MONDO:0019026,autosomal recessive osteopetrosis
HGNC:600,APOA1
HGNC:9204,PON1
HP:0010828,Hemifacial spasm
MONDO:0007803,multiple system atrophy
HP:0012163,Carotid artery dilatation
HP:0001133,Constriction of peripheral visual field
HGNC:10289,RPA1
MONDO:0008734,"adrenocortical carcinoma, hereditary"
chembl:CHEMBL225072,PEMETREXED
chembl:CHEMBL177809,CHEMBL177809
chembl:CHEMBL602260,CHEMBL602260
HGNC:14406,PTPN23
RGD:1310512,Mpv17
HGNC:24275,SCCPDH
HGNC:18551,DGCR6L
HGNC:10996,SLC27A2
HGNC:2153,CNGB3
chembl:CHEMBL253570,GOSSYPETIN
chembl:CHEMBL602012,CHEMBL602012
CHEBI:32682,L-argininium(1+)
chembl:CHEMBL2108338,OBINEPITIDE
HGNC:9279,PDP1
chembl:CHEMBL3544906,BENZPHETAMINE HYDROCHLORIDE
chembl:CHEMBL3545059,ALISKIREN FUMARATE
HGNC:3686,FGF8
chembl:CHEMBL457092,BESTATIN METHYL ESTER
HGNC:30184,PTPDC1
HP:0011393,Aplasia of the vestibular nerve.
HGNC:83,ACAA2
chembl:CHEMBL90555,VINCRISTINE
UBERON:0001150,body of pancreas
chembl:CHEMBL1200870,TIMOLOL MALEATE
HP:0010950,Abnormal fourth ventricle morphology
HGNC:291,ADSL
chembl:CHEMBL219410,ZOTAROLIMUS
chembl:CHEMBL1997335,CHEMBL1997335
HGNC:11587,TBL3
NCBIGene:512098,CES1
HGNC:5237,HSPA4
HGNC:14351,CLEC2D
HGNC:24460,EIF3M
HP:0004373,Focal dystonia
HGNC:9768,RAB28
HGNC:10729,SEMA4A
chembl:CHEMBL225519,CHEMBL225519
HGNC:20505,H3C15
chembl:CHEMBL483254,PANOBINOSTAT
RGD:1359613,Creb3l1
MONDO:0008201,Perry syndrome
MGI:1915271,Bphl
MONDO:0012549,"autosomal recessive ataxia, Beauce type"
MONDO:0002601,teratoma
Reactome:R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC
HP:0031986,Polyminimyoclonus
CHEBI:36005,docosahexaenoic acid
HGNC:9060,PLCD1
MONDO:0013257,"leprosy, susceptibility to, 6"
CHEBI:3992,cyclic ketone
chembl:CHEMBL421,SULFASALAZINE
chembl:CHEMBL1334033,PERHEXILINE MALEATE
chembl:CHEMBL267777,RITANSERIN
chembl:CHEMBL10284,SB-222200
HGNC:16277,TRIM6
MGI:1917428,Abhd17c
HGNC:4180,GBE1
MONDO:0019268,epidermal disease
HGNC:7883,NOTCH3
HGNC:4175,GATM
MONDO:0002558,melanotic neurilemmoma
HGNC:16833,SOCS6
chembl:CHEMBL1502,PANTOPRAZOLE
RGD:708502,Slc45a1
chembl:CHEMBL487,DROLOXIFENE
HP:0007272,Progressive psychomotor deterioration
MONDO:0004985,bipolar disorder
HGNC:17379,APBB1IP
HGNC:35164,C12orf75
chembl:CHEMBL1486690,PYRONIN Y
chembl:CHEMBL36148,(S)-VERAPAMIL
CHEBI:16856,glutathione
chembl:CHEMBL2001019,PF-04217903
chembl:CHEMBL2171206,EUCALYPTIN A
HGNC:4727,H2AC14
UBERON:0002358,peritoneum
MONDO:0015753,cap myopathy
MONDO:0011201,"tremor, hereditary essential, 2"
HGNC:12513,UCHL1
CHEBI:29806,fumarate(2-)
MONDO:0016429,Marburg acute multiple sclerosis
chembl:CHEMBL327919,BENOMYL
HGNC:19195,ABLIM2
HGNC:30722,TEX101
chembl:CHEMBL86754,IODOQUINOL
chembl:CHEMBL91163,CHEMBL91163
HGNC:22407,TMEM106B
MONDO:0005578,arthritic joint disease
CHEBI:100246,norfloxacin
HGNC:42,ABCB11
chembl:CHEMBL267458,BMS-182874
chembl:CHEMBL99,TRICHOSTATIN
HGNC:17881,NRSN1
HP:0001131,Corneal dystrophy
chembl:CHEMBL4297190,SURUFATINIB
chembl:CHEMBL832,SULFINPYRAZONE
HGNC:7523,TRIM37
chembl:CHEMBL533226,CHEMBL533226
chembl:CHEMBL587620,CHEMBL587620
chembl:CHEMBL1072,BUMETANIDE
chembl:CHEMBL301982,CELASTROL
chembl:CHEMBL1608067,CHEMBL1608067
ZFIN:ZDB-GENE-040912-168,etfdh
MONDO:0015244,autosomal recessive cerebellar ataxia
HGNC:7059,MGMT
MONDO:0004114,urinary bladder small cell neuroendocrine carcinoma
NCBITaxon:1769,Mycobacterium leprae
HP:0002063,Rigidity
MONDO:0002671,signet ring cell breast carcinoma
chembl:CHEMBL2068724,ACAMPROSATE CALCIUM
MONDO:0000414,childhood electroclinical syndrome
chembl:CHEMBL107,COLCHICINE
CHEBI:26776,stilbenoid
GO:0019897,extrinsic component of plasma membrane
HGNC:397,ALAS2
HP:0003072,Hypercalcemia
FB:FBgn0037153,olf413
HGNC:6323,KIF5A
chembl:CHEMBL1643,RIBAVIRIN
chembl:CHEMBL8260,BAICALEIN
chembl:CHEMBL2106798,NERAMEXANE MESYLATE
HGNC:4600,GRM8
HP:0008945,Loss of ability to walk in early childhood
MONDO:0014681,"thyroid cancer, nonmedullary, 4"
MONDO:0008768,"ceroid lipofuscinosis, neuronal, 6B (Kufs type)"
PomBase:SPBC21C3.01c,vps1301
HGNC:4061,SLC37A4
MGI:1321161,Ppp2cb
MONDO:0018222,obsolete X-linked intellectual disability due to GRIA3 anomalies
MONDO:0020574,central nervous system nongerminomatous germ cell tumor
chembl:CHEMBL56543,CHEMBL56543
chembl:CHEMBL3545351,AV-101
HP:0003077,Hyperlipidemia
chembl:CHEMBL4112930,PAMIPARIB
HP:0031354,Sleep onset insomnia
HGNC:15939,WFDC2
HP:0011345,Moderate expressive language delay
MONDO:0005336,myopathy
CHEBI:25696,organic anion
chembl:CHEMBL3545377,LY-2606368
HGNC:8874,PFKFB3
HGNC:13723,CTCF
HP:0033755,Increased left ventricular end-diastolic volume
chembl:CHEMBL223228,EFAVIRENZ
HGNC:20717,KLC3
chembl:CHEMBL1291,METIPRANOLOL
HP:0100816,Lip hyperpigmentation
HGNC:3776,AFF2
HGNC:9621,TWF2
HGNC:14562,BET1
MONDO:0002742,cervical mucinous adenocarcinoma
chembl:CHEMBL1878267,FLUAZINAM
HP:0009725,Bladder neoplasm
chembl:CHEMBL530049,CHEMBL530049
chembl:CHEMBL701,BACLOFEN
MONDO:0003768,signet ring cell variant cervical mucinous adenocarcinoma
MONDO:0100352,episodic kinesigenic dyskinesia 1
HGNC:16937,ARL6IP5
chembl:CHEMBL1160160,ROSE BENGAL
MGI:1923038,Smurf1
HGNC:19277,RNASE8
MONDO:0014163,left ventricular noncompaction 10
HGNC:2637,CYP3A4
chembl:CHEMBL1070,NABUMETONE
HP:0000066,Labial hypoplasia
MONDO:0005618,anxiety disorder
MONDO:0004478,pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma
chembl:CHEMBL1683544,ERIBULIN MESYLATE
chembl:CHEMBL2109355,DUSIGITUMAB
GO:0016085,myoinhibitory hormone activity
GO:0017045,corticotropin-releasing hormone activity
chembl:CHEMBL3545339,FRUQUINTINIB
NCBIGene:771510,NDUFS5
HP:0001338,Partial agenesis of the corpus callosum
HGNC:3228,EFNB3
chembl:CHEMBL538921,SAPONARIN
HP:0001386,Joint swelling
Reactome:R-BTA-71403,Citric acid cycle (TCA cycle)
HGNC:3434,ERCC2
HGNC:17789,LIN7C
chembl:CHEMBL2103879,GANETESPIB
chembl:CHEMBL101253,VATALANIB
HP:0025613,Focal emotional seizure
chembl:CHEMBL464433,"4',7-DIMETHOXY-5-HYDROXYGENISTEIN"
MONDO:0011836,thyroid Hurthle cell carcinoma
HGNC:14234,NSD1
MONDO:0800029,interstitial lung disease 2
HP:0001188,Hand clenching
chembl:CHEMBL469912,PUROMYCIN
HP:0003701,Proximal muscle weakness
UBERON:0010414,omental fat pad
chembl:CHEMBL3707313,TRIFAROTENE
MONDO:0008438,hereditary spastic paraplegia 4
WB:WBGene00000066,act-4
HGNC:177,ACY1
HP:0006844,Absent patellar reflexes
HGNC:2213,COL6A3
HGNC:977,BCAT2
HGNC:14333,BAALC
chembl:CHEMBL2002849,CHEMBL2002849
MGI:2181202,Pfkfb3
HP:0010923,Anterior subcapsular cataract
HP:0031764,Fully accomodative esotropia
chembl:CHEMBL1206690,PARECOXIB
HGNC:25035,YOD1
PR:000007495,fibroblast growth factor 4
HGNC:2718,DDB2
MONDO:0004277,gonorrhea
HP:0002974,Radioulnar synostosis
RGD:1308810,Blm
HGNC:216,ADAM9
chembl:CHEMBL3989407,QUARFLOXIN
MONDO:0033638,"mitochondrial complex 4 deficiency, nuclear type 8"
HP:0001941,Acidosis
HGNC:12840,YARS1
chembl:CHEMBL1503729,CHEMBL1503729
HP:0002352,Leukoencephalopathy
MONDO:0002423,rectosigmoid junction neoplasm
MONDO:0012801,"autism, susceptibility to, 15"
chembl:CHEMBL1200471,PYRITHIONE ZINC
HGNC:30424,SPPL3
HGNC:24591,CLEC4G
HP:0001371,Flexion contracture
HP:0031252,Dilated left subclavian artery
HGNC:5248,HSPB3
chembl:CHEMBL1201583,BEVACIZUMAB
chembl:CHEMBL2108651,TALACTOFERRIN ALFA
chembl:CHEMBL253144,CORTODOXONE
chembl:CHEMBL1237080,GRANISETRON HYDROCHLORIDE
HP:0006879,Pontocerebellar atrophy
HGNC:358,AIP
HGNC:1722,CDK1
HP:0005943,Respiratory arrest
HGNC:1686,CD53
HGNC:12442,TYR
WB:WBGene00000289,cam-1
chembl:CHEMBL1494499,SAVIRIN
chembl:CHEMBL1087126,2'-METHOXYFORMONETIN
MONDO:0060671,"epilepsy, juvenile myoclonic, susceptibility to, 10"
chembl:CHEMBL607309,CHEMBL607309
HGNC:8994,PIP5K1A
HGNC:14405,KIF13B
chembl:CHEMBL260451,CHEMBL260451
chembl:CHEMBL1478,LITHOCHOLIC ACID
HGNC:250,ADH1B
MONDO:0014693,Noonan syndrome 10
chembl:CHEMBL1513,IRBESARTAN
MONDO:0007329,"cirrhosis, familial"
chembl:CHEMBL313244,4-METHYLESCULETIN
MONDO:0020525,transient neonatal diabetes mellitus
chembl:CHEMBL237347,GW559768X
MONDO:0100342,malignant glioma
HGNC:11344,ST14
HGNC:2860,DHCR7
HP:0001623,Breech presentation
MONDO:0044937,rectal carcinoma
NCBITaxon:2039,Tropheryma whipplei
MONDO:0018614,undetermined early-onset epileptic encephalopathy
HGNC:7967,NR1H4
HP:0011443,Abnormality of coordination
MONDO:0016333,familial dilated cardiomyopathy
CHEBI:87211,fluoroquinolone antibiotic
HGNC:7234,MRRF
HGNC:21100,QKI
HGNC:894,AVP
MONDO:0008029,Bethlem myopathy
HGNC:21143,ZBTB24
HGNC:18133,TAOK3
chembl:CHEMBL1174,EPTIFIBATIDE
chembl:CHEMBL1762621,BARDOXOLONE METHYL
chembl:CHEMBL945,AMILORIDE
chembl:CHEMBL297453,EPIGALOCATECHIN GALLATE
HGNC:7699,NDUFB4
HGNC:1383,CA9
HGNC:565,AP2S1
Reactome:R-CFA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
HGNC:28079,ZNF598
HP:0010871,Sensory ataxia
HP:0002544,Retrocollis
MONDO:0018160,hereditary retinoblastoma
HGNC:21024,CUL7
HGNC:10934,SLC18A1
CHEBI:66924,creatinate
chembl:CHEMBL888,GEMCITABINE
MONDO:0012444,neurodegeneration with brain iron accumulation 2B
HGNC:130,ACTA2
MONDO:0014165,multiple congenital anomalies-hypotonia-seizures syndrome 3
HGNC:2158,CNP
WB:WBGene00020506,dop-3
chembl:CHEMBL38508,CHEMBL38508
chembl:CHEMBL85139,RUTAECARPINE
HGNC:3701,FHIT
HP:0000083,Renal insufficiency
HGNC:10989,SLC25A3
HGNC:236,ADCY5
HP:0003736,Autophagic vacuoles
CHEBI:23888,drug
chembl:CHEMBL589366,3R14S-OCHRATOXIN A
MONDO:0015026,cerebroretinal microangiopathy with calcifications and cysts 2
HGNC:16763,ZBTB32
HGNC:10496,S100A6
HGNC:7545,MYB
HGNC:10258,RORA
ECTO:0001108,
Xenbase:XB-GENE-964419,slc6a17
HGNC:7459,MT-ND4
CHEBI:18249,"ergosta-5,7,22,24(28)-tetraen-3beta-ol"
chembl:CHEMBL2311030,ERGOLOID MESYLATES
chembl:CHEMBL1514735,CEFDITORIN PIVOXIL
MONDO:0017176,Machado-Joseph disease type 3
HP:0031955,Antalgic gait
MONDO:0003193,bile duct adenocarcinoma
HGNC:868,ATP6AP1
HGNC:9021,PKM
HGNC:903,AXIN1
HGNC:5048,HNRNPU
chembl:CHEMBL1370446,METIZOLINE
chembl:CHEMBL1551165,IOPHENOXIC ACID
chembl:CHEMBL20,ACETAZOLAMIDE
HGNC:18303,ATP6V1H
PATO:0001673,cystic
HGNC:2750,DHX9
chembl:CHEMBL272682,CHEMBL272682
HGNC:2362,CRK
MONDO:0002648,mammary Paget disease
MONDO:0005087,respiratory system disorder
HP:0002829,Arthralgia
HGNC:15910,NFS1
CHEBI:51026,macrocycle
HGNC:3333,EMP1
GO:0006613,cotranslational protein targeting to membrane
MONDO:0002425,rectosigmoid junction cancer
CHEBI:22720,benzodiazepine
HGNC:14273,BOLL
HP:0007885,Slowed horizontal saccades
HGNC:4599,GRM7
chembl:CHEMBL1079175,MK-2206
chembl:CHEMBL406834,CHEMBL406834
HGNC:10588,SCN2A
MONDO:0013755,PYCR1-related de Barsy syndrome
UBERON:0000310,breast
HP:0007936,Restrictive external ophthalmoplegia
chembl:CHEMBL1201156,NORTRIPTYLINE HYDROCHLORIDE
MONDO:0002940,anal margin basal cell carcinoma
HGNC:2150,CNGA3
HGNC:24979,HS1BP3
chembl:CHEMBL520095,CHEMBL520095
HGNC:11825,NKX2-1
HGNC:5297,HTR3A
HGNC:16406,EFHC1
chembl:CHEMBL336961,AZAKENPAULLONE
HGNC:1802,CDSN
HGNC:7422,MT-CO3
HGNC:18002,TOMM22
MONDO:0014503,autosomal recessive spinocerebellar ataxia 17
MONDO:0001627,dementia
chembl:CHEMBL1625,OXYBENZONE
chembl:CHEMBL473535,FENTICLOR
chembl:CHEMBL20562,ZAPA
MONDO:0004530,early invasive cervical adenocarcinoma
HGNC:1943,CHN1
CHEBI:16414,L-valine
chembl:CHEMBL16685,CHEMBL16685
chembl:CHEMBL2108724,SEMAGLUTIDE
CHEBI:63726,neuroprotective agent
chembl:CHEMBL366861,FUMARPROTOCETRARIC ACID
chembl:CHEMBL441765,U-50488 METHANE SULFONATE
HGNC:10591,SCN4A
MONDO:0005008,colorectal adenocarcinoma
HP:0002312,Clumsiness
HGNC:1530,MICU1
CHEBI:144644,a tetracycline zwitterion
HGNC:6879,MAPK6
NCBIGene:515773,CYB5R3
HGNC:18268,LMBR1L
chembl:CHEMBL400777,ROBUSTIC ACID
HP:0001288,Gait disturbance
Reactome:R-HSA-549127,Organic cation transport
CHEBI:2639,amiloride
chembl:CHEMBL3545426,CC-115
chembl:CHEMBL599924,CHEMBL599924
MONDO:0015760,T-cell non-Hodgkin lymphoma
HGNC:800,ATP1A2
HGNC:30953,ZBTB10
GO:0034486,vacuolar transmembrane transport
HGNC:4019,FUT8
chembl:CHEMBL1601,CEFONICID
chembl:CHEMBL602718,CHEMBL602718
MONDO:0013120,"46,XY sex reversal 5"
chembl:CHEMBL153505,CHEMBL153505
HGNC:26101,ACSF2
HGNC:24936,EEF1AKMT3
MONDO:0005554,rheumatic disorder
HP:0200101,Decreased/absent ankle reflexes
HGNC:12674,VDAC3
chembl:CHEMBL1200609,PAROXETINE MESYLATE
MGI:2156841,Recql5
HP:0010820,Focal emotional seizure with crying
HGNC:975,BCAS2
MONDO:0009855,d-bifunctional protein deficiency
HGNC:163,ACTN1
CHEBI:17359,sulfite
HP:0003677,Slowly progressive
HGNC:4851,HTT
HGNC:10741,SEMA7A
MONDO:0005229,bacterial infectious disease with sepsis
HGNC:28321,ANKRD22
MONDO:0019496,neuroendocrine neoplasm
HP:0006859,Posterior leukoencephalopathy
HP:0002515,Waddling gait
chembl:CHEMBL1256719,CHEMBL1256719
WB:WBGene00022533,cutl-19
HGNC:16994,OS9
chembl:CHEMBL1256697,CHEMBL1256697
HGNC:10046,RNASE3
CHEBI:17026,progesterone
chembl:CHEMBL1743052,OPORTUZUMAB MONATOX
HGNC:12310,TRIP4
chembl:CHEMBL40,PHENOBARBITAL
chembl:CHEMBL3545432,IXAZOMIB CITRATE
chembl:CHEMBL1329029,TETROQUINONE
HGNC:6570,LGALS9
HP:0002018,Nausea
HGNC:4226,GDI1
MONDO:0009300,Perrault syndrome 1
HP:0000128,Renal potassium wasting
chembl:CHEMBL384467,DEXAMETHASONE
chembl:CHEMBL296419,ASTEMIZOLE
MONDO:0013217,Diamond-Blackfan anemia 10
HGNC:6663,LORICRIN
HGNC:6876,MAPK14
GO:1902334,fructose export from vacuole to cytoplasm
HGNC:607,APOC1
HP:0002591,Polyphagia
CHEBI:27405,streptidine
HGNC:19083,CKS1B
chembl:CHEMBL597744,TRIACETYLRESVERATROL
MONDO:0018604,familial colorectal cancer type X
MONDO:0005284,chronic progressive multiple sclerosis
HGNC:21645,CHCHD2
HGNC:3435,ERCC3
MONDO:0002058,breast adenoma
chembl:CHEMBL448399,HYDROXYTOLUIC ACID
UPHENO:0080033,increased reflex in pelvic complex
HGNC:8522,OTX2
MONDO:0002615,xanthomatosis
chembl:CHEMBL506048,CHEMBL506048
MONDO:0004582,rheumatic myocarditis
HP:0002373,Febrile seizure (within the age range of 3 months to 6 years)
HGNC:6657,LNX1
HGNC:2295,CP
chembl:CHEMBL33845,DICHLOROPHEN
MONDO:0002744,fallopian tube mucinous adenocarcinoma
CHEBI:16134,ammonia
HP:3000067,Abnormal lateral cricoarytenoid muscle morphology
HGNC:30959,ZC3H7A
chembl:CHEMBL104,CLOTRIMAZOLE
HP:0009023,Abdominal wall muscle weakness
HP:0033201,Biceps hyporeflexia
HP:0030050,Narcolepsy
MONDO:0002120,neuroendocrine carcinoma
HGNC:24535,DCAF13
HGNC:17164,BCL2L13
HP:0001181,Adducted thumb
HGNC:9721,PYCR1
HGNC:17341,TRNT1
HGNC:17851,REXO2
HP:0030082,Abnormal drinking behavior
MONDO:0011826,glucocorticoid deficiency 2
RGD:68328,Slc2a5
chembl:CHEMBL1513686,12A-HYDROXY-5-DEOXYDEHYDROMUNDUSERONE
MONDO:0016216,adult hepatocellular carcinoma
HGNC:7427,MT-CYB
HGNC:11471,SUPV3L1
HGNC:16952,TXNIP
HGNC:13352,MAP1LC3B
HGNC:16187,SLC52A3
GO:0090482,vitamin transmembrane transporter activity
UBERON:0001872,parietal lobe
chembl:CHEMBL388590,BENZBROMARONE
chembl:CHEMBL274064,SB-220025
HP:0002305,Athetosis
HP:0010885,Avascular necrosis
chembl:CHEMBL1493986,METHYL ANTHRANILATE
chembl:CHEMBL916,TIROFIBAN
chembl:CHEMBL600347,CHEMBL600347
chembl:CHEMBL1269845,CHEMBL1269845
chembl:CHEMBL195008,NECROSTATIN
MGI:96067,Htt
HP:0040148,Cortical myoclonus
WB:WBGene00004978,spg-7
chembl:CHEMBL160,CYCLOSPORINE
HP:0032006,Lip tremor
MONDO:0005227,abscess
CHEBI:25235,monomethoxybenzene
GO:0030280,structural constituent of skin epidermis
HGNC:6396,KPNA3
MONDO:0017394,ketamine-induced biliary dilatation
chembl:CHEMBL588,FENOLDOPAM
MONDO:0002679,cerebral infarction
HGNC:12843,YME1L1
HGNC:6840,MAP2K1
HGNC:9449,PRNP
HGNC:7559,MYCN
CHEBI:15891,taurine
chembl:CHEMBL4297540,4-ISOTHIOUREIDOBUTYRONITRILE
HGNC:24731,NHLRC2
HGNC:4854,HDAC3
HGNC:1876,CFLAR
chembl:CHEMBL1397308,CHEMBL1397308
chembl:CHEMBL1214274,CHEMBL1214274
MONDO:0012449,spinocerebellar ataxia type 23
HP:0006813,Focal hemiclonic seizure
UBERON:0001155,colon
HGNC:12461,UBAP1
NCBIGene:512590,RECQL5
HGNC:18037,ARID2
HGNC:17731,CLASRP
chembl:CHEMBL1333386,CHEMBL1333386
MONDO:0011963,Joubert syndrome 2
CHEBI:34995,teicoplanin A2-1
HP:0007338,Hypermetric saccades
chembl:CHEMBL116955,CONGO RED
MONDO:0021022,hereditary hyperekplexia
HP:0001102,Angioid streaks of the fundus
chembl:CHEMBL584442,CHEMBL584442
CHEBI:17234,glucose
HGNC:6616,LIMS1
HGNC:20303,SLC30A8
HGNC:4912,HINT1
HGNC:12666,VCP
chembl:CHEMBL13209,NITRAZEPAM
chembl:CHEMBL1330352,CHEMBL1330352
chembl:CHEMBL266510,FLINDOKALNER
CHEBI:26188,polyketide
HGNC:32949,SMPD4
GO:0010243,response to organonitrogen compound
HGNC:12362,TSC1
HGNC:29990,NUPR1
HGNC:493,ANK2
CHEBI:18344,kynurenic acid
HGNC:3058,DTNB
GO:0014070,response to organic cyclic compound
chembl:CHEMBL3301576,PEGPLERANIB SODIUM
HGNC:1791,CDKN3
chembl:CHEMBL1200434,OXTRIPHYLLINE
MONDO:0021136,rare
HGNC:12518,UCP2
MONDO:0013665,"epilepsy, juvenile myoclonic, susceptibility to, 9"
MONDO:0002531,skin neoplasm
chembl:CHEMBL1420181,CHEMBL1420181
MONDO:0018925,familial or sporadic hemiplegic migraine
MGI:1927091,Myo1g
chembl:CHEMBL38576,"ICI-199,441"
HP:0003307,Hyperlordosis
MONDO:0011764,autosomal dominant Parkinson disease 8
GO:0019904,protein domain specific binding
chembl:CHEMBL2304041,SAGOPILONE
chembl:CHEMBL3545365,ALTIRATINIB
CHEBI:50267,protective agent
CHEBI:606565,N-benzoylglycinate
HP:0045007,Abnormal substantia nigra morphology
HP:0007675,Progressive night blindness
HP:0002346,Head tremor
MGI:95755,Slc2a1
HP:0003584,Late onset
MONDO:0002656,skin carcinoma
PATO:0002132,"neoplastic, non-invasive"
CHEBI:59163,biomarker
HP:0003549,Abnormality of connective tissue
chembl:CHEMBL90593,PRASTERONE
chembl:CHEMBL1422,SITAGLIPTIN
HP:0010545,Downbeat nystagmus
dictyBase:DDB_G0283755,arpC
HP:0001262,Excessive daytime somnolence
chembl:CHEMBL279564,PYRENE
chembl:CHEMBL408,TROGLITAZONE
HP:0002070,Limb ataxia
chembl:CHEMBL2105708,PONATINIB HYDROCHLORIDE
HGNC:17427,DPF3
ZFIN:ZDB-GENE-040718-448,cox6b1
dictyBase:DDB_G0286725,vps13A
HGNC:1925,CHEK1
HGNC:11405,BRSK2
HGNC:29233,MAVS
HGNC:18514,SPART
HP:0000651,Diplopia
chembl:CHEMBL37161,FENBENDAZOLE
MONDO:0007435,dentatorubral-pallidoluysian atrophy
chembl:CHEMBL707,DOXAZOSIN
HP:0000739,Anxiety
GO:0009433,"bacterial-type flagellum basal body, C ring"
HP:0007058,Generalized cerebral atrophy/hypoplasia
HGNC:1404,CACNB4
HP:0011397,Abnormality of the dorsal column of the spinal cord
chembl:CHEMBL141,LAMIVUDINE
HGNC:9352,PRDX1
chembl:CHEMBL2178577,AZD-5363
chembl:CHEMBL3039522,BIRINAPANT
MONDO:0005694,cecal neoplasm
HP:0002359,Frequent falls
HGNC:5465,IGF1R
MONDO:0013803,leukoencephalopathy with calcifications and cysts
HGNC:6233,KCNC1
MONDO:0012081,15q11q13 microduplication syndrome
HP:0002756,Pathologic fracture
chembl:CHEMBL550348,DEFERASIROX
MONDO:0007628,foveal hypoplasia 1
UPHENO:0077857,abnormal lateral crico-arytenoid morphology
HGNC:21059,MAD2L1BP
chembl:CHEMBL1201177,LEVOBUNOLOL HYDROCHLORIDE
chembl:CHEMBL293030,BUNOLOL
chembl:CHEMBL1927684,CHEMBL1927684
MONDO:0002666,pancreatic signet ring cell adenocarcinoma
HP:0025405,Visual fixation instability
chembl:CHEMBL475251,R-406
FB:FBgn0026761,Trap1
MONDO:0016491,hemoglobin E-beta-thalassemia syndrome
chembl:CHEMBL95692,SB-242235
NCBIGene:428563,MTARC1
HGNC:7200,MOV10
HGNC:9928,RBX1
MONDO:0005359,drug-induced liver injury
GO:0101003,ficolin-1-rich granule membrane
chembl:CHEMBL468403,QUINOCIDE
RGD:727803,Cd2ap
HP:0001649,Tachycardia
MONDO:0013995,"cholestasis, intrahepatic, of pregnancy, 3"
HGNC:4566,GRB2
GO:0015152,glucose-6-phosphate transmembrane transporter activity
chembl:CHEMBL451887,CARFILZOMIB
MONDO:0007863,Kleine-Levin syndrome
HP:0000486,Strabismus
UPHENO:0080041,increased reflex in independent continuant
chembl:CHEMBL343002,CHEMBL343002
HGNC:25550,RMDN3
HP:0000613,Photophobia
FB:FBgn0038922,Idh3b
chembl:CHEMBL2095222,OCRIPLASMIN
HGNC:25186,TMEM240
HGNC:2254,CORO1C
HP:0011441,Abnormal medulla oblongata morphology
HGNC:9674,PTPRK
chembl:CHEMBL1494650,CHEMBL1494650
HGNC:4389,GNAO1
HP:0000732,Inflexible adherence to routines
chembl:CHEMBL263116,DIMETHYL YELLOW
MONDO:0011576,familial hyperaldosteronism type II
chembl:CHEMBL15927,OLEAMIDE
chembl:CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE
HGNC:14928,UBXN6
HGNC:18445,CALML4
GO:0000774,adenyl-nucleotide exchange factor activity
HGNC:13886,ABCG5
RGD:3705,Slc2a2
chembl:CHEMBL3545027,XL-281
CHEBI:16015,L-glutamic acid
HGNC:8772,PDE10A
ZFIN:ZDB-GENE-040912-86,ndufs6
chembl:CHEMBL1289494,TIVOZANIB
chembl:CHEMBL1606022,SAPPANONE A TRIMETHYL ETHER
CHEBI:24436,guanidines
Reactome:R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
GO:0005634,nucleus
HP:0011344,Severe global developmental delay
HGNC:12643,VAMP2
Reactome:R-HSA-432047,Passive transport by Aquaporins
chembl:CHEMBL51931,"9,10-PHENANTHRENEQUINONE"
chembl:CHEMBL429023,ROTENONE
HGNC:9894,RBL2
MONDO:0014464,progressive encephalopathy with leukodystrophy due to DECR deficiency
chembl:CHEMBL2103875,TRAMETINIB
HGNC:3211,EEF1D
HGNC:10799,SFTPA2
MONDO:0800044,congenital disorder of deglycosylation 1
HP:0001417,X-linked inheritance
WB:WBGene00016449,tost-1
CHEBI:28680,cytarabine
CHEBI:16162,o-orsellinate
HGNC:2570,CYB5A
HGNC:9093,PLTP
chembl:CHEMBL1175,DULOXETINE
MONDO:0003332,malignant struma ovarii
chembl:CHEMBL69367,CHEMBL69367
HP:0025357,Erratic myoclonus
HP:0002089,Pulmonary hypoplasia
HGNC:22652,NOMO2
Reactome:R-SSC-211945,Phase I - Functionalization of compounds
HGNC:4597,GRM5
CHEBI:16469,17beta-estradiol
HGNC:3413,EPM2A
HP:0002131,Episodic ataxia
HP:0003739,Myoclonic spasms
MONDO:0100545,hereditary neurological disease
GO:0005764,lysosome
HP:0032011,Heterophoria
HGNC:15911,NOP56
HGNC:10345,RPL35A
HGNC:26442,NUDT16
MONDO:0009804,osteogenesis imperfecta type 3
HP:0003745,Sporadic
chembl:CHEMBL605003,CHEMBL605003
MONDO:0009480,Joubert syndrome with oculorenal defect
HGNC:18159,VCX3A
HGNC:25230,AHDC1
NCBIGene:480511,AOC3
MONDO:0014668,"cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4"
chembl:CHEMBL2017974,BUPARLISIB
chembl:CHEMBL123292,CYCLOHEXIMIDE
HGNC:8636,PC
HGNC:1787,CDKN2A
GO:0015881,creatine transmembrane transport
CHEBI:15551,prostaglandin E2
HP:0009072,Decreased Achilles reflex
HGNC:3749,FLI1
chembl:CHEMBL403989,TG100-801
chembl:CHEMBL1503,OMEPRAZOLE
CHEBI:35474,anxiolytic drug
HGNC:33437,GSTT2B
HGNC:590,BIRC2
HGNC:9759,RAB10
HP:0001986,Hypertonic dehydration
GO:0006357,regulation of transcription by RNA polymerase II
HGNC:20157,HECTD1
MONDO:0014862,"cerebral palsy, spastic quadriplegic, 3"
GO:0140930,fructose:sodium symporter activity
chembl:CHEMBL2108709,COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
CHEBI:133610,N-isobutyrylglycinate
HGNC:5258,HSP90AB1
HGNC:14884,DNAJA2
HGNC:3465,ESD
chembl:CHEMBL53898,CHEMBL53898
HGNC:51483,LINC02210-CRHR1
HGNC:667,RHOA
HP:0000590,Progressive external ophthalmoplegia
HP:0030955,Alcoholism
HGNC:5261,HSPD1
HGNC:7126,MLF2
HGNC:5382,IDH1
chembl:CHEMBL186720,PHENYLTOLOXAMINE
HGNC:4837,HCCS
chembl:CHEMBL275938,AURINTRICARBOXYLIC ACID
MONDO:0005074,papillary cystadenocarcinoma
MONDO:0014557,ataxia - oculomotor apraxia type 4
chembl:CHEMBL331627,GLIOTOXIN
HGNC:23526,MCU
HGNC:28596,B3GALNT2
chembl:CHEMBL717,MEDROXYPROGESTERONE ACETATE
GO:0036126,sperm flagellum
MONDO:0004884,eye degenerative disorder
chembl:CHEMBL4297366,CG-200745
HP:0003198,Myopathy
HP:0031848,Cock-walk gait
HGNC:1161,CEP55
chembl:CHEMBL973,TERIFLUNOMIDE
MONDO:0021275,papilloma of eyelid
UBERON:0001873,caudate nucleus
HP:0010952,Mild fetal ventriculomegaly
HP:0001152,Saccadic smooth pursuit
HP:0000748,Inappropriate laughter
chembl:CHEMBL43048,MIDOMAFETAMINE
HP:0011968,Feeding difficulties
HP:0001137,Alternating esotropia
chembl:CHEMBL1823681,ETILEVODOPA
UBERON:0001468,intervertebral joint
UBERON:0001184,renal artery
CHEBI:30772,butyric acid
chembl:CHEMBL1319047,ANTIAROL
HGNC:8811,PDK3
MONDO:0800351,left ventricular noncompaction 5
chembl:CHEMBL312443,GABOXADOL
MONDO:0002816,adrenal cortex disorder
MONDO:0014084,ataxia with oculomotor apraxia type 3
chembl:CHEMBL74913,CHEMBL74913
HGNC:8540,P2RY11
HGNC:17019,PRICKLE1
HGNC:7872,NOS1
chembl:CHEMBL372764,PERIFOSINE
chembl:CHEMBL1201576,RITUXIMAB
HGNC:3678,FGF21
chembl:CHEMBL1201063,PROPAFENONE HYDROCHLORIDE
CHEBI:32689,D-argininium(1+)
HGNC:1514,CASR
chembl:CHEMBL3989912,IBERDOMIDE HYDROCHLORIDE
MONDO:0004979,asthma
HP:0002439,Frontolimbic dementia
HP:0007083,Hyperactive patellar reflex
HP:0002282,Gray matter heterotopia
UPHENO:0078579,abnormal visual pursuit
HGNC:7973,NR2E1
MONDO:0956975,T2-high asthma
chembl:CHEMBL36506,NOVOBIOCIN
chembl:CHEMBL66953,PURPUROGALLIN
MONDO:0044705,paranasal sinus squamous cell carcinoma
CHEBI:7809,oxacillin
HGNC:938,BAG2
HGNC:15606,LAMTOR3
chembl:CHEMBL3833368,RUCAPARIB CAMSYLATE
HGNC:12713,VPS41
HP:0002905,Hyperphosphatemia
chembl:CHEMBL1528531,PHOSALONE
HGNC:7125,MLF1
HGNC:8907,PGM3
GO:0007420,brain development
chembl:CHEMBL598903,CHEMBL598903
HGNC:1918,CHD3
HP:0005528,Bone marrow hypocellularity
MONDO:0019303,premature aging syndrome
HGNC:8783,PDE4D
MONDO:0016778,iatrogenic botulism
HP:0001140,Limbal dermoid
chembl:CHEMBL468,THALIDOMIDE
HGNC:1151,BUB3
HP:0002361,Psychomotor deterioration
CHEBI:17620,ferulic acid
HGNC:23067,TRAPPC5
HGNC:365,AK5
HGNC:30313,UBR4
MONDO:0005371,mood disorder
chembl:CHEMBL2165224,ANISODAMINE
NCBIGene:327669,IDH2
HP:0012166,Skin-picking
HP:0100299,Muscle fiber inclusion bodies
MONDO:0014667,"cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3"
HGNC:17677,RABEP1
HP:0002871,Central apnea
HGNC:10585,SCN1A
HGNC:1868,CETN3
MONDO:0001406,peripheral nervous system neoplasm
HGNC:24997,WDR91
MGI:1932872,Ctns
HGNC:9137,EXOSC9
MONDO:0019170,polyarteritis nodosa
HGNC:7803,NFX1
chembl:CHEMBL105,MITOMYCIN
chembl:CHEMBL1586,BECLOMETHASONE
chembl:CHEMBL1397833,VITAMIN B2
chembl:CHEMBL108829,2-PHENYLPHENOL
CHEBI:48132,tetracenomycin
HGNC:7960,NR0B1
MONDO:0005258,autism spectrum disorder
HGNC:3608,FCAR
MONDO:0003820,mature ovarian teratoma
HGNC:3260,EIF2B4
wikidata:Q29006728,ZELBORAF
HGNC:6076,INPP5A
HGNC:10371,RPLP0
MGI:1096574,Car4
HP:0002286,Fair hair
chembl:CHEMBL405,AMPHETAMINE
HGNC:16767,GRIN3A
HGNC:29898,C15orf48
MONDO:0011561,Alzheimer disease 6
chembl:CHEMBL184074,CHEMBL184074
chembl:CHEMBL518292,ISOVELLERAL
MONDO:0007614,congenital fibrosis of extraocular muscles
HGNC:20712,ZDHHC18
HGNC:8804,PDGFRB
UBERON:0001893,telencephalon
CHEBI:10023,voriconazole
HP:0034339,Pseudoautosomal inheritance
MONDO:0011513,"Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology"
chembl:CHEMBL3989934,AVADOMIDE
CHEBI:17824,propan-2-ol
HGNC:11546,TAF13
HGNC:16507,SYNPR
HGNC:3010,DPP6
HP:0002470,Nonprogressive cerebellar ataxia
chembl:CHEMBL17205,CYCLOVALONE
NCBITaxon:227984,SARS coronavirus Tor2
MONDO:0044871,"dystonia, focal, task-specific"
chembl:CHEMBL325041,BORTEZOMIB
CHEBI:51323,cinchona alkaloid
HGNC:8607,PRKN
MONDO:0019792,autosomal dominant cerebellar ataxia type I
MONDO:0036511,childhood malignant kidney neoplasm
HGNC:6112,IRAK1
MONDO:0005613,mesonephric adenocarcinoma
chembl:CHEMBL1200895,PHENELZINE SULFATE
chembl:CHEMBL186366,PINOSYLVIN METHYL ETHER
chembl:CHEMBL464982,GAMOLENIC ACID
CHEBI:167095,secondary fatty alcohol
chembl:CHEMBL1576338,CHEMBL1576338
chembl:CHEMBL86464,CHEMBL86464
MONDO:0010464,X-linked cerebral-cerebellar-coloboma syndrome syndrome
UPHENO:0071321,abnormally formed posterior cranial fossa
HGNC:408,ALDH5A1
chembl:CHEMBL1170,TESTOSTERONE PROPIONATE
HGNC:29641,PWWP3A
RGD:71024,Actr3
MONDO:0019755,developmental defect during embryogenesis
chembl:CHEMBL3544971,DEXTROAMPHETAMINE SULFATE
HGNC:25666,ATOSB
chembl:CHEMBL56393,CHEMBL56393
HGNC:855,ATP6V0C
GO:0031526,brush border membrane
MGI:2443220,Slc4a5
MONDO:0011366,ovarian germ cell tumor
chembl:CHEMBL1534,RIBOFLAVIN
HGNC:25539,RFWD3
chembl:CHEMBL275787,PRODIGIOSIN
chembl:CHEMBL172439,SLAZINIC ACID
HP:0001231,Abnormal fingernail morphology
MONDO:0002547,nerve sheath neoplasm
chembl:CHEMBL790,CHLORHEXIDINE
chembl:CHEMBL575867,4-CHLOROMERCURIBENZOIC ACID
chembl:CHEMBL1516890,GW441756X
chembl:CHEMBL583578,CHEMBL583578
chembl:CHEMBL503,LOVASTATIN
CHEBI:17303,morphine
MONDO:0000589,autoimmune disorder of musculoskeletal system
HGNC:3402,EPHX2
MONDO:0002652,anus adenocarcinoma
UPHENO:0084155,abnormally dilated fourth ventricle
HGNC:13666,AAAS
HGNC:12648,VAPA
MONDO:0004830,fasciitis
HP:0002019,Constipation
HGNC:3942,MTOR
MONDO:0012627,"epilepsy, idiopathic generalized, susceptibility to, 13"
HP:0011151,Atypical absence status epilepticus
chembl:CHEMBL222993,CHEMBL222993
HGNC:9118,PMP22
HP:0025268,Stuttering
chembl:CHEMBL646,TRIAZOLAM
HGNC:851,ATP6V1A
MONDO:0002848,skeletal muscle neoplasm
HGNC:18746,SLURP1
chembl:CHEMBL979,MEPROBAMATE
MONDO:0012166,autosomal dominant sensory ataxia 1
HGNC:13444,SLC2A10
CHEBI:6121,ketamine
MONDO:0002301,frontal sinus squamous cell carcinoma
chembl:CHEMBL7728,HEXOBARBITAL
HGNC:9783,RAB5A
HGNC:11647,TCIRG1
HGNC:28526,EOGT
HP:0006932,Transient psychotic episodes
MONDO:0013763,Joubert syndrome 15
HGNC:9281,PPP1CA
chembl:CHEMBL190474,CHEMBL190474
Reactome:R-CEL-390650,Histamine receptors
MGI:1351617,Abca3
chembl:CHEMBL591137,CHEMBL591137
HGNC:4432,GOT1
HGNC:4422,GNS
MONDO:0005055,Kaposi's sarcoma
HGNC:18407,AGMAT
HGNC:11390,AURKB
MONDO:0002492,acute kidney failure
HGNC:6215,KARS1
HGNC:4739,H2AX
HGNC:5,A1BG
MONDO:0005126,tuberculoid leprosy
MONDO:0011819,spinocerebellar ataxia type 19/22
HGNC:12693,VIP
GO:0031000,response to caffeine
MONDO:0012231,Charcot-Marie-Tooth disease type 2A2
HP:0002500,Abnormal cerebral white matter morphology
chembl:CHEMBL362558,LY-2090314
GO:0030141,secretory granule
chembl:CHEMBL462880,ISOBOLDINE
NCBIGene:420989,AHRR
HGNC:15833,PHACTR3
HGNC:11105,SMARCC2
HGNC:3033,ATN1
HGNC:28862,NIPBL
HGNC:29587,RFESD
HGNC:20150,RAB15
chembl:CHEMBL528807,CHEMBL528807
WB:WBGene00008278,npr-10
MONDO:0005154,liver disorder
chembl:CHEMBL4297189,CERALASERTIB
HP:0001197,Abnormality of prenatal development or birth
HP:0000028,Cryptorchidism
HGNC:17052,SEC31A
chembl:CHEMBL232201,BENZIODARONE
chembl:CHEMBL1410006,"6,4'-DIMETHOXYFLAVONE"
MONDO:0014487,congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome
chembl:CHEMBL528712,CHEMBL528712
CHEBI:66884,N-alkylglycine zwitterion
HGNC:445,SETX
HGNC:7827,NIPSNAP1
MONDO:0958234,Bethlem myopathy 1C
HGNC:941,BAG5
HP:0001919,Acute kidney injury
chembl:CHEMBL487187,THIOPHANATE METHYL
chembl:CHEMBL1200395,ORPHENADRINE CITRATE
HP:0034360,Action myoclonus
chembl:CHEMBL2036124,CHEMBL2036124
HGNC:12788,WNT8A
FB:FBgn0263933,ebi
HGNC:1591,CCNF
chembl:CHEMBL170365,ACETALDEHYDE
chembl:CHEMBL1522984,CHEMBL1522984
WB:WBGene00001519,gar-3
HGNC:15852,ARFGAP1
chembl:CHEMBL494089,GSK-690693
chembl:CHEMBL1712842,MEPAZINE ACETATE
chembl:CHEMBL600336,CHEMBL600336
chembl:CHEMBL1103,FURAZOLIDONE
MONDO:0002168,rectum sarcoma
HGNC:11312,TRIM21
chembl:CHEMBL632,BETAMETHASONE
HGNC:21163,MDC1
HP:0007010,Poor fine motor coordination
chembl:CHEMBL897,PROBENECID
chembl:CHEMBL863,CYSTEINE
NCBIGene:327696,SDHC
chembl:CHEMBL856,PRIMIDONE
chembl:CHEMBL294878,CHEMBL294878
chembl:CHEMBL38380,FASUDIL
HGNC:494,ANK3
HGNC:7652,NBN
chembl:CHEMBL1201154,PROCHLORPERAZINE EDISYLATE
HGNC:30185,CRBN
CHEBI:26878,tertiary alcohol
chembl:CHEMBL584520,CHEMBL584520
HP:0005506,Chronic myelogenous leukemia
chembl:CHEMBL23293,SALIRASIB
HGNC:15879,CTNNBL1
chembl:CHEMBL3137320,TALAZOPARIB
HGNC:28962,SPCS2
HP:0034674,Abnormal ankle physiology
HP:0002200,Pseudobulbar signs
HGNC:30599,CHMP4C
CHEBI:87113,antibiotic antifungal drug
HGNC:5724,RBPJ
chembl:CHEMBL416288,(S)APOMORPHINE
CHEBI:34998,teicoplanin A2-5
chembl:CHEMBL304818,DOCEBENONE
chembl:CHEMBL581194,CHEMBL581194
Reactome:R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs
CHEBI:37532,phorbol ester
RGD:621281,Naip6
HGNC:2077,CLN6
HP:0000405,Conductive hearing impairment
HP:0000711,Restlessness
HGNC:1052,BIN1
HGNC:483,ANG
HGNC:318,AGA
HGNC:13178,IKZF3
HGNC:1549,CBR3
chembl:CHEMBL3353410,OSIMERTINIB
MONDO:0014796,autosomal recessive early-onset Parkinson disease 23
HGNC:9039,PLA2G6
chembl:CHEMBL1117,IDARUBICIN
HGNC:5293,HTR2A
HP:0000012,Urinary urgency
chembl:CHEMBL223360,LINIFANIB
chembl:CHEMBL2108717,ALGENPANTUCEL-L
CHEBI:35692,dicarboxylic acid
HGNC:25732,KLHL25
chembl:CHEMBL1236962,OMIPALISIB
HP:0002395,Lower limb hyperreflexia
HGNC:28217,TMEM203
HGNC:3282,EIF4A1
chembl:CHEMBL654,MIRTAZAPINE
HGNC:4404,GNG2
chembl:CHEMBL1257,ENFLURANE
chembl:CHEMBL1515,METHIMAZOLE
MONDO:0002251,hepatitis
chembl:CHEMBL589258,CHEMBL589258
MONDO:0006917,posterior cerebral artery infarction
chembl:CHEMBL631,PROPAFENONE
HGNC:25223,COQ2
HGNC:1157,BYSL
GO:0031133,regulation of axon diameter
MONDO:0008062,narcolepsy 1
MONDO:0014108,Fanconi anemia complementation group Q
CHEBI:36816,oxime O-ether
chembl:CHEMBL1560680,PROTHIOFOS
chembl:CHEMBL75267,"7,8-DIHYDROXYFLAVONE"
chembl:CHEMBL2303630,SPARSOMYCIN
CHEBI:46195,paracetamol
MONDO:0002853,rectum rhabdomyosarcoma
HGNC:32225,WIPI2
HP:0002104,Apnea
chembl:CHEMBL1743082,TRASTUZUMAB EMTANSINE
Reactome:R-DME-390651,Dopamine receptors
MGI:1098687,Aak1
MONDO:0013978,autosomal recessive nonsyndromic hearing loss 70
HGNC:2861,DHFR
chembl:CHEMBL601167,CHEMBL601167
chembl:CHEMBL580851,CHEMBL580851
chembl:CHEMBL2109602,IMC-3C5
MONDO:0002911,brain stem glioma
HGNC:11621,HNF1A
HGNC:7132,KMT2A
FB:FBgn0003189,r
GO:0044381,glucose import in response to insulin stimulus
HGNC:11137,SNAPC4
HP:0000411,Protruding ear
HGNC:601,APOA2
HP:0002345,Action tremor
chembl:CHEMBL1200515,DESERPIDINE
chembl:CHEMBL1064,SIMVASTATIN
UBERON:0035825,left adrenal gland cortex
HGNC:253,ADH5
MONDO:0012266,preeclampsia/eclampsia 4
HGNC:30075,POLR3G
HP:0011713,Left bundle branch block
HP:0010553,Oculogyric crisis
HGNC:25790,FASTKD5
HGNC:14348,HTRA2
CL:0000084,T cell
FB:FBgn0036316,nebu
CHEBI:20106,vanillylmandelic acid
chembl:CHEMBL1201213,ISOETHARINE
chembl:CHEMBL1619,CLADRIBINE
MONDO:0014179,inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3
CHEBI:17833,gentamycin
HGNC:4661,GTF2IRD1
GO:0050896,response to stimulus
HGNC:11158,SNRPD1
chembl:CHEMBL289351,FOSBRETABULIN DISODIUM
HGNC:10064,TRIM3
HGNC:122,ACP1
HGNC:11920,FAS
HP:0001344,Absent speech
HGNC:11399,NEK4
CHEBI:6636,magnesium dichloride
CHEBI:27690,acetazolamide
NCBIGene:424256,UMPS
HGNC:24596,DYNLL2
CHEBI:47518,"(2S,4R)-ketoconazole"
HGNC:2500,CCN2
Reactome:R-CFA-390666,Serotonin receptors
CHEBI:50733,nutraceutical
chembl:CHEMBL511667,TRIBUTYLTIN-OXIDE
HGNC:17169,PRDX4
HGNC:28396,TMEM67
chembl:CHEMBL2110814,DELUCEMINE
chembl:CHEMBL1312,REVERSETRIIODOTHYRONINE
HGNC:2964,DYNC1I2
chembl:CHEMBL586078,CHEMBL586078
CHEBI:41922,diethylstilbestrol
HGNC:7897,NPC1
Reactome:R-GGA-500753,Pyrimidine biosynthesis
GO:0097306,cellular response to alcohol
HGNC:29148,FBXO45
HGNC:2593,CYP17A1
HGNC:13887,ABCG8
HGNC:14601,ECI2
MONDO:0021568,renal tubule disorder
chembl:CHEMBL3544917,RAPASTINEL
HGNC:3691,FGFR4
chembl:CHEMBL942,BISACODYL
CHEBI:57540,NAD(1-)
HP:0009591,Abnormality of the vestibulocochlear nerve
UPHENO:0084109,abnormally dilated telencephalic ventricle
Xenbase:XB-GENE-987974,jph3
CHEBI:35933,cinchonan
chembl:CHEMBL1549738,CHEMBL1549738
HGNC:4084,GABRD
CHEBI:66933,N-alkylglycine
HGNC:5033,HNRNPA2B1
HGNC:10432,RPS6KA3
chembl:CHEMBL1637,GEMCITABINE HYDROCHLORIDE
HGNC:877,ALDH7A1
chembl:CHEMBL260028,CHEMBL260028
CHEBI:50249,anticoagulant
HGNC:17175,PLCE1
UBERON:0002129,cerebellar cortex
chembl:CHEMBL49120,PD-0166285
chembl:CHEMBL1164992,TRICIFEROL
HGNC:9052,PLAU
chembl:CHEMBL1628227,DOXEPIN
HGNC:2896,DLAT
MONDO:0008199,late-onset Parkinson disease
HGNC:11179,SOD1
HP:0004808,Acute myeloid leukemia
GO:0006600,creatine metabolic process
HGNC:16844,CREB5
CHEBI:29016,arginine
MONDO:0009240,formiminoglutamic aciduria
chembl:CHEMBL3663929,NAQUOTINIB
MONDO:0010150,head and neck squamous cell carcinoma
chembl:CHEMBL482967,CYC-116
HGNC:12849,YWHAB
HGNC:7230,MRE11
chembl:CHEMBL1314,TIOPRONIN
MONDO:0030323,"spinocerebellar ataxia, autosomal recessive 31"
HP:0033054,Myoclonic tremor
HGNC:1273,GATD3
CHEBI:57248,echinocandin
GO:0010759,positive regulation of macrophage chemotaxis
HGNC:30500,PRRT2
HP:0030083,Salt craving
chembl:CHEMBL541400,CHEMBL541400
HP:0008936,Axial hypotonia
MONDO:0018772,Joubert syndrome
chembl:CHEMBL189963,PALBOCICLIB
MONDO:0009875,achromatopsia 3
chembl:CHEMBL17157,TERFENADINE
HGNC:2194,COL17A1
chembl:CHEMBL57,NEVIRAPINE
Reactome:R-RNO-211945,Phase I - Functionalization of compounds
chembl:CHEMBL415324,TRANILAST
chembl:CHEMBL553,ERLOTINIB
HP:5200045,Reduced impulse control
HGNC:589,ATG5
chembl:CHEMBL482581,ESCULIN
HGNC:16806,UBR5
HGNC:5959,ELP1
HGNC:11118,SMN2
GO:0005737,cytoplasm
chembl:CHEMBL414890,PROTOAPIGENONE
NCBIGene:428525,LOC428525
HP:0000519,Developmental cataract
chembl:CHEMBL528181,CHEMBL528181
HGNC:29506,SRCIN1
MONDO:0014937,aniridia 2
HGNC:2345,CREB1
chembl:CHEMBL714,ALBUTEROL
MONDO:0024619,central nervous system infectious disorder
WB:WBGene00008730,F13B12.2
chembl:CHEMBL3188386,WNT-974
HP:0007370,Aplasia/Hypoplasia of the corpus callosum
HGNC:4659,GTF2I
chembl:CHEMBL645,BISOPROLOL
chembl:CHEMBL477772,PAZOPANIB
HGNC:81,ABR
HGNC:11355,STAG2
MONDO:0007100,familial amyloid neuropathy
HP:0001460,Aplasia/Hypoplasia involving the skeletal musculature
NCBIGene:537043,DRD3
HP:0002181,Cerebral edema
HGNC:26401,MARVELD2
chembl:CHEMBL14935,TEZAMPANEL
GO:0034614,cellular response to reactive oxygen species
HGNC:17589,LTO1
HGNC:1094,BPHL
MONDO:0014200,aldosterone-producing adenoma with seizures and neurological abnormalities
HP:0011977,Elevated urinary homovanillic acid
HGNC:30292,G3BP1
HGNC:9822,RAD51B
CHEBI:61355,3-hydroxy carboxylic acid
HP:0100297,Increased endomysial connective tissue
HGNC:12252,TRD
chembl:CHEMBL1201420,UROKINASE
MONDO:0009902,cutaneous porphyria
MONDO:0002939,skin pigmented basal cell carcinoma
MONDO:0005260,autism
HGNC:1473,CANX
MONDO:0023249,polyarticular juvenile rheumatoid arthritis
MGI:1313136,Clip2
HGNC:11200,SOX4
HGNC:4598,GRM6
HP:0003241,External genital hypoplasia
chembl:CHEMBL538943,VINORELBINE TARTRATE
NCBIGene:515757,AFG3L2
chembl:CHEMBL655,MIDAZOLAM
HGNC:87,ACAD8
HP:0025097,Eyelid myoclonus
chembl:CHEMBL182150,CHEMBL182150
chembl:CHEMBL1256851,CHEMBL1256851
HP:0032794,Myoclonic seizure
chembl:CHEMBL1380,ABACAVIR
MONDO:0012265,preeclampsia/eclampsia 3
MONDO:0032726,combined oxidative phosphorylation deficiency 39
HGNC:2228,COMT
HGNC:11556,TAL1
HGNC:28171,HDHD3
HGNC:6250,KCNH1
GO:0018107,peptidyl-threonine phosphorylation
HP:0001281,Tetany
chembl:CHEMBL940,GABAPENTIN
HGNC:11006,SLC2A2
chembl:CHEMBL3707228,PLOZALIZUMAB
chembl:CHEMBL1723343,ZOLPIDEM TARTRATE
HGNC:6446,KRT8
HP:0011425,Fetal ultrasound soft marker
HGNC:7698,NDUFB3
HGNC:3775,FMR1
HGNC:23160,SAT2
HGNC:943,ADGRB1
chembl:CHEMBL3707379,PF-04958242
CHEBI:17347,testosterone
CHEBI:5280,gatifloxacin
HGNC:26025,MARCHF5
HGNC:4734,H2AC4
HGNC:13584,FBXO5
HP:0100754,Mania
GO:0008982,protein-N(PI)-phosphohistidine-sugar phosphotransferase activity
HGNC:30306,PHB2
MONDO:0004210,colonic L-cell glucagon-like peptide producing tumor
HGNC:16870,MELK
chembl:CHEMBL223448,BROXYQUINOLINE
chembl:CHEMBL1200468,MALATHION
chembl:CHEMBL1201729,DRONEDARONE HYDROCHLORIDE
HGNC:9385,PRKAG1
chembl:CHEMBL3707399,CX1739
HGNC:24374,CYB5B
HP:0002474,Expressive language delay
HP:0010521,Gait apraxia
MONDO:0021605,benign eyelid neoplasm
MGI:1927133,Gmfb
HP:0002795,Abnormal respiratory system physiology
CHEBI:35358,sulfonamide
MONDO:0003245,aflatoxin-related hepatocellular carcinoma
chembl:CHEMBL1086440,TRICLABENDAZOLE
NCBIGene:396086,RAD51
GO:0017124,SH3 domain binding
MGI:2140940,Acacb
CHEBI:30816,vanillic acid
HP:0002624,Abnormal venous morphology
HP:0030319,Weakness of facial musculature
MONDO:0018982,Niemann-Pick disease type C
MONDO:0002275,generalized atherosclerosis
HGNC:28611,RICTOR
MONDO:0006130,central nervous system neoplasm
chembl:CHEMBL575448,BMS-754807
MONDO:0004537,intestinal variant cervical mucinous adenocarcinoma
chembl:CHEMBL52,NORDIHYDROGUAIARETIC ACID
chembl:CHEMBL25,ASPIRIN
chembl:CHEMBL1607480,OXYTETRACYCLINE HYDROCHLORIDE
HGNC:13546,POLE3
chembl:CHEMBL260560,CHEMBL260560
chembl:CHEMBL926,DOBUTAMINE
HGNC:17208,BICD2
HGNC:7696,NDUFB10
HP:0008736,Hypoplasia of penis
MONDO:0014795,"exercise intolerance, riboflavin-responsive"
HGNC:4584,GRIN1
chembl:CHEMBL1605700,TETRAHYDROGAMBOGIC ACID
chembl:CHEMBL1507526,CHEMBL1507526
HGNC:20454,POLR1B
MGI:1349414,Cops4
MONDO:0016058,paroxysmal dystonia
MGI:2675603,Trpm6
MONDO:0001824,polyneuropathy
chembl:CHEMBL848,LENALIDOMIDE
HP:0009878,Cerebellar ataxia associated with quadrupedal gait
chembl:CHEMBL1200467,HYDROXYZINE PAMOATE
chembl:CHEMBL17201,CHEMBL17201
chembl:CHEMBL220241,GSK-269962A
HGNC:11584,TBK1
CHEBI:50845,doxycycline
HP:0000639,Nystagmus
MGI:1919412,Dhx36
MONDO:0012205,autosomal dominant striatal neurodegeneration type 1
HGNC:48955,UMAD1
chembl:CHEMBL128988,FRENTIZOLE
HP:0006961,Jerky head movements
chembl:CHEMBL641,ATOMOXETINE
MGI:1918128,Ccdc136
HGNC:1840,CECR2
MONDO:0850285,environmental induced asthma
HGNC:18803,ATPAF1
HGNC:9935,RCN2
UBERON:0000997,mammalian vulva
FB:FBgn0025682,scf
CHEBI:27701,oxytetracycline
HGNC:4553,GPX1
HGNC:91,ACADSB
HGNC:23297,KCTD15
chembl:CHEMBL2022560,APRATOXIN F
HP:0010935,Abnormality of the upper urinary tract
chembl:CHEMBL3545299,BMS-698769
HGNC:10469,RTN3
chembl:CHEMBL429,LABETALOL
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules
MONDO:0009667,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3"
HGNC:9066,PLCG2
HP:0012389,Appendicular hypotonia
chembl:CHEMBL459324,DIACETYLMORPHINE
chembl:CHEMBL565,CLOFIBRATE
chembl:CHEMBL483847,CHEMBL483847
MONDO:0000133,immunodeficiency-centromeric instability-facial anomalies syndrome
HGNC:6524,LCK
GO:0003674,molecular_function
chembl:CHEMBL560579,PROPICONAZOLE
chembl:CHEMBL601547,CHEMBL601547
MONDO:0014787,severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome
MONDO:0000903,myoclonus-dystonia syndrome
chembl:CHEMBL436774,AR9281
HGNC:9388,PRKAR1A
HGNC:30605,SEPSECS
HGNC:16422,CARD10
MONDO:0958012,neurodegeneration with brain iron accumulation 9
chembl:CHEMBL1258517,PKI-179
HGNC:12632,USP9X
CHEBI:43968,meropenem
chembl:CHEMBL346516,METHYL PARATHIONE
chembl:CHEMBL9514,NOCODAZOLE
CHEBI:478164,cefepime
CHEBI:28600,farnesol
NCBIGene:416571,NDUFAB1
UPHENO:0048015,increased thickness of the corpus callosum
HGNC:4279,GJA5
chembl:CHEMBL1484,NICARDIPINE
chembl:CHEMBL44,GENISTEIN
NCBIGene:416391,NDUFB6
HGNC:15454,SHOC2
chembl:CHEMBL524376,CHEMBL524376
FB:FBgn0033194,Vps13
HGNC:7103,MIP
chembl:CHEMBL1346946,"DIBENZ[A,H]ANTHRACENE"
chembl:CHEMBL1442890,PROSULTIAMINE
chembl:CHEMBL399491,PYRROLIDINE DITHIOCARBAMATE
HGNC:8003,NRM
chembl:CHEMBL1402420,PIFEXOLE
CHEBI:87101,triazole antifungal drug
HGNC:15840,KMT2B
chembl:CHEMBL162358,TOMELUKAST
HGNC:24821,RFFL
chembl:CHEMBL27810,CELIPROLOL
chembl:CHEMBL1449187,"3,7-DIMETHOXYFLAVONE"
HP:0031475,Status epilepticus without prominent motor symptoms
CHEBI:38166,organic heteropolycyclic compound
MONDO:0018780,congenital generalized hypercontractile muscle stiffness syndrome
HGNC:12485,UBE2I
HP:0002659,Increased susceptibility to fractures
HGNC:4403,GNG11
HGNC:9585,PTCH1
chembl:CHEMBL3545218,VORUCICLIB
NCBIGene:489526,ALDH3A1
RGD:1311340,Vps13a
UPHENO:0009339,absent vestibular nerve
HGNC:28449,ZFTA
HGNC:14310,BRD7
MONDO:0004784,allergic asthma
MONDO:0005533,distal colitis
HP:0010531,Spinal myoclonus
MONDO:0002378,dermoid cyst
HGNC:1097,BRAF
chembl:CHEMBL258805,SU-9516
HGNC:14628,CDCA7
HP:0009894,Thickened ears
HGNC:4588,GRIN2D
chembl:CHEMBL601140,CHEMBL601140
GO:0001164,RNA polymerase I core promoter sequence-specific DNA binding
HP:0010788,Testicular neoplasm
HGNC:5036,HNRNPD
HP:0010536,Central sleep apnea
HGNC:23177,KEAP1
HP:0002583,Colitis
MONDO:0020067,infectious encephalitis
HGNC:16803,UBE3C
HP:0011976,Elevated urinary catecholamine level
UPHENO:0075900,abnormal cochlear nerve
MONDO:0020120,skeletal muscle disorder
chembl:CHEMBL4297774,JNJ-61186372
MONDO:0010100,Tay-Sachs disease
HP:0006931,Pericallosal lipoma
HP:0000643,Blepharospasm
CHEBI:25106,macrolide
Reactome:R-HSA-8986944,Transcriptional Regulation by MECP2
HP:0025062,Geophagia
HP:0008665,Clitoral hypertrophy
MONDO:0018161,non-hereditary retinoblastoma
chembl:CHEMBL1543865,CHEMBL1543865
CHEBI:38104,oxacycle
HP:0002076,Migraine
HGNC:10431,RPS6KA2
CHEBI:138856,oxolinic acid
HP:0002619,Varicose veins
MONDO:0016102,subacute inflammatory demyelinating polyneuropathy
UPHENO:0079845,abnormal social behavior
chembl:CHEMBL484853,CARNOSIC ACID
MONDO:0003517,mature teratoma
HGNC:4082,GABRB2
chembl:CHEMBL242383,RESOKAEMPFEROL
HGNC:9305,PPP2R2B
HGNC:20246,RAB2B
HGNC:12373,TSHR
HP:0001017,Anemic pallor
MONDO:0016809,spinocerebellar ataxia with epilepsy
MONDO:0005091,severe acute respiratory syndrome
CHEBI:16828,L-tryptophan
chembl:CHEMBL125044,CHEMBL125044
chembl:CHEMBL471225,CHEMBL471225
Reactome:R-BTA-611105,Respiratory electron transport
HGNC:2431,CSE1L
MONDO:0010342,"autism, susceptibility to, X-linked 3"
chembl:CHEMBL291143,CHEMBL291143
chembl:CHEMBL472172,CHEMBL472172
chembl:CHEMBL118,CELECOXIB
chembl:CHEMBL284906,NICORANDIL
HGNC:8809,PDK1
CHEBI:7852,oxycodone
chembl:CHEMBL2219422,AFURESERTIB
MONDO:0013265,"autism, susceptibility to, 17"
HGNC:29605,SH2B3
MONDO:0044350,"hyperparathyroidism, primary, caused by water clear cell hyperplasia"
HP:0004887,Respiratory failure requiring assisted ventilation
HGNC:6858,MAP3K6
HGNC:3522,EYA4
chembl:CHEMBL509256,GERALDOL
HGNC:3070,DUSP4
chembl:CHEMBL710,FINASTERIDE
GO:0005543,phospholipid binding
MGI:107619,Hrh1
MGI:105100,Ctnnd1
chembl:CHEMBL328710,CHEMBL328710
GO:1904659,glucose transmembrane transport
HP:0001315,Reduced tendon reflexes
MONDO:0003007,childhood kidney cell carcinoma
CHEBI:16330,17beta-hydroxy-5alpha-androstan-3-one
HGNC:11261,SPRR2A
HGNC:4023,FXR1
HP:0002586,Peritonitis
chembl:CHEMBL558752,RAF-265
chembl:CHEMBL1534525,MIBEFRADIL DIHYDROCHLORIDE
HGNC:4025,FXYD1
chembl:CHEMBL275707,RIMCAZOLE
HGNC:30033,PHPT1
HP:0012044,Seesaw nystagmus
chembl:CHEMBL1921976,ORTERONEL
HGNC:16488,UNC119B
HGNC:20820,TPCN2
chembl:CHEMBL1876799,CLANFENUR
HP:0002166,Impaired vibration sensation in the lower limbs
chembl:CHEMBL577887,CHEMBL577887
chembl:CHEMBL299853,CHEMBL299853
HGNC:3278,EIF3D
GO:0042552,myelination
HGNC:10069,RNF6
MGI:2148520,Vmn1r41
HGNC:9258,PPIE
chembl:CHEMBL474376,TRIPHENYLSTANNYL ACETATE
HGNC:24138,DNAJC5B
HGNC:1778,CDK7
MONDO:0024621,serous cystadenocarcinoma
HP:0011346,Mild expressive language delay
HGNC:8982,PIK3R4
CHEBI:47788,3-oxo steroid
chembl:CHEMBL514409,HESPERADIN
ZFIN:ZDB-GENE-050828-1,ndufa12
GO:0005743,mitochondrial inner membrane
MONDO:0014804,sideroblastic anemia 3
MONDO:0009340,non-spherocytic hemolytic anemia due to hexokinase deficiency
UBERON:0002483,trabecular bone tissue
GO:0017098,sulfonylurea receptor binding
chembl:CHEMBL1200322,ESCITALOPRAM OXALATE
HP:0010533,Spasmus nutans
chembl:CHEMBL79993,Z-PRO-PROLINAL
MONDO:0011339,hereditary spastic paraplegia 8
HGNC:11817,TIMM8A
MGI:1923442,Abhd12
HGNC:2712,DCTN2
HGNC:4506,GPR50
chembl:CHEMBL283196,ALPHA-NAPHTHOFLAVONE
HP:0010522,Dyslexia
HGNC:6178,ITPKA
GO:0007286,spermatid development
chembl:CHEMBL2005186,CHEMBL2005186
HGNC:11796,THRA
chembl:CHEMBL565612,SOTRASTAURIN
MONDO:0033481,spinocerebellar ataxia 46
chembl:CHEMBL296407,CHEMBL296407
HGNC:2719,DDC
MONDO:0021152,inherited
MONDO:0100244,paroxysmal nocturnal hemoglobinuria
HGNC:16667,TMEM30A
MONDO:0019032,X-linked intellectual disability with isolated growth hormone deficiency
HP:0000545,Myopia
MONDO:0016814,maternally-inherited Leigh syndrome
chembl:CHEMBL276618,4-METHYLDAPHNETIN
UPHENO:0081343,vestibular nerve hypoplasia
chembl:CHEMBL2107801,RESEQUINIL
chembl:CHEMBL2079588,TELATINIB
HP:0009916,Anisocoria
HGNC:19344,DENND5A
chembl:CHEMBL2105717,CABOZANTINIB
chembl:CHEMBL1257030,LONIDAMINE
MONDO:0020485,King-Denborough syndrome
HGNC:11875,TMPO
HP:0000268,Dolichocephaly
MONDO:0011439,spinocerebellar ataxia type 12
HP:0001305,Dandy-Walker malformation
CHEBI:3393,carbenicillin
chembl:CHEMBL244707,CHEMBL244707
HGNC:10301,RPL11
GO:0005789,endoplasmic reticulum membrane
HGNC:25782,MCMBP
MONDO:0012399,complex cortical dysplasia with other brain malformations 7
MONDO:0012430,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2"
chembl:CHEMBL3545097,SAPANISERTIB
HP:0025331,Upgaze palsy
chembl:CHEMBL1199080,BRETYLIUM
HGNC:6180,ITPR1
HGNC:15574,RB1CC1
CHEBI:456215,adenosine 5'-monophosphate(2-)
NCBIGene:769492,NDUFS8
chembl:CHEMBL586,SALICYLURIC ACID
CHEBI:38532,hydrazone
chembl:CHEMBL2325741,CAPIVASERTIB
chembl:CHEMBL331237,TRICIRIBINE
HGNC:12428,TWIST1
MONDO:0018439,eosinophilic colitis
chembl:CHEMBL220492,TOPIRAMATE
UBERON:0004502,skeletal muscle tissue of biceps brachii
chembl:CHEMBL1201115,ESMOLOL HYDROCHLORIDE
GO:0031252,cell leading edge
chembl:CHEMBL52606,COLFORSIN
HGNC:5341,IBSP
GO:0001784,phosphotyrosine residue binding
HP:0000722,Compulsive behaviors
HP:0006528,Chronic lung disease
MONDO:0013594,spinocerebellar ataxia type 36
HGNC:9827,RAD9A
HGNC:6872,MAPK10
HGNC:8788,PDE6D
HP:0031856,Hobby horse gait
MONDO:0010128,thyrocerebrorenal syndrome
chembl:CHEMBL93240,METITEPINE
HGNC:18265,ATP6V1G3
CHEBI:31941,oxaliplatin
HGNC:535,ANXA11
MONDO:0015518,infantile bilateral striatal necrosis
chembl:CHEMBL4297608,ELDECALCITOL
HP:0011351,Moderate receptive language delay
HP:0000013,Hypoplasia of the uterus
HGNC:18040,ARID1B
HGNC:307,TLE5
HP:0000751,Personality changes
chembl:CHEMBL9470,SHIKONIN
CHEBI:58092,N-phosphocreatinate(2-)
chembl:CHEMBL1358709,AZOCYCLOTIN
GO:0055056,D-glucose transmembrane transporter activity
Reactome:R-DRE-549127,Organic cation transport
HGNC:10628,CCL3L1
chembl:CHEMBL601618,CHEMBL601618
MGI:1914497,Mtarc2
MGI:107813,Tubb3
CHEBI:39867,valproic acid
MONDO:0013310,congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
chembl:CHEMBL43,AMSACRINE
HGNC:5383,IDH2
HGNC:7436,MTHFR
UPHENO:0075796,abnormal musculature of neck
HGNC:29091,ATG13
CHEBI:4781,emetine
chembl:CHEMBL1370646,CHLORPYRIFOS-METHYL
WB:WBGene00004779,ser-4
MONDO:0002503,adult astrocytic tumor
chembl:CHEMBL591,ETHCHLORVYNOL
chembl:CHEMBL817,TOLAZAMIDE
MONDO:0020300,autosomal dominant nocturnal frontal lobe epilepsy
chembl:CHEMBL253969,OSI-632
Xenbase:XB-GENE-921721,slc2a3
chembl:CHEMBL1221986,WITHAFERIN A
HP:0025253,Claustrophobia
HGNC:11579,TBCA
HGNC:14215,TRIM55
HP:0500018,Abnormal cardiac exercise stress test
UPHENO:0080591,abnormal irritability behavior
chembl:CHEMBL131,PREDNISOLONE
chembl:CHEMBL21241,GW7647
chembl:CHEMBL585769,CHEMBL585769
chembl:CHEMBL2396661,ALPELISIB
chembl:CHEMBL408194,OBATOCLAX
HGNC:22965,PEX26
NCBIGene:492299,SLC5A1
HGNC:16228,TRIB3
HGNC:16666,KIF9
HGNC:32068,MICOS10
chembl:CHEMBL465226,GEDUNIN
HGNC:588,ATG12
WB:WBGene00013344,ebp-1
CHEBI:72596,papulacandin
HGNC:9065,PLCG1
MONDO:0004986,urinary bladder carcinoma
HGNC:3189,EEF1A1
chembl:CHEMBL1472895,FENBUTATIN OXIDE
HP:0007103,Hypointensity of cerebral white matter on MRI
CHEBI:23994,ethyl methanesulfonate
HGNC:18263,RAB21
GO:0043197,dendritic spine
HP:0007266,Cerebral dysmyelination
HP:0006938,Impaired vibration sensation at ankles
chembl:CHEMBL52609,THYMIDINE
Reactome:R-MMU-390650,Histamine receptors
HGNC:10810,SGK1
MONDO:0003646,rectum neuroendocrine neoplasm
HP:0001363,Craniosynostosis
HP:0000719,Inappropriate behavior
HGNC:622,APPBP2
HP:0002174,Postural tremor
chembl:CHEMBL1395447,NITROVIN
HGNC:6871,MAPK1
HGNC:6148,ITGAL
NCBIGene:481907,HTR1E
HGNC:5456,IFRD1
MONDO:0850287,aspirin-induced respiratory disease
HGNC:6374,KLRC1
CHEBI:50995,secondary amino compound
HGNC:8853,PEX11B
HGNC:5241,HSPA8
HGNC:1665,SCARB2
chembl:CHEMBL2338397,CRENIGACESTAT
MONDO:0041086,mixed anxiety and depressive disorder
HP:0031629,Impaired tandem gait
CHEBI:35337,central nervous system stimulant
GO:0006423,cysteinyl-tRNA aminoacylation
HGNC:18475,ZDHHC9
MONDO:0012015,"nystagmus 3, congenital, autosomal dominant"
chembl:CHEMBL28626,MORIN
HP:0012473,Tongue atrophy
chembl:CHEMBL1487,ATORVASTATIN
chembl:CHEMBL404505,CHEMBL404505
chembl:CHEMBL282731,CICHORIC ACID
HGNC:7490,MT-TL1
MONDO:0000605,hypersensitivity reaction disease
chembl:CHEMBL1221911,LACTIMIDOMYCIN
MONDO:0014100,dilated cardiomyopathy 1KK
chembl:CHEMBL1869353,ACEQUINOCYL
HP:0100025,Overfriendliness
MGI:2152844,Slc2a9
HP:0006937,Impaired distal tactile sensation
chembl:CHEMBL3894518,AZD-8835
chembl:CHEMBL2108619,LONTUCIREV (REPLICATING ADENOVIRUS)
HGNC:18418,HYPK
HGNC:12412,TUBB2A
HGNC:26068,LAMTOR1
HGNC:4916,HIRA
HGNC:17284,POT1
HGNC:2555,CUL4B
UPHENO:0080598,abnormal emotional behavior
chembl:CHEMBL482050,CHEMBL482050
HGNC:1499,CASP1
chembl:CHEMBL1614766,RO-4987655
HP:0001626,Abnormality of the cardiovascular system
HGNC:12692,VIM
chembl:CHEMBL186179,MURAGLITAZAR
chembl:CHEMBL510279,DIHYDROXANTHOHUMOL
chembl:CHEMBL225230,R-N-PROPYLNORAPOMORPHINE
HGNC:11985,TOMM70
chembl:CHEMBL1489769,LASALOCID A SODIUM
HP:0000966,Hypohidrosis
MONDO:0020835,"methemoglobinemia, alpha type"
NCBIGene:420337,NDUFB9
HGNC:11209,SP4
HGNC:9187,POLR2A
HGNC:8062,NUP153
HGNC:7467,MTTP
HGNC:14677,DEAF1
HGNC:9642,PTPN1
FB:FBgn0039358,Idh3g
chembl:CHEMBL582030,CHEMBL582030
HGNC:12271,TRG
Reactome:R-HSA-5620924,Intraflagellar transport
chembl:CHEMBL274318,FLAVANONE
chembl:CHEMBL23393,SODIUM LAURYL SULFATE
HGNC:1681,CD44
HGNC:12679,VDR
HGNC:25532,MTPAP
HGNC:17117,SLC35C2
MONDO:0012450,spinocerebellar ataxia type 28
HGNC:12930,ZBTB16
HGNC:6984,ME2
chembl:CHEMBL344469,"0-HEXYL-1,3-DIAMINE-PLATINUM 2,2-DICHLORIDE"
HGNC:118,ACO2
CHEBI:28077,rifampicin
chembl:CHEMBL2074725,ACETYLDIGOXIN
chembl:CHEMBL1726,NISOLDIPINE
MONDO:0006694,cerebral atherosclerosis
GO:0005654,nucleoplasm
CHEBI:8707,quetiapine
chembl:CHEMBL1614701,SELUMETINIB
HGNC:30417,SH2B1
chembl:CHEMBL602970,CHEMBL602970
MONDO:0004790,fatty liver disease
HP:0002145,Frontotemporal dementia
HGNC:1720,CDC16
chembl:CHEMBL600734,CHEMBL600734
HGNC:12505,UBL4A
chembl:CHEMBL727,THIOGUANINE
wikidata:Q27077026,DEUTETRABENAZINE
GO:0046323,glucose import
HGNC:5467,IGF2R
HGNC:29255,USP53
MONDO:0005070,neoplasm
MONDO:0009518,"leprosy, susceptibility to, 3"
HGNC:5414,IFITM3
HGNC:3064,DUSP1
HGNC:1356,ERLIN2
HGNC:24565,KANSL1
MONDO:0018208,neurofibromatosis type 1 due to NF1 mutation or intragenic deletion
chembl:CHEMBL60718,TPCK
HGNC:719,ARSL
chembl:CHEMBL1705373,THIOCOLCHICOSIDE
chembl:CHEMBL3989941,TINOSTAMUSTINE
HGNC:7683,NDUFA1
chembl:CHEMBL192264,CHEMBL192264
HP:0010984,Digenic inheritance
chembl:CHEMBL1068,OXCARBAZEPINE
HP:0002637,Cerebral ischemia
MONDO:0006915,polyradiculoneuropathy
chembl:CHEMBL6640,TRYPTAMINE
HGNC:7060,MGP
chembl:CHEMBL152231,AMOSULALOL
chembl:CHEMBL46,ONDANSETRON
HP:0001450,Y-linked inheritance
chembl:CHEMBL468439,CYCLOPROPARADICICOL
HGNC:10468,RTN2
HP:0002817,Abnormality of the upper limb
HGNC:8808,PDHB
HGNC:9251,CTSA
HGNC:2495,CTBP2
chembl:CHEMBL1200802,TALBUTAL
HGNC:8785,PDE6A
CHEBI:29687,teicoplanin
HP:0001337,Tremor
chembl:CHEMBL356066,DACINOSTAT
MONDO:0001106,kidney failure
chembl:CHEMBL105712,PHENACYL CHLORIDE
HGNC:7672,NCOR1
HGNC:10569,SERPINB3
UPHENO:0013942,cerebellum atrophy
HP:0010936,Abnormality of the lower urinary tract
chembl:CHEMBL3545134,LY-2780301
HGNC:18155,TXNRD2
NCBIGene:476004,NDUFV1
HGNC:11065,SLC7A7
MONDO:0002543,adult oligodendroglioma
chembl:CHEMBL1370561,AMINOPHYLLINE
chembl:CHEMBL405110,METHYLTHIONINIUM CHLORIDE
HGNC:4587,GRIN2C
HP:0000717,Autism
HP:0001256,"Intellectual disability, mild"
chembl:CHEMBL269644,ACETANILIDE
HGNC:20001,PCSK9
CHEBI:15428,glycine
HP:0007340,Lower limb muscle weakness
chembl:CHEMBL111654,2-MERCAPTOBENZOTHIAZOLE
HP:0000725,Psychotic episodes
HGNC:4068,GABARAPL1
chembl:CHEMBL255231,LADOSTIGIL
chembl:CHEMBL1354502,KOPARIN
HGNC:12754,WDR1
HP:0001136,Retinal arteriolar tortuosity
HGNC:9362,PRG2
HGNC:6518,LBR
MONDO:0011671,Huntington disease-like 2
MONDO:0003978,colon small cell neuroendocrine carcinoma
CHEBI:59137,(8xi)-cinchonan
HGNC:830,ATP5F1B
HGNC:18118,RSF1
HGNC:1493,CARS1
chembl:CHEMBL1286,LEVETIRACETAM
chembl:CHEMBL357995,BOPINDOLOL
chembl:CHEMBL1328968,MELENGESTROL ACETATE
chembl:CHEMBL42055,E-FLUPENTIXOL
HP:0001273,Abnormal corpus callosum morphology
chembl:CHEMBL7301,FENRETINIDE
CHEBI:35341,steroid
MONDO:0100087,familial Alzheimer disease
MONDO:0024614,neurotic depression
chembl:CHEMBL2108110,THROMBIN
chembl:CHEMBL576409,CHEMBL576409
chembl:CHEMBL2336666,CHEMBL2336666
HGNC:31399,SLC6A17
HGNC:20604,DIS3
MONDO:0004542,"cervical adenosquamous carcinoma, glassy cell variant"
HGNC:3778,FN1
MONDO:0012084,aromatic L-amino acid decarboxylase deficiency
MONDO:0024564,cerebroretinal microangiopathy with calcifications and cysts 1
chembl:CHEMBL1240772,GLP-1
HGNC:29685,IARS2
chembl:CHEMBL1201151,MESTRANOL
HGNC:710,ARR3
HP:0001212,Prominent fingertip pads
chembl:CHEMBL866,MYCOPHENOLIC ACID
HP:0003209,Decreased pyruvate carboxylase activity
chembl:CHEMBL281350,SB-224289
MONDO:0016171,polyradiculoneuropathy associated with IgG/IgA/IgM monoclonal gammopathy without known antibodies
HGNC:16983,OLIG1
CHEBI:28694,copper atom
HGNC:4189,GCDH
HGNC:5014,HMOX2
chembl:CHEMBL456,ETHACRYNIC ACID
chembl:CHEMBL300138,ENZASTAURIN
CHEBI:16151,"3,4-dihydrocoumarin"
HGNC:2355,CRH
HGNC:20233,COQ6
MONDO:0017593,juvenile amyotrophic lateral sclerosis
chembl:CHEMBL428789,CHEMBL428789
HP:0002311,Incoordination
HGNC:2494,CTBP1
NCBIGene:509751,AOC1
MONDO:0010789,MELAS syndrome
chembl:CHEMBL1201361,ALCLOMETASONE
chembl:CHEMBL454173,ZEARALENONE
MONDO:0956976,T2-low asthma
chembl:CHEMBL39,SEROTONIN
HGNC:9812,RAD23A
chembl:CHEMBL2108309,CUSTIRSEN
chembl:CHEMBL1224755,CHEMBL1224755
HGNC:7583,MYL2
CHEBI:36027,stilbenol
chembl:CHEMBL1643895,RAMOSETRON
HGNC:2445,CSN1S1
HP:0007179,Absent smooth pursuit
HP:0001824,Weight loss
CHEBI:47519,ketoconazole
HGNC:2577,CYBA
HGNC:12012,TPM3
HGNC:5961,IKBKG
HP:0003141,Increased LDL cholesterol concentration
HP:0025267,Snoring
HP:0002374,Diminished movement
HGNC:16283,TRIM14
HP:0001608,Abnormality of the voice
MONDO:0020800,demyelinating disease of central nervous system
MONDO:8000012,"neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1"
wikidata:Q47520887,ADRIAMYCIN
HP:0025190,Bilateral tonic-clonic seizure with generalized onset
MGI:2442535,Slc6a17
HGNC:4010,FUS
GO:0017151,DEAD/H-box RNA helicase binding
HGNC:3020,DRD1
WB:WBGene00000063,act-1
chembl:CHEMBL12252,"5,7-DIHYDROXY-4-METHYLCOUMARIN"
CHEBI:18012,fumaric acid
MONDO:0006268,liver diffuse large B-cell lymphoma
chembl:CHEMBL2105705,LUNACALCIPOL
MONDO:0010826,childhood absence epilepsy
MONDO:0017884,papillary renal cell carcinoma
HGNC:28496,POGLUT3
chembl:CHEMBL448382,RESINIFERATOXIN
chembl:CHEMBL3707248,VALBENAZINE TOSYLATE
HGNC:2074,CLN3
HGNC:14076,CERS2
GO:0031175,neuron projection development
HGNC:5294,HTR2B
chembl:CHEMBL716,QUETIAPINE
HGNC:362,AK2
HGNC:16526,ACSL5
chembl:CHEMBL1200418,DOBUTAMINE HYDROCHLORIDE
HGNC:691,PHOX2A
HP:0010868,Ocular dyssynergia
chembl:CHEMBL590985,TALOTREXIN
chembl:CHEMBL2103882,TIVANTINIB
HP:0200085,Limb tremor
chembl:CHEMBL1451,TRIAMCINOLONE
HGNC:6842,MAP2K2
HP:0031473,Hostility
FB:FBgn0261929,5-HT2B
MONDO:0013392,autosomal recessive spinocerebellar ataxia 10
HGNC:16100,FAM209A
CHEBI:58189,GDP(3-)
chembl:CHEMBL248564,CORONOPILIN
chembl:CHEMBL1201752,IXABEPILONE
chembl:CHEMBL3545358,4SC-203
MONDO:0005550,infectious disease
HP:0000768,Pectus carinatum
chembl:CHEMBL2095095,CHEMBL2095095
HGNC:9226,PPA1
chembl:CHEMBL275742,DEXPROPRANOLOL
HGNC:24525,MMACHC
HP:0032308,Increased circulating procalcitonin concentration
MONDO:0005020,intestinal disorder
CHEBI:142677,triazinoindole
MP:0003312,abnormal locomotor coordination
HP:0011396,Abnormality of the cochlear nerve
HGNC:1771,CDK2
HGNC:410,ALDH3B1
HP:0045037,Abnormality of jaw muscles
HP:0003614,Trimethylaminuria
GO:0005829,cytosol
HP:0032588,Hand apraxia
HGNC:29239,INTU
HP:0010975,Abnormal B cell count
chembl:CHEMBL347698,FENITROTHION
MONDO:0004586,rheumatoid lung disease
MONDO:0002368,papillary serous cystadenocarcinoma
chembl:CHEMBL1118,DESVENLAFAXINE
MONDO:0018027,duplication/inversion 15q11
chembl:CHEMBL1222251,INOSITOL
chembl:CHEMBL550,PILOCARPINE
UBERON:0001882,nucleus accumbens
MONDO:0008845,atonic-astatic syndrome of Foerster
chembl:CHEMBL28517,E927A
chembl:CHEMBL33864,"LIPOIC ACID, ALPHA"
HGNC:13740,SNTG1
RGD:621618,Icmt
HP:0030917,Low APGAR score
chembl:CHEMBL53929,OCTOPAMINE
HGNC:4853,HDAC2
HGNC:1044,BGN
HP:0009113,Diaphragmatic weakness
HGNC:663,ARG1
GO:0005884,actin filament
HGNC:11389,STK11
HP:0006824,Cranial nerve paralysis
HP:0000824,Decreased response to growth hormone stimulation test
HGNC:9053,PLAUR
chembl:CHEMBL538798,CHEMBL538798
MONDO:0005113,bacterial infectious disease
chembl:CHEMBL80155,CHEMBL80155
chembl:CHEMBL604664,CHEMBL604664
chembl:CHEMBL191003,JNJ-7706621
chembl:CHEMBL164,MYRICETIN
HGNC:6297,KCNQ3
chembl:CHEMBL1200425,PARGYLINE HYDROCHLORIDE
chembl:CHEMBL878,METOLAZONE
HGNC:1078,BMPR2
HP:0012174,Glioblastoma multiforme
HGNC:30546,FDX2
MONDO:0009698,Unverricht-Lundborg syndrome
HP:0007549,Desquamation of skin soon after birth
CHEBI:16857,L-threonine
MONDO:0004699,gastrointestinal lymphoma
HGNC:15446,PRPF31
HGNC:12974,RNF113A
MONDO:0002938,metatypical basal cell carcinoma
HP:0003577,Congenital onset
MONDO:0001763,ethmoid sinus cancer
HGNC:7773,NF2
HGNC:6407,KRAS
MONDO:0019218,inborn disorder of bile acid synthesis
chembl:CHEMBL30816,DICHLOROISOPROTERENOL
GO:0004674,protein serine/threonine kinase activity
HGNC:11190,SOX10
HGNC:17805,DIRC3
MONDO:0000108,"bacteremia, susceptibility"
HGNC:8768,AIFM1
HP:0000549,Abnormal conjugate eye movement
chembl:CHEMBL3545032,PF-04634817
Reactome:R-CEL-71403,Citric acid cycle (TCA cycle)
HGNC:753,ASNS
HGNC:8599,PANX1
HGNC:14336,PLEKHA2
chembl:CHEMBL303958,CHEMBL303958
HGNC:6117,IRF2
chembl:CHEMBL1078983,AZD-2014
HP:0007843,Attenuation of retinal blood vessels
MONDO:0019216,inborn disorder of amino acid transport
chembl:CHEMBL967,TEMAZEPAM
HP:0031004,Hemiareflexia
chembl:CHEMBL1200874,"TOLBUTAMIDE SODIUM, STERILE"
HGNC:27683,ALKAL2
HGNC:25473,KANSL3
MONDO:0002947,adamantinoid basal cell epithelioma
MONDO:0024607,congenital muscular dystrophy with cataracts and intellectual disability
chembl:CHEMBL1214407,CHEMBL1214407
HGNC:4067,GABARAP
WB:WBGene00006411,octr-1
MONDO:0005153,cervical adenocarcinoma
MONDO:0003689,familial hemolytic anemia
chembl:CHEMBL85,RISPERIDONE
GO:0044877,protein-containing complex binding
chembl:CHEMBL3989682,BECAMPANEL
MONDO:0004187,nodular fasciitis
MONDO:0016418,"multiple system atrophy, cerebellar type"
HGNC:17996,NAGS
chembl:CHEMBL414357,EXENATIDE
GO:0020016,ciliary pocket
MONDO:0011781,spinocerebellar ataxia type 17
NCBIGene:504261,CAD
HP:0001396,Cholestasis
GO:0120041,positive regulation of macrophage proliferation
chembl:CHEMBL227959,CHEMBL227959
HP:0030219,Semantic dementia
CHEBI:71337,minocycline(1-)
CHEBI:2682,amphotericin B
chembl:CHEMBL605077,CHEMBL605077
HP:0100543,Cognitive impairment
HGNC:164,ACTN2
WB:WBGene00012340,dct-15
HGNC:10992,SLC25A6
CHEBI:142544,tamsulosin(1+)
chembl:CHEMBL1200703,CHLORDIAZEPOXIDE HYDROCHLORIDE
HGNC:9154,PNKP
HGNC:11630,HNF1B
HGNC:4803,HADHB
HGNC:7737,NEFH
MONDO:0012321,Alzheimer disease 10
UBERON:0002581,postcentral gyrus
chembl:CHEMBL443684,NAVITOCLAX
chembl:CHEMBL1405979,CHEMBL1405979
chembl:CHEMBL17289,CHS-828
HGNC:60,ABCC9
HP:0010831,Impaired proprioception
chembl:CHEMBL1491099,GANGALEOIDIN
HP:0000571,Hypometric saccades
chembl:CHEMBL501867,VINCRISTINE SULFATE
HP:0002333,Motor deterioration
HGNC:19089,SLC30A5
HGNC:9262,PPIL3
chembl:CHEMBL2105732,LEVOMILNACIPRAN HYDROCHLORIDE
CHEBI:34999,teicoplanin A3-1
CL:0000019,sperm
WB:WBGene00000199,arx-1
chembl:CHEMBL3545071,SERIBANTUMAB
HGNC:14064,HDAC6
MONDO:0011451,"cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1"
HGNC:90,ACADS
HP:0000618,Blindness
HP:0003326,Myalgia
CHEBI:36063,oxytocic
chembl:CHEMBL476,DACARBAZINE
CHEBI:17688,(S)-nicotine
FB:FBgn0262559,Mdh2
MONDO:0005394,brain infarction
FB:FBgn0010100,mAcon1
CHEBI:15765,L-dopa
CHEBI:15356,cysteine
HGNC:29590,CTU1
UPHENO:0080957,absent social behavior
HP:0000347,Micrognathia
GO:0110165,cellular anatomical entity
HP:0031964,Elevated circulating alanine aminotransferase concentration
chembl:CHEMBL428647,PACLITAXEL
chembl:CHEMBL419296,ZOLANTIDINE
HGNC:2551,CUL1
chembl:CHEMBL3545151,CC-223
chembl:CHEMBL1611308,CHEMBL1611308
chembl:CHEMBL3545003,MSC-2363318A
CHEBI:35821,anticholesteremic drug
GO:1903491,response to simvastatin
HGNC:8876,PFKL
chembl:CHEMBL1980391,RG-1530
HP:0033228,Triceps areflexia
MONDO:0020674,vascular insufficiency disorder
HGNC:11450,SUCLG2
chembl:CHEMBL1408862,BRONOPOL
HGNC:29330,METTL14
HGNC:30551,TXNL4A
MONDO:1010000,pythiosis
HGNC:13797,PRX
HGNC:3437,ERCC5
MONDO:0007496,dystonia 12
chembl:CHEMBL1575,ESTRAMUSTINE
MONDO:0002271,colon adenocarcinoma
chembl:CHEMBL1517542,CHEMBL1517542
chembl:CHEMBL306764,CHEMBL306764
FB:FBgn0014028,SdhB
HGNC:10760,SET
MONDO:0004648,vascular dementia
HGNC:9942,PRPH2
chembl:CHEMBL1714,KETAMINE HYDROCHLORIDE
MONDO:0009141,torsion dystonia 2
MGI:107678,Slc5a1
CHEBI:28793,beta-D-glucan
CHEBI:18420,magnesium(2+)
chembl:CHEMBL3707400,INDANTADOL
HP:0007859,Congenital horizontal nystagmus
HP:0010862,Delayed fine motor development
MONDO:0020043,autosomal recessive congenital cerebellar ataxia
HGNC:18119,AFG2A
HGNC:783,ATF1
chembl:CHEMBL1852688,INFIGRATINIB
ZFIN:ZDB-GENE-040426-874,sdha
HGNC:92,ACADVL
HP:0020036,Upper limb dysmetria
HGNC:8010,NRXN3
RGD:1559857,Ahrr
MONDO:0012188,neuronal ceroid lipofuscinosis 9
HGNC:3073,DUSP7
HGNC:346,AHRR
HGNC:11919,CD40
HGNC:9788,RAB7A
HGNC:4118,GALK1
HP:0001265,Hyporeflexia
HGNC:9008,PKD1
HGNC:7173,MMP3
HP:0002313,Spastic paraparesis
HGNC:16993,SEC61B
HP:0000843,Hyperparathyroidism
FB:FBgn0004573,5-HT7
UPHENO:0088436,abnormality of tarsal region physiology
Reactome:R-HSA-3214841,PKMTs methylate histone lysines
chembl:CHEMBL164660,PSORALEN
HGNC:19681,DUSP13B
HGNC:7694,NDUFAB1
HGNC:11655,TCP1
MONDO:0100035,structural epilepsy
HGNC:1864,CES2
MONDO:0002495,colon signet ring cell adenocarcinoma
UPHENO:0078005,decreased reflex in jaw muscle
HP:0007351,Upper limb postural tremor
UBERON:0001156,ascending colon
HGNC:10440,RPS7
HGNC:4922,HK1
chembl:CHEMBL1084546,PF-00562271
HP:0041051,Ageusia
FB:FBgn0038063,Octβ2R
MGI:1345143,Pde10a
chembl:CHEMBL2103863,ABEXINOSTAT
HP:0000735,Impaired social interactions
HP:0003324,Generalized muscle weakness
chembl:CHEMBL3544911,PREXASERTIB
HGNC:9688,CAVIN1
HGNC:10362,RPL6
CHEBI:38582,difluorobenzene
CHEBI:36141,quinone
HGNC:3076,DUSP9
HGNC:13919,BAG6
HGNC:2039,CLDN18
chembl:CHEMBL738,THIOPENTAL SODIUM
HGNC:25890,TMEM25
HP:0002599,Head titubation
MONDO:0004286,pancreatic intraductal papillary-mucinous neoplasm
HP:0005957,Breathing dysregulation
chembl:CHEMBL391997,CAPSAZEPINE
HGNC:26244,CEP97
chembl:CHEMBL1684984,PA-799
chembl:CHEMBL48166,HOMIDIUM
MONDO:0002851,mediastinum rhabdomyosarcoma
chembl:CHEMBL2216870,IDELALISIB
chembl:CHEMBL1254091,CHEMBL1254091
HGNC:17821,DDX39A
HGNC:20952,TMEM14C
MONDO:0012103,spinocerebellar ataxia type 25
HP:0001419,X-linked recessive inheritance
NCBITaxon:2697049,Severe acute respiratory syndrome coronavirus 2
HP:0031763,Cyclic esotropia
FB:FBgn0004396,CrebA
HP:0000721,Lack of spontaneous play
MONDO:0003335,chronic polyneuropathy
HP:0033202,Brachioradialis hyporeflexia
CHEBI:131609,pneumocandin B0
chembl:CHEMBL276473,4'-HYDROXYCHALCONE
NCBIGene:615979,COX16
chembl:CHEMBL486816,HARMALOL HYDROCHLORIDE
GO:0001578,microtubule bundle formation
HGNC:16916,CLEC10A
chembl:CHEMBL4297485,CFG-920
HGNC:7693,NDUFA9
chembl:CHEMBL750,ZONISAMIDE
UPHENO:0088329,abnormally decreased number of neuron in the basal ganglion
chembl:CHEMBL107498,DECANOIC ACID
HP:0012675,Iron accumulation in brain
GO:0004359,glutaminase activity
MONDO:0100340,Friedreich ataxia 1
HGNC:20692,TPH2
HGNC:10405,RPS20
MGI:1277959,Dlg4
HGNC:20093,ADSS1
HGNC:5394,CFI
MONDO:0019500,extragonadal teratoma
CHEBI:75954,vancomycin aglycone zwitterion
MONDO:0006424,soft tissue neoplasm
HGNC:19016,TRIM44
NCBIGene:614700,COX6C
chembl:CHEMBL1440119,IRIGINOL HEXAACEATATE
HGNC:443,ALS2
HGNC:24666,FAF2
chembl:CHEMBL122972,2-ARACHIDONOYLGLYCEROL
UPHENO:0047459,dysgenesis of the corpus callosum
chembl:CHEMBL592068,CHEMBL592068
HGNC:9969,RFC1
HP:0002436,Occipital meningocele
chembl:CHEMBL601146,CHEMBL601146
HGNC:14339,PLEKHA4
chembl:CHEMBL41355,EZOGABINE
HGNC:7865,NODAL
MONDO:0008938,early-onset cerebellar ataxia with retained tendon reflexes
HP:0007325,Generalized dystonia
HGNC:12475,UBE2D2
HP:0008897,Postnatal growth retardation
chembl:CHEMBL715,OLANZAPINE
wikidata:Q21044462,DEL-22379
chembl:CHEMBL2431768,LCL-161
MONDO:0001429,transient arthropathy
chembl:CHEMBL602763,CHEMBL602763
NCBIGene:420624,CYCS
HP:0007024,Pseudobulbar paralysis
HP:0001642,Pulmonic stenosis
chembl:CHEMBL1237023,DENOSUMAB
chembl:CHEMBL388757,N6-BENZYLADENOSINE
MONDO:0015002,"developmental and epileptic encephalopathy, 49"
HGNC:1033,BDNF
NCBIGene:475739,COX7A2L
chembl:CHEMBL3545085,XL-228
chembl:CHEMBL3545419,TELISOTUZUMAB
HGNC:14203,JPH3
HGNC:11142,SIK1
chembl:CHEMBL2182009,CHEMBL2182009
chembl:CHEMBL593254,CHEMBL593254
HGNC:28572,FRMPD2
MONDO:0006704,CNS demyelinating autoimmune disease
HGNC:28881,PATJ
HP:0001319,Neonatal hypotonia
HP:0002870,Obstructive sleep apnea
chembl:CHEMBL516616,CHEMBL516616
GO:0031091,platelet alpha granule
chembl:CHEMBL452,CLONAZEPAM
HP:0003204,Intracellular accumulation of autofluorescent lipopigment storage material
MONDO:0011706,Kufor-Rakeb syndrome
HGNC:119,ACOX1
chembl:CHEMBL105310,"2',4'-DIHYDROXYCHALCONE"
MONDO:0002923,uterine corpus endometrial stromal sarcoma
GO:0042802,identical protein binding
HGNC:5175,AGFG1
HP:0000016,Urinary retention
CHEBI:58297,glutathione disulfide(2-)
GO:0017085,response to insecticide
CHEBI:24373,glycine derivative
HGNC:17597,NCDN
chembl:CHEMBL588028,CHEMBL588028
HGNC:6763,MAD2L1
chembl:CHEMBL1398631,LAURYL ISOQUINOLINIUM
CHEBI:22729,benzoquinones
WB:WBGene00014097,ZK829.9
HP:0007109,Periventricular cysts
GO:0006302,double-strand break repair
HGNC:11868,TRAPPC10
HP:0000297,Facial hypotonia
GO:0150034,distal axon
CHEBI:41774,tamoxifen
chembl:CHEMBL3644587,2X-121
chembl:CHEMBL8145,DAIDZEIN
CHEBI:192486,ciprofloxacin(1+)
chembl:CHEMBL551842,LOBARIC ACID
HGNC:12799,WWOX
HGNC:7582,MYL1
MONDO:0010983,dystonia 9
HGNC:4079,GABRA5
HP:0000822,Hypertension
MONDO:0018213,hereditary sensory and autonomic neuropathy type 1
HP:0001955,Unexplained fevers
chembl:CHEMBL4297181,SAMOTOLISIB
HP:0001310,Dysmetria
HGNC:144,ACTG1
MONDO:0032814,"microangiopathy and leukoencephalopathy, pontine, autosomal dominant"
chembl:CHEMBL450786,PHA-665752
chembl:CHEMBL281622,CP-339818
HP:0030765,Sleep terror
MGI:106913,Abi2
HGNC:9787,KIF20A
CHEBI:57292,succinyl-CoA(5-)
HGNC:30747,COPS2
MONDO:0020841,neurodevelopmental disorder with cerebellar atrophy and with or without seizures
chembl:CHEMBL17127,SCH-58261
GO:0006836,neurotransmitter transport
HGNC:29427,SH3TC2
CHEBI:4139,D-galactopyranose
HP:0002062,Morphological abnormality of the pyramidal tract
HGNC:3430,ERBB2
MONDO:0002746,fallopian tube adenocarcinoma
MONDO:0003441,dystonic disorder
HGNC:16704,SLC17A7
HGNC:16768,GRIN3B
chembl:CHEMBL972,SELEGILINE
HGNC:15559,CHCHD10
HP:0003542,Increased serum pyruvate
HGNC:5387,IDI1
GO:0042908,xenobiotic transport
HGNC:6176,ITPA
chembl:CHEMBL3544983,TESEVATINIB
HP:0002757,Recurrent fractures
CHEBI:35476,antipsychotic agent
HGNC:9086,PLP1
UPHENO:0080597,abnormal physical aggression behavior
HGNC:2665,CD55
chembl:CHEMBL1179743,CHEMBL1179743
HGNC:25443,C19orf12
HP:0006866,Midline central nervous system lipomas
MONDO:0010041,Charlevoix-Saguenay spastic ataxia
chembl:CHEMBL88272,CHEMBL88272
HP:0040322,Purple urine
HGNC:3708,VEGFD
HGNC:30760,TMEM165
HGNC:18258,VEZT
chembl:CHEMBL8618,NAN-190
HP:0025401,Staring gaze
HGNC:4638,GSTP1
HGNC:14559,STOML2
chembl:CHEMBL2036119,CHEMBL2036119
HGNC:17780,ACTBL2
HGNC:9816,RAD50
HGNC:31369,TOMM5
HP:0012379,Abnormal circulating enzyme concentration or activity
MONDO:0007164,spastic ataxia 1
chembl:CHEMBL612,DEXTROAMPHETAMINE
HGNC:949,BAK1
HGNC:14938,PIGT
Reactome:R-DDI-71403,Citric acid cycle (TCA cycle)
MONDO:0958233,Bethlem myopathy 1B
GO:0015911,long-chain fatty acid import across plasma membrane
HP:0000817,Reduced eye contact
MONDO:0013188,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3"
CHEBI:35610,antineoplastic agent
MONDO:0002291,cutaneous granular cell tumor
HP:0003470,Paralysis
chembl:CHEMBL41286,DIACEREIN
HP:0002664,Neoplasm
HGNC:28852,SYCE1
CHEBI:26789,streptothricin
HP:0034206,Abnormal fetal central nervous system morphology
HP:0007054,Proximal hyperreflexia
HGNC:6990,MECP2
MONDO:0018256,acute myeloid leukemia with t(8;16)(p11;p13) translocation
CHEBI:26255,prenylquinone
CHEBI:16113,cholesterol
chembl:CHEMBL53628,DESMOSDUMOTIN C
HGNC:961,BAZ1B
chembl:CHEMBL1536,ERGOCALCIFEROL
HGNC:15476,DYNLL1
chembl:CHEMBL1438439,IRIGENOL
HGNC:9758,RAB1A
HGNC:7526,MMUT
MONDO:0004975,Alzheimer disease
HGNC:396,ALAS1
HP:0002198,Dilated fourth ventricle
HGNC:823,ATP5F1A
MONDO:0009747,mitochondrial DNA depletion syndrome 6 (hepatocerebral type)
HGNC:18683,EIF4A3
HP:0001511,Intrauterine growth retardation
CHEBI:46915,sarcosinate
UBERON:0000159,anal canal
MONDO:0011663,juvenile primary lateral sclerosis
HGNC:14256,BRPF3
chembl:CHEMBL571546,KX2-391
HP:0001269,Hemiparesis
MONDO:0012432,Joubert syndrome 5
HGNC:13607,FBXW11
chembl:CHEMBL1519374,CHEMBL1519374
HGNC:6296,KCNQ2
HGNC:6896,MARK1
MONDO:0004766,status asthmaticus
UPHENO:0081742,increased reflex in patella
HGNC:19012,CORIN
CHEBI:32688,D-argininate
HGNC:23302,HKDC1
HGNC:21495,KIF12
HP:0002058,Myopathic facies
MONDO:0014285,congenital dyserythropoietic anemia type type 1B
MONDO:0006162,colorectal neuroendocrine tumor G1
HGNC:367,AKAP1
HGNC:23663,VKORC1
Reactome:R-DME-390666,Serotonin receptors
chembl:CHEMBL333826,DEQUALINIUM
HGNC:6387,KLC1
HGNC:11100,SMARCA4
HGNC:9407,PRKD1
MONDO:0007193,primary biliary cholangitis 1
GO:0097180,serine protease inhibitor complex
chembl:CHEMBL2107881,REGRAMOSTIM
chembl:CHEMBL1241268,CHEMBL1241268
MONDO:0700217,neonatal sepsis
HP:0001903,Anemia
chembl:CHEMBL2108336,LIXISENATIDE
MONDO:0018585,pediatric arterial ischemic stroke
HGNC:29823,MYL6B
HGNC:7527,MUTYH
chembl:CHEMBL506538,TRIPHENYLSTANNANOL
HP:0030187,Titubation
HGNC:738,ASCL1
chembl:CHEMBL537,HYDROQUINONE
HGNC:6210,CD82
chembl:CHEMBL2133806,JNJ-38877605
HP:0045084,Limb myoclonus
HGNC:7553,MYC
HGNC:3120,E2F6
HP:0000097,Focal segmental glomerulosclerosis
HP:0001765,Hammertoe
chembl:CHEMBL609606,CHEMBL609606
MONDO:0000200,Zimmermann-Laband syndrome
HGNC:28817,LRRC59
chembl:CHEMBL1358,FULVESTRANT
chembl:CHEMBL257158,CHEMBL257158
HGNC:9976,TRIM13
MONDO:0003541,adult acute lymphoblastic leukemia
chembl:CHEMBL2368925,DOLASETRON
MONDO:0011156,progressive familial intrahepatic cholestasis type 2
GO:0009743,response to carbohydrate
chembl:CHEMBL46286,OMACETAXINE MEPESUCCINATE
HGNC:12500,UBE4B
HGNC:9218,POU4F1
CHEBI:35344,21-hydroxy steroid
MONDO:0013056,"developmental and epileptic encephalopathy, 39"
HP:0025236,Somnambulism
ZFIN:ZDB-GENE-050522-377,ndufa2
chembl:CHEMBL283754,CINALUKAST
HGNC:9380,PRKACA
HGNC:8609,PARN
GO:0016068,type I hypersensitivity
CHEBI:171664,antiamoebic agent
HGNC:8157,SIGMAR1
MONDO:0012700,"renal tubular acidosis, distal, 4, with hemolytic anemia"
Xenbase:XB-GENE-955485,nqo1
chembl:CHEMBL225071,RALTITREXED
HGNC:7463,MTNR1A
chembl:CHEMBL837,7-ETHYL-10-HYDROXYCAMPTOTHECIN
CHEBI:59676,nystatins
chembl:CHEMBL2203843,CHEMBL2203843
MONDO:0016387,mitochondrial oxidative phosphorylation disorder
HP:0030810,Abnormal tongue physiology
ZFIN:ZDB-GENE-040625-168,ndufa1
HGNC:3214,EEF2
HGNC:25629,OTULINL
HGNC:11935,CD40LG
chembl:CHEMBL554,LAPATINIB
chembl:CHEMBL3244648,METHOTREXATE SODIUM
HGNC:711,ARRB1
chembl:CHEMBL2170369,CHEMBL2170369
WB:WBGene00000554,cnb-1
MONDO:0021085,gastric neoplasm
MONDO:0003864,chronic lymphocytic leukemia/small lymphocytic lymphoma
MONDO:0003090,extrahepatic bile duct carcinoma
MONDO:0016368,Rothmund-Thomson syndrome type 1
chembl:CHEMBL182,GANCICLOVIR
HP:0002401,Stroke-like episode
HP:0025352,Typically de novo
Reactome:R-HSA-390651,Dopamine receptors
HP:0000338,Hypomimic face
HP:0001943,Hypoglycemia
chembl:CHEMBL1519327,ZIRAM
HGNC:7864,EMC8
NCBITaxon:480418,Mycobacterium lepromatosis
chembl:CHEMBL242341,FORMONONETIN
HP:0001763,Pes planus
chembl:CHEMBL1454910,NITROXOLINE
UBERON:0005343,cortical plate
chembl:CHEMBL7568,QUINACRINE
CHEBI:146260,spectinomycin(1+)
HP:0000556,Retinal dystrophy
HP:0002511,Alzheimer disease
HGNC:20738,SYVN1
HP:0032005,Hemidystonia
CHEBI:16581,pregnenolone
NCBITaxon:2,Bacteria
chembl:CHEMBL159,VINBLASTINE
chembl:CHEMBL1200980,ESTROPIPATE
CHEBI:57288,acetyl-CoA(4-)
HGNC:1424,CAD
HGNC:30100,PSENEN
chembl:CHEMBL580609,CHEMBL580609
HGNC:819,ATP4A
HGNC:7441,MTIF2
Reactome:R-BTA-390651,Dopamine receptors
HGNC:25222,ERLEC1
HP:0000154,Wide mouth
chembl:CHEMBL254348,GRAMINE
HP:0002354,Memory impairment
HGNC:349,AHSG
HGNC:2592,CYP11B2
MONDO:0044787,nasal cavity and paranasal sinus squamous cell carcinoma
HGNC:2148,CNGA1
MONDO:0000402,small cell carcinoma
HGNC:11103,SMARCB1
HGNC:4092,GAD1
HP:0007326,Progressive choreoathetosis
HGNC:3098,TOR1A
HP:0011008,Temporal pattern
HGNC:4829,HBD
HGNC:4766,H3C1
HGNC:11701,CRIPTO
HGNC:8001,NRIP1
HP:0031954,Dystonic gait
HGNC:2291,COX7B
HP:0003759,Hypoplasia of lymphatic vessels
HGNC:6182,ITPR3
MONDO:0002093,acanthoma
HP:0002102,Pleuritis
chembl:CHEMBL247920,CHEMBL247920
HP:0001967,Diffuse mesangial sclerosis
chembl:CHEMBL448515,"2,6-DIMETHOXYQUINONE"
HP:0005946,Ventilator dependence with inability to wean
chembl:CHEMBL359744,DOXORUBICIN HYDROCHLORIDE
MONDO:0032750,"arthrogryposis, distal, type 2B2"
chembl:CHEMBL602213,CHEMBL602213
HGNC:864,ATP6V1G1
HGNC:8801,PDGFC
HGNC:20156,JPH4
HGNC:4195,GCK
HGNC:14620,TES
HGNC:1618,CCT5
MONDO:0003011,mucinous tubular and spindle renal cell carcinoma
MONDO:0012883,acute promyelocytic leukemia
MONDO:0019502,autosomal recessive non-syndromic intellectual disability
chembl:CHEMBL579045,CHEMBL579045
HP:0002079,Hypoplasia of the corpus callosum
HGNC:15888,RTEL1
WB:WBGene00019760,calu-1
chembl:CHEMBL597244,CHEMBL597244
GO:0005402,carbohydrate:monoatomic cation symporter activity
chembl:CHEMBL1615025,TAK-733
HGNC:10555,ATXN2
chembl:CHEMBL73151,TERGURIDE
HGNC:7500,MT-TV
HP:0009062,Infantile axial hypotonia
MONDO:0043218,neurovascular disorder
MONDO:0014019,dystonia 24
chembl:CHEMBL1409,FLUVOXAMINE MALEATE
GO:0003909,DNA ligase activity
HP:0002078,Truncal ataxia
ZFIN:ZDB-GENE-030131-1058,cs
HGNC:9888,RBBP5
CHEBI:61049,tacrolimus (anhydrous)
chembl:CHEMBL4298018,LY-3164530
HGNC:4055,XRCC6
HP:0003438,Absent Achilles reflex
UBERON:0013540,Brodmann (1909) area 9
chembl:CHEMBL572881,MOTESANIB
HGNC:9200,POLRMT
GO:0007595,lactation
HGNC:16468,LACTB
chembl:CHEMBL924,ZOLEDRONIC ACID
HP:0002384,Focal impaired awareness seizure
HGNC:2717,DDB1
MONDO:0957993,"progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 6"
chembl:CHEMBL471498,MITIGLINIDE
MONDO:0001241,transient neonatal neutropenia
MONDO:0000314,primary bacterial infectious disease
GO:0005324,long-chain fatty acid transporter activity
HP:0012547,Abnormal involuntary eye movements
HGNC:6846,MAP2K6
chembl:CHEMBL444109,GAMBOGIC AMIDE
HGNC:777,ZFHX3
CHEBI:315019,cilofungin
chembl:CHEMBL3545199,RG-7741
HGNC:3261,EIF2B5
chembl:CHEMBL195350,CHEMBL195350
chembl:CHEMBL371523,DIBENZOYLMETHANE
chembl:CHEMBL113,CAFFEINE
HP:0100725,Lichenification
HGNC:11007,SLC2A3
HP:0007346,Subcortical white matter calcifications
chembl:CHEMBL446567,CHEMBL446567
HP:0002578,Gastroparesis
HP:0031873,Early chronotype
HP:0001945,Fever
MONDO:0016486,beta-thalassemia major
MONDO:0004836,intravascular fasciitis
MONDO:0042980,Westphal disease
chembl:CHEMBL3990012,PEGAPAMODUTIDE
WB:WBGene00000416,ced-2
chembl:CHEMBL231616,TRIAPINE
chembl:CHEMBL601364,CHEMBL601364
HGNC:8630,PEBP1
MONDO:0003352,colon sarcoma
chembl:CHEMBL1201748,CABAZITAXEL
UBERON:0001535,vertebral artery
HGNC:2186,COL11A1
MONDO:0019544,cocaine intoxication
HGNC:3819,FOXO1
HP:0002015,Dysphagia
chembl:CHEMBL1303948,CHEMBL1303948
HP:0002123,Generalized myoclonic seizure
CHEBI:25105,macrolide antibiotic
MONDO:0017721,"Sandhoff disease, infantile form"
HGNC:30321,MPRIP
HGNC:2867,DHODH
HP:0100738,Abnormal eating behavior
chembl:CHEMBL301735,HOECHST 33258
WB:WBGene00006865,slcf-2
chembl:CHEMBL550011,CHLORPYRAMIN HYDROCHLORIDE
CHEBI:49302,2-hydroxy monocarboxylic acid
chembl:CHEMBL206834,BAFETINIB
CHEBI:139590,primary alpha-hydroxy ketone
FB:FBgn0039112,SdhD
chembl:CHEMBL2087337,VELUSETRAG
Reactome:R-DDI-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
chembl:CHEMBL1529609,CHEMBL1529609
HGNC:12586,UQCRC2
CHEBI:145565,macrolide lactam
chembl:CHEMBL336095,CHEMBL336095
chembl:CHEMBL41306,CNS-5161
MONDO:0013674,neurodegeneration with brain iron accumulation 4
HGNC:359,AIPL1
UPHENO:0075942,abnormal vestibular nerve
HGNC:18025,COA6
HGNC:3068,DUSP2
chembl:CHEMBL585591,CHEMBL585591
chembl:CHEMBL533293,CHEMBL533293
MONDO:0008767,neuronal ceroid lipofuscinosis 3
MONDO:0013359,familial hyperaldosteronism type III
HGNC:20038,DDX52
HGNC:2459,CSNK2A2
HGNC:3602,FBLN5
chembl:CHEMBL582715,CHEMBL582715
Reactome:R-CEL-390651,Dopamine receptors
CHEBI:38824,fluorocarbon
chembl:CHEMBL1983268,ENTRECTINIB
chembl:CHEMBL117,CHRYSIN
CHEBI:23527,cytochalasin B
FB:FBgn0000042,Act5C
UBERON:0001233,right adrenal gland
chembl:CHEMBL2022241,CHEMBL2022241
CHEBI:37941,clopidogrel
HGNC:5234,HSPA1L
CHEBI:16236,ethanol
MONDO:0018242,autoimmune hypoparathyroidism
chembl:CHEMBL284609,CHEMBL284609
HGNC:21208,WDR26
MONDO:0012173,long chain 3-hydroxyacyl-CoA dehydrogenase deficiency
HP:0000726,Dementia
chembl:CHEMBL430266,CALYCULIN A
Reactome:R-DME-71403,Citric acid cycle (TCA cycle)
MONDO:0005101,ulcerative colitis
HP:0007193,Bilateral tonic-clonic seizure on awakening
MONDO:0015452,Coffin-Siris syndrome
UBERON:0012336,perianal skin
OBA:1000400,
ZFIN:ZDB-GENE-040718-199,uqcrq
chembl:CHEMBL59990,MAFOSFAMIDE
HP:0030148,Heart murmur
HGNC:169,ACTR2
HGNC:16628,SLC49A4
chembl:CHEMBL1173055,RUCAPARIB
CL:0000842,mononuclear cell
CHEBI:18946,delta-lactone
HGNC:2911,DLST
chembl:CHEMBL1743024,GANITUMAB
HP:0011477,Upbeat nystagmus
chembl:CHEMBL3707402,PF-06372865
chembl:CHEMBL1370698,CHEMBL1370698
chembl:CHEMBL407,FLUMAZENIL
WB:WBGene00018964,F56D2.2
HGNC:25556,DNAJC17
HGNC:714,ARSB
HGNC:10420,RPS3
HGNC:693,ARL2
MONDO:0002254,syndromic disease
HGNC:6816,MAK
MONDO:0016318,progressive multifocal leukoencephalopathy
MONDO:0045048,toxemia of pregnancy
CHEBI:35346,11beta-hydroxy steroid
HGNC:1005,BCL7B
HGNC:12005,TPD52
HGNC:18039,KDM5B
HGNC:9302,PPP2R1A
CHEBI:9168,sirolimus
MONDO:0005125,borderline leprosy
MONDO:0014157,mandibular hypoplasia-deafness-progeroid syndrome
MONDO:0001617,transient global amnesia
HP:0007772,Impaired smooth pursuit
MONDO:0014024,hereditary spastic paraplegia 43
HGNC:8854,PEX12
HP:0007098,Paroxysmal choreoathetosis
GO:0022855,protein-N(PI)-phosphohistidine-glucose phosphotransferase system transporter activity
HP:0002134,Abnormal basal ganglia morphology
HGNC:7050,SCGB2A2
chembl:CHEMBL3545006,PWT-33587
HGNC:12635,UTRN
chembl:CHEMBL12131,CLOSANTEL
chembl:CHEMBL1421,DASATINIB
HP:0006460,Increased laxity of ankles
MONDO:0002867,pancreatic cystadenocarcinoma
HGNC:1426,CADPS
chembl:CHEMBL262083,N6-PHENYLADENOSINE
GO:0033574,response to testosterone
HP:0012758,Neurodevelopmental delay
CHEBI:15422,ATP
HP:0008640,Congenital macroorchidism
chembl:CHEMBL4,OFLOXACIN
HGNC:19297,TNK2
HGNC:21957,KCTD7
chembl:CHEMBL1200558,BACITRACIN
chembl:CHEMBL178,DAUNORUBICIN
GO:0000002,mitochondrial genome maintenance
MONDO:0005127,lepromatous leprosy
Reactome:R-DRE-500753,Pyrimidine biosynthesis
GO:0004088,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity
MONDO:0024651,corticosteroid-induced osteoporosis
HGNC:4402,GNG10
MONDO:0002463,lacrimal gland carcinoma
HGNC:4669,GTPBP1
HGNC:17383,HRH4
chembl:CHEMBL679,EPINEPHRINE
chembl:CHEMBL465339,MUNDULONE
HGNC:2553,CUL3
chembl:CHEMBL490,PAROXETINE
HGNC:12682,VEGFC
MONDO:0800330,"myoclonic epilepsy, juvenile, 2"
HP:0007302,Bipolar affective disorder
HGNC:11161,SNRPE
HP:0001287,Meningitis
chembl:CHEMBL294264,PURPURIN
HGNC:238,ADCY7
HGNC:15586,LRRC4
chembl:CHEMBL1472891,CHEMBL1472891
HGNC:24953,HEXIM1
HGNC:19102,RIGI
HGNC:7226,MPZL1
HGNC:28116,CPTP
HP:0003355,Aminoaciduria
HGNC:16389,HSPBAP1
chembl:CHEMBL276727,IODOACETAMIDE
NCBIGene:478639,NDUFB5
MONDO:0003650,mixed hepatoblastoma
chembl:CHEMBL602150,CHEMBL602150
ECTO:0000509,
HP:0033526,Limited ankle dorsiflexion
RGD:68434,Pde10a
chembl:CHEMBL1476605,CLOFOCTOL
MONDO:0016160,X-linked intellectual disability-epilepsy syndrome
MONDO:0011497,hereditary North American Indian childhood cirrhosis
HGNC:19743,POMT2
HGNC:20778,TUBB
chembl:CHEMBL321582,BUCINDOLOL
Xenbase:XB-GENE-1016087,cyb5b
HP:0001268,Mental deterioration
HP:0003477,Peripheral axonal neuropathy
HGNC:3763,FLT1
HGNC:6700,LRP8
HP:0007052,Multifocal cerebral white matter abnormalities
HGNC:6973,MDM2
HGNC:1260,CFAP410
HGNC:26267,POMK
chembl:CHEMBL184412,DRONEDARONE
HP:0001289,Confusion
GO:0035579,specific granule membrane
chembl:CHEMBL260342,CHEMBL260342
HGNC:560,AP1S2
HP:0020206,Simple ear
ZFIN:ZDB-GENE-040428-2,actr3
CHEBI:142348,hexahydronaphthalenes
CHEBI:17076,streptomycin
HGNC:9716,PXMP2
HGNC:3091,DYRK1A
MONDO:0002009,major depressive disorder
MONDO:0018467,nephropathic infantile cystinosis
MONDO:0011025,Cayman type cerebellar ataxia
CHEBI:20156,3-oxo-Delta(1) steroid
HGNC:25084,TMEM116
chembl:CHEMBL388342,BOLDINE
chembl:CHEMBL1566650,ACACETIN DIACETATE
MONDO:0030360,"cholestasis, progressive familial intrahepatic, 6"
chembl:CHEMBL2094573,CHEMBL2094573
GO:0007268,chemical synaptic transmission
chembl:CHEMBL1348974,(4-CHLOROPHENYL)(MORPHOLINO)METHANETHIONE
GO:0019838,growth factor binding
HGNC:15864,RBCK1
chembl:CHEMBL45029,MEPHOBARBITAL
chembl:CHEMBL13280,FLUNITRAZEPAM
MONDO:0006209,fibroblastic neoplasm
chembl:CHEMBL429335,CHEMBL429335
HP:0011448,Ankle clonus
GO:0015631,tubulin binding
chembl:CHEMBL1234354,PF-04691502
NCBIGene:476754,NDUFS7
chembl:CHEMBL453,SULFISOXAZOLE
chembl:CHEMBL1725279,SP-600125
UBERON:0000988,pons
HP:0003401,Paresthesia
HP:0007364,Aplasia/Hypoplasia of the cerebrum
chembl:CHEMBL52347,"1,2-NAPHTHOQUINONE"
HGNC:17615,PCGF1
chembl:CHEMBL176045,FANCHININ
HGNC:7525,MUSK
chembl:CHEMBL546797,CHEMBL546797
chembl:CHEMBL3301610,ABEMACICLIB
MONDO:0002936,scrotum basal cell carcinoma
chembl:CHEMBL513994,PRX-08066
CHEBI:24532,organic heterocyclic compound
chembl:CHEMBL2109589,L19TNFA
MONDO:0023258,glycogen storage disease type 1 due to SLC37A4 mutation
HGNC:8778,PDE3A
HGNC:3383,STOM
HGNC:1769,CDIPT
chembl:CHEMBL1565133,SANGUINARINE SULFATE
CHEBI:59770,cyclic acetal
MONDO:0014638,Fanconi anemia complementation group T
HGNC:14111,GLOD4
chembl:CHEMBL493646,CUCURBITACIN D
CL:0002576,perineurial cell
HGNC:15456,MBTPS1
HGNC:18170,CMPK1
HGNC:17722,SPRED2
chembl:CHEMBL444376,CHEMBL444376
HGNC:24824,FZR1
chembl:CHEMBL305380,BUPRANOLOL
HGNC:9414,PRKG1
HGNC:14342,C1QTNF7
HGNC:12811,XK
CHEBI:43474,hydrogenphosphate
chembl:CHEMBL3301595,DASOTRALINE
HGNC:2518,CTNS
CHEBI:15414,S-adenosyl-L-methionine
MONDO:0036193,parkinsonism with polyneuropathy
MONDO:0007766,Morgagni-Stewart-Morel syndrome
HP:0031760,Non-accomodative esotropia
HP:0030051,Tip-toe gait
HGNC:3596,FAT2
HP:0003226,Rectilinear intracellular accumulation of autofluorescent lipopigment storage material
MONDO:0003644,cavernous hemangioma of colon
HGNC:1616,CCT3
HGNC:845,ATP5PD
HP:0007334,Bilateral tonic-clonic seizure with focal onset
chembl:CHEMBL578257,CHEMBL578257
UPHENO:0084533,hypertrophic muscle of neck
chembl:CHEMBL1320139,HELIOMYCIN
HGNC:18116,KHDRBS1
NCBIGene:426488,NDUFV2
HP:0010546,Muscle fibrillation
CHEBI:32696,argininium(1+)
HGNC:11317,SSBP1
HGNC:6954,MCPH1
GO:0001666,response to hypoxia
chembl:CHEMBL1765371,CHEMBL1765371
chembl:CHEMBL27577,SALICYLAMIDE
chembl:CHEMBL1256813,CHEMBL1256813
HGNC:28487,GOT1L1
NCBIGene:428252,DRD2
HGNC:11164,SNRPN
HGNC:57,ABCC6
chembl:CHEMBL1170485,CHEMBL1170485
HGNC:12155,TRB
HGNC:11535,TAF1
HGNC:11648,TCL1A
HGNC:28161,DUSP26
chembl:CHEMBL562,GRISEOFULVIN
GO:0051082,unfolded protein binding
HGNC:19988,ANAPC1
MONDO:0008136,isolated optic nerve hypoplasia
CHEBI:32681,L-argininate
chembl:CHEMBL116548,CHEMBL116548
GO:0045202,synapse
HGNC:11782,TH
HGNC:25402,OTUD5
chembl:CHEMBL283552,FLUOROSALAN
chembl:CHEMBL6995,PRACTOLOL
MGI:1349765,Rcn2
HP:0034353,Appendicular spasticity
CHEBI:34994,teicoplanin A2
HGNC:8881,PFN1
HGNC:7856,NQO2
MONDO:0032817,"neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies"
chembl:CHEMBL124706,PHTHALAZINONE
chembl:CHEMBL726,FLUPHENAZINE
chembl:CHEMBL126804,CHEMBL126804
HGNC:2898,DLD
HGNC:5291,HTR1E
HGNC:6847,MAP2K7
Reactome:R-DRE-390651,Dopamine receptors
HGNC:6255,KCNJ1
HGNC:19832,CLEC14A
HGNC:11359,STAR
HP:0002555,Absent pubic hair
chembl:CHEMBL473074,CYCLOASPEPTIDE A
HGNC:7989,NRAS
HGNC:8979,PIK3R1
chembl:CHEMBL314010,BEVANTOLOL
HGNC:17635,CD274
MONDO:0011327,neuronal intranuclear inclusion disease
MONDO:0014604,Parkinson disease 21
MONDO:0024295,skin disease caused by bacterial infection
HGNC:15522,KCNIP2
HGNC:12022,TPT1
HGNC:17992,TRPM3
HGNC:11837,TLE1
MONDO:0002651,anal Paget disease
HP:0002549,Deficit in phonologic short-term memory
chembl:CHEMBL190,THEOPHYLLINE
HGNC:6229,KCNAB2
HP:0012170,Nail-biting
HGNC:17631,POLR1E
HP:0001561,Polyhydramnios
HGNC:30309,RER1
HGNC:12565,UNC119
chembl:CHEMBL661,ALPRAZOLAM
CHEBI:38940,sunitinib
HGNC:2451,CSNK1A1
HGNC:23251,AWAT2
chembl:CHEMBL567,PERPHENAZINE
chembl:CHEMBL2043437,GLASDEGIB
HGNC:23641,NIPSNAP3B
HGNC:19181,KIF14
HGNC:17113,HIF1AN
HGNC:12667,VCX
HP:0003798,Nemaline bodies
chembl:CHEMBL2096631,CLORAZEPATE DIPOTASSIUM
HP:0004322,Short stature
chembl:CHEMBL3545143,SR-13668
GO:0006541,glutamine metabolic process
MONDO:0011401,Alzheimer disease without neurofibrillary tangles
chembl:CHEMBL1169388,CHEMBL1169388
chembl:CHEMBL78150,TYRPHOSTIN A9
HGNC:6643,LMO3
MONDO:0002546,schwannoma
HGNC:9547,PSMC1
MONDO:0002416,ethmoid sinus squamous cell carcinoma
chembl:CHEMBL572878,TOZASERTIB
HP:0001182,Tapered finger
MONDO:0005072,neuroblastoma
HP:0010530,Palatal tremor
GO:0005768,endosome
HGNC:237,ADCY6
chembl:CHEMBL1289,HALOPROGIN
HP:0007649,Congenital hypertrophy of retinal pigment epithelium
MONDO:0013584,hereditary sensory neuropathy-deafness-dementia syndrome
chembl:CHEMBL112060,CHEMBL112060
GO:0009060,aerobic respiration
chembl:CHEMBL72631,INDOMETHACIN MORPHOLINYLAMIDE
HGNC:6179,ITPKB
HGNC:5229,DNAJA1
chembl:CHEMBL89786,2-PHENYLQUINOLINE
chembl:CHEMBL421701,DITHIAZANINE IODIDE
MONDO:0014688,short-rib thoracic dysplasia 14 with polydactyly
HGNC:21050,CDKAL1
MONDO:0002277,arteriosclerosis disorder
chembl:CHEMBL605747,CHEMBL605747
MONDO:0016621,juvenile Huntington disease
chembl:CHEMBL548286,CHEMBL548286
CHEBI:7660,nystatin
chembl:CHEMBL275391,CHRYSIN DIMETHYL ETHER
MONDO:0012671,"tremor, hereditary essential, 3"
chembl:CHEMBL2108308,TERTOMOTIDE
MONDO:0011584,Fanconi anemia complementation group D1
HGNC:8583,SERPINE1
chembl:CHEMBL43452,POMALIDOMIDE
HGNC:30024,PEX5L
HGNC:12013,TPM4
MONDO:0012565,Fanconi anemia complementation group N
HP:0001583,Rotary nystagmus
HGNC:7566,MYF6
chembl:CHEMBL281211,ARACHIDONYL TRIFLUOROMETHYLKETONE
chembl:CHEMBL4209157,LIFIRAFENIB
HP:0003115,Abnormal EKG
chembl:CHEMBL222556,CHEMBL222556
MONDO:0003789,hereditary papillary renal cell carcinoma
chembl:CHEMBL94007,ETHACRIDINE
HP:0000649,Abnormality of visual evoked potentials
HP:0007263,Spinocerebellar atrophy
CHEBI:142676,ribozinoindole-1
chembl:CHEMBL1481974,CHEMBL1481974
chembl:CHEMBL261123,CHEMBL261123
chembl:CHEMBL603154,CHEMBL603154
MONDO:0005525,T-cell leukemia
MONDO:0021444,benign neoplasm of large intestine
HGNC:3530,F12
chembl:CHEMBL1079593,VS-5584
Reactome:R-DRE-71288,Creatine metabolism
HP:0100852,Abnormal fear/anxiety-related behavior
MONDO:0002815,acute myocarditis
chembl:CHEMBL468167,CHLOROTHALONIL
Reactome:R-GGA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
HP:0410219,Hypoplasia of mandible relative to maxilla
HGNC:6759,MARCKS
MONDO:0016547,Beckwith-Wiedemann syndrome due to NSD1 mutation
UBERON:0001697,orbit of skull
HP:0009891,Underdeveloped supraorbital ridges
HGNC:11134,SNAPC1
HGNC:1603,CCR2
ZFIN:ZDB-GENE-121031-5,slc2a3b
chembl:CHEMBL1078244,CHEMBL1078244
HP:0030953,Conjunctival hyperemia
chembl:CHEMBL239439,CHEMBL239439
CHEBI:8058,phencyclidine
chembl:CHEMBL388978,STAUROSPORINE
chembl:CHEMBL566757,DAPORINAD
Reactome:R-HSA-9022537,Loss of MECP2 binding ability to the NCoR/SMRT complex
chembl:CHEMBL3264610,SEVITERONEL
CHEBI:149548,emetine(2+)
CHEBI:4290,"1,1-dimethyl-4-phenylpiperazinium iodide"
HP:0003217,Hyperglutaminemia
HGNC:9678,PTPRO
HP:0025269,Panic attack
chembl:CHEMBL284348,DALFAMPRIDINE
chembl:CHEMBL576412,CHEMBL576412
MONDO:0013062,long QT syndrome 12
HGNC:10879,STIL
chembl:CHEMBL1851943,PRACINOSTAT
chembl:CHEMBL84010,CHEMBL84010
chembl:CHEMBL1736123,CINTAZONE
MONDO:0005621,vascular brain injury
MONDO:0042964,Machado-Joseph disease type 4
MGI:2156687,Slc2a10
HGNC:6764,MAD2L2
HP:0002415,Leukodystrophy
HGNC:25228,SGSM3
HGNC:9604,PTGS1
chembl:CHEMBL279998,ISONIPECOTIC ACID
HGNC:21699,CERKL
MONDO:0056797,neurodevelopmental disorder with midbrain and hindbrain malformations
chembl:CHEMBL1395579,CAPTAMINE
chembl:CHEMBL1201550,DENILEUKIN DIFTITOX
NCBIGene:508566,NQO2
HP:0034734,Elevated CSF argininosuccinic acid concentration
chembl:CHEMBL1401508,SILIBININ
HGNC:27638,SYPL2
CHEBI:61057,tacrolimus hydrate
MONDO:0004583,transient retinal arterial occlusion
chembl:CHEMBL150,KAEMPFEROL
MGI:96245,Hspa9
HGNC:16947,ERLIN1
GO:0006366,transcription by RNA polymerase II
chembl:CHEMBL2220486,LUCITANIB
HGNC:7723,NEDD1
HGNC:18649,GULP1
MONDO:0005096,squamous cell carcinoma
HGNC:3519,EYA1
HGNC:3706,ATP8B1
MONDO:0030513,dystonia 33
HP:0000298,Mask-like facies
chembl:CHEMBL1116,RALOXIFENE HYDROCHLORIDE
chembl:CHEMBL508112,BENZOTHIAZYL DISULFIDE
MONDO:0013270,"Rett syndrome, congenital variant"
HP:0012043,Pendular nystagmus
chembl:CHEMBL508779,CAULIBUGULONE B
WB:WBGene00008799,fdgt-2
chembl:CHEMBL599100,CHEMBL599100
chembl:CHEMBL386630,TESTOSTERONE
HP:0012762,Cerebral white matter atrophy
HGNC:5348,ICAM5
CHEBI:17754,glycerol
chembl:CHEMBL377300,BRIVANIB
MONDO:0014094,severe congenital hypochromic anemia with ringed sideroblasts
chembl:CHEMBL580421,CHEMBL580421
HGNC:9533,PSMA4
chembl:CHEMBL578515,CHEMBL578515
HGNC:2714,DCX
HP:0011147,Typical absence seizure
WB:WBGene00013074,hmit-1.2
NCBIGene:476722,NDUFA7
GO:0005356,glucose:proton symporter activity
HP:0030500,Yellow/white lesions of the macula
HP:0001263,Global developmental delay
HGNC:9664,PTPRA
MONDO:0019588,"hearing loss, autosomal recessive"
MONDO:0010543,Barth syndrome
CHEBI:29919,hydrosulfide
chembl:CHEMBL396609,MACROCARPAL A
chembl:CHEMBL284104,DIPICOLINIC ACID
HGNC:29682,GFM2
HGNC:17059,SACM1L
HGNC:1527,CAV1
HGNC:8794,PDE8B
MONDO:0003010,multilocular clear cell renal cell carcinoma
HGNC:12592,UROS
CHEBI:64618,phosphagen
HP:0006829,Severe muscular hypotonia
chembl:CHEMBL1439833,CHEMBL1439833
chembl:CHEMBL472,GLYBURIDE
chembl:CHEMBL1449007,2-(2'-METHOXYPHENYL)-1H-INDOLE
chembl:CHEMBL120563,THIRAM
HP:0002754,Osteomyelitis
chembl:CHEMBL60824,"4-AMINO-[1,2]NAPHTHOQUINONE"
MONDO:0018342,Joubert syndrome with Jeune asphyxiating thoracic dystrophy
CHEBI:146295,pyranobenzodioxin
Reactome:R-HSA-5610787,Hedgehog 'off' state
HGNC:3806,FOXE1
CHEBI:9948,verapamil
CHEBI:17823,calcitriol
HP:0012690,T2 hypointense thalamus
FB:FBgn0034756,Cyp6d2
HGNC:11403,STK24
MONDO:0800340,"seasonal affective disorder, susceptibility to"
MONDO:0015247,opsoclonus-myoclonus syndrome
HGNC:18664,FAM3C
chembl:CHEMBL289469,GRANISETRON
HGNC:29878,NIT2
HP:0002750,Delayed skeletal maturation
MONDO:0021736,proctosigmoiditis
HGNC:9376,PRKAA1
HGNC:10303,RPL13
HGNC:21555,EYS
HP:0030213,Emotional blunting
HP:0012462,Chin myoclonus
chembl:CHEMBL1642672,CHEMBL1642672
WB:WBGene00004259,pyr-1
HGNC:13083,ZBTB21
chembl:CHEMBL1235966,SCOULERINE
chembl:CHEMBL273891,CHEMBL273891
chembl:CHEMBL2103778,CILANSETRON
chembl:CHEMBL1389794,CHEMBL1389794
PomBase:SPAC630.03,arp3
HGNC:19737,TNS2
HGNC:16903,TNIP1
MONDO:0008458,spinocerebellar ataxia type 2
HGNC:6254,KCNH5
SGD:S000004636,ARP9
HP:0003826,Stillbirth
chembl:CHEMBL635,PREDNISONE
chembl:CHEMBL258465,CHEMBL258465
HGNC:14902,RAB6B
chembl:CHEMBL18797,SULINDAC SULFIDE
MONDO:0002159,fallopian tube leiomyosarcoma
chembl:CHEMBL1317986,CHEMBL1317986
chembl:CHEMBL2393130,APABETALONE
chembl:CHEMBL1431,METFORMIN
chembl:CHEMBL51483,GOSSYPOL
HGNC:1780,CDK9
chembl:CHEMBL578061,CHEMBL578061
chembl:CHEMBL465843,PIPLARTINE
HGNC:4827,HBB
chembl:CHEMBL577711,LY-2334737
chembl:CHEMBL15766,LY-255283
HP:0032491,Increased circulating argininosuccinic acid
HGNC:6083,INSIG1
chembl:CHEMBL585444,CHEMBL585444
chembl:CHEMBL310798,TYRPHOSTIN 25
chembl:CHEMBL3545252,DOCETAXEL
HGNC:10982,SLC25A12
HGNC:10819,SGTA
HP:0003805,Rimmed vacuoles
HGNC:1697,CD74
HGNC:492,ANK1
HGNC:30858,EFTUD2
HGNC:24667,MAPK15
chembl:CHEMBL4297067,FLUORESCEIN
HGNC:10050,RNASEL
HGNC:1725,CDC25A
HGNC:17563,METTL3
MGI:97360,Nos1
HGNC:7850,NME2
HGNC:9283,PPP1CC
CHEBI:16551,"alpha,alpha-trehalose"
HGNC:26053,THG1L
CHEBI:28697,21-deoxycortisol
MGI:105053,Hsph1
CHEBI:139588,alpha-hydroxy ketone
HP:0002356,Writer's cramp
chembl:CHEMBL25856,DIHYDREXIDINE
chembl:CHEMBL1490495,MECYSTEINE HYDROCHLORIDE
GO:0045893,positive regulation of DNA-templated transcription
chembl:CHEMBL88055,RIMITEROL
HGNC:17757,TNMD
MONDO:0012100,major depressive disorder 2
HGNC:2529,CTSD
chembl:CHEMBL1565322,NIHYDRAZONE
chembl:CHEMBL24944,TRIBROMSALAN
MONDO:0012204,familial pseudohyperkalemia
chembl:CHEMBL1077391,CHEMBL1077391
chembl:CHEMBL253551,FRAXIDIN METHYL ETHER
chembl:CHEMBL1554,DACTINOMYCIN
HGNC:6501,LAMP2
HGNC:21479,DCBLD1
MONDO:0014113,cardiofaciocutaneous syndrome 3
HGNC:2372,MED23
HP:0006812,White mater abnormalities in the posterior periventricular region
HGNC:14277,MRPL9
chembl:CHEMBL42,CLOZAPINE
MONDO:0007298,spinocerebellar ataxia type 29
MONDO:0006499,hamartoma
HGNC:406,ALDH4A1
chembl:CHEMBL215853,MONOCILLIN I
HGNC:289,GRK2
HGNC:3380,EPB41L3
chembl:CHEMBL1567,SUNITINIB MALATE
MONDO:0100054,idiopathic anaphylaxis
HGNC:9781,RAB4A
HGNC:14525,CHORDC1
Reactome:R-DME-500753,Pyrimidine biosynthesis
CHEBI:194499,oripavine(1+)
chembl:CHEMBL3545359,ARRY-300
MONDO:0018307,neurodegeneration with brain iron accumulation
chembl:CHEMBL1752,DYPHYLLINE
HGNC:23038,LMBRD1
HGNC:6843,MAP2K3
HGNC:9206,PON3
HP:0002521,Hypsarrhythmia
HGNC:16783,CDC73
MONDO:0014231,juvenile onset Parkinson disease 19A
HGNC:143,ACTC1
HGNC:2379,CRTAP
HGNC:9395,PRKCB
HGNC:11160,SNRPD3
HP:0010850,EEG with spike-wave complexes
HP:0011999,Paranoia
MGI:2181411,Slc5a2
HGNC:4847,HCRT
chembl:CHEMBL242080,E319
HGNC:25321,SHARPIN
HP:0000122,Unilateral renal agenesis
MONDO:0018760,DeSanto-Shinawi syndrome
chembl:CHEMBL1521,ZALEPLON
chembl:CHEMBL356388,ETAZOLATE
GO:0048018,receptor ligand activity
HGNC:12582,UQCRB
UBERON:0000397,colonic epithelium
HGNC:30262,PYCR2
chembl:CHEMBL1897483,TRIFLOXYSTROBIN
HP:0025668,Abnormal neck morphology
HGNC:11273,SPTAN1
chembl:CHEMBL1441961,SOFALCONE
HGNC:6021,IL6ST
HP:0007737,Bone spicule pigmentation of the retina
HGNC:25008,BABAM1
HP:0000657,Oculomotor apraxia
HGNC:11119,SMO
HP:0007002,Motor axonal neuropathy
HGNC:25773,WDR76
HP:0000736,Short attention span
HGNC:28781,MDP1
HGNC:10852,SHMT2
UPHENO:0079846,abnormal emotional behavior
HGNC:24887,PNPLA4
HGNC:9387,PRKAG3
HP:0008994,Proximal muscle weakness in lower limbs
chembl:CHEMBL1362503,CHEMBL1362503
chembl:CHEMBL138649,6-HYDROXYFLAVONE
MONDO:0007739,Huntington disease
GO:0007565,female pregnancy
chembl:CHEMBL86,METOCLOPRAMIDE
CHEBI:142517,tschimganine
HGNC:1497,CASK
MGI:95771,Gnai1
MGI:2653235,Slc45a1
HP:0009027,Foot dorsiflexor weakness
HGNC:282,ADRA2B
HP:0003828,Variable expressivity
HGNC:11522,TACC1
HP:0006896,Hypnopompic hallucinations
chembl:CHEMBL4298027,PRX-321
HGNC:10808,SGCE
chembl:CHEMBL1909354,GW459057A
HGNC:17366,AASS
HGNC:11257,SPR
HGNC:11641,TCF7L2
chembl:CHEMBL276832,HYDRALAZINE
HP:0002323,Anencephaly
HGNC:1815,CEACAM3
UBERON:0002245,cerebellar hemisphere
HGNC:6882,MAPK8IP1
chembl:CHEMBL15770,SULINDAC
HGNC:11741,TFAM
HP:0000508,Ptosis
MONDO:0006693,cerebral arterial disease
chembl:CHEMBL1200996,MEPHENTERMINE SULFATE
HGNC:3185,EEA1
MONDO:0017091,bilateral polymicrogyria
HP:0020045,Esodeviation
HP:0100786,Hypersomnia
Reactome:R-HSA-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL3545119,BMS-794833
HGNC:8125,OGG1
HGNC:2666,DAG1
HGNC:15528,CGRRF1
NCBIGene:474572,LRPPRC
HGNC:2084,CLPP
CHEBI:28498,acadesine
HGNC:18608,LRRK1
CHEBI:36699,corticosteroid hormone
MONDO:0005292,colitis
chembl:CHEMBL1708,PAROXETINE HYDROCHLORIDE
chembl:CHEMBL1144,PRAVASTATIN
chembl:CHEMBL1459280,CHEMBL1459280
chembl:CHEMBL261641,CHEMBL261641
CHEBI:37565,GTP(4-)
HGNC:11779,TGM3
HGNC:4283,GJB1
HP:0010818,Generalized tonic seizure
CHEBI:18409,(2S)-2-hydroxy-2-methyl-3-oxobutanoic acid
MONDO:0005929,postpartum depression
HGNC:28106,TMEM97
WB:WBGene00000247,bec-1
HP:0002539,Cortical dysplasia
HGNC:11185,SORL1
HP:0004325,Decreased body weight
chembl:CHEMBL3545324,RG-7666
CHEBI:57865,uridine 5'-monophosphate(2-)
chembl:CHEMBL1208572,SALINOMYCIN
chembl:CHEMBL526,PROPOFOL
MONDO:0015405,cerebrofacial arteriovenous metameric syndrome
CHEBI:38164,organic heteropentacyclic compound
HGNC:4616,GSK3A
chembl:CHEMBL3707219,REMETINOSTAT
chembl:CHEMBL709,ALFUZOSIN
HP:0002442,Dyscalculia
HGNC:10717,SEL1L
HGNC:21641,TSPAN12
MONDO:0015159,multiple congenital anomalies/dysmorphic syndrome-intellectual disability
HGNC:6188,JAG1
chembl:CHEMBL2146883,COBIMETINIB
HP:0001028,Hemangioma
HP:0410020,Fish odor
chembl:CHEMBL1489988,N-HISTIDYL-2-AMINONAPHTHALENE (BETANA)
chembl:CHEMBL24057,FURAMIDINE
HP:0033229,Brachioradialis areflexia
GO:0015755,fructose transmembrane transport
HP:0000158,Macroglossia
HGNC:1232,EGLN1
HP:0002406,Limb dysmetria
chembl:CHEMBL580207,CHEMBL580207
HGNC:28395,SGMS2
MGI:2145977,Dip2b
chembl:CHEMBL28721,CHEMBL28721
HGNC:18667,PMPCA
HGNC:10683,SDHD
HGNC:11506,SYP
chembl:CHEMBL1436860,DIMETHYL GAMBOGATE
HGNC:23116,SENP2
Xenbase:XB-GENE-5806705,cyp2a6.8
NCBIGene:615660,COX20
MONDO:0000315,commensal bacterial infectious disease
HGNC:3595,FAT1
